<SEC-DOCUMENT>0001641172-25-014324.txt : 20250609
<SEC-HEADER>0001641172-25-014324.hdr.sgml : 20250609
<ACCEPTANCE-DATETIME>20250609163021
ACCESSION NUMBER:		0001641172-25-014324
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250609
FILED AS OF DATE:		20250609
DATE AS OF CHANGE:		20250609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		251034507

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>

</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a) of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Securities Exchange Act of 1934 (Amendment No. )</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by the Registrant &#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by a Party other than the Registrant &#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT>&#9744;</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &#167;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>IMUNON, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
LENOX DRIVE, SUITE 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
NJ 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE HELD VIRTUALLY ON FRIDAY, JULY 11, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AT
10:00 A.M., EASTERN TIME</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
Our Stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
is hereby given that the annual meeting (the &#8220;Annual Meeting&#8221;) of the stockholders of IMUNON, INC., a Delaware corporation
(the &#8220;Company&#8221;), will be held at 10:00 a.m., local time, on Friday, July 11, 2025. You will be able to attend the Annual
Meeting, vote, and submit your questions during the meeting via live webcast through the link <B><I><FONT STYLE="text-decoration: underline">www.virtualshareholdermeeting.com/IMNN2025
</FONT></I></B>and entering your 16-digit control number included on your
proxy card or in the instructions that accompanied your proxy materials. We have adopted a virtual meeting format to expand access to
the meeting, improve communications and impose lower costs on our stockholders, the Company and the environment. We believe virtual meetings
enable increased stockholder participation from locations around the world. The Annual Meeting shall be held for the following purposes,
all as more fully described in the accompanying Proxy Statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect two Class III Directors to serve until the Annual Meeting of Stockholders in 2028 or until their successors are duly elected
    and qualified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the selection of WithumSmith+Brown PC as the Company&#8217;s independent registered public accounting firm for the fiscal
    year ending December 31, 2025;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT>To
    approve, by a non-binding advisory vote, the 2024 executive compensation for the Company&#8217;s Named Executive Officers;</FONT> </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">4)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock
underlying certain warrants issued by us pursuant to that certain Securities Purchase Agreement, dated as of May 23, 2025, by and among
us and certain institutional and accredited investors, and the Engagement Letter, between the Company and H.C. Wainwright &amp; Co., LLC,
dated as of May 22, 2025 (the &#8220;Issuance Proposal&#8221;);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">5)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">To approve an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to increase the
number of our authorized shares of common stock from 112,500,000 shares to 350,000,000 shares and to make a corresponding change to the
number of authorized shares of capital stock (the &#8220;Authorized Share Increase&#8221;);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to effect, at the discretion of our
    Board of Directors, a reverse stock split at a ratio between, and including, 1:5 and 1:18, with the exact ratio to be set within
    that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the &#8220;Reverse
    Stock Split&#8221;); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an Amendment to the IMUNON, INC. 2018 Stock Incentive Plan to increase the aggregate number of shares of common stock that
    may be delivered pursuant to all awards granted under the Plan; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve any adjournment or postponement of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient
    votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    consider and act upon any other matters that may properly come before the Annual Meeting or any adjournment or postponement thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The close of business on May 13, 2025 has been fixed as the record date
for the determination of stockholders of the Company entitled to notice of, and to vote at the Annual Meeting. Only stockholders of record
at the close of business on May 13, 2025 are entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
stockholders are cordially invited to attend the Annual Meeting. However, whether or not you expect to attend via the live webcast, please
complete, sign, date and return the enclosed Proxy Card as promptly as possible in the envelope provided for that purpose. Returning
your Proxy Card will ensure your representation and help to ensure the presence of a quorum at the Annual Meeting. Your proxy is revocable,
as set forth in the accompanying Proxy Statement. Therefore, you may attend the Annual Meeting and vote your shares via the live webcast
even if you send in your Proxy Card.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Susan Eylward</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                            9,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
    NJ</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
                                            Eylward</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Corporate Secretary</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YOUR
VOTE IS IMPORTANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PROXY STATEMENT IS FURNISHED IN CONNECTION WITH THE SOLICITATION OF PROXIES BY THE COMPANY, ON BEHALF OF THE BOARD OF DIRECTORS, FOR
THE 2025 ANNUAL MEETING OF STOCKHOLDERS. THE PROXY STATEMENT AND THE RELATED PROXY FORM ARE BEING DISTRIBUTED ON OR ABOUT JUNE 9,
2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YOU
CAN VOTE YOUR SHARES USING ONE OF THE FOLLOWING METHODS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPLETE
    AND RETURN A WRITTEN PROXY CARD</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTEND
    THE COMPANY&#8217;S 2025 ANNUAL MEETING OF STOCKHOLDERS VIA LIVE WEBCAST AND VOTE AT THE ANNUAL MEETING </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTE
    VIA THE INTERNET AT <FONT STYLE="text-decoration: underline">WWW.PROXYVOTE.COM </FONT></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTE
    BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING VOTING DOCUMENT</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALL
STOCKHOLDERS ARE CORDIALLY INVITED TO ATTEND THE MEETING. HOWEVER, TO ENSURE YOUR REPRESENTATION AT THE MEETING, YOU ARE URGED TO COMPLETE,
SIGN, DATE AND RETURN THE ACCOMPANYING PROXY CARD AS PROMPTLY AS POSSIBLE IN THE POSTAGE-PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR
SUBMIT YOUR VOTE VIA THE INTERNET AT <I><FONT STYLE="text-decoration: underline">WWW.PROXYVOTE.COM</FONT></I> OR VOTE BY PHONE BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING
VOTING DOCUMENT. ANY STOCKHOLDER ATTENDING THE MEETING VIA THE LIVE WEBCAST MAY VOTE EVEN IF YOU HAVE RETURNED A PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON FRIDAY, JULY 11, 2025. THE PROXY STATEMENT
AND OUR 2024 ANNUAL REPORT TO STOCKHOLDERS ARE AVAILABLE AT <I><FONT STYLE="text-decoration: underline">WWW.PROXYVOTE.COM</FONT>.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADDITIONALLY,
YOU CAN FIND A COPY OF OUR ANNUAL REPORT ON FORM 10-K, WHICH INCLUDES OUR FINANCIAL STATEMENTS, FOR THE FISCAL YEAR ENDED DECEMBER 31,
2024, ON THE WEBSITE OF THE SECURITIES AND EXCHANGE COMMISSION (THE &#8220;SEC&#8221;) AT WWW.SEC.GOV, OR UNDER &#8220;FINANCIAL INFORMATION&#8221;
IN THE &#8220;NEWS AND INVESTORS&#8221; SECTION OF OUR WEBSITE AT WWW.IMUNON.COM. YOU MAY ALSO OBTAIN A PRINTED COPY OF OUR ANNUAL REPORT
ON FORM 10-K, INCLUDING OUR FINANCIAL STATEMENTS, FREE OF CHARGE, FROM US BY SENDING A WRITTEN REQUEST TO: IMUNON, INC, 997 LENOX DRIVE,
SUITE 100, LAWRENCEVILLE, NJ 08648. EXHIBITS WILL BE PROVIDED UPON WRITTEN REQUEST AND PAYMENT OF AN APPROPRIATE PROCESSING FEE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_001">INFORMATION
    CONCERNING SOLICITATION AND VOTING</A></B></FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_002">BENEFICIAL
    OWNERSHIP OF COMMON STOCK</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_003">DELINQUENT
    SECTION 16(A) REPORTS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_004">DIRECTORS,
    EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_005">REPORT
    OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_006">EXECUTIVE
    AND DIRECTOR COMPENSATION</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_007">CERTAIN
    RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_008">PROPOSAL
    NO. 1: ELECTION OF DIRECTORS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_009">PROPOSAL
    NO. 2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_010">PROPOSAL
    NO. 3: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#Aa_011"><B>PROPOSAL NO. 4: APPROVAL OF THE ISSUANCE PROPOSAL</B></A></TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#Aa_017"><B>PROPOSAL NO. 5: APPROVAL OF THE AUTHORIZED SHARE INCREASE PROPOSAL</B></A></TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">42</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#Aa_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT STYLE="text-transform: uppercase">PROPOSAL NO. 6: Amendment to the Company&#8217;s Certificate of Incorporation, as amended, to effect a reverse stock split</FONT></B></FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">44</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A HREF="#Aa_012">PROPOSAL
    NO. 7: Approval of Amendment to the IMUNON, INC. 2018 Stock Incentive Plan</A></B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></B></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">51</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A HREF="#Aa_013">PROPOSAL
    NO. 8: Approval of the adjournment or postponement of the Annual Meeting</A></B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></B></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">59</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_014">STOCKHOLDER
    NOMINATIONS AND PROPOSALS FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_015">OTHER
    MATTERS</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#Aa_016">WHERE
    YOU CAN FIND ADDITIONAL INFORMATION</A></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_001"></FONT>INFORMATION
CONCERNING SOLICITATION AND VOTING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Proxy Statement is being furnished in connection with the solicitation of proxies by the Board of Directors of IMUNON, INC., a Delaware
corporation (sometimes referred to in this Proxy Statement as the &#8220;Company&#8221;, &#8220;IMUNON&#8221;, &#8220;we&#8221; or &#8220;us&#8221;),
for exercise in voting at the Company&#8217;s 2025 Annual Meeting of Stockholders to be held on Friday, July 11, 2025 (the &#8220;Annual
Meeting&#8221;) for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders (the &#8220;Notice&#8221;). We
are first sending this Proxy Statement, accompanying Proxy Card, the Notice and the Company&#8217;s 2024 annual report to stockholders
to our stockholders on or about June 9, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be held on Friday, July 11, 2025. The Proxy Statement
and our 2024 annual report to stockholders are available at <I><FONT STYLE="text-decoration: underline">www.proxyvote.com</FONT></I> or you may request a printed or electronic
set of the proxy materials at no charge.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instructions
on how to access the proxy materials over the Internet and how to request a printed copy may be found on the Notice. In addition, any
stockholder may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. Choosing to
receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact
on our environment. A stockholder who chooses to receive future proxy materials by email will receive an email prior to next year&#8217;s
Annual Meeting with instructions containing a link to those materials and a link to the proxy voting website. A stockholder&#8217;s election
to receive proxy materials by email will remain in effect until such election is terminated by the stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
About the Annual Meeting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Date,
Time and Place of the Annual Meeting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Annual Meeting will be held at 10:00 a.m., Eastern Time, on Friday, July 11, 2025. You will be able to attend the 2025 Annual Meeting,
vote, and submit your questions during the meeting via live webcast through the <B><I>www.virtualshareholdermeeting.com/IMNN2025</I></B>
and enter your 16-digit control number included on your proxy card or
in the instructions that accompanied your proxy materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
is the Annual Meeting a virtual, online meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted this technology to expand access to the meeting, improve communications and impose lower costs on our stockholders, the
Company and the environment. The online format allows us to communicate more effectively via a pre-meeting forum that you can enter by
visiting the meeting via live webcast through the link <B><I><FONT STYLE="text-decoration: underline">www.virtualshareholdermeeting.com/IMNN2025</FONT></I></B> and entering your
16-digit control number included on your proxy card or in the instructions
that accompanied your proxy materials. We believe that hosting a virtual meeting will facilitate shareholder attendance and participation
by enabling stockholders to participate from any location around the world and improve our ability to communicate more effectively with
our stockholders. We have designed the virtual meeting to provide substantially the same opportunities to participate as you would have
at an in-person meeting. You will be provided with the opportunity to submit questions via the live webcast during the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Who
May Attend the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
stockholders who own our common stock, par value $0.01 per share, as of the close of business on May 13, 2025, the record date for
the Annual Meeting (the &#8220;Record Date&#8221;), will be entitled to attend the Annual Meeting. At the discretion of management, we
may also permit certain individuals to attend the Annual Meeting, including professional service providers and our employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Who
May Vote at the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of our common stock outstanding on the Record Date entitles the holder thereof to one vote on each matter submitted to the stockholders
at the Annual Meeting. Only stockholders who own common stock as of the close of business on the Record Date are entitled to notice of,
and to vote at, the Annual Meeting. As of the Record Date, there were 17,541,732 shares of our common stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
to Vote</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were a holder of our common stock as of the Record Date, you are entitled to vote at the Annual Meeting, and we encourage you to
vote your shares by attending the meeting via live webcast of the Annual Meeting<B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can vote your shares using one of the following methods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
                                            and return a written proxy card</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend
                                            the Company&#8217;s 2025 annual meeting of stockholders via live webcast and vote at the
                                            Annual Meeting</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
                                            via the internet at <FONT STYLE="text-decoration: underline">www.proxyvote.com</FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
                                            by phone by calling the number printed on the accompanying voting document</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Telephone
and internet voting facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m. Eastern Time
on July 10, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOWEVER,
WHETHER OR NOT YOU INTEND TO ATTEND THE ANNUAL MEETING, PLEASE COMPLETE, SIGN, DATE AND RETURN THE ACCOMPANYING PROXY CARD IN THE ENCLOSED
PRE-ADDRESSED AND POSTAGE-PAID ENVELOPE OR SUBMIT YOUR VOTE VIA THE INTERNET AT WWW.PROXYVOTE.COM OR BY CALLING THE NUMBER PRINTED ON
THE ACCOMPANYING PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in the name of a bank, broker, or other holder of record, you will receive instructions from the holder of record
that you must follow in order for your shares to be voted. If your shares are not registered in your own name and you plan to vote your
shares via the live webcast at the Annual Meeting, you should contact your broker or agent to obtain a proxy in order to vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting
by Proxy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you vote by proxy, the individuals named on the proxy, or their substitutes, will vote your shares in the manner you indicate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you <FONT STYLE="background-color: white">are a stockholder of record and </FONT>date, sign, and return the proxy card without indicating
your instructions, your shares will be voted as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 1.</B> &#8220;<B>FOR</B>&#8221; (if authority to do so is not withheld) the election of the nominees for the Class III Directors
    to serve until the earlier of the Company&#8217;s Annual Meeting of Stockholders in 2028 or until their successors are duly elected
    and qualified;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 2. &#8220;FOR&#8221;</B> the ratification of the appointment of WithumSmith+Brown PC as our independent registered public accounting
    firm for the year ending December 31, 2025; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 3. &#8220;FOR&#8221;</B> the approval of, by a non-binding advisory vote, the 2024 executive compensation for the Company&#8217;s
    Named Executive Officers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>Proposal No. 4. &#8220;FOR&#8221;</B> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    approval of the Issuance Proposal;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>Proposal No. 5. &#8220;FOR&#8221;</B> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    approval of an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to increase the number of our authorized
    shares of common stock from 112,500,000 shares to 350,000,000 shares and to make a corresponding change to the number of authorized
    shares of capital stock; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 6. &#8220;FOR&#8221; </B>the approval of an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation
    to effect a reverse stock split at a ratio between, and including, 1:5 and 1:18, with the exact ratio to be set within that range
    at the discretion of our Board of Directors without further approval or authorization of our stockholders; </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 7. &#8220;FOR&#8221; </B>the approval of an amendment to the IMUNON, INC. 2018 Stock Incentive Plan; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
    No. 8. &#8220;FOR&#8221;</B> the approval of any adjournment or postponement of the Annual Meeting, if necessary, to solicit additional
    proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at
    the Annual Meeting; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
    Business.</B> In the discretion of your proxy holder (one of the individuals named on your proxy card), to consider and act on any
    other matter properly presented at the Annual Meeting or any adjournment or postponement thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a beneficial owner who holds shares in street name does not provide specific voting instructions to their brokerage firm, bank, broker
dealer or other nominee, under the rules of certain securities exchanges, including Nasdaq Marketplace Rules, the brokerage firm, bank,
broker dealer or other nominee holding those shares may generally vote as the nominee determines in its discretion on behalf of the beneficial
owner on routine matters but cannot vote on non-routine matters, the latter of which results in &#8220;broker non-votes.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals No. 2, 5 6 and 8 involve matters we believe to be routine in nature. Accordingly, if you are a beneficial
owner who holds shares in street name and you do not give instructions to your broker, the broker may vote your shares in its discretion
on Proposals No. 2, 5, 6 and 8, and therefore, no broker non-votes are expected in connection with such proposals. Proposal Nos. 1, 3,
4 and 7 involve matters we consider non-routine under the applicable rules. If you do not give your broker specific instructions, the
broker will not vote your shares on Proposal Nos. 1, 3, 4 and 7, and your shares will constitute broker non-votes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may revoke or change your proxy at any time before it is exercised by delivering to us a signed proxy with a date later than your previously
delivered proxy, by re-voting via internet or by telephone, by voting via the live webcast at the Annual Meeting, or by sending a written
revocation of your proxy addressed to our Corporate Secretary at our principal executive office. Your latest dated proxy card is the
one that will be counted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Quorum
Requirement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum is necessary to hold a valid meeting. The presence of holders of our common stock entitled to cast one-third (33.33%) of all the
votes entitled to be cast at the Annual Meeting constitutes a quorum for the transaction of business. Abstentions and broker non-votes
are counted as present for purposes of establishing a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting
Requirements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 1.</B> The election of the Class III Directors at the Annual Meeting will be by a plurality of the votes cast. This means if the
director nominees receive the greatest number of votes cast by the holders of our common stock in the election of the Class III Directors,
they will be elected. Stockholders may not cumulate their votes in electing directors. Stockholders entitled to vote at the Annual Meeting
may either vote &#8220;FOR&#8221; the nominee for election as a director or may &#8220;WITHHOLD&#8221; authority for the nominee. Shares
represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nominee named below in
Proposal No. 1. If a stockholder withholds authority to vote with respect to the nominees for director, the shares held by that stockholder
will be counted for purposes of establishing a quorum but will have no effect on the election of the nominees. <FONT STYLE="background-color: white">Brokerage
firms do not have authority to vote customers&#8217; unvoted shares held by the firms in street name for the election of the directors.
As a result, any shares not voted by a customer will be treated as a broker non-vote. </FONT>Broker non-votes will have no effect on
the election of the nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 2.</B> Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on Proposal No. 2 regarding
the ratification of the selection of WithumSmith+Brown PC (&#8220;Withum&#8221;) as the Company&#8217;s independent registered public
accounting firm for the year ending December 31, 2025. The affirmative vote of <FONT STYLE="background-color: white">a majority of the
votes cast affirmatively or negatively for this proposal will</FONT> be required to ratify the selection of Withum. Abstentions will
have no effect on the results of the vote on Proposal No. 2. <FONT STYLE="background-color: white">Brokerage firms have authority to
vote customers&#8217; unvoted shares held by the firms in street name on this proposal. If a broker does not exercise this authority,
such broker non-votes will have </FONT>no effect on Proposal No. 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 3.</B> Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on Proposal No. 3 to approve,
by a non-binding advisory vote, the 2024 compensation for the Company&#8217;s Named Executive Officers. The affirmative vote of <FONT STYLE="background-color: white">a
majority of the votes cast affirmatively or negatively for this proposal </FONT>will be required to ratify the 2024 compensation for
the Company&#8217;s executive officers. Abstentions will have no effect on the results of the vote on Proposal No. 3. <FONT STYLE="background-color: white">Brokerage
firms do not have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. </FONT>Broker
non-votes will have no effect on Proposal No. 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>Proposal No. 4</B>. Stockholders may
vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on Proposal No. 4 to approve the Issuance Proposal to approve
the issuance of shares of our common stock underlying certain warrants issued by us. The affirmative vote of a majority of the votes
cast affirmatively or negatively for this proposal will be required to approve the Issuance Proposal. Abstentions will have no effect
on the results of the vote on Proposal No. 4. Brokerage firms do not have authority to vote customers&#8217; unvoted shares held by the
firms in street name on this proposal. Broker non-votes will have no effect on Proposal No. 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>Proposal No. 5</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on the Authorized Share Increase proposal
to amend the Company&#8217;s Amended and Restated Certificate of Incorporation to increase the number of our authorized shares of common
stock from 112,500,000 shares to 350,000,000 shares and to make a corresponding change to the number of authorized shares of capital
stock. The affirmative vote of a majority of the votes cast affirmatively or negatively for this proposal will be required to approve
the proposal; provided that our common stock is listed on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) immediately before the amendment
to the Amended and Restated Certificate of Incorporation to effect the proposal becomes effective and meets the listing requirements
of Nasdaq relating to the minimum number of holders immediately after such amendment to the Amended and Restated Certificate of Incorporation
becomes effective (the &#8220;Listing Condition&#8221;), in which case, abstentions with respect to the proposal will not be considered
&#8220;votes cast&#8221; and will have no effect on the proposal. If the Listing Condition is not met, the Authorized Share Increase
proposal must receive the affirmative vote of the holders of a majority of our issued and outstanding shares of common stock as of the
Record Date, and any abstentions with respect to the Authorized Share Increase proposal would have the same effect as a vote against
the Authorized Share Increase proposal. Brokerage firms have authority to vote customers&#8217; unvoted shares held by the firms
in street name on this proposal. If the Listing Condition is met, any broker non-votes (if any) will have no effect on the Authorized
Share Increase proposal. If the Listing Condition is not met, any broker non-votes (if any) will be treated as a vote against the Authorized
Share Increase proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 6</B>. Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may
&#8220;ABSTAIN&#8221; on the Reverse Stock Split proposal to amend the Company&#8217;s Amended and Restated Certificate of Incorporation
to effect a reverse stock split at a ratio between, and including, 1:5 and 1:18, with the exact ratio to be set within that range at the
discretion of our Board of Directors without further approval or authorization of our stockholders. The affirmative vote of a majority
of the votes cast affirmatively or negatively for this proposal will be required to approve the proposal; provided that our common stock
meets the Listing Condition, in which case, abstentions with respect to the proposal will not be considered &#8220;votes cast&#8221; and
will have no effect on the proposal. If the Listing Condition is not met, the Reverse Stock Split proposal must receive the affirmative
vote of the holders of a majority of our issued and outstanding shares of common stock as of the Record Date, and any abstentions with
respect to the Reverse Stock Split proposal would have the same effect as a vote against the Reverse Stock Split proposal. Brokerage firms have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. If the Listing Condition
is met, any broker non-votes (if any) will have no effect on the Reverse Stock Split proposal. If the Listing Condition is not met, any
broker non-votes (if any) will be treated as a vote against the Reverse Stock Split proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 7</B>. Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on Proposal No. 7, to approve
an Amendment to the IMUNON, INC. 2018 Stock Incentive Plan. The affirmative vote of the holders a majority of the votes cast affirmatively
or negatively for this proposal will be required to approve the Amendment. Abstentions will have no effect on the results of the vote
on Proposal No. 7. Broker non-votes will have no effect on Proposal No. 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal
No. 8</B>. Stockholders may vote &#8220;FOR&#8221; or &#8220;AGAINST&#8221; or may &#8220;ABSTAIN&#8221; on the Adjournment Proposal
The approval of the Adjournment Proposal requires the affirmative vote of a majority of the votes cast affirmatively or negatively
for this proposal. Abstentions will have no effect on the results of the vote on Proposal No. 8. Brokerage firms have
authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. Broker non-votes (if any) will
have no effect on Proposal No. 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Matters</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors knows of no other matters that may be presented for stockholder action at the Annual Meeting. It is not anticipated
that other matters will be brought before the Annual Meeting. If other matters do properly come before the Annual Meeting, or any adjournments
or postponements thereof, however, persons named as proxies will vote upon them in their discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
about the Proxy Statement and the Solicitation of Proxies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
enclosed proxy is solicited by our Board of Directors, and we will bear the costs of preparing, assembling, printing and mailing this
Proxy Statement, accompanying Proxy Card, Notice of Annual Meeting of Stockholders and the Company&#8217;s 2024 annual report to stockholders,
as well as any additional materials that we may furnish to stockholders in connection with the Annual Meeting. Copies of our solicitation
materials will be furnished to brokerage houses, fiduciaries and custodians to forward to beneficial owners of stock held in the names
of such nominees. We will, upon request, reimburse those parties for their reasonable expenses in forwarding proxy materials to the beneficial
owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Annual
Report</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2024 annual report is being mailed to stockholders together with this Proxy Statement and contains financial and other information about
IMUNON, including audited financial statements for our fiscal year ended December 31, 2024. A copy of our 2024 Annual Report on Form
10-K, as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;), but excluding exhibits, is available on our website and
additional copies may be obtained without charge, upon written request directed to the Corporate Secretary, IMUNON, INC., 997 Lenox Drive,
Suite 100, Lawrenceville, New Jersey 08648.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Householding
of Annual Meeting Materials</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and
annual reports. This means that only one copy of our Proxy Statement or 2024 annual report to stockholders may have been sent to multiple
stockholders in your household. The Company will promptly deliver a separate copy of either document to you if you write or call the
Company at the following address or telephone number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suite
100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville,
New Jersey 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Attention:
Corporate Secretary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609)
896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you would like to receive separate copies of the proxy materials in the future, or if you are receiving multiple copies and would like
to receive only one copy for your household, you should contact your bank, broker, or other nominee record holder, or you may contact
the Company at the address and telephone number set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
COMPLETE, SIGN, DATE AND RETURN THE ACCOMPANYING WHITE PROXY CARD IN THE ENCLOSED PRE-ADDRESSED AND POSTAGE-PAID ENVELOPE AS PROMPTLY
AS POSSIBLE OR SUBMIT YOUR VOTE VIA THE INTERNET AT <I><FONT STYLE="text-decoration: underline">WWW.PROXYVOTE.COM</FONT></I> OR BY CALLING THE NUMBER PRINTED ON THE ACCOMPANYING
PROXY CARD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_002"></FONT>BENEFICIAL
OWNERSHIP OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is furnished by the Company and sets forth certain information known to the Company regarding the beneficial ownership
of the Company&#8217;s common stock as of May 13, 2025 by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person or group known by us to own beneficially more than 5% of the Company&#8217;s outstanding common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and the director nominees, as well as each executive officer named in the Summary Compensation Table appearing under
    the heading &#8220;Executive Compensation;&#8221; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    directors and executive officers as a group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine beneficial ownership in accordance with the rules of the SEC. Under SEC rules, beneficial ownership for purposes of this table
takes into account shares as to which the individual has voting or investment power (including shares held indirectly through the Imunon,
Inc. 401(k) Plan), as well as shares that may be acquired within 60 days of May 13, 2025. Shares of common stock subject to options that
are currently exercisable or that become exercisable within 60 days of May 13, 2025, are treated as outstanding and beneficially owned
by the holder of such options. However, these shares are not treated as outstanding for purposes of computing the percentage ownership
of any other person. Unless otherwise indicated or as to the interests of spouses, the persons included in the table have sole voting
and investment power with respect to all shares beneficially owned thereby. <FONT STYLE="background-color: white">Percentage ownership
calculations are based on 17,541,732 shares outstanding as of May 13, 2025.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAME
    OF BENEFICIAL OWNER</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NUMBER
    OF<BR>
    SHARES OF<BR>
    COMMON STOCK<BR>
    BENEFICIALLY<BR>
    OWNED (1)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERCENT
    OF<BR>
    SHARES OF<BR>
    COMMON<BR>
    STOCK<BR>
    OUTSTANDING (2)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ayrton
    Capital LLC (3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,250,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer<B>* </B>(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz<B>* </B>(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,593</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Braun<B>* </B>(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,591</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari<B>*</B> (7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,773</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno<B>* </B>(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">417,635</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    Lindborg* (9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">166,648</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer<B>* </B>(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,725</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Church* (11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,422</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward* (12)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,125</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Faller MD*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corrine
    LeGoff* (13)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Executive Officers as a group (12 persons) (14)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,045,530</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.96</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address of each of the individuals named is c/o IMUNON, INC., 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than one percent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Ownership is
    determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities.
    Except as indicated by footnote, and subject to community property laws where applicable, the persons named in the table above have
    sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 17,541,732 shares
    of common stock outstanding as of May 13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the Schedule 13G
    filed by Ayrton Capital, LLC (&#8220;Ayrton Capital&#8221;) on February 13, 2025, reporting beneficial ownership as of December 31,
    2024 and represents shares of Common Stock issuable on the exercise of certain warrants held by the reporting persons. The Schedule
    13G provides information only as of December 31, 2024, and, consequently, the beneficial ownership of the abovementioned reporting
    person may have changed between December 31, 2024 and February 21, 2025. Shares reported herein were held by Alto Opportunity Master
    Fund, SPC &#8211; Segregated Master Portfolio B, a Cayman Islands exempted company (the &#8220;Fund&#8221;). The Fund is a private
    investment vehicle for which Ayrton Capital LLC, a Delaware limited liability company (the &#8220;Investment Manager&#8221;), serves
    as the investment manager. Waqas Khatri serves as the managing member of the Investment Manager. The address of the principal business
    and office of Ayrton Capital LLC and its affiliates is 55 Post Rd West, 2<SUP>nd</SUP> Floor, Westport Ct, 06880.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 16,018 shares
    of common stock underlying options currently exercisable or exercisable within 60 days of May 13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 11,766 shares
    of common stock and 28,827 shares of common stock underlying options currently exercisable or exercisable within 60 days of May 13,
    2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 25,597 shares
    of common stock and 25,994 shares of common stock underlying options currently exercisable or exercisable within 60 days of May 13,
    2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 20,773 shares
    of common stock underlying options currently exercisable or exercisable within 60 days of May 13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 73,714 shares
    of common stock and 343,921 shares of common stock underlying options currently exercisable or exercisable within 60 days of May
    13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 28,056 shares
    of common stock and 138,592 shares of common stock underlying options currently exercisable or exercisable within 60 days of May
    13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 44,565 shares
    of common stock and 153,160 shares of common stock underlying options currently exercisable or exercisable within 60 days of May
    13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 2,338 shares of
    common stock and 76,084 shares of common stock underlying options currently exercisable or exercisable within 60 days of May 13,
    2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 3,125 shares of
    common stock underlying options currently exercisable or exercisable within 60 days of May 13, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 53,000 shares
    of common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
239,036 of common stock and 806,494 shares of common stock underlying options currently exercisable or exercisable within 60 days of
May 13, 2025. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_003"></FONT>DELINQUENT
SECTION 16(A) REPORTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) requires our executive officers, directors
and persons who own more than 10% of our common stock to file reports of ownership and reports of changes in ownership of common stock
and other equity securities of the Company with the SEC. Executive officers, directors and greater than 10% stockholders are required
by SEC regulations to furnish us with copies of all Section 16(a) forms they file.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have identified the following reports required to be filed by insiders under Section 16(a) of the Exchange Act that were not filed in
a timely manner: one late report by Stacy Lindborg relating to one transaction and one late report by Donald Braun relating to one transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_004"></FONT>DIRECTORS,
EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors currently consists of six members and is divided into three classes of directors serving staggered three-year terms.
Directors for each class are elected at the Annual Meeting of Stockholders held in the year in which the term for their class expires
and hold office for a three-year term and until their successors are duly elected and qualified, or their earlier death, resignation
or removal. In accordance with our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, our Board may fill
any vacancy on the Board by appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is certain information regarding our Company&#8217;s current directors, as well as our non-director executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAME</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGE</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POSITION(S)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLASS</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Braun, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Scientific Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Corporate Secretary</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    Faller, MD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Class
III Director Nominees (If reelected, term expires in 2028)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Donald P. Braun.</B> Dr. Braun was appointed to our Board of Directors in December 2015. Dr. Braun has over 35 years of research experience
in oncology, cancer immunology, cancer immunotherapy, and inflammatory diseases. He is the author of more than 120 published peer-reviewed
manuscripts, twenty-five reviews and book chapters, and co-editor of a book on the role of prostaglandins and other COX 2 metabolites
in cancer patient immunity and immunotherapy. He served from 2006 to 2014 as Vice President Clinical Research, after which he served
as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America until his retirement in
May 2016. Prior to this role, he was the Scientific Director of the Cancer Center and Professor of Medicine and Immunology at Rush Medical
College in Chicago from 1978 to 1999, and the Administrative Director of the Cancer Institute and a Professor of Surgery with tenure
at the Medical College of Ohio from 1999 to 2006. He received his Ph.D. in Immunology and Microbiology from the University of Illinois
at the Medical Center in Chicago. Dr. Braun has served as an advisor to numerous public agencies and private corporations concerned with
cancer therapeutics and diagnostics. At the National Cancer Institute, Dr. Braun served as a member of the Experimental Therapeutics
Study Section; the Small Business Innovation Grant Review Study Section; and the Experimental Therapy program for &#8220;Molecular Targets
in Lung Cancer.&#8221; He served as a member of the Immunology and Immunotherapy Study Section of the American Cancer Society-National
Division; as a Member of the Ohio Cancer Incidence Surveillance System; as a Member of the Biomedical Research Technology Transfer Commission
for the State of Ohio; and as an advisor to the State of Arizona&#8217;s Disease Research Control Commission. Dr. Braun has also served
as a consultant to numerous pharmaceutical and biotechnology companies developing cancer treatments and diagnostics including Pfizer
Inc. (NYSE: PFE), Sterling Winthrop, Abbott Laboratories (NYSE: ABT), Boehringer Mannheim, Serono Corporation, Biomira Inc., Centocor
and Merck KGA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Michael H. Tardugno.</B> Mr. Tardugno was appointed President and Chief Executive Officer of the Company on January 3, 2007, and was
elected to the Board of Directors on January 22, 2007. In October of 2014, Mr. Tardugno was appointed by our Board of Directors as our
Chairman. Effective July 18, 2022, Mr. Tardugno transitioned from the roles of President, Chief Executive Officer and Chairman to the
position of Executive Chairman of the Board. From March 15, 2024, Mr. Tardugno served as interim Chief Executive Officer until the appointment
of Dr. Lindborg effective May 13, 2024. Prior to joining the Company and for the period from February 2005 to December 2006, Mr. Tardugno
served as Senior Vice President and General Manager of Mylan Technologies, Inc., a subsidiary of Mylan Inc. From 1998 to 2005, Mr. Tardugno
was Executive Vice President of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. From 1996 to 1998,
he was Senior Vice President of Technical Operations worldwide for a division of Bristol-Myers Squibb (NYSE: BMY), and from 1977 to 1995,
he held increasingly senior executive positions including Senior Vice President of Worldwide Technology Development with Bausch &amp;
Lomb (NYSE, TSX: BLCO) and Abbott Laboratories (NYSE: ABT). Mr. Tardugno holds a B.S. degree from St. Bonaventure University and completed
the Harvard Business School Program for Management Development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors concluded that Mr. Michael
H. Tardugno and Dr. Donald P. Braun have the requisite experience, qualifications, attributes and skills necessary to serve as a member
of our Board of Directors based on his respective leadership attributes, management experience in the pharmaceutical industry and professional
and educational background.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continuing
Class I Directors (Term expires in 2026)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Frederick J. Fritz.</B> Mr. Fritz was appointed to our Board of Directors in July 2011. Mr. Fritz has served as CEO and Founder of NeuroDx,
a development stage diagnostic device company focused on the neurosurgery market, since 2006. Mr. Fritz joined NeuroDx from Valeo Medical,
a biotechnology company he founded in 2003 to develop the world&#8217;s first non-invasive diagnostic test for endometriosis. Prior to
that, Mr. Fritz was President and CEO of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. Mr. Fritz
began his career in marketing management and new product development. He joined Schering Plough&#8217;s Wesley Jessen in 1985 as VP Marketing
and Sales in 1986. He was promoted to general manager of Schering&#8217;s Over the Counter pharmaceutical business in 1988 and of the
podiatric products business in 1990. He was President of Coleman North America from 1995 to 1997. Mr. Fritz holds a bachelor&#8217;s
degree in engineering (summa cum laude) from University of Illinois and an MBA degree from Harvard University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ms.
Christine A. Pellizzari. </B>Ms. Pellizzari was appointed to our Board of Directors in June 2021. Ms. Pellizzari <FONT STYLE="background-color: white">most
recently served as the Chief Legal Officer and Human Resources Officer of Science 37 </FONT>(formerly Nasdaq: SNCE), a developer of leading
decentralized clinical trial solutions, where she had global responsibility for both the legal and human resource functions and also
oversaw quality and privacy, from 2021 through 2024. <FONT STYLE="background-color: white">Immediately prior to joining Science 37, Ms.
Pellizzari served as the General Counsel and Corporate Secretary of Insmed, Inc., (Nasdaq: INSM) a publicly traded biotech company focused
on serious and rare diseases, from 2013 to 2018 and as Chief Legal Officer from 2018 to 2021. From 2007 through 2012, Ms. Pellizzari
held various legal positions of increasing responsibility at Aegerion Pharmaceuticals, most recently as Executive Vice President, General
Counsel and Corporate Secretary. Prior to Aegerion, Ms. Pellizzari was Senior Vice President, General Counsel and Secretary at Dendrite
International, Inc., a formerly publicly traded company that provided sales effectiveness, promotional and compliance solutions to the
pharmaceutical industry. Ms. Pellizzari joined Dendrite from the law firm of Wilentz, Goldman &amp; Spitzer, where she specialized in
health care transactions and related regulatory matters. Ms. Pellizzari has nearly three decades of relevant experience, including having
served for over 25 years as Chief Legal Officer and General Counsel of publicly traded companies in biopharmaceutical and related industries.
Ms. Pellizzari also serves on the board of directors of Tempest Therapeutics (Nasdaq: TPST), a public clinical-stage oncology company,
and Neurosense Therapeutics (Nasdaq: NRSN), a public clinical-stage development company advancing treatments for severe neurodegenerative
diseases. Ms. Pellizzari received her Bachelor of Arts, cum laude, from the University of Massachusetts (Amherst) and her Juris Doctor
degree from the University of Colorado School of Law. She is a member of Global Leaders in Law, </FONT>Executive Women in Bio, Women
Corporate Directors, National Association of Corporate Directors, Association of Corporate Counsel, Society for Corporate Governance
and National Association of Stock Plan Professionals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continuing
Class II Directors (Term expires in 2027)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
James E. Dentzer. </B>Mr. Dentzer was appointed to our Board of Directors in September 2022. He has been President and Chief Executive
Officer and a member of the Board of Directors of Curis, Inc. (Nasdaq: CRIS) since September 2018. From March 2018 to September 2018,
Mr. Dentzer served as Curis&#8217; Chief Operating Officer and Chief Financial Officer. From March 2016 to March 2018, Mr. Dentzer served
as Curis&#8217; Chief Administrative Officer and Chief Financial Officer. Mr. Dentzer has also held the positions of secretary and treasurer
from March 2016 to March 2019. Prior to joining Curis, Mr. Dentzer served as Chief Financial Officer of Dicerna Pharmaceuticals, Inc.,
a formerly publicly traded biotechnology company, from December 2013 to December 2015. Prior to that, he was the Chief Financial Officer
of Valeritas, Inc., a formerly publicly traded medical technology company, from March 2010 to December 2013. Prior to joining Valeritas,
Inc., he was the Chief Financial Officer of Amicus Therapeutics, Inc. (Nasdaq: FOLD), a biotechnology company, from October 2006 to October
2009. In prior positions, he spent six years as Corporate Controller of Biogen Inc. (Nasdaq: BIIB), a biotechnology company, and six
years in various senior financial roles at E.I. du Pont de Nemours and Company, a chemical, petroleum and biotechnology company, in the
U.S. and Asia. Mr. Dentzer holds a B.A. degree in Philosophy from Boston College and an M.B.A. from the University of Chicago.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Stacy R. Lindborg</B>. Dr. Lindborg, a director since 2021, has served as President and Chief Executive Officer of the Company since
May 2024. Dr. Lindborg, a globally recognized biostatistician, brings to Imunon nearly 30 years of pharmaceutical and biotech industry
experience with a particular focus on R&amp;D, regulatory affairs, executive management and strategy. She has worked with biologics,
small molecules and cell therapies to address a broad range of diseases and disorders, including multiple Orphan drug products, along
with extensive experience in early-stage development having taken molecules from first-in-human studies into the clinic, through regulatory
approval and commercial launch. Prior to joining the Company, Dr. Lindborg held the position of co-Chief Executive Officer at Brainstorm
Cell Therapeutics (Nasdaq: BCLI), which she joined in 2020, and where she also currently serves as an independent director since May
2024. From 2012 to 2020, she held positions of increasing responsibility at Biogen, and served as Vice President for Global Analytics
and Data Sciences. Prior to her time at Biogen, Dr. Lindborg had worked at Eli Lilly and Company (NYSE: LLY) since 1996 advancing through
the organization to serve from 2010 to 2012 as Head of R&amp;D Strategy with responsibility for characterizing the productivity of the
portfolio and advancing key R&amp;D strategy projects by connecting individual drug-development decisions to portfolio risk practices
and driving fundamental R&amp;D decisions to increase the number of drug launches. Dr. Lindborg received an M.A. and a Ph.D. in statistics
from Baylor University. She has authored more than 50 abstracts, 200 presentations and 40 manuscripts that have been published in peer-reviewed
journals. She has held numerous positions within the American Statistical Association and International Biometric Society and was elected
Fellow in 2008.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors concluded that all of the continuing directors have the requisite experience, qualifications, attributes and skill
necessary to serve as a member of the Board of Directors based on, among other things, their:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leadership
    attributes and experience;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    experience in the pharmaceutical industry and/or business experience in countries in which we are conducting clinical trials; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    and educational background.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Executive
Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the biographical summaries for each of our executive officers. Each executive officer is elected by, and serves at the
pleasure of, our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Khursheed
Anwer, Ph.D. </B>Dr. Anwer joined the Company in June 2014 as Executive Vice President and Chief Scientific Officer, in connection with
our acquisition of all the assets of EGWU, Inc. (formerly known as Egen, Inc.), an Alabama corporation (or &#8220;EGEN&#8221;). Before
joining the Company, Dr. Anwer served as EGEN&#8217;s President and Chief Scientific Officer, a position he held since 2009. He joined
EGEN in July 2002 as Vice President of Research and Development and directed EGEN&#8217;s clinical and research and development functions.
Before joining EGEN, Dr. Anwer was Director of Pre-Clinical Development at Valentis, Inc. from July 2000 to June 2002. From 1993 to 1999,
he served in several positions at GeneMedicine, Inc., where he led several research projects in the area of non-viral gene therapy. He
has authored more than 40 publications in the area of non-viral gene therapy, resulting from his active career in research and development.
Dr. Anwer holds a Ph.D. in physiology/pharmacology from Ohio University and received post-doctoral training from the University of Texas
Health Science Center at Houston. Dr. Anwer also has a master&#8217;s in business administration from the University of Alabama.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Susan
Eylward.</B> Ms. Eylward joined the Company in October 2024 as General Counsel and Corporate Secretary. Prior to her position with the
Company, Ms. Eylward served as Senior Counsel at Science 37, Inc. (formerly Nasdaq: SNCE), a solutions organization focused on decentralized
clinical trials, from January 2022 through April 2024, where she was responsible for a variety of complex legal matters, including, among
others, corporate governance, securities compliance, executive compensation, and acquisitions. Prior to that, Ms. Eylward served as corporate
counsel and Vice President at the Allstate Corporation (NYSE: ALL) during 2021, at National General Holdings Corp. (formerly Nasdaq:
NGHC) from September 2014 through December 2020, and at Tower Group International, Ltd. (formerly Nasdaq: TWGP) from May 2009 through
September 2014, and at each of the foregoing, she had responsibility for various corporate legal matters including governance, securities
law, alternative investments and transactions. From 2004 through 2009, Ms. Eylward practiced law at Dewey &amp; LeBoeuf LLP, where she
represented public and private companies for equity and debt offerings, as well as mergers and acquisitions. Ms. Eylward received a Juris
Doctor from New York Law School and a Bachelor of Arts in Accounting from Boston College.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Faller, MD.</B> Dr. Faller, an internationally recognized oncologist/hematologist and scientist, has nearly 30 years of pharmaceutical
and biotech industry experience with a particular focus on clinical R&amp;D, discovery, regulatory affairs, and strategy development.
He has worked with small molecules, gene therapies, biologics and cell therapies to address a range of malignant and non-malignant diseases
and disorders, including rare and genetic diseases, and neurological and neuropsychiatric disorders. He has extensive experience in early-stage
development as well as global late-stage development and world-wide marketing approvals. He has taken molecules (including those discovered
in his own academic laboratories) from first-in-human studies in the clinic, through registrational trials, international regulatory
approvals and commercial launch. Prior to his position with the Company, Dr. Faller served as Chief Medical Officer of Skyhawk Therapeutics
beginning in 2024, where he led the development of splicing modulators for the treatment of oncological and neurological disorders. From
2022 through 2024, he served as Chief Medical Officer of Oryzon Genomics, leading the development of epigenetic-modifying small molecules
in oncology and neuropsychiatric disorders, and prior to that role, from 2015 through 2022, Dr. Faller was Executive Medical Director
at Takeda Pharmaceuticals, where he led multiple programs in hematologic oncology, solid tumor malignancies and rare diseases, from first-in-human
to global registrational trials and post-marketing trials. He was also extensively involved in Business Development for oncology, hematology
and rare diseases. Dr. Faller was the scientific founder and CMO/CSO of Viracta Therapeutics, which he joined in 2019 and remained through
2021, after it became publicly traded and launched a pivotal trial of his therapeutic. Dr. Faller is the scientific founder or co-founder
of four biopharma companies. Prior to working full-time in the biopharmaceutical industry, Dr. Faller was a professor at Harvard Medical
School, and an attending physician at Brigham and Women&#8217;s Hospital, Boston Children&#8217;s Hospital and Dana-Farber Cancer Institute.
He founded and directed the Comprehensive Cancer Center at Boston University, where he also served as the first Grunebaum Professor for
Cancer Research, Vice-Chairman of the Department of Medicine, and Professor of Medicine, Biochemistry, Pediatrics, Microbiology, Pathology
and Laboratory Medicine. Dr. Faller received a B.S. in biochemistry from the Massachusetts Institute of Technology, an MD from Harvard
Medical School, and a PhD from the Massachusetts Institute of Technology in cancer molecular biology. He has authored more than 300 abstracts,
230 presentations and 375 manuscripts that have been published in peer-reviewed journals. He is certified in Internal Medicine, Hematology
and Oncology, and is a Fellow of the American College of Physicians.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
Gaiero.</B> Mr. Gaiero joined the Company in May 2024 as Chief Financial Officer pursuant to a professional agreement (the &#8220;Agreement&#8221;)
between the Company and Monomoy Advisors, LLC, a financial advisory services firm (&#8220;Monomoy&#8221;). Prior to joining Monomoy in
May 2024, Mr. Gaiero served as Chief Financial Officer of Cyteir Therapeutics, Inc. Prior to joining Cyteir Therapeutics in December
2020, Mr. Gaiero served in various roles at Wave Life Sciences (Nasdaq: WVE) from July 2017 to December 2020, most recently serving as
Interim Chief Financial Officer and prior to that, serving as Vice President and Corporate Controller. Prior to joining Wave Life Sciences,
from September 2015 to July 2017, Mr. Gaiero served as Vice President and Corporate Controller of OvaScience, Inc. Prior to that, Mr.
Gaiero held various positions of increasing responsibility and scope in finance and accounting at iRobot Corporation. Mr. Gaiero began
his career in public accounting at PricewaterhouseCoopers LLP. Mr. Gaiero received a B.B.A. in Accounting from the University of Massachusetts,
Amherst, and is a Certified Public Accountant in Massachusetts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Involvement
in Certain Legal Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the filing of this Proxy Statement, there are no legal proceedings, and during the past ten years there have been no legal proceedings,
that are material to the ability or integrity of any of our directors, director nominees or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Leadership Structure and Role in Risk Oversight</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
Leadership</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that it is important to select our Chairman of the Board and our Chief Executive Officer in the manner it
considers in our best interests. The members of our Board of Directors possess considerable business experience and in-depth knowledge
of the issues we face and are therefore in the best position to evaluate our needs and how best to organize and adopt our leadership
structure to meet those needs. Accordingly, our Chairman and the Chief Executive Officer may be filled by one individual or by two different
individuals, and our chairman may be a Company insider or an independent director. Mr. Tardugno currently serves as Executive Chairman
of our Board of Directors and Dr. Stacy Lindborg currently serves as the Company&#8217;s President and Chief Executive Officer. Currently,
all the other directors of our Board of Directors are independent under applicable SEC and Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
Oversight of Risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is responsible for oversight of the various risks we face. In this regard, the Board of Directors seeks to understand
and oversee the most critical risks relating to our business and operations, allocate responsibilities for the oversight of risks among
the full Board of Directors and its committees, and see that management has in place effective systems and processes for managing risks
we face. Overseeing risk is an ongoing process, and risk is inherently tied to our strategy and to strategic decisions. Accordingly,
our Board of Directors considers risk throughout the year and with respect to specific proposed actions. Our Board of Directors recognizes
that it is neither possible nor prudent to eliminate all risk. Indeed, purposeful and appropriate risk-taking is essential for us to
be competitive and to achieve our business objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our Board of Directors oversees risk, management is charged with identifying and managing risk. We have robust internal processes and
a strong internal control environment to identify and manage risks and to communicate information about risk to the Board of Directors.
Management communicates routinely with our Board of Directors, Board Committees (as defined below) and individual directors on the significant
risks identified and how they are being managed. Our directors are free to, and indeed often do, communicate directly with senior management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Good
Governance Practices</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has a commitment to strong and sustainable corporate governance. As such, we continuously review our practices to
ensure effective collaboration between management and our Board. Highlights of our Board of Directors&#8217; best practices are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Four
    of the six Board directors are independent;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Board of Directors has adopted and published committee charters (available on our website at www.imunon.com);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Board of Directors conducts an annual review of Board independence;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">New
    directors participate in an orientation program and receive a current state briefing before their first Board meeting;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    have stock ownership and stock retention guidelines for our directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    have policies and practices to specifically align executive compensation with long-term stockholder interests;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    have a policy prohibiting hedging and pledging, short sales, purchases or sales of puts or calls, and other derivative transactions
    of our stock (including any transaction that provides the economic equivalent of ownership) by our executive officers and directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">An
    executive compensation clawback policy was adopted by our Board of Directors in October 2023;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Board of Directors reviews management talent and succession annually with our chief executive officer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
    is no automatic enhancement of executive incentive compensation upon a change-in-control.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insider
Trading Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted an insider trading policy which governs the purchase, sales, and/or other dispositions of our securities
by directors, officers, and employees. Our insider trading policy prohibits our officers, directors, and employees from, among other
things, engaging in short sales, transactions in derivative securities (including put and call options) or other forms of hedging transactions
(i.e., zero-cost collars, equity swaps, exchange funds and forward sale contracts) that are designed to hedge or offset any decrease
in the market value of equity securities (1) granted to the executive officer or director by the Company as part of the compensation
of such individual, or (2) held, directly or indirectly, by the executive officer or director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a Code of Ethics and Business Conduct (the &#8220;Code of Ethics&#8221;) applicable to its directors, officers, including
the Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and other officers performing similar functions, and employees.
This Code of Ethics constitutes a code of ethics applicable to senior financial officers within the meaning of the Sarbanes-Oxley Act
of 2002 and SEC rules. A copy of the Code of Ethics is available on the Company&#8217;s website at <I>http://www.imunon.com</I> and any
stockholder may obtain a copy by making a written request to the Company&#8217;s Corporate Secretary, 997 Lenox Drive, Suite 100, Lawrenceville,
NJ 08648. In the event of any amendments to or waivers of the terms of the Code of Ethics, such matters will be posted promptly to the
Company&#8217;s website in lieu of disclosure on Form 8-K in accordance with Item 5.05(c) of Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors implements its risk oversight function both as a whole and through delegation to various committees (the &#8220;Board
Committees&#8221;). These Board Committees meet regularly and report back to our full Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Audit Committee oversees the management of financial, accounting, internal controls, disclosure controls and the engagement arrangement
    and regular oversight of the independent auditors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Compensation Committee is responsible for the design and oversight of our compensation programs. Based on a review of our company-wide
    compensation programs, including the compensation programs for our executive officers, our Compensation Committee has concluded that
    these programs do not create risks that are likely to have a material adverse effect on us.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our Nominating and Governance Committee periodically reviews our corporate governance practices, including the risks that those practices
are intended to address. It
    also periodically reviews the composition of our Board of Directors to help ensure that a diversity of skills and experiences is
    represented by the members of our Board of Directors, taking into account the stage of our growth and strategic direction.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
    Science and Technology Committee assists our Board of Directors in monitoring the state of science and technology capabilities within
    the Company and associated risks and overseeing the development of key technologies and major science and medicine-driven innovation
    initiatives essential to our long-term success.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee consists of Mr. James A. Dentzer (Chair), Mr. Frederick J. Fritz and Ms. Christine Pellizzari. Our Audit Committee operates
under a written charter that is available on our web site, located at <I><FONT STYLE="text-decoration: underline">http://www.imunon.com</FONT></I>. Additional copies of the charter
are available upon written request to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee assists our Board of Directors in fulfilling its responsibility to oversee management&#8217;s implementation of our financial
reporting process. In discharging its oversight role, the Audit Committee reviewed and discussed the audited financial statements contained
in our 2024 Annual Report on Form 10-K with our management and independent registered public accounting firm. Management is responsible
for the financial statements and the reporting process, including the system of internal controls. Our independent registered public
accounting firm is responsible for expressing an opinion on the conformity of those financial statements with accounting principles generally
accepted in the U.S. (&#8220;U.S. GAAP&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has determined that all members of the Audit Committee meet the independence standards established by the SEC and Nasdaq. Our Board
has determined that Mr. Dentzer is qualified to serve as the &#8220;audit committee financial expert&#8221; as defined by Item 407(d)(5)
of Regulation S-K and that Mr. Fritz and Ms. Pellizzari meet the financial literacy requirements under applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee is responsible for establishing and administering the compensation policies applicable to our directors, officers,
and key personnel, for determining the compensation arrangements to our President and Chief Executive Officer and for evaluating the
performance of senior management. Our Compensation Committee operates under a written charter that is available on our web site, located
at <I><FONT STYLE="text-decoration: underline">www.imunon.com</FONT></I>. Additional copies of the charter are available upon written request to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee does not delegate the authority to approve compensation policies and actions affecting our Named Executive Officers
or directors. Our Compensation Committee applies discretion in determining compensation for our executives. Our Compensation Committee
has not established any equity or other security ownership requirements or guidelines in respect of our executive officers. Our Executive
Chairman and our President and Chief Executive Officer assist the Compensation Committee in evaluating the performance of other executive
officers and by providing information to directors as and when requested, such as salary surveys and compensation paid by our competitors,
to the extent such information is publicly available. Members of our Compensation Committee undertake to verify such information prior
to referring to it in determining executive compensation. The compensation of our President and Chief Executive Officer is determined
by the Compensation Committee based on their evaluation of her performance and with reference to such external or competitive data as
they consider necessary. The compensation of the other Named Executive Officers is determined by our Compensation Committee based on
its evaluation of their individual performance and the recommendations of our Executive Chairman and our President and Chief Executive
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Frederick J. Fritz (Chair), Dr. Donald P. Braun and Ms. Christine Pellizzari currently comprise our Compensation Committee. Our Board
has determined that all members of our Compensation Committee are independent under the applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nominating
and Governance Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee is responsible for identifying and recruiting new members of our Board of Directors when vacancies
arise, identifying and recruiting nominees for election as directors, reconsideration of incumbent directors in connection with nominations
for elections of directors and ensuring that our Board of Directors is properly constituted to meet its corporate governance obligations.
Our Nominating and Governance Committee operates under a written charter that is available on our web site, located at <I><FONT STYLE="text-decoration: underline">www.imunon.com</FONT></I>.
The current members of our Nominating and Governance Committee are Dr. Donald P. Braun and Mr. James A. Dentzer. Our Board has determined
that Dr. Braun and Mr. Dentzer are deemed to be independent under applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Science
and Technology Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary purpose of our Science and Technology Committee is to assist our Board of Directors in monitoring the state of science and technology
capabilities within our Company and associated risks and overseeing the development of key technologies and major science and medicine-driven
innovation initiatives essential to our long-term success. Our Science and Technology Committee&#8217;s responsibilities includes reviewing
technologies and technology programs of significance to us, with special focus on major external initiatives, observing the evolution
of science and medicine outside the Company, participating in the development of metrics to assess the state of our science and technology
in subject areas including, but not limited to, patent estate, freedom to operate, productivity, capability and external benchmarks,
providing guidance for our external science and technology alliances, and providing guidance on the direction of our science and technology
activities, as appropriate. The current members of our Science and Technology Committee are Dr. Donald P. Braun (Chair) and Dr. Stacy
R. Lindborg.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings
of the Board And its Committees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, there were a total of five regular meetings of our Board. All of our directors attended all of the
meetings of our Board and the Board committees on which they served that were held during the period for which they were a director or
committee member, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, our Audit Committee met four times, our Compensation Committee met one time, and our Nominating and
Governance Committee met one time. Our Science and Technology Committee did not meet during 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Nominations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
role of our Nominating and Governance Committee is to act on behalf of our Board of Directors to ensure that our Board of Directors and
its standing committees are appropriately constituted to meet their fiduciary and corporate governance obligations. In this role, our
Nominating and Governance Committee is responsible for identifying and recruiting new members of our Board of Directors when vacancies
arise, identifying and recruiting nominees for election as directors and reconsidering incumbent directors in connection with nominations
for elections of directors. Our Nominating and Governance Committee is also charged with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and recommending changes in the size and composition of our Board of Directors and Board committees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
    and maintaining criteria and processes for selecting candidates for election as directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
    and recruiting candidates to stand for election as directors and determining whether incumbent directors should stand for reelection;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensuring
    that we and our Board of Directors operate in accordance with current best practices;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
    for ongoing director training and education;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
    to our Board of Directors on Nominating and Governance Committee activities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
    reviewing the Nominating and Governance Committee&#8217;s performance of its responsibilities and duties; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;annually
    reviewing the Nominating and Governance Committee Charter, the structure and the processes and membership requirements of the Nominating
    and Governance Committee and recommending to our Board of Directors any improvements or amendments that our Nominating and Governance
    Committee considers appropriate or necessary.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Qualifications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is a policy of our Nominating and Governance Committee that candidates for director be determined to have unquestionable integrity and
the highest ethical character. Candidates must demonstrate the ability to exercise sound, mature and independent business judgment in
the best interests of the stockholders as a whole and may not have any interests that would, in the view of our Nominating and Governance
Committee, impair their ability to exercise independent judgment or otherwise discharge the fiduciary duties owed as a director. Candidates
must have experience and demonstrated achievement in one or more fields of business, professional, governmental, communal, scientific
or educational endeavors which will complement the talents of the other members of our Board of Directors and further our interests,
bearing in mind the composition of our Board of Directors and the current state of the Company and the state of the biotechnical/biopharmaceutical
industry generally. In particular, our Nominating and Governance Committee believes it is important for one or more members of our Board
of Directors to have in-depth experience in the biotechnical/biopharmaceutical industry. Our Nominating and Governance Committee has
determined that one or more of its members, including the incumbents nominated to stand for reelection at the Annual Meeting, should
have such biotechnical/biopharmaceutical experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Candidates
are expected to have an appreciation of the major issues facing public companies of a size and operational scope similar to us, including
contemporary governance concerns, regulatory obligations of a public issuer, strategic business planning, competition in a global economy,
and basic concepts of corporate finance. Candidates must also have the willingness and capability to devote the time necessary to participate
actively in meetings of our Board of Directors and Board Committee meetings and related activities, the ability to work professionally
and effectively with other members of the Board of Directors and Company management, and the ability and intention to remain on our Board
of Directors long enough to make an effective contribution. Among candidates who meet the foregoing criteria, our Nominating and Governance
Committee also considers the Company&#8217;s current and anticipated needs, including expertise, diversity and balance of inside, outside
and independent directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee, encouraging diversity, endeavors to comprise our Board of Directors of members with a broad mix
of professional and personal backgrounds. Thus, our Nominating and Governance Committee accords some weight to the individual professional
background and experience of each director. Further, in considering nominations, our Nominating and Governance Committee considers how
a candidate&#8217;s professional background would fit into the mix of experiences represented by the then-current Board of Directors.
When evaluating a nominee&#8217;s overall qualifications, our Nominating and Governance Committee does not assign specific weights to
particular criteria, and no particular criterion is necessarily required of all prospective nominees. In addition to the aforementioned
criteria, when evaluating a director for re-nomination to our Board of Directors, our Nominating and Governance Committee will also consider
the director&#8217;s history of attendance at board and committee meetings, the director&#8217;s preparation for and participation in
such meetings, and the director&#8217;s tenure as a member of our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Diversity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board
    Diversity Matrix (As of May 13, 2025)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Number of Directors: 6</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="6"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Part I: Gender
    Identity</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Female</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Male</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="8" STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Part II: Demographic Background</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">African American or Black</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alaskan Native or Native American</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Asian</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hispanic or Latinx</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Native Hawaiian or Pacific Islander</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">White</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Two or More Races or Ethnicities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">LGBTQ+</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD COLSPAN="5" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Did Not Disclose Demographic Background</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD COLSPAN="5" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the rules of the SEC and Nasdaq, the Company requires that at least a majority of the directors serving at any time on
the Board of Directors be independent, that at least three directors satisfy the financial literacy requirements for service on the Audit
Committee and that at least one member of the Audit Committee qualify as an &#8220;audit committee financial expert&#8221; under those
rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Dentzer acts as the chairman of our Audit Committee. The Board has determined that Mr. James E. Dentzer is qualified to serve as the
&#8220;audit committee financial expert&#8221; as defined by Item 407(d)(5) of Regulation S-K and that Mr. Fritz and Ms. Pellizzari meet
the financial literacy requirements under applicable SEC and Nasdaq rules. The Board of Directors determined that of the six currently
serving directors, four directors (Dr. Braun, Messrs. Dentzer and Fritz and Ms. Pellizzari) are independent under applicable SEC and
Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
and Governance Committee Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
selecting candidates for our Board of Directors, the Nominating and Governance Committee begins by determining whether the incumbent
directors whose terms expire at the annual meeting of stockholders desire and are qualified to continue their service on our Board of
Directors. Under its charter, our Nominating and Governance Committee is charged with considering incumbent directors as if they were
new candidates. However, our Nominating and Governance Committee recognizes the significant value of the continuing service of qualified
incumbents in promoting stability and continuity, providing the benefit of the familiarity and insight into our affairs and enhancing
our Board of Directors&#8217; ability to work as a collective body. Therefore, it is the policy of our Nominating and Governance Committee,
absent special circumstances, to nominate qualified incumbent directors who our Nominating and Governance Committee believes will continue
to make important contributions to our Board of Directors and who consent to stand for re-election. If any member of our Board of Directors
does not wish to continue in service or if our Nominating and Governance Committee or our Board of Directors decides not to re-nominate
a member, there is an existing vacancy on our Board of Directors, or our Board of Directors, upon the recommendation of the Nominating
and Governance Committee, elects to expand the size of our Board of Directors, the following process would be followed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee develops a profile for candidates&#8217; skills and experience, based on the criteria described
    above.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee initiates a search, polling members of the Board of Directors and management, and retaining a
    search firm if the Nominating and Governance Committee deems this appropriate.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee has a policy with respect to stockholders&#8217; suggestions for nominees for directorships.
    Under this policy, stockholder nominees are given identical consideration as nominees identified by the Nominating and Governance
    Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    process by which stockholders may submit potential nominees is described below under &#8220;Stockholder Recommendation Process.&#8221;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee then determines the eligibility and suitability of any candidate based on the criteria described
    above and the Nominating and Governance Committee&#8217;s search profile.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Chairman of the Board of Directors and at least one member of the Nominating and Governance Committee interview prospective candidate(s)
    who satisfy the qualifications described above.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee offers other members of the Board of Directors the opportunity to interview the candidate(s)
    and then meets to consider and approve the final candidate(s).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Nominating and Governance Committee seeks endorsement of the final candidate(s) from the full Board of Directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    final candidate(s) are nominated by the Board of Directors for submission to a stockholder vote or elected to fill a vacancy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Recommendation Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee will consider for nomination any qualified director candidates recommended by our stockholders. Any
stockholder who wishes to recommend a director candidate is directed to submit in writing the candidate&#8217;s name, biographical information
and relevant qualifications to our Corporate Secretary at our principal executive offices. All written submissions received from our
stockholders will be reviewed by the Nominating and Governance Committee at the next appropriate meeting. The Nominating and Governance
Committee will evaluate any suggested director candidates received from our stockholders in the same manner as recommendations received
from management, committee members or members of our board. The Company or the Nominating and Governance Committee may require a stockholder
who proposes a nominee to furnish such other information as may reasonably be required by the Company to determine the eligibility or
suitability of the proposed nominee to serve as director of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revisions
to Nomination Process</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee and stockholder recommendation processes have been developed to provide a flexible framework to permit
the director nomination process to move forward effectively. Our Nominating and Governance Committee intends to review these processes
from time to time in light of our evolving needs and changing circumstances, as well as changes in legal requirements and stock exchange
listing standards. The Nominating and Governance Committee may revise these processes or adopt new ones based on such periodic reviews.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Communications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted a process through which interested stockholders may communicate with our Board of Directors. Stockholders
who wish to send communications to our Board of Directors, or any particular director, should address such communications to the Corporate
Secretary, at the Company&#8217;s headquarters at 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey, 08648. The envelope containing
any such communication should be prominently marked &#8220;To the Attention of the Board of Directors&#8221; or to a particular committee
or director, and the communication should include a representation from the stockholder indicating the stockholder&#8217;s address and
the number of shares of our common stock beneficially owned by the stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Corporate Secretary is primarily responsible for monitoring communications from stockholders. Depending upon the content of a particular
communication, as he deems appropriate, our Corporate Secretary will: (i) forward the communication to the director, directors or committee
to whom it is addressed; (ii) attempt to handle the inquiry directly, for example where the stockholder communication consists of a request
for information about the Company or is a stock-related matter; or (iii) not forward communications such as solicitations, junk mail
and obviously frivolous or inappropriate communications. At each meeting of our Board of Directors, the Corporate Secretary will present
a summary of all communications, whether or not forwarded, received since the last meeting and will make those communications available
to the directors on request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Attendance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors strongly encourages, but does not require, all directors, to the extent reasonable and practicable, to attend the
Company&#8217;s Annual Meetings of Stockholders in person. All of the current members of our Board of Directors were present at the Company&#8217;s
2024 Annual Meeting of Stockholders held on June 12, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_005"></FONT>REPORT
OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is primarily responsible for our internal control and financial reporting process. Our independent registered public accounting
firm, WithumSmith+Brown, PC, is responsible for performing an independent audit of our consolidated financial statements and issuing
opinions on the conformity of those audited financial statements with U.S. GAAP and the effectiveness of our internal control over financial
reporting. Our Audit Committee monitors our financial reporting process and reports to the Board on its findings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this context, the Audit Committee hereby reports as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Audit Committee has reviewed and discussed the audited financial statements with our management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Audit Committee has discussed with our independent registered public accounting firm the matters required to be discussed under the
rules adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Audit Committee has received from the independent registered public accounting firm the written disclosures and the letter required
by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the
Audit Committee concerning independence and has discussed with the independent registered public accounting firm its independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Based on the review and discussions referred to in paragraphs (1) through (3) above, our Audit Committee recommended to the Board that
the audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31,
2024, for filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Members
of the Audit Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
James E. Dentzer (Chairman)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Frederick J. Fritz</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Christine A. Pellizzari</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report does not constitute &#8220;soliciting material&#8221; and shall not be deemed filed or incorporated by reference into any filing
under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent we specifically incorporate this
report by reference and shall not otherwise be deemed filed under such Acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_006"></FONT>EXECUTIVE
AND DIRECTOR COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
of Executive Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section discusses the material components of the executive compensation program for our executive officers who are named in the &#8220;2024
Summary Compensation Table&#8221; below. In 2024, our &#8220;named executive officers&#8221; and their positions were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    Lindborg, our President and Chief Executive Officer;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Tardugno, our Executive Chairman and former President and Chief Executive Officer; </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne
    Le Goff, our former President and Chief Executive Officer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed
    Anwer, our Executive Vice President and Chief Scientific Officer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero, our Chief Financial Officer; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Church, our former Executive Vice President, Chief Financial Officer and Corporate Secretary. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2024
Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the total compensation for services rendered in all capacities during the years ended
December 31, 2024 and 2023, awarded to, paid to, or earned by each &#8220;Named Executive Officer.&#8221;. All compensation awarded to,
earned by, or paid to IMUNON&#8217;s Named Executive Officers is included in the table below for the years ended December 31, 2024 and
2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name and Principal
    Position</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Salary</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bonus</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock<BR>
    Awards (1)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option<BR>
    Awards<BR> (2)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-Equity<BR>
    Incentive Plan<BR> Compensation<BR> (3)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    Other<BR> Compensation<BR> (4)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stacy Lindborg
    (5)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">341,954</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">335,641</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">283,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">201,745</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,189,339</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">President &amp; CEO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Michael Tardugno (6)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">336,639</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">213,072</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">175,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,099</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,810</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Chairman &amp; former interim CEO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Corinne Le Goff (7)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">148,869</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">148,869</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Former President and CEO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">658,080</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">107,775</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">274,959</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,055,814</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Khursheed Anwer (8)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">385,610</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">87.678</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">119,267</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">149,125</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">741,680</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive VP &amp; CSO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">412,760</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,900</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">125,281</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94,218</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">680,159</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">David Gaiero (9)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">280,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">280,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">CFO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jeffrey Church (10)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">251,337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,816</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,219</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">498,615</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">807,987</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Former Executive VP &amp; CFO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">441,296</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,900</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,726</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">679,922</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            value reported for restricted stock awards is the aggregate grant date fair value of restricted
                                            stock granted to the Named Executive Officer in the year shown, determined in accordance
                                            with FASB ASC Topic 718.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for option awards is the aggregate grant date fair value of stock options granted to the Named Executive Officers
    in the years shown, determined in accordance with FASB ASC Topic 718, disregarding adjustments for forfeiture assumptions. The assumptions
    for making the valuation determinations are set forth in Note 11 and Note 12 to the Company&#8217;s financial statements for the
    years ended December 31, 2024 and December 31, 2023, respectively, included in the Company&#8217;s Annual Reports on Form 10-K for
    each of those years. With respect to Dr. Lindborg, the column includes the annual grant of options to Dr. Lindborg as part of the
    non-employee director compensation program.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&#8217;
    bonuses under our annual incentive program are based on the achievement of specific performance measures established at the beginning
    of the fiscal year by our Compensation Committee. Historically, our Compensation Committee has awarded the annual incentive bonus
    for each year in the first quarter of the following year. In the first quarter of 2025, our Compensation Committee approved the amount
    and the payment of the incentive bonus for 2024 for each of the Named Executive Officers in the form of Non-Equity (Cash) Incentive
    Plan Compensation. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            column includes other compensation as indicated below and matching and discretionary contributions
                                            made by the Company for the Named Executive Officers under our 401(k) plan. Our matching
                                            contribution is equal to 50% of the employee&#8217;s deferrals under the plan up to 6% of
                                            the employee&#8217;s compensation, subject to applicable IRS limitations, and are made in
                                            shares of our common stock.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                            Lindborg, a director since 2021, joined the Company as President and Chief Executive Officer,
                                            effective as of May 13, 2024. Dr. Lindborg became a Named Executive Officer for the first
                                            time in 2024. For Dr. Lindborg, the amount in the &#8220;Salary&#8221; column reflects $14,838
                                            that Dr. Lindborg received as her cash retainer for her service as a non-employee director
                                            prior to becoming the Company&#8217;s President and CEO in May 2024, as well as the base
                                            salary amount received by Dr. Lindborg during fiscal year 2024, which was pro-rated for the
                                            time served in her employee positions during fiscal year 2024. For Dr. Lindborg &#8220;All
                                            Other Compensation&#8221; for 2024 consists of a 401(k)-plan matching contribution of $1,745
                                            in our common stock.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Tardugno, the Company&#8217;s Executive Chairman, served as the Company&#8217;s interim Chief Executive Officer from March 15, 2024
    until May 13, 2024. For Mr. Tardugno, &#8220;All Other Compensation&#8221; for 2024 consists of a 401(k)-plan matching contribution
    of $10,099 in our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Le Goff joined the Company as President and Chief Executive Officer and as a director, effective as of July 18, 2022, and stepped
    down from these positions, effective March 15, 2024. For Dr. Le Goff, the amount in the &#8220;Salary&#8221; column reflects the
    base salary amount received by Dr. Le Goff during fiscal year 2024, which was pro-rated for the time served in her employee positions
    during fiscal year 2024. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Dr. Anwer, &#8220;All Other Compensation&#8221; for 2024 consists of $133,000 for a retention bonus paid in July 2024, $5,775 for
    discretionary spending allowance and a 401(k)-plan matching contribution of $10,350 in our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Gaiero joined the Company as Chief Financial Officer, effective as of June 1, 2024. For Mr. Gaiero, the amount in the &#8220;Salary&#8221;
    column reflects the pro-rated amount received by Monomoy Advisors, LLC for the time served by Mr. Gaiero in his position of CFO during
    fiscal year 2024. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Church retired from the positions of Executive Vice President and Chief Financial Officer, effective as of June 1, 2024. For Mr.
    Church, the amount in the &#8220;Salary&#8221; column reflects the base salary amount received by Mr. Church during fiscal year 2024,
    which was pro-rated for the time served in his employee positions during fiscal year 2024. For Mr. Church &#8220;All Other Compensation&#8221;
    for 2024 consists of $428,615 in severance paid, in connection with his retirement, and $70,000 for consulting services he provided
    in 2024 post-retirement.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 25; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Narrative
Disclosure to 2024 Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Payments Upon Termination or Change in Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Arrangements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Agreement with Stacy R. Lindborg, Ph.D.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Lindborg entered into an employment agreement effective as of May 31, 2024, in connection with her appointment as President
and Chief Executive Officer. Pursuant to the Employment Agreement, the Company agreed to pay Dr. Lindborg an initial salary of $567,000
and a targeted annual performance bonus of 100% of her annual base salary (pro-rated for the year ended December 31, 2024). Dr. Lindborg
also received (i) an option to purchase 112,500 shares of the Company&#8217;s common stock and (ii) an additional option to purchase
112,500 shares of the Company&#8217;s common stock following the Company&#8217;s 2024 annual meeting of stockholders. Both stock options
will vest in equal fourths over four years, with the first 28,125 options vesting on the first anniversary of the date of grant and the
remaining three-fourths vesting in equal parts on subsequent anniversaries of the grant date. Dr. Lindborg is eligible to receive a sign-on
bonus from the Company of $200,000, subject to certain conditions. Dr. Lindborg&#8217;s initial term of employment pursuant to the Employment
Agreement is one year, to be extended automatically by an additional year at the end of such term and each subsequent one-year term absent
three months&#8217; prior written notice by Dr. Lindborg or the Company. Following the effective date of her employment with the Company,
Dr. Lindborg did not receive any additional compensation for her service on the Board. Dr. Lindborg&#8217;s employment agreement provides
that, upon a termination of Dr. Lindborg&#8217;s employment by the Company without &#8220;cause&#8221; or by Dr. Lindborg for &#8220;good
reason,&#8221; as each such term is defined in her employment agreement: (x) outside the Change in Control Protection Period (as defined
in the employment agreement), (i) Dr. Lindborg will be entitled to receive an amount equal to 12 months of her then-current base salary,
payable in equal monthly installments during the 12-month period following such termination and reimbursement of her COBRA premiums for
up to 12 months, and (ii) all of her options and similar awards would generally remain exercisable for the remainder of the original
term of the award, and (y) during the Change in Control Protection Period<B><I>, </I></B>(i) Dr. Lindborg will be entitled to receive
an amount equal to 24 months of her then-current base salary, payable in equal monthly installments during the 12-month period following
such termination and reimbursement of her COBRA premiums for up to 12 months, (ii) full acceleration of then-unvested portions of the
options awarded to Dr. Lindborg in connection with her appointment as CEO and (iii) all of her options and similar awards would generally
remain exercisable for the remainder of the original term of the award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Agreement with Corinne Le Goff</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&#160;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Le Goff entered into an employment agreement, effective as of July 18, 2022, in connection with her appointment as President
and Chief Executive Officer. Pursuant to the employment agreement, the Company agreed to pay Dr. Le Goff an initial salary of $624,000
and a signing bonus of $50,000. Dr. Le Goff&#8217;s targeted annual performance bonus was 72% of her annual base salary (pro-rated for
the year ended December 31, 2022). Dr. Le Goff also received (i) an option to purchase 177,000 shares of the Company&#8217;s common stock
that vested with respect to 25% of the subject shares on July 18, 2023 and the remaining 75% percent to vest in equal quarterly installments
thereafter such that the stock option would be fully vested and exercisable as of the fourth anniversary of July 18, 2022, and (ii) a
restricted stock award of 53,000 restricted shares that vested on July 18, 2023. Dr. Le Goff did not receive any additional compensation
for her service on the Board. The agreement had no set term of employment and provided that in the event of termination by the Company
other than for cause, Dr. Le Goff would receive an amount equal to one year&#8217;s salary as a severance payment. Effective March 15,
2024, Dr. Le Goff resigned from her positions as President, Chief Executive Officer and Director of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Agreement with Michael H. Tardugno</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
July 18, 2022, Mr. Tardugno transitioned from his roles as Chairman, President and Chief Executive Officer to the position of Executive
Chairman of the Board. Mr. Tardugno and the Company entered into an employment agreement, effective as of July 18, 2022, that superseded
the previous employment agreement with Mr. Tardugno. The agreement has a term ending on December 31, 2024, with the option for a one-year
extension that was exercised. Under the agreement, the Company agreed to pay Mr. Tardugno a base salary of $500,000 (prorated to $240,000)
for 2022 and a base salary of $350,000 for 2023 and 2024, and to reimburse him for all reasonable business expenses. Mr. Tardugno remains
eligible for annual performance bonuses and equity awards and may participate in all compensation and benefit programs generally made
available to other senior executives. In the event of termination by the Company other than for cause, Mr. Tardugno will receive an amount
equal to one year&#8217;s salary as a severance payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Consulting
Agreement with Monomoy Advisors, LLC</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Monomoy Advisors, LLC (&#8220;Monomoy&#8221;), a financial advisory services firm, entered into a professional consulting
agreement, effective as of June 1, 2024, in connection with the appointment of David Gaiero as the Company&#8217;s Chief Financial Officer.
Mr. Pursuant to the Agreement, the Company agreed to pay Monomoy $35,000 per month for Mr. Gaiero&#8217;s service as the Company&#8217;s
Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Retirement
and Consulting Agreement with Jeffrey Church</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 1, 2024, Mr. Church retired from his roles as Executive Vice President, Chief Financial Officer and Corporate Secretary. On May
17, 2024, the Company and Mr. Church entered into a retirement and consulting agreement (the &#8220;Retirement and Consulting Agreement&#8221;)
that superseded the previous employment agreement with Mr. Church, pursuant to which he agreed to provide the Company consulting services
for a term ending on December 31, 2024, with an option for an agreed upon extension (the &#8220;Consulting Period&#8221;). During the
Consulting Period, the Company agreed to pay Mr. Church a monthly retainer of $10,000, plus an additional $250 for each hour of services
performed in excess of 40 hours per month. In addition, pursuant to the Retirement and Consulting Agreement, Mr. Church received (i)
within 30 days following his Retirement Date, any accrued but unpaid salary and any unreimbursed business expenses incurred prior to
his Retirement Date and (ii) a retirement bonus in the amount of $428,615. Mr. Church also remained eligible to receive a pro-rated bonus
for 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Offer Letter with Khursheed Anwer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Dr. Anwer entered into an employment offer letter effective as of June 20, 2014. Dr. Anwer&#8217;s employment with us is
&#8220;at-will&#8221;; however, subject to the retention and severance agreement between the Company and Dr. Anwer dated as of May 28,
2014, if we terminate Dr. Anwer&#8217;s employment without cause (as such term is defined in the retention and severance agreement),
he will be entitled to receive cash severance equal to 12 months of his base salary and reimbursement of his COBRA premiums for up to
12 months. Dr. Anwer&#8217;s right to receive these severance benefits is subject to his providing a release of claims in favor of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>CIC
Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an amended and restated double-trigger change in control severance agreement (CIC Agreement) with Mr. Tardugno to provide
severance benefits to him should his employment terminate in certain circumstances in connection with a change in control of the Company
(a &#8220;CIC&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the amended and restated CIC Agreement, in the event that, on or within two years after a CIC, we terminate the executive&#8217;s employment
without cause or in the event that the executive terminates his employment for good reason, the executive would be entitled to receive
a cash lump sum payment equal to two (2) times the sum of (1) the executive&#8217;s annual base salary and (2) the executive&#8217;s
target annual bonus for the fiscal year in which the termination occurs. (For these purposes, the terms &#8220;cause,&#8221; &#8220;good
reason&#8221; and &#8220;change in control&#8221; are each defined in the CIC Agreement.) In addition, we will pay or reimburse the executive
for the cost of COBRA premiums and life insurance coverage for the executive and his eligible dependents, in each case for a period of
up to two years following the termination. The executive would also be entitled to full acceleration of his then-outstanding equity awards
granted to him by us. However, as to any equity award agreement that is subject to performance-based vesting requirements, the vesting
of such an award will continue to be governed by its terms. In the case of options or similar awards, the award would generally remain
exercisable for the remainder of the original term of the award (or, in the case of awards that vested after the date of the CIC, for
the lesser of 12 months following the last day such award would have been exercisable under the applicable award agreement and the remainder
of the original term). The benefits provided under the CIC Agreement are in addition to, and not in lieu of, any severance benefits the
executive may be entitled to receive in connection with the termination of his employment under any other agreement with the Company.
The executive&#8217;s right to benefits under the CIC Agreement is subject to his execution of a release of claims in favor of the Company
upon the termination of his employment. The CIC Agreements do not provide for any tax gross-ups.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Material
Terms of Equity Grants During 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the equity awards granted to the Named Executive Officers in 2024 was granted under, and is subject to, the terms of the IMUNON, INC.
2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;). The 2018 Plan is administered by the Compensation Committee, which has authority
to interpret the plan provisions and make all required determinations under the plan. This authority includes making required proportionate
adjustments to outstanding awards upon the occurrence of certain corporate events such as reorganizations, mergers, and stock splits,
and making provision to ensure that any tax withholding obligations incurred in respect of awards are satisfied. Awards granted under
the plan are generally only transferable to a beneficiary of a Named Executive Officer upon his death. Under the terms of the 2018 Plan,
if there is a change in control of the Company, each Named Executive Officer&#8217;s outstanding awards granted under the plan will generally
terminate, unless the Compensation Committee provides for the substitution, assumption, exchange or other continuation or settlement
(in cash, securities, or property) of the outstanding awards. The Compensation Committee has the discretion to provide for outstanding
awards to become vested in connection with a change in control. The Compensation Committee does not take material nonpublic information
into account when determining the timing and terms of equity awards. The Company does not time the disclosure of material nonpublic information
for the purpose of affecting the value of executive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
option granted to the Named Executive Officers in 2024 was granted with a per-share exercise price equal to the closing price of our
common stock on the grant date. Each option is scheduled to vest in three installments, with one-half vesting on the date of grant and
one-fourth vesting on the first and second anniversary of the date of the grant, subject in each case to the executive&#8217;s continued
employment through the applicable vesting date and has a maximum term of ten years. However, vested options may terminate earlier in
connection with a change in control transaction or a termination of the Named Executive Officer&#8217;s employment. Subject to any accelerated
vesting that may apply in the circumstances, the unvested portion of the option will immediately terminate upon a termination of the
Named Executive Officer&#8217;s employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of restricted stock granted to Dr. Lindborg in 2024 is scheduled to fully vest on the first anniversary of the grant date, subject
to the executive&#8217;s continued employment through the applicable vesting date. Subject to any accelerated vesting that may apply
in the circumstances, the unvested portion of the restricted stock will immediately terminate upon the termination of the Named Executive
Officer&#8217;s employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the stock options and restricted stock shares granted to our named executive officers in the 2024 fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Named
    Executive Officer</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024
                                            Stock</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
                                            Granted</FONT></P></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024
    Restricted Stock Shares Granted</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stacy Lindborg</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">293,102</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Michael Tardugno</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">207,926</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Corinne Le Goff</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Khursheed Anwer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">90,653</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">David Gaiero</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jeff Church</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<!-- Field: Page; Sequence: 28; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2024
Outstanding Equity Awards at Year-End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the number of shares of the Company&#8217;s common stock underlying outstanding equity incentive plan awards
for each Named Executive Officer as of December 31, 2024. None of the Named Executive Officers held any other outstanding stock awards
as of December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant
    Date</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares or Units of Stock</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">No.
    of Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Exercisable</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">No.
    of Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Unexercisable</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                            Exercise<BR> Price</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option<BR>
    Expiration<BR> Date</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 13%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Michae H. Tardugno</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 13%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,333</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25.80</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 12%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2029</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/04/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">80,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.60</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/04/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">90,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.93</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.32</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2033</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,463</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,463</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/18/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.83</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/18/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stacy R. Lindborg PhD</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/4/2021</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,666</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18.60</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/4/2031</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/4/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.60</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/4/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.93</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.32</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2033</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/13/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">112,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.48</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/13/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">112,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,801</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,801</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jeffrey Church</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,334</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25.80</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2029</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.93</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.32</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2033</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Khursheed Anwer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,832</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25.80</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/3/2029</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/04/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.60</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/04/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.93</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/13/2032</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.32</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/17/2033</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,327</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,327</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
    of these stock option grants vest in three equal installments, with one-third of the grant vesting each immediately, on the first
    anniversary, and on the second anniversary of the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
    of these stock option grants vest one half of the grant vesting on date of grant and one-fourth on the first and second anniversary
    of the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr.
    Lindborg received a restricted stock grant, which vests fully on the first anniversary of date of the grant.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2024
Option Exercises and Stock Vested</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, none of the Named Executive Officers exercised any of their vested stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pay
Versus Performance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reports the compensation of our principal executive officer (PEO) and the average compensation of the other named executive
officers (Other NEOs) as reported in the Summary Compensation Table for the past three fiscal years, as well as their &#8220;compensation
actually paid&#8221; as calculated pursuant to recently adopted SEC rules and certain performance measures required by the rules, including
total stockholder return (&#8220;TSR&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Year <FONT STYLE="font-family: Times New Roman, Times, Serif">(1)(2)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Summary Compensation Table (SCT) Total for PEO (Mr. Tardugno)</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Summary Compensation Table (SCT) Total for PEO (Dr. Le Goff)</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Summary Compensation Table (SCT) Total for PEO (Dr. Lindborg)</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Mr. Tardugno) <FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Dr. Le Goff) <FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Dr. Lindborg) <FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Average SCT Total for Other NEOs</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Average
    Compensation Actual Paid to Other NEOs <FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Value
    of Initial Fixed $100 Investment Based on TSR <FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Net
    Loss <FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&#160;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 9%; text-align: center; padding-bottom: 1pt">2024(a)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 7%; text-align: right">734,810</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">148,869</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">1,189,339</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">690,584</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">(6,685</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">1,129,602</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">567,201</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">684,636</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">10.25</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 6%; text-align: right">(18,620,242</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1pt">2023(b)</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT><FONT STYLE="display: none; font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,055,814</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT><FONT STYLE="display: none; font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT><FONT STYLE="display: none">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">910,533</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT><FONT STYLE="display: none">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">680,040</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">612,061</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6.38</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(19,514,977</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; padding-bottom: 1pt">2022(c)</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,085,391</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">883,794</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="display: none">-</FONT></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,876,247</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">755,144</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&#160;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;N/A</FONT><FONT STYLE="display: none">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">692,890</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">695,311</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12.68</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&#160;</TD><TD STYLE="padding-bottom: 1pt">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(35,465,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    are a smaller reporting company and, accordingly, we have not included any information in this table for 2021 or 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    PEOs and Other NEOs for the applicable years were as follows:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2024 Summary Compensation Table totals reported for the PEOs and the average of the Other NEOs for each year were subject to the following
adjustments per item 402(v)(2)(iii) of Regulations S-K to calculate &#8220;compensation actually paid&#8221;:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(4)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Measured
                                            as the value of a $100 investment in Imunon common stock at market close on December 31,
                                            2021, the last trading day in 2021, through and including the end of the indicated year.</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
in accordance with U.S. GAAP.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024:
    Dr. Le Goff served as the PEO until March 2024, Mr. Tardugno served as the PEO until May 2024, and Dr. Lindborg joined in May 2024
    as the PEO. Although Mr. Tardugno was an executive officer but not the PEO for the latter part of 2024, since he served as the PEO
    for a portion of the year he is not included as an Other NEO for any portion of 2024. Dr. Anwer, Mr. Gaiero and Mr. Church served
    as the Other NEO&#8217;s for 2024.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023:
    Dr. Le Goff served as the PEO, and Dr. Anwer and Mr. Church as the Other NEO&#8217;s for 2023.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022:
    Mr. Tardugno served as the PEO until July 2022 and Dr. Le Goff joined in July 2022 as the PEO, and Dr. Anwer and Dr. Nicholas Borys
    as the Other NEO&#8217;s for 2022. Although Mr. Tardugno was an executive officer but not the PEO for the latter part of 2022, since
    he served as the PEO for a portion of the year he is not included as an Other NEO for any portion of 2022.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
    are a smaller reporting company and, accordingly, we have not included any information in this table for 2021 or 2020.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; display: none">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
    PEOs and Other NEOs for the applicable years were as follows:</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024:
    Dr. Le Goff served as the PEO until March 2024, Mr. Tardugno served as the PEO until May 2024, and Dr. Lindborg joined in May 2024
    as the PEO. Although Mr. Tardugno was an executive officer but not the PEO for the latter part of 2024, since he served as the PEO
    for a portion of the year he is not included as an Other NEO for any portion of 2024. Dr. Anwer, Mr. Gaiero and Mr. Church served
    as the Other NEO&#8217;s for 2024.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023:
    Dr. Le Goff served as the PEO, and Dr. Anwer and Mr. Church as the Other NEO&#8217;s for 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022:
    Mr. Tardugno served as the PEO until July 2022 and Dr. Le Goff joined in July 2022 as the PEO, and Dr. Anwer and Dr. Nicholas Borys
    as the Other NEO&#8217;s for 2022. Although Mr. Tardugno was an executive officer but not the PEO for the latter part of 2022, since
    he served as the PEO for a portion of the year he is not included as an Other NEO for any portion of 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2024 Summary Compensation Table totals reported for the PEOs and the average of the Other NEOs for each year were subject to the
    following adjustments per item 402(v)(2)(iii) of Regulations S-K to calculate &#8220;compensation actually paid&#8221;:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO
    (Mr. Tardugno)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO
    (Dr. Le Goff)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO
    (Dr. Lindborg)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average
    for Other NEOs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average
    for Other NEOs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO
    (Mr. Tardugno)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PEO
    (Dr. Le Goff)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average
    for Other NEOs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Summary Compensation Table Total</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,810</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">148,869</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,189,339</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;567,201</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,055,814</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;&#160;680,040</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,085,391</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">883,794</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;&#160;692,890</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">ADJUSTMENTS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deductions for amounts reported under the &#8220;Stock
    Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table(a)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(213,072</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(362,141</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">90,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(107,775</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(83,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(506,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(406,064</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(68,893</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase for the inclusion of Rule 402(v) Equity
    Value (a)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">168,846</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(155,554</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">302,404</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,486</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(37,506</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,120</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">297,356</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">277,414</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">71,314</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation Actually Paid</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">690,584</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,685</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,129,602</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">684,636</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">910,533</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">612,061</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,876,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">755,144</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">695,311</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually
Paid excludes the Stock Awards and Option Awards columns from the relevant fiscal year&#8217;s Summary Compensation Table total. The
Rule 402(v) Equity Values instead reflect the aggregate of the following components, as applicable: (i) the fair value as of the end
of the listed fiscal year of unvested equity awards granted in that year; (ii) the change in fair value during the listed fiscal year
of equity awards granted in prior years that remained outstanding and unvested at the end of the listed fiscal year; and (iii) the change
in fair value during the listed fiscal year through the vesting date of equity awards granted in prior years that vested during the listed
fiscal year, less the fair value at the end of the prior year of awards granted prior to the listed fiscal year that failed to meet applicable
vesting conditions during the listed fiscal year. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation
assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Measured
    as the value of a $100 investment in Imunon common stock at market close on December 31, 2021, the last trading day in 2021, through
    and including the end of the indicated year.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    in accordance with U.S. GAAP.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
Performance Measures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently use financial performance measures to link executive compensation actually paid to our NEOs to our performance. However,
as discussed above under &#8220;Executive Compensation,&#8221; we do utilize non-financial measures such as clinical development progress
and timelines, manufacturing measures and progress towards commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Analysis
of the Information Presented in the Pay Versus Performance Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in more detail above under &#8220;Compensation Discussion and Analysis&#8221; our executive compensation is designed to (1)
attract, motivate and retain talented executives with total compensation that is competitive in our industry; (2) align the interests
of our executives and our stockholders; and (3) award behavior which results in optimizing the commercial potential of our development
program. We use various performance measures to align executive compensation with our performance which are not presented in the Pay
Versus Performance table. In accordance with Item 402(v) of Regulation S-K, we are providing the following description of the relationships
between the information presented in the Pay Versus Performance table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&#160;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Table
Compensation Actually Paid and Cumulative TSR</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to Dr. Lindborg, Mr. Tardugno and Dr. Le Goff in 2024, Dr. Le Goff in 2023, and Mr. Tardugno and
Dr. Le Goff in 2022 is aligned with our TSR over the two years presented in the table, reflecting the impact of (i) the hiring of Dr.
Lindborg as President and Chief Executive Officer in 2024 and the termination of Dr. Le Goff in 2024 and cash payments made in connection
therewith and (ii) the hiring of Dr. Le Goff as President and Chief Executive Officer and the transition of Mr. Tardugno from those roles
to the role of Executive Chairman during 2022 and cash payments made in connection therewith. Notwithstanding those payments, a substantial
amount of Dr. Lindborg&#8217;s compensation was in the form of stock option awards that vest in four equal installments, with one-fourth
of the grant vesting each on the first, second, third and fourth anniversary of the date of grant. A substantial amount of Mr. Tardugno&#8217;s
compensation was in the form of stock option awards that vest one-half immediately and one-fourth on each of the first and second anniversary
of the date of grant. A substantial amount of Dr. Le Goff&#8217;s compensation was in the form of stock option awards that vest in three
equal installments, with one-third of the grant vesting each on the first, second and third anniversary of the date of grant. As the
trading price of our common stock fluctuates so does the value of the stock options and, accordingly, the amount of the compensation
actually paid to the PEO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to the Other NEOs is aligned with our TSR over the three years presented in the table. A significant
portion of the compensation actually paid to the Other NEOs is composed of stock option awards which vest either (i) in three installments,
commencing one-third immediately and one-third on each of the first and second anniversary of the date of grant or (iii) one-half immediately
and one-fourth on each of the first and second anniversary of the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&#160;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Actually Paid and Net Income</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of compensation actually paid to Dr. Lindborg, Mr. Tardugno and Dr. Le Goff in 2024, Dr. Le Goff in 2023, and Mr. Tardugno and
Dr. Le Goff in 2022 and to the Other NEOs is not aligned with our net income over the three years presented in the table. As a clinical
stage biotechnology company, we have incurred substantial operating losses, principally from expenses associated with the Company&#8217;s
research and development programs, clinical trials conducted in connection with the Company&#8217;s drug candidates, and applications
and submissions to the U.S. Food and Drug Administration. We have substantial future capital requirements to continue our research and
development activities and advance our drug candidates through various development stages. Accordingly, net income is not a performance
measure we use in determining executive compensation. As discussed above, under &#8220;Compensation Discussion and Analysis,&#8221; we
use a number of corporate goals that may include research and development, regulatory, manufacturing, organization and financial goals
which we believe are important to building stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2024, our net loss was $18.6 million compared to a net loss of $19.5 million for the year ended December
31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information as of December 31, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Plan Category</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of<BR> securities to be<BR> issued upon<BR> exercise of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>outstanding<BR>
                                            options, warrants</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
                                            rights </B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average<BR>
    exercise price<BR> of outstanding<BR> options, warrants<BR> and rights (1)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of<BR> Securities<BR> remaining<BR> available for<BR> future issuance<BR> under equity<BR> compensation<BR> plans (excluding<BR>
    securities reflected<BR> in first column)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity compensation plans approved
    by securityholders</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,555,073</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP>&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.03</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(3)</SUP>&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity compensation plans not approved by securityholders</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">130,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(4)</SUP>&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.07</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8211;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,685,573</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.95</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the weighted average exercise price of outstanding stock options and does not take into account
                                            restricted stock awards, which do not have an exercise price.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under the 2018 Plan. These awards have a weighted
    average remaining term of 8.7 years.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares available for award grant purposes under the 2018 Plan. Subject to certain express limits of the plan, shares available under
    the plan generally may be used for any type of award authorized under that plan including options, stock appreciation rights, restricted
    stock and other forms of awards granted or denominated in shares of our common stock or units of our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    both vested and unvested options to purchase common stock and unvested stock grants under inducement grants provided certain employees
    as an inducement to accept employment with the Company. These awards have a weighted average remaining term of 9.5 years. These grants
    are similar to those granted under the 2018 Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2024
Non-Employee Director Compensation Table</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the cash and non-cash compensation paid to the Company&#8217;s directors who were not employed by the Company
or any of its subsidiaries (&#8220;Non-Employee Directors&#8221;) for the year ended December 31, 2024. Other than as set forth in the
table, we did not pay any compensation, make any equity awards or non-equity awards to, or pay any other compensation to any of the Non-Employee
Directors in 2024. The compensation paid to any director who was also one of our employees during fiscal year 2024 is presented in the
&#8220;2024 Summary Compensation Table&#8221; and the information that follows that table. Such employee directors did not receive separate
compensation for their service on the Board of Directors or any of its Committees (other than Dr. Lindborg prior to her appointment as
CEO and President of the Company as described in Footnote (1) below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name (1)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fees
    Earned<BR> ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards<BR> ($) (2)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total<BR>
    ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">James E. Dentzer</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,839</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,144</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63,983</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Frederick J. Fritz</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">93,419</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,309</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">106,728</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Donald P. Braun</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,949</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12.651</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">71,600</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Christine A. Pellizzari</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,039</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,456</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,495</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                            Lindborg did not participate in the non-employee director compensation program following
                                            her appointment as CEO and President of the Company. The compensation received by Dr. Lindborg
                                            during 2024, including the compensation received solely for her service as a non-employee
                                            director, is reported in the Summary Compensation Table above.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    value reported for Option Awards is the aggregate grant date fair value of stock options granted to each Director in 2024, determined
    in accordance with FASB ASC Topic 718. The assumptions for making the valuation determinations are set forth in Note 11 to our financial
    statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. As of December 31, 2024, Mr. Dentzer
    had 17,301 option awards outstanding; Mr. Fritz had 32,070 option awards outstanding; Dr. Braun had 28,905 option awards outstanding;
    and Ms. Pellizzari had 23,630 option awards outstanding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth stock option grants awarded to the Company&#8217;s Non-Employee Directors for the year ended December 31,
2024. Employee directors do not receive separate equity awards for service on the Board of Directors or any of the Board committees.
Dr. Lindborg did not participate in the non-employee director compensation program following her appointment as CEO and President of
the Company. Equity awards received by Dr. Lindborg during 2024 for her service as a non-employee director are reported in the Summary
Compensation Table above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-Employee
    Director Stock Option and Grant Awards Table</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of<BR> Options Granted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(#)
                                            (1)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
                                            Price</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant
    Date</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expiration
    Date</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
                                            Date</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
                                            Value</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">James E. Dentzer</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.79</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.12</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,634</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.99</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Frederick J. Fritz</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.79</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.12</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,737</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.99</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Donald P. Braun</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.79</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.12</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,072</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.99</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Christine A. Pellizzari</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.86</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/15/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.79</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.12</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,964</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/6/2034</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.99</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of these stock option grants vests with one-half of the grant vesting on the date of grant and one fourth of the grant vesting on
    each of the first and second anniversary of the date of grant, subject to the applicable director&#8217;s continued service as a
    member of our Board through each applicable vesting date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2024, each Non-Employee Director of the Company received annual cash compensation in the amount of $27,450
payable in quarterly installments, and an additional $1,980 for attendance at regular meetings of the Board of Directors and $1,080 for
each meeting of a committee of the Board of Directors that was not held in conjunction with a meeting of the Board of Directors. Each
Non-Employee director is reimbursed for the out-of-pocket costs of attending meetings of the Board of Directors and of committees of
the Board of Directors. In 2024, the Chairman of the Audit Committee received an additional annual cash fee of $12,150 and the Chairman
of the Compensation Committee received an additional annual cash fee of $9,450.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Acting
on behalf of the Board of Directors, Mr. Fritz also received fees totaling $43,200 in 2024 for his role as a Board Liaison to our Board
of Directors. Mr. Fritz&#8217;s responsibilities as Board Liaison include the following: (i) serve as an initial sounding board for our
management regarding issues, matters, or communications to be brought or potentially to be brought before the Board of Directors; (ii)
provide input and feedback to management regarding strategic matters, business matters, major scientific, clinical, collaboration, or
corporate development matters, key personnel matters, or other items of significance regarding which management would like to obtain
initial or further Board guidance, including, but not limited to, guidance regarding timing and content of communications regarding such
matters or items with the full Board or any of its committees; (iii) remain accessible to management to provide guidance on business
or strategy issues or other issues of significance on an as-needed basis; (iv) participate in meetings and relevant discussions as requested
by management; (v) conduct general advisory or liaison services to the Board, including relaying to management requests from other members
of the Board regarding desired additional information or clarification or suggestions or feedback regarding improvement in Board processes
or communications; (vi) serve as a conduit for informal communications between management and the Board; and (vii) any other such services
established by the Board from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on behalf of our Board of Directors, Dr. Braun also received fees totaling $22,500 in 2024 for his role as a strategic advisor to our
Executive Chairman and our Chief Executive Officer. Dr. Braun&#8217;s responsibilities as a strategic advisor include the following:
(i) provide strategic and tactical advice to our Chief Executive Officer; (ii) evaluate international subsidiary options; (iii) develop
strategies to secure business relationships other than in the U.S.; and (iv) having done both (ii) and (iii), develop high potential
ex-US market strategies that address the objectives for broad and profitable sales of its commercial products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Ownership Guidelines for Non-Employee and Executive Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that, as a matter of sound corporate governance, non-employee and executive directors should have a significant
personal financial stake in our performance. Consequently, in February 2011, our Board of Directors adopted stock ownership guidelines
for non-employee and executive directors. Our corporate governance guidelines require that each non-employee director acquire and hold
shares of our common stock having an aggregate value equal to two times the director&#8217;s total compensation in the first year of
service and that our executive director acquire and hold shares of our common stock having an aggregate value equal to the executive
director&#8217;s total compensation in the first year of service. Each director is expected to satisfy the applicable ownership guideline
within three years after his or her appointment to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock that count toward satisfaction of these ownership guidelines include, unless beneficial ownership therein is disclaimed:
(i) shares owned outright by the director or executive officer or their immediate family members residing in the same household, whether
held individually or jointly; (ii) shares held in a trust, family limited partnership or similar entity solely for the benefit of the
director or executive officer and/or their immediate family members; (iii) shares of restricted stock and restricted stock units awarded
under our equity incentive plans, including vested and unvested awards; and (iv) shares acquired upon stock option exercise, but not
shares underlying unexercised stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_007"></FONT>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Code of Ethics requires all of our directors, officers and employees to give their complete loyalty to the best interests of the Company
and to avoid any action that may involve, or that even may appear to involve, a conflict of interest with the Company. The Code of Ethics
also requires any of our directors, officers or employees who become aware of a conflict or potential conflict to bring it to the attention
of supervisor, manager or other appropriate personnel or consult the compliance procedures provided in the Code of Ethics. The Board
of Directors reviews and approves or ratifies all relationships and transactions between us and (i) any of our directors or executive
officers, (ii) any nominee for election as a director, (iii) any securityholder who is known to us to own beneficially or of record more
than five percent of our common stock or (iv) any member of the immediate family of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 16, 2022, the Company entered into a Convertible Note Purchase Agreement with Transomic Technologies, Inc. (&#8220;Transomic&#8221;)
whereby the Company purchased $375,000 of convertible notes secured by certain assets held by Transomic and warrants. As a result of
this investment in Transomic, Imunon&#8217;s executive chairman, Mr. Michael Tardugno, was appointed to the Board of Directors of Transomic.
The Company is disclosing the notes receivable as a related party transaction. In December 2023, Transomic filed a formal certificate
of dissolution of the company resulting in a complete write off of the convertible note and related warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_008"></FONT>PROPOSAL
NO. 1:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Amended and Restated Certificate of Incorporation provides that the number of directors that constitutes the Board of Directors is to
be fixed by, or in the manner provided in, our Amended and Restated Bylaws, as amended (the &#8220;Bylaws&#8221;). The Amended and Restated
Certificate of Incorporation also provides that the Board of Directors is to be divided into three classes, designated as Class I, Class
II and Class III, and it is our practice to have such classes as even in size as possible. The Bylaws provide that the Board of Directors
is to consist of between three and eight directors, with the exact number to be fixed by action of the Board of Directors. The current
number of directors has been fixed by the Board of Directors at six. Currently, no Board seats remain vacant, and the Board of Directors
consists of six directors, four of which are independent under applicable SEC and Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has nominated each of Mr. Michael H. Tardugno and Dr. Donald P. Braun to stand for re-election to the Board of Directors
as a Class III Director, with a term expiring at the Annual Meeting of Stockholders to be held in 2028 or with the election and qualification
of a successor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that Mr. Michael H. Tardugno or Dr. Donald P. Braun become unavailable for election as a result of an unexpected occurrence,
the designated proxies will vote in their discretion for a substitute nominee, or our Board of Directors may reduce the number of directors
serving on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
election of Class III Directors at the Annual Meeting will be by a plurality of the votes cast. This means that the director nominee
receiving the greatest number of votes cast, via the live webcast or by proxy, by the holders of our common stock in the election of
the Class III Director, will be elected. Stockholders may not cumulate their votes in electing directors. Stockholders entitled to vote
at the Annual Meeting may either vote &#8220;FOR&#8221; the nominee for election as a director or may &#8220;WITHHOLD&#8221; authority
for the nominee. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the
nominee named above in Proposal No. 1. If a stockholder withholds authority to vote with respect to the nominee for director, the shares
held by that stockholder will be counted for purposes of establishing a quorum but will have no effect on the election of the nominee.
Broker non-votes will have no effect on the election of the nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OUR
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;<I>FOR&#8221;</I> THE ELECTION OF EACH OF THE DIRECTOR NOMINEES NAMED ABOVE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_009"></FONT>PROPOSAL
NO. 2:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFICATION
OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has appointed WithumSmith+Brown, PC (&#8220;Withum&#8221;) as the independent registered public accounting firm of the
Company to audit our financial statements for the fiscal year ending December 31, 2025, and our Board requests stockholder ratification
of such selection. Withum, Brown + Smith PC (&#8220;Withum&#8221;) has served as our independent accountants since 2017 and has advised
us that neither Withum nor any of its members has, or has had in the past three years, any financial interest in the Company or any relation
to the Company other than as auditors and accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives
of Withum are expected to be present at the 2025 Annual Meeting and will be given the opportunity to make a statement if they so desire
and respond to appropriate questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees as invoiced for professional audit services rendered for the fiscal years ended December 31, 2024 and December
31, 2023, and fees for other services rendered during those periods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">FEE CATEGORY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMOUNT</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%
    <BR> OF TOTAL</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMOUNT</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%<BR>
    OF TOTAL</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit Fees</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,240</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">68</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit Related Fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,200</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,705</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,272</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,750</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">All Other Fees</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45,240</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">78,885</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Fees</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">211,952</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">252,340</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
fees consist of fees for professional services rendered by Withum for the audits of our annual financial statements in our Annual Reports
on Form 10-K and for reviews of the quarterly financial statements included in the Company&#8217;s Quarterly Reports on Form 10-Q. Audit-related
fees pertain to the work performed during our equity offerings in 2024 and 2023. Tax fees consist of fees for preparation of the Company&#8217;s
federal and state tax returns. All other fees consist of fees for attendance at the Company&#8217;s annual meetings, review of registration
statements and similar matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Services
by Employees of Withum</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
part of Withum&#8217;s engagement to audit the Company&#8217;s financial statements for the years ended December 31, 2024 and 2023 was
attributable to work performed by persons other than Withum&#8217;s full-time, permanent employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Committee Policy on Approval of Audit and Non-Audit Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the policy of the Audit Committee to pre-approve all audit and permissible non-audit services provided by our independent accountants,
in accordance with rules prescribed by the SEC. These services may include audit services, audit-related services, tax services, and
other services. Pre-approval is based on a written proposal, accompanied by a cost estimate, and estimated budget. The Audit Committee
has delegated to its chairman the authority to pre-approve audit and non-audit services with an estimated cost of up to $25,000, provided
the exercise of such authority is reported to the Audit Committee at its next regular meeting. The Audit Committee reserves the right,
from time to time, to delegate pre-approval authority to other of its members, so long as such members are independent directors. All
audit and permissible non-audit services during 2024 and 2023 were approved by the Audit Committee in accordance with its pre-approval
policy and the approval requirements of the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the votes cast affirmatively or negatively for this proposal will be required to ratify
the selection of Withum as the Company&#8217;s independent registered public accounting firm for the year ending December 31, 2025. Abstentions
will have no effect on the results of the vote on Proposal No. 2. No broker non-votes are expected to exist in connection with this vote,
as ratification of the independent registered public accounting firm is considered a routine matter under applicable rules, but any broker
non-votes would have no effect on Proposal No. 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE PROPOSAL TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFY
THE SELECTION OF WITHUM AS THE COMPANY&#8217;S INDEPENDENT REGISTERED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PUBLIC
ACCOUNTING FIRM FOR THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_010"></FONT>PROPOSAL
NO. 3:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADVISORY
VOTE TO APPROVE EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is providing its stockholders with the opportunity to cast a non-binding, advisory vote on the compensation of our Named Executive
Officers as disclosed pursuant to the SEC&#8217;s executive compensation disclosure rules and set forth in this proxy statement (including
in the compensation tables and narratives accompanying those tables).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive compensation program is guided by the principle that the compensation of the Company&#8217;s executive officers should encourage
the creation of stockholder value and achievement of strategic corporate objectives. In furtherance of this principle, the Company&#8217;s
executive compensation program includes a number of features intended to reflect best practices in the market and help ensure that the
program reinforces stockholder interests. These features include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    significant amount of the executives&#8217; compensation is at risk. For fiscal year 2024, Approximately 30% of Dr. Lindborg&#8217;s
    target total direct compensation was performance-based and/or linked to the value of the Company&#8217;s stock price.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&#8217;
    bonuses under our annual incentive program are principally based on the achievement of specific performance objectives established
    at the beginning of the fiscal year by the Compensation Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executives&#8217;
    equity awards are granted in the form of stock options that help to align the executives&#8217; interests with those of our stockholders
    as the options will not have value unless there is appreciation in the Company&#8217;s stock price after the option is granted.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the requirements of Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer
Protection Act) and the related rules of the SEC, the Board of Directors will request your advisory vote on the following resolution
at the Annual Meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESOLVED,
</B>that the compensation paid to the Company&#8217;s Named Executive Officers, as disclosed in this proxy statement pursuant to the
SEC&#8217;s executive compensation disclosure rules (which disclosure includes the compensation tables and the narrative discussion that
accompanies the compensation tables), is hereby approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
vote is an advisory vote only and is non-binding on the Company, the Board of Directors or the Compensation Committee, and will not be
construed as overruling a decision by, or creating or implying any additional fiduciary duty for, the Board of Directors or the Compensation
Committee. However, the Compensation Committee, which is responsible for designing and administering the Company&#8217;s executive compensation
program, values the opinions expressed by stockholders in their vote on this proposal, and will consider the outcome of the vote when
making future compensation decisions for Named Executive Officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast affirmatively or negatively for this proposal will be required to approve, on an advisory
basis, the 2024 executive compensation for the Company&#8217;s Named Executive Officers. Abstentions and broker non-votes will have no
effect on Proposal No. 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#8220;FOR&#8221; THE ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_011"></FONT>PROPOSAL
NO. 4:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE ISSUANCE PROPOSAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is asking stockholders to consider and vote upon a proposal to approve the issuance of shares of our common stock underlying certain
warrants issued in May 2025, in accordance with Nasdaq Listing Rule 5635(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2025, we entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain institutional and accredited
investors for the issuance and sale in a private placement (the &#8220;Private Placement&#8221;) of (i)&#160;2,777,779 shares (the &#8220;Shares&#8221;)
of the Company&#8217;s common stock, (ii) pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to 4,444,444 shares
of common stock at an exercise price of $0.0001 per share, and (iii) warrants (the &#8220;Common Warrants&#8221;) to purchase up to 14,444,446
shares of common stock at an exercise price of $0.45 per share. The purchase price per Share and accompanying Common Warrant was $0.45
and the purchase price per Pre-Funded Warrant and accompanying Common Warrant was $0.4499.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants were exercisable immediately, may be exercised at any time until all of the Pre-Funded Warrants are exercised in
full, and have an exercise price of $0.0001 per share. The Common Warrants will be exercisable beginning on the effective date of Stockholder
Approval (as defined below) of the issuance of the Warrant Shares (as defined below). The Common Warrants will expire three years from
the effective date of Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of the Pre-Funded Warrants and the Common Warrants may not exercise any portion of such holder&#8217;s Pre-Funded Warrants or
Common Warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election
of the holder, 9.99%) of our outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#8217;
prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number
of shares of common stock outstanding immediately after giving effect to the exercise. In the event of certain fundamental transactions,
the holders of Common Warrants have the right to require the Company or a successor entity to purchase the Common Warrants from the holder
for an amount of consideration equal to the Black Scholes Value (as defined in the Common Warrants) of the remaining unexercised portion
of the Common Warrants concurrently with or within 30 days following the consummation of a fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, we entered into a registration rights agreement (&#8220;Registration Rights Agreement&#8221;),
dated as of May 23, 2025, with the investors, pursuant to which we agreed to prepare and file a registration statement with the SEC registering
the resale of the Shares and the shares of common stock underlying the Pre-Funded Warrants and the Common Warrants no later than 15 days
after the date of the Registration Rights Agreement (the &#8220;Registration Statement&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) acted as our lead placement agent, and Brookline Capital Markets, a division of
Arcadia Securities, LLC, acted as co-placement agent, in connection with the Private Placement, pursuant to the Engagement Letter dated
as of May 22, 2025 (the &#8220;Engagement Letter&#8221;), between us and Wainwright. In addition, we issued to Wainwright, or its designees,
warrants (the &#8220;Placement Agent Warrants&#8221; and together with the Common Warrants, the &#8220;Warrants&#8221;) to purchase up
to an aggregate of 361,111 shares of common stock at an exercise price equal to $0.5625 per share (the &#8220;Placement Agent Warrant
Shares&#8221; and together with the Common Warrant Shares, the &#8220;Warrant Shares&#8221;). The Placement Agent Warrants have substantially
the same terms as the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule 5635 requires that a listed company seek stockholder approval in certain circumstances, including prior to the issuance,
in a transaction other than a public offering, of 20% or more of the company&#8217;s outstanding common stock or voting power outstanding
before the issuance at a price that is less than the lower of (i) the Nasdaq Official Closing Price (as reflected on Nasdaq.com) immediately
preceding the signing of the binding agreement in connection with such transaction, or (ii) the average Nasdaq Official Closing Price
of the common stock (as reflected on Nasdaq.com) for the five trading days immediately preceding the signing of such binding agreement
(the &#8220;Minimum Price&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2025 and December 31, 2024, we had cash and cash equivalents of $2.9 million and $5.9 million, respectively. We
previously received a delisting notice from Nasdaq, as we are not in compliance with certain listing requirements. On May 29,
2025, the Company appealed the Nasdaq staff&rsquo;s determination to a&nbsp;Nasdaq&nbsp;Hearings&nbsp;Panel, which
will stay the delisting and suspension of the Company&rsquo;s common stock pending a decision by
the&nbsp;Nasdaq&nbsp;Hearings&nbsp;Panel. There can be no assurance that our request for continued listing will be granted. We
believe that the Private Placement, which yielded gross proceeds of approximately $3.25 million, was necessary in light of our cash
and funding requirements at the time. In addition, at the time of the Private Placement, our Board considered numerous other
alternatives to the transaction, none of which proved to be feasible or, in the opinion of our Board, would have resulted in
aggregate terms equivalent to, or more favorable than, the terms obtained in the Private Placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Purchase Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains representations and warranties of us and the institutional and accredited investors, which are typical for
transactions of this type. In addition, the Purchase Agreement contains customary covenants on our part that are typical for transactions
of this type, including the following (each as set forth more fully in the Purchase Agreement):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&#160;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            agreed not to effect or agree to effect any variable rate transactions until one year after
                                            the effective date of the Registration Statement, subject to certain exceptions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&#160;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            agreed not to issue any shares of common stock or common stock equivalents or to file any
                                            other registration statement with the SEC (in each case, subject to certain exceptions) until
                                            30 days after the effective date of the Registration Statement; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&#160;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            agreed to seek stockholder approval in accordance with the applicable rules and regulations
                                            of Nasdaq (&#8220;Stockholder Approval&#8221;) of, and to solicit our stockholders&#8217;
                                            affirmative vote for approval of, the issuance of the Warrant Shares at our Annual Meeting,
                                            and, if Stockholder Approval is not obtained at the Annual Meeting, to call a meeting every
                                            90 days thereafter to seek such Stockholder Approval until the earlier of the date on which
                                            Stockholder Approval is obtained or the Warrants are no longer outstanding. This Issuance
                                            Proposal is intended to fulfill this final covenant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Engagement Letter</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Engagement Letter, we paid Wainwright a total cash fee equal to 7.0% of the aggregate gross proceeds of the Private Placement,
as well as certain expenses, and Brookline received up to 15% of the cash fee. In addition, the Company issued to Wainwright, or its
designees, the Placement Agent Warrants to purchase up to an aggregate of 361,111 shares of common stock at an exercise price equal to
$0.5625 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants are exercisable on or after Stockholder Approval until the three-year anniversary of the Stockholder Approval. The Common
Warrants have an exercise price of $0.45 per share. The exercise price and number of shares issuable upon exercise of the Common Warrants
is subject to appropriate adjustment in the event of stock dividends, stock splits, subsequent rights offerings, pro rata distributions,
reorganizations, or similar events affecting the common stock and the exercise price. Upon any such price-based adjustment to the exercise
price, the number of shares issuable upon exercise of the Common Warrants will be adjusted proportionately. The Common Warrants may be
exercised for cash, provided that, if there is no effective registration statement available registering resale of the Common Warrant
Shares, the Common Warrants may be exercised on a cashless basis. The Placement Agent Warrants have substantially the same terms as the
Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
of the Issuance of the Common Stock Underlying the Pre-Funded Warrants and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
potential issuance of the shares of common stock underlying the Pre-Funded Warrants and Warrants would result in an increase in the number
of shares of common stock outstanding, and our stockholders would incur dilution of their percentage ownership to the extent that the
holders thereof exercise their warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for Nasdaq Stockholder Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule 5635(d) requires us to obtain stockholder approval prior to the issuance of securities in connection with a transaction
other than a public offering involving the sale, issuance or potential issuance by us of our common stock (or securities convertible
into or exercisable for our common stock) at a price less than the Minimum Price. In the case of the Private Placement, the 20% threshold
is determined based on the shares of our common stock outstanding immediately preceding the signing of the Purchase Agreement, which
we signed on May 23, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 40; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the execution of the Purchase Agreement, we had 17,541,732 shares of common stock issued and outstanding, including 2,921,000
shares of common stock issued on May 13, 2025, pursuant to an exchange agreement entered into with holders of certain warrants issued
on August 1, 2024. Therefore, the potential issuance of 14,805,557 Warrant Shares (consisting of 14,444,446 Common Warrant Shares and
361,111 Placement Agent Warrant Shares) would have constituted greater than 20% of the shares of common stock outstanding immediately
prior to the execution of the Purchase Agreement. We are seeking stockholder approval under Nasdaq Listing Rule 5635(d) for the sale,
issuance or potential issuance by us of our common stock (or securities exercisable for our common stock) in excess of 20% of the shares
of common stock outstanding immediately prior to the execution of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict whether or when the Warrant holders will exercise their Warrants. For these reasons, we are unable to accurately forecast
or predict with any certainty the total amount of Warrant Shares that may ultimately be issued. Under certain circumstances, however,
it is possible, that we will issue more than 20% of our outstanding shares of common stock to the Warrant holders. Therefore, we are
seeking stockholder approval under this proposal to issue more than 20% of our outstanding shares of common stock, if necessary, to the
Warrant holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
by our stockholders of this Issuance Proposal is also one of the conditions for us to receive up to an additional approximately $6.7
million upon the exercise of the Warrants, if exercised for cash. Loss of these potential funds could jeopardize our ability to execute
our business plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
transaction requiring approval by our stockholders under Nasdaq Listing Rule 5635(d) would likely result in a significant increase in
the number of shares of our common stock outstanding, and, as a result, our current stockholders will own a smaller percentage of our
outstanding shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nasdaq Listing Rules, we are not permitted (without risk of delisting) to undertake a transaction that could result in a change in
control of us without seeking and obtaining separate stockholder approval. We are not required to obtain stockholder approval for the
Private Placement under Nasdaq Listing Rule 5635(b) because the terms of the Warrants include beneficial ownership limitations that prohibit
the exercise of the Warrants to the extent that such exercise would result in the holder and its affiliates, collectively, beneficially
owning or controlling more than 4.99% (which percentage can be increased to 9.99%) of the total outstanding shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Consequences of Not Approving the Issuance Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is not seeking the approval of our stockholders to authorize our entry into or consummation of the transactions contemplated by
the Purchase Agreement, as the Private Placement has already been completed, and the Warrants have already been issued. We are only asking
for approval to issue the shares of common stock underlying the Warrants upon exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure of our stockholders to approve the Issuance Proposal will mean that: (i) we cannot permit the exercise of the Warrants and (ii)
may incur substantial additional costs and expenses, including the costs and expense of seeking stockholder approval until our stockholders
approve the issuance of the shares underlying the Warrants pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
would realize an aggregate of up to approximately $6.7 million in gross proceeds if all the Warrants were exercised for cash. If the
Warrants cannot be exercised, we will not receive any such proceeds, which could adversely impact our ability to fund our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Further
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Private Placement, including the Warrants, are complex and the material terms thereof are only briefly summarized above.
For further information regarding the Private Placement and the Warrants, please refer to our Current Report on Form 8-K filed with the
SEC May 27, 2025. The discussion herein is qualified in its entirety by reference to such filed transaction documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the votes cast affirmatively or negatively for this proposal will be required to approve
the Issuance Proposal. Abstentions and broker non-votes will have no effect on the results of the vote on Proposal No. 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE &#8220;FOR&#8221; THE ISSUANCE PROPOSAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 41; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_017"></FONT>PROPOSAL
NO. 5:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE AUTHORIZED SHARE INCREASE PROPOSAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has approved, subject to stockholder approval, an amendment to our Amended and Restated Certificate of Incorporation to increase
the number of authorized shares of common stock from 112,500,000 to 350,000,000&#160;and to make a corresponding change to the number
of authorized shares of capital stock. The form of this proposed certificate of amendment to the Amended and Restated Certificate of
Incorporation (the &#8220;Authorized Share Increase Amendment&#8221;) is attached to this Proxy Statement as an exhibit. We currently
have a total of 112,600,000 shares of capital stock authorized under our Amended and Restated Certificate of Incorporation, consisting
of 112,500,000 shares of common stock and 100,000 shares of preferred stock. If the Authorized Share Increase proposal is approved by
our stockholders, our Board of Directors will be authorized, in its discretion, to file the Authorized Share Increase Amendment with
the office of the Secretary of State of the State of Delaware, which would have the effect of increasing the number of authorized shares
of common stock from 112,500,000 to 350,000,000&#160;and increasing the number of authorized shares of all classes of stock from 112,600,000
to 350,100,000. The number of shares of authorized preferred stock would remain unchanged. Each additional authorized share of common
stock would have the same rights and privileges as each share of currently authorized common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Authorized Share Increase</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes it to be in our best interests to have sufficient additional authorized but unissued shares of common stock
available in order to provide flexibility for corporate action in the future. Management believes that the availability of additional
authorized shares for issuance from time-to-time&#160;in our Board of Directors&#8217; discretion in connection with future financings,
investment opportunities, stock splits or dividends, equity incentive plan arrangements or for other corporate purposes is desirable
in order to avoid repeated separate amendments to our Amended and Restated Certificate of Incorporation and the delay and expense incurred
in holding meetings of the stockholders to approve such amendments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Adverse Effects of the Authorized Share Increase</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorization of additional shares of common stock sought by this proposal would not have any immediate dilutive effect upon the proportionate
voting power or rights of our existing stockholders; however, to the extent that the additional authorized shares of common stock are
issued in the future, including in connection with future capital raising transactions or strategic transactions, such issuance will
likely decrease existing stockholders&#8217; percentage equity ownership, be dilutive to existing stockholders and have a negative effect
upon the market price of the common stock. Our stockholders do not have any preemptive right to purchase or subscribe for any part of
any new or additional issuance of our securities by virtue of their holding shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increased proportion of unissued authorized shares compared to issued shares could, under certain circumstances, have an anti-takeover
effect (for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition
of our Board of Directors or contemplating a tender offer or other transaction for our combination with another company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 42; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
Plans, Proposals or Arrangements to Issue Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 4, 2025, there were (i) 21,303,358 shares of our common stock were issued and outstanding, (ii) 1,942,351 shares
of common stock issuable upon the exercise of outstanding stock options, having a weighted average exercise price of $1.78 per share,
(iii) 39,700 shares of common stock issuable upon the vesting of common stock awards, having a weighted average grant date fair value
of $0.99 per share, (iv) 1,250,213 shares of common stock issuable upon the exercise of outstanding warrants (other than the Pre-Funded
Warrants and Warrants), having a weighted average exercise price of $4.12 per share, (v) 223,522 shares of common stock reserved
for future issuance pursuant to our 2018 Plan, (vi)&#160;4,444,444&#160;shares of common stock issuable upon exercise of the outstanding
Pre-Funded&#160;Warrants, and (vii) up to 14,805,557 of our authorized shares were reserved for issuance upon the exercise of the Warrants
issued in the Private Placement assuming approval of the Issuance Proposal in Proposal No. 4. Pursuant to Proposal&#160;No.&#160;7, we
are also seeking approval of an amendment to our 2018 Plan to&#160;increase the number of shares authorized for the issuance of awards
by 2,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the approval and filing of the Certificate of Amendment relating to the Authorized Share Increase, we may explore additional financing
opportunities or strategic transactions that would require the issuance of additional shares of our common stock. If we issue additional
shares, the ownership interest of holders of our capital stock will be diluted. Other than as set forth above or elsewhere in this proxy
statement, we have no current plans, proposals or arrangements to issue any of the additional authorized shares of common stock that
would become available as a result of the filing of the Certificate of Amendment relating to the Authorized Share Increase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest
of Certain Persons in Matters to Be Acted Upon</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
with respect to their continued employment as officers or directors of the Company, no director or executive officer has any substantial
interest, direct or indirect, by security holdings or otherwise, in this proposal that is not shared by all of our other stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Procedure
for Implementing the Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in our authorized shares of common stock will become effective upon the filing of the Certificate of Amendment relating to the
Authorized Share Increase or such later time as specified in the filing with the Secretary of State of Delaware. The timing of the filing
of the Certificate of Amendment will be determined by the Board of Directors based on its evaluation as to when such action will be the
most advantageous to the Company and our stockholders. The Board reserves the right to abandon the Authorized Share Increase without
further action by our stockholders at any time before the proposed amendment becomes effective, even if stockholders approve such amendment
at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Authorized Share Increase proposal to be approved, the number of votes cast &#8220;FOR&#8221; the proposal must exceed the number
of votes cast &#8220;AGAINST&#8221; the proposal; provided that our common stock meets the Listing Condition, in which case, abstentions
with respect to the proposal will not be considered &#8220;votes cast&#8221; and will have no effect on the proposal. If the Listing
Condition is not met, the proposal must receive the affirmative vote of the holders of a majority of our issued and outstanding shares
of common stock as of the Record Date, and any abstentions with respect to the proposal would have the same effect as a vote &#8220;AGAINST&#8221;
the proposal. Brokerage firms have authority to vote customers&#8217; unvoted shares held by the firms in street name on this
proposal. If the Listing Condition is met, any broker non-votes (if any)&#160;will have no effect on the proposal. If the Listing Condition
is not met, any broker non-votes (if any)&#160;will be treated as a vote &#8220;AGAINST&#8221; the proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS RECOMMENDS A VOTE TO APPROVE THE AMENDMENT OF OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE
TOTAL SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER FROM 112,500,000 SHARES TO 350,000,000 SHARES. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 43; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_018"></FONT>PROPOSAL NO. 6:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF AN AMENDMENT TO THE COMPANY&#8217;S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AT
A RATIO BETWEEN</B>, <B>AND INCLUDING, 1:5 <FONT STYLE="text-transform: uppercase">and</FONT> 1:18, WITH THE EXACT RATIO TO BE <FONT STYLE="text-transform: uppercase">set
within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the &#8220;Reverse
Stock Split&#8221;)</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board has adopted a resolution approving and recommending to the Company&#8217;s
stockholders for their approval a proposal to amend the Amended and Restated Certificate of Incorporation to effect a reverse stock split
of outstanding shares of common stock at a ratio between, and including, 1:5 and 1:18, with the exact ratio to be set within that range
at the discretion of our Board of Directors without further approval or authorization of our stockholders. If the Reverse Stock Split
is implemented, pursuant to the amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation that gives effect to
the Reverse Stock Split, the total number of authorized shares of common stock will not change, as the Reverse Stock Split will not have
any effect on the authorized number of shares of our common stock. The form of this proposed certificate of amendment to the Amended and
Restated Certificate of Incorporation (the &#8220;Reverse Stock Split Amendment&#8221;) is attached to this Proxy Statement as an exhibit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this proposal is approved by the stockholders, the Board of Directors may subsequently effect, in its sole discretion, the Reverse Stock
Split using a ratio between, and including, 1:5 and 1:18. Approval of this proposal by the stockholders would give the Board of Directors
authority to implement the Reverse Stock Split at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors believes that stockholder approval of a range of potential ratios (rather than a single ratio) provides the Board
of Directors with the flexibility to achieve the desired results of the Reverse Stock Split. If the stockholders approve this proposal,
the Reverse Stock Split will be effected only upon a determination by the Board of Directors that the Reverse Stock Split is in the best
interests of the stockholders at that time, and the Board of Directors, in its discretion, may determine not to proceed with the Reverse
Stock Split. In connection with any determination to effect the Reverse Stock Split, the Board of Directors will set the timing for such
a split and select the specific ratio from within the range of ratios set forth herein. The Board reserves the right to abandon the Reverse
Stock Split without further action by our stockholders at any time before the proposed amendment becomes effective, even if stockholders
approve such amendment at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split would affect all holders of our outstanding common stock uniformly and would not affect any stockholder&#8217;s percentage
ownership or proportionate voting and other rights in our common stock, except for adjustments that might result from the treatment of
fractional shares as described below. Pursuant to the Reverse Stock Split Amendment, the number of authorized shares of our common stock
would not change and the par value of our common stock would remain unchanged at $0.01 per share. The Reverse
Stock Split Amendment would not impact the total authorized number of shares of Preferred Stock or the par value thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation currently authorizes us to issue a maximum of 112,500,000 shares of common stock, par value $0.01 per share,
and 100,000 shares of preferred stock, $0.01 par value per share. Our issued and outstanding securities as of June 4, 2025 are
21,303,358 shares of common stock.<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Excluding 22 shares of treasury stock; 20,500,214 shares of common stock for outstanding warrants to purchase common stock;
and 2,205,573 shares of common stock have been reserved for options and stock grants either granted or remaining to be granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the Record Date, no shares of the Company&#8217;s preferred stock were issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below illustrates the effect of the Reverse Stock Split on the number of shares of our common stock that would be issued and outstanding,
authorized and reserved for issuance and authorized and unreserved for issuance based on our capitalization as of June 4, 2025:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Issued and Outstanding</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Authorized and Reserved for Issuance</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Authorized and Unreserved for Issuance</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Authorized</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif">As of June 4, 2025</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,303,358</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,705,809</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">68,490,833</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">112,500,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Following 5-for-1 Reverse Stock Split</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,260,672</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,541,162</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,698,167</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Following 10-for-1 Reverse Stock Split</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,130,336</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,270,581</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,099,083</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Following 18-for-1 Reverse Stock Split</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,183,520</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,434</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,055,046</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table above does not take into account the treatment of fractional shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Reverse Stock Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that the increase in the number of available shares of common stock following the Reverse Stock Split will provide the
Company with the ability to support its future anticipated growth and would provide greater flexibility to consider and respond to future
business opportunities and needs as they arise, including equity financings and stock-based acquisitions of new technology and product
development candidates. The availability of additional shares of common stock would permit the Company to undertake certain of the foregoing
actions without delay and expense associated with holding an Annual or Special Meeting of Stockholders to obtain stockholder approval
each time such an opportunity arises that would require the issuance of shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the Company compensates key employees through equity-based compensation programs. This compensation program is essential to the high-risk
nature of the business and provides the ability to align the interests of key employees with stockholders. Without an increase in the
number of available shares of common stock, the Company will not be able to recruit, retain and reward key employees, which includes
non-employee directors, officers, other employees, consultants, independent contractors and agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Reverse Stock Split will allow us to attempt to increase the bid price of our common stock by reducing the number of outstanding
shares of our common stock. To continue listing on The Nasdaq Capital Market, we must comply with the applicable listing requirements
under Nasdaq Marketplace Rules, which requirements include, among others, a minimum bid price of at least $1.00 per share. On November
26, 2024, we received a letter from Nasdaq indicating that the closing bid price of our common stock fell below $1.00 per share for the
previous 30 consecutive business days, and that we are therefore not in compliance with the minimum bid price requirement for continued
inclusion on The Nasdaq Capital Market. As the Company did not regain compliance with the minimum bid price requirement by May 27, 2025,
it was determined that the Company is not eligible for another 180 calendar-day extension because it did not meet the minimum stockholders&#8217;
equity initial listing requirements of $5,000,000 for Nasdaq, as set forth under Nasdaq Listing Rule 5505(b), and the Company received
a delisting determination letter on May 28, 2025. On May 29, 2025, the Company appealed the Nasdaq staff&rsquo;s determination to
a Nasdaq Hearings Panel, which will stay the delisting and suspension of the Company&rsquo;s common stock pending a decision by the Nasdaq
Hearings Panel. There can be no assurance that our request for continued listing will be granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has considered the potential harm to us if we are not able to regain compliance and our common stock becomes
delisted from The Nasdaq Capital Market. If our common stock were delisted from The Nasdaq Capital Market, trading of our common stock
would most likely take place on an over-the-counter market established for unlisted securities, such as the Pink Sheets or the OTC Bulletin
Board. An investor would likely find it less convenient to sell, or to obtain accurate quotations in seeking to buy, our common stock
on an over-the-counter market. As a result, many investors would likely not buy or sell our common stock due to difficulty in accessing
over-the-counter markets, policies preventing them from trading in securities not listed on a national exchange or other reasons. In
addition, as a delisted security, our common stock would be subject to SEC rules regarding &#8220;penny stock,&#8221; which impose additional
disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with the typically higher cost per trade
to the investor of penny stocks due to factors such as broker commissions generally representing a higher percentage of the price of
a penny stock than of a higher-priced stock, would further limit the ability of investors to trade in our common stock. For these reasons
and others, delisting would likely adversely affect the liquidity, trading volume and price of our common stock, causing the value of
an investment in us to decrease and having an adverse effect on our business, financial condition and results of operations, including
our ability to attract and retain qualified employees and to raise capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that a Reverse Stock Split is a potentially effective means for the Company to regain and maintain compliance with
Nasdaq Marketplace Rules and to avoid, or at least mitigate, the likely adverse consequences of common stock being delisted from The
Nasdaq Capital Market by producing the immediate effect of increasing the bid price of our common stock. The Reverse Stock Split will
also enable the Company to support its anticipated growth, provide greater flexibility to consider and respond to future business opportunities
and to recruit, retain and reward key employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Procedure
for Affecting the Reverse Stock Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board unanimously approved and recommended seeking shareholder approval of the Reverse Stock Split proposal on March 14, 2025. If our
stockholders approve the Reverse Stock Split, the Board would determine the ratio from the range between, and including, 1:5 and 1:18
options. Based, in part, on the price of the common stock on the days leading up to the filing of the Reverse Stock Split Amendment,
the Board will determine the ratio of the Reverse Stock Split. The Board will publicly announce the ratio selected for the Reverse Stock
Split prior to the effectiveness of the Reverse Stock Split within the limits set forth in the Reverse Stock Split proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split Amendment would be filed with the Secretary of State of the State of Delaware. As of the effective date set forth
in the Reverse Stock Split Amendment (the &#8220;Reverse Stock Split Effective Date&#8221;), the outstanding shares of our common stock
would be combined and converted into a lesser number of shares of common stock calculated in accordance with the ratio set by the Board,
within the specified range of potential ratios, and without further action on the part of the Company and our stockholders. For instance,
if a stockholder presently holds 100 shares of our common stock, the stockholder will hold 10 shares of our common stock following a
Reverse Stock Split effected at a ratio of one-for-ten.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fractional
Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares will be issued in connection with the Reverse Stock Split. To avoid the existence of fractional shares of the Company&#8217;s
common stock, any fractional shares that would otherwise be issued as a result of the Reverse Stock Split will be rounded up to the nearest
whole share. </FONT>For example, if the Board effects a one-for-ten split, and you held nine shares of our common stock immediately
prior to the Reverse Stock Split Effective Date, you would hold one share of our common stock following the Reverse Stock Split.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Record
and Beneficial Stockholders</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Reverse Stock Split Effective Date, our common stock would have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;)
number, a number used to identify our common stock. Stock certificates with the old CUSIP number would need to be exchanged for stock
certificates with the new CUSIP number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Reverse Stock Split, stockholders of record holding some or all of their shares of our Common Stock electronically in book-entry
form under the direct registration system for securities would receive a transaction statement at their address of record indicating
the number of shares of our Common Stock they held after the Reverse Stock Split. Stockholders of record holding all of their shares
in certificate form, or a combination of certificate and book-entry form, would receive transmittal letters from our transfer agent,
Equiniti Trust Company (the &#8220;Transfer Agent&#8221;), as soon as practicable after the Reverse Stock Split Effective Date.
The letters of transmittal would contain instructions on how the stockholders of record must surrender the certificates representing
the pre-Reverse Stock Split shares to the Transfer Agent to be exchanged for stock certificates representing post-Reverse Stock Split
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
holding our Common Stock in &#8220;street name,&#8221; through a brokerage firm, bank, broker-dealer or other nominee, would be treated
in the same manner as stockholders of record whose shares are held in their own names with the Transfer Agent. However, stockholders
should contact their brokerage firm, bank, broker-dealer or other nominee for more information regarding their particular procedures
for processing the Reverse Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDERS
SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY STOCK CERTIFICATE(S) UNTIL REQUESTED TO DO SO.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effects
of the Reverse Stock Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Effect
on Warrants, Stock Options and Equity Plans</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Reverse Stock Split ratio selected by the Board, proportionate adjustments would also be made to the per share conversion price
or exercise price, as the case may be, and the number of shares issuable upon the conversion or exercise of all of our warrants, options
and any other similar rights or securities entitling their holders to purchase or obtain shares of our Common Stock. In addition, the
number of shares of our Common Stock reserved for issuance under our equity compensation plans would be reduced by the exchange ratio
selected by the Board for the Reverse Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Effect
on Par Value and Accounting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Reverse Stock Split, the par value per share of our Common Stock would remain at $0.01 per share. Total stockholders&#8217; equity
would remain unchanged. Net loss per share and net book value per share would be increased as a result of the Reverse Stock Split since
fewer shares of our Common Stock would be outstanding. All share and per share information in our financial statements would be restated
to reflect the Reverse Stock Split for all periods presented in filings after the Reverse Stock Split Effective Date with the SEC and
The Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Certain
Other Effects</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Reverse Stock Split, we would continue to be subject to the periodic reporting requirements of the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;), and outstanding shares of our Common Stock would remain fully paid and non-assessable. Our
Common Stock would continue to be reported on The Nasdaq Capital Market under the symbol &#8220;IMNN,&#8221; or on the market on which
our Common Stock is then trading, although it is likely that Nasdaq would add the letter &#8220;D&#8221; to the end of the trading
symbol for a period of twenty trading days after the Reverse Stock Split Effective Date to indicate that the Reverse Stock Split had
occurred. We would make all necessary filings with Nasdaq or the applicable trading market as required by SEC Rule 10b-17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Potential
Negative Effects of the Reverse Stock Split</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
immediate effect of the Reverse Stock Split would be to reduce the number of shares of our outstanding Common Stock and to increase the
bid price of our Common Stock. However, we cannot guarantee that the Reverse Stock Split would lead to an increase in the bid price of
our Common Stock in proportion to the reduction in the number of shares of our outstanding Common Stock or result in a permanent increase
in the bid price of our Common Stock. Indeed, because the bid price of our Common Stock depends on our performance, prospects, general
market conditions and other factors unrelated to the number of shares of our Common Stock outstanding at any given time, the bid price
of our Common Stock might decline after the Reverse Stock Split (perhaps by an even greater percentage than would have occurred in the
absence of the Reverse Stock Split). As a result, we might still be at risk for adverse consequences associated with lower-priced stocks
generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that the Reverse Stock Split would have the desired effect of regaining and maintaining compliance with Nasdaq
Marketplace Rules relating to our bid price and our Common Stock would not remain subject to the risk of being delisted.
Furthermore, the Reverse Stock Split would make it more difficult for us to meet certain other requirements for continued listing on
The Nasdaq Capital Market, including rules related to the minimum number of shares that must be in the public float, the minimum market
value of the public float and the minimum number of round lot holders. Our Common Stock might experience reduced liquidity and trading
volume due to the availability of fewer shares for trading after the Reverse Stock Split and certain investors could still consider the
bid price of our Common Stock to be too low, including investors with express policies prohibiting transactions involving lower-priced
stocks or investors who are reluctant to incur transaction costs that represent a higher percentage of the stock price of lower-priced
stocks than of higher-priced stocks. In addition, customers, suppliers or employees might consider a company with a low stock price and
reduced liquidity and trading volume as risky and might accordingly be less likely to transact business with us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 47; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split might also produce other negative effects. Investors might consider the increased proportion of unissued authorized
shares to issued shares to have an anti-takeover effect under certain circumstances, since the proportion allows for dilutive issuances
which could prevent certain stockholders from changing the composition of the Board or render tender offers for a combination with another
entity more difficult to successfully complete. The Board does not intend for the Reverse Stock Split to have any anti-takeover effects
or to be part of a &#8220;going private&#8221; transaction within the meaning of Rule 13e-3 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
stockholders might be adversely affected disproportionately by the Reverse Stock Split. Other stockholders might end up owning
&#8220;odd-lots&#8221; of less than 100 shares as a result of the Reverse Stock Split, which would likely result in brokerage
commissions and other transaction costs that are higher than the costs associated with transactions in even multiples of 100
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the General Corporation Law of the State of Delaware, our stockholders are not entitled to appraisal rights with respect to the Reverse
Stock Split, and we would not independently provide our stockholders with such rights if the Reverse Stock Split is effected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
United States Federal Income Tax Consequences of the Reverse Stock Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of certain material U.S. federal income tax consequences of the Reverse Stock Split. This discussion is based
on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), applicable Treasury regulations promulgated under the
Code, judicial decisions and administrative rulings, all as of the date hereof. Any of these authorities could be repealed, overruled
or modified at any time. Any such change could be retroactive and could cause the U.S. federal income tax consequences of the Reverse
Stock Split to vary substantially from those described herein. This discussion does not address U.S. federal taxes other than those pertaining
to U.S. federal income taxation (such as estate or gift taxes, the alternative minimum tax or the Medicare tax on investment income).
Nor does it address any aspects of U.S. state or local or non-U.S. taxation. We have not and do not intend to seek any ruling from the
U.S. Internal Revenue Service (the &#8220;IRS&#8221;) regarding any U.S. federal income tax consequences described herein. There can
be no assurance that the IRS will not take positions inconsistent with the consequences discussed below or that any such positions would
not be sustained by a court. All stockholders are urged to consult with their tax advisors with respect to the tax consequences of the
Reverse Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion applies only to stockholders that are U.S. Holders (as defined below) and does not address all aspects of U.S. federal income
taxation that may be relevant to stockholders in light of their particular circumstances or to stockholders that may be subject to special
tax rules, including (i) stockholders subject to the alternative minimum tax; (ii) banks, insurance companies, or other financial institutions;
(iii) tax-exempt organizations; (iv) dealers in securities or commodities; (v) regulated investment companies or real estate investment
trusts; (vi) traders in securities that elect to use a mark-to-market method of accounting; (vii) stockholders whose functional currency
is not the U.S. dollar; (viii) persons holding our Common Stock as a position in a hedging transaction, straddle, conversion transaction
or other risk reduction transaction; (ix) persons who acquired shares of our Common Stock in connection with employment or other performance
of services; (x) U.S. expatriates; (xi) partnerships (including entities or arrangements treated as partnerships for U.S. federal income
tax purposes); and (xii) S corporations. This discussion assumes that the pre-Reverse Stock Split shares of Common Stock were, and the
post-Reverse Stock Split shares of Common Stock will be, held as a &#8220;capital asset,&#8221; as defined in Section 1221 of the Code.
If a partnership (including any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds shares of
our Common Stock, the tax treatment of a partner in the partnership generally will depend upon the status of the partner and the activities
of the partnership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, the term &#8220;U.S. Holder&#8221; is a beneficial owner of Common Stock that is, for U.S. federal income tax purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual citizen or resident of the United States,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity that is treated as a corporation for U.S. federal income tax purposes) that is created or organized
    (or treated as created or organized) in or under the laws of the United States or any state thereof or the District of Columbia,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate whose income is subject to U.S. federal income tax regardless of its source, or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust if (i) a U.S. court can exercise primary supervision over the administration of such trust and one or more U.S. persons have
    the authority to control all substantial decisions of the trust or (ii) it has a valid election in place to be treated as a U.S.
    person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALL
STOCKHOLDERS ARE URGED TO CONSULT WITH THEIR TAX ADVISORS WITH RESPECT TO THE TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split is intended to be treated as a &#8220;recapitalization&#8221; for U.S. federal income tax purposes within the meaning
of Section 368(a)(1)(E) of the Code that is not part of a plan to periodically increase any stockholder&#8217;s proportionate interest
in the assets or earnings and profits of the Company. The remainder of this discussion assumes the Reverse Stock Split is so treated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder should not recognize gain or loss upon the Reverse Stock Split, except possibly with respect to any additional fractions
of a share of the Company&#8217;s common stock received as a result of the rounding up of any fractional shares that would otherwise
be issued, as discussed below. Subject to the following discussion regarding a U.S. Holder&#8217;s receipt of a whole share of the Company&#8217;s
common stock in lieu of a fractional share, a U.S. Holder&#8217;s aggregate tax basis in the shares of the Company&#8217;s common stock
received pursuant to the Reverse Stock Split should equal the aggregate tax basis of the shares of the Company&#8217;s common stock surrendered
(possibly, increased by any income or gain recognized on receipt of a whole share in lieu of a fractional share), and such U.S. Holder&#8217;s
holding period in the shares of the Company&#8217;s common stock received should include the holding period in the shares of the Company&#8217;s
common stock surrendered. Treasury regulations promulgated under the Code provide detailed rules for allocating the tax basis and holding
period of the shares of the Company&#8217;s common stock surrendered to the shares of the Company&#8217;s common stock received pursuant
to the Reverse Stock Split. U.S. Holders of shares of the Company&#8217;s common stock acquired on different dates and at different prices
should consult their own tax advisors regarding the allocation of the tax basis and holding period of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above, no fractional shares of the Company&#8217;s common stock will be issued as a result of the Reverse Stock Split. Instead,
if the Reverse Stock Split would result in a U.S. Holder receiving fractional shares, the number of shares to be issued to such U.S.
Holder will be rounded up to the nearest whole share. The U.S. federal income tax consequences of the receipt of such additional fraction
of a share of the Company&#8217;s common stock are not clear. A U.S. Holder who receives one whole share of the Company&#8217;s common
stock in lieu of a fractional share may possibly recognize income or gain in an amount not to exceed the excess of the fair market value
of such share over the fair market value of the fractional share to which such U.S. Holder was otherwise entitled. The holding period
for the portion of a whole share of the Company&#8217;s common stock treated as a distribution or as to which a U.S. Holder recognizes
gain might not include the holding period of such U.S. Holder&#8217;s pre-Reverse Stock Split shares of the Company&#8217;s common stock
surrendered. The Company is not making any representation as to whether the receipt of one whole share in lieu of a fractional share
will result in income or gain to any stockholder, and stockholders are urged to consult their own tax advisors as to the possible tax
consequences of receiving a whole share in lieu of a fractional share in the Reverse Stock Split. In addition, backup withholding may
apply to a U.S. Holder who receives a whole share of the Company&#8217;s common stock in lieu of a fractional share unless such U.S.
Holder provides the Exchange Agent with appropriate documentation establishing that backup withholding is not required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interests
of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the Board has a substantial interest, directly or indirectly, in the matters set forth in the Reverse Stock Split Proposal,
except to the extent of each member&#8217;s ownership of shares of our Common Stock or restricted stock or options or warrants to purchase
shares of our Common Stock. The Reverse Stock Split would result in the increased number of available authorized
shares of Common Stock, some of which could be used as compensation for non-employee directors or executive directors in connection with
equity compensation plans. All such plans have been approved (or will be approved) by the stockholders of the Company at general meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required for Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Reverse Stock Split proposal to be approved, the number of votes cast &#8220;FOR&#8221; the proposal must
exceed the number of votes cast &#8220;AGAINST&#8221; the proposal; provided that our common stock meets the Listing Condition, in which
case, abstentions with respect to the proposal will not be considered &#8220;votes cast&#8221; and will have no effect on the proposal.
If the Listing Condition is not met, the proposal must receive the affirmative vote of the holders of a majority of our issued and outstanding
shares of common stock as of the Record Date, and any abstentions with respect to the proposal would have the same effect as a vote &#8220;AGAINST&#8221;
the proposal. Brokerage firms have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal.
If the Listing Condition is met, any broker non-votes (if any)&#160;will have no effect on the proposal. If the Listing Condition is not
met, any broker non-votes (if any)&#160;will be treated as a vote &#8220;AGAINST&#8221; the proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE AMENDMENT TO THE COMPANY&#8217;S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
TO EFFECT A REVERSE STOCK SPLIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AT
A RATIO BETWEEN</B>, <B>AND INCLUDING, 1:5 <FONT STYLE="text-transform: uppercase">and</FONT> 1:18, WITH THE EXACT RATIO TO BE <FONT STYLE="text-transform: uppercase">set
within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the &#8220;Reverse
Stock Split&#8221;)</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>


<!-- Field: Page; Sequence: 50; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_012"></FONT>PROPOSAL
NO. 7:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
OF THE IMUNON, INC. 2018 STOCK INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BACKGROUND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2025 Annual Meeting, stockholders will be asked to approve the following amendment to the 2018 Plan, which amendment was approved
by our Board of Directors on March 14, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Increase
in Aggregate Share Limit. </B>The 2018 Plan currently limits the aggregate number of shares of common stock that may be delivered pursuant
to all awards granted under the 2018 Plan to 1,970,000 shares. As of June 4, 2025, only 223,522 shares remain available for future
grants (and such amount of available shares is subject to adjustment upon the Reverse Stock Split described in Proposal 6, if approved
and implemented). The proposed amendment would increase this limit by an additional 2,000,000 shares so that the new aggregate share
limit for the 2018 Plan would be 3,970,000, subject to the Reverse Stock Split as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 4, 2025, a total of 1,751,551 shares of common stock were subject to outstanding stock options and restricted stock awards
granted under the 2018 Plan. The outstanding stock options have a weighted average strike price of $1.88 per share with a weighted average
term of 8.4 years. A remainder of 223,522 shares of common stock were available for new award grants under the 2018 Plan. If the Reverse
Stock Split is approved and implemented, these share numbers will be adjusted by the Reverse Stock Split. Our Board of Directors recommends
the increase in the number of shares available under the 2018 Plan to provide us the ability to provide eligible officers, directors,
key employees, and other individuals with additional incentives to contribute to our future success. In the judgment of the Board of
Directors, awards under the 2018 Plan are a valuable and critical incentive and will serve to the ultimate benefit of the stockholders
by aligning more closely the interests of the 2018 Plan participants with those of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that the proposed 2018 Plan amendment is essential for our ongoing success and our ability to recruit, retain
and reward key employees. The Board of Directors also believes that if the proposed amendment is not approved, our ability to align the
interests of key employees with stockholders through equity-based compensation would be compromised, disrupting our compensation program,
and impairing our ability to recruit and retain key employees. The Board of Directors recommends approval of the proposed 2018 Plan amendment
for the following reasons:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    align the interests of our stockholders and recipients of awards under the 2018 Plan by increasing the proprietary interest of such
    recipients in our growth and success;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    advance our interests of the Company by attracting and retaining non-employee directors, officers, other employees, consultants,
    independent contractors, and agents; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    motivate such persons to act in the long-term best interests of the Company and its stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consider equity and equity-based compensation to be a key component of our compensation program and believe that it is essential to attract,
motivate, and retain talented, experienced, and committed employees and to incentivize our employees to achieve our short- and long-term
goals. On February 12, 2018, the Board of Directors, upon the recommendation of the Compensation Committee, adopted the IMUNON, INC.
2018 Stock Incentive Plan which later was approved by our stockholders at the 2018 Annual Meeting on May 15, 2018. The 2018 Plan replaced
our 2007 Stock Incentive Plan (the &#8220;2007 Plan&#8221;). The 2018 Stock Incentive Plan constitutes the only plan we currently utilize
to provide equity and equity-based incentive compensation to eligible employees, consultants, and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Historical
Company Equity Usage. </I>We believe that our historic equity usage has been reasonable in light of competitive considerations and the
potential dilutive impact of equity award grants on our stockholders. Our average three-year &#8220;run rate&#8221; was 6.6% as a percentage
of weighted common shares outstanding which compares favorably to the non-Russell 3000 Index (Pharmaceuticals, Biotechnology &amp; Life
Science) mean run rate of 8.6% for that same three-year period (with the run rate in each case calculated the number of shares subject
to stock options and other equity awards granted during that period). We do not currently anticipate that our future annual long-term
incentive grants will significantly exceed this run rate. As noted above, the number of shares of common stock currently available for
future grants under the 2018 Plan is only 223,522 shares, demonstrating our need for additional shares to provide us greater flexibility
to structure future incentives and to better attract, retain and award key employees to execute our current business plans and strategies.
For more information on our past grants under the 2018 Plan, see &#8220;Potential Dilution and Burn Rate&#8221; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
Need to Provide Competitive Compensation</I>. Similar to other companies in our industry, we believe equity compensation is integral
in providing a competitive total compensation package necessary to recruit, retain and reward key employees. Equity awards are commonly
used by companies our size, and the ability to provide competitive grants is essential to competing in our labor markets. Therefore,
we believe it is imperative to provide long-term incentive awards as a component of our compensation program. We will continue to seek
an appropriate balance between meeting employee hiring, retention, and compensation goals and avoiding excessive stockholder dilution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Compensation Expense Increase</I>. If our ability to provide equity compensation is impaired, our cash compensation costs could increase
substantially to offset equity compensation typically provided in the marketplace. We believe it is important that we use our cash resources
to operate and expand our business, rather than unnecessarily diverting cash to pay compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
stockholders do not approve this 2018 Plan amendment, the current share limit under, and other terms and conditions of the 2018 Plan,
will continue in effect (to be adjusted by the Reverse Stock Split, if approved and implemented).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Dilution and Burn Rate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following paragraphs include additional information to help you assess the potential dilutive impact of the Company&#8217;s outstanding
equity awards under the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the total number of shares of our common stock that were subject to outstanding restricted stock granted under
the 2018 Plan, that were subject to outstanding stock options granted under the 2018 Plan, and that were then available for new award
grants under the 2018 Plan as of December 31, 2024 and as of June 4, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31, 2024</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of June 4, 2025</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares subject to outstanding stock
    options</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 22%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,515,373</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 22%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,751,551</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares subject to outstanding restricted stock
    awards</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares available for new award grants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,522</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, a total of 1,515,373 shares of our common stock were subject to all outstanding awards granted under the 2018 Plan.
All outstanding stock option awards were subject to outstanding stock options having a weighted average strike price of $2.03 per share
with a remaining term of 8.7 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 4, 2025, a total of 1,751,551 shares of our common stock were subject to all outstanding awards granted under the 2018
Plan. All outstanding stock option awards and restricted stock awards have a weighted average strike price of $1.88 per share with a
remaining term of 8.4 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation Committee anticipates that the aggregate share limit of
2,000,000 shares requested for the 2018 Plan, assuming usual levels of shares becoming available for new awards as a result of forfeitures
of outstanding awards, will provide us with flexibility to continue to grant equity awards under the 2018 Plan for the next two years.
However, this is only an estimate, in our judgment, based on current circumstances. The total number of shares that are subject to the
Company&#8217;s award grants in any one year or from year-to-year may change based on any number of variables, including, without limitation,
the value of our common stock (since higher stock prices generally require fewer shares to be issued to produce awards of the same grant
date fair value), changes in competitors&#8217; compensation practices, changes in compensation practices in the market generally, changes
in the number of employees, changes in the number of directors and officers, whether and the extent to which vesting conditions applicable
to equity-based awards are satisfied, acquisition activity and the need to grant awards to new employees in connection with acquisitions,
the need to attract, retain and incentivize key talent, the type of awards we grant and how we choose to balance total compensation between
cash and equity-based awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
DESCRIPTION OF THE 2018 PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary provides a description of the significant provisions of the 2018 Plan as amended to date and proposed to be amended
by this Proposal No. 5. However, the summary is qualified in its entirety by reference to the full text of the 2018 Plan as proposed
to be amended, which has been filed as an exhibit to the copy of this Proxy Statement that was filed electronically with the SEC and
can be reviewed on the SEC&#8217;s website at <FONT STYLE="text-decoration: underline">http://www.sec.gov</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Plan
Highlights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the key features of the 2018 Plan include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan is administered by our Compensation Committee comprised entirely of independent directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    and SARs granted under the 2018 Plan may not be repriced without shareholder approval other than in connection with a Change in Control
    or adjustments described in the 2018 Plan;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2018 Plan as proposed to be amended by Proposal No. 5 the maximum number of shares our common stock available for awards, other than
awards granted as substitute awards in connection with a corporate transaction, will be 3,970,000;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan prohibits liberal share recycling &#8211; meaning that shares tendered to pay the exercise price, or the withholding taxes
    related to an award may not be recycled back into the 2018 Plan;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    exercise price of options and the base price for SARs granted under the 2018 Plan may not be less than the fair market value of a
    share of our common stock on the date of grant, subject to certain exceptions for substitute awards granted in connection with a
    corporate transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan prohibits the grant of dividend equivalents with respect to options and SARs and subjects all dividends and dividend equivalents
    paid with respect to restricted stock awards, restricted stock unit awards or performance awards to the same vesting conditions as
    the underlying awards;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan does not contain a liberal change in control definition; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2018 Plan provides that awards and any cash payment or shares our common stock delivered pursuant to an award are subject to forfeiture,
    recovery by us or other action pursuant to the applicable award agreement or any claw back or recoupment policy that we may adopt
    from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Administration</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan is administered by a committee designated by our Board of Directors (unless the Board elects to administer the plan), consisting
of two or more members of the Board, each of whom may be (i) a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 under
the Exchange Act and (ii) &#8220;independent&#8221; within the meaning of the rules of the Nasdaq Capital Market or, if Company common
stock is not listed on the Nasdaq Capital Market, within the meaning of the rules of the principal stock exchange on which Company common
stock is then traded. Our Compensation Committee currently administers the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the express provisions of the 2018 Plan, the Compensation Committee has the authority to select eligible persons to receive awards
and determine all of the terms and conditions of each award. All awards will be evidenced by an agreement containing such provisions
not inconsistent with the 2018 Plan as the Compensation Committee will approve. The Compensation Committee also has authority to establish
rules and regulations for administering the 2018 Plan and to decide questions of interpretation or application of any provision of the
2018 Plan. The Compensation Committee may, in its sole discretion and for any reason at any time, take action such that (i) any or all
outstanding options and SARs will become exercisable in part or in full, (ii) all or a portion of a restriction period on any award will
lapse, (iii) all or a portion of any performance period applicable to any award will lapse and (iv) any performance measures applicable
to any outstanding award will be deemed satisfied at target, maximum or any other level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may delegate some or all of its power and authority under the 2018 Plan to the Board of Directors (or any members
thereof) or, subject to applicable law, a subcommittee of the Board of Directors, a member of the Board of Directors, the Chief Executive
Officer or other executive officer of the Company as the Compensation Committee deems appropriate, except that it may not delegate its
power and authority to a member of the Board, the Chief Executive Officer or any executive officer with regard to awards to persons who
are subject to Section 16 of the Exchange Act. The Compensation Committee has not made such a delegation of authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Available
Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the adjustment provisions set forth in the 2018 Plan, the number of shares of common stock available for awards under the 2018 Plan,
as proposed to be amended by Proposal No. 5, other than substitute awards granted in connection with a corporate transaction, will be
3,970,000. All of the available shares of common stock under the 2018 Plan may be issued in connection with incentive stock
options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of available shares will be reduced by the sum of the aggregate number of shares of common stock which become subject to outstanding
options, free-standing SARs, stock awards and performance awards. To the extent that shares of common stock subject to an outstanding
option, free-standing SARs, stock award or performance award granted under the 2018 Plan or the 2007 Plan, other than substitute awards
granted in connection with a corporate transaction, are not issued or delivered by reason of (i) the expiration, termination, cancellation
or forfeiture of such award (excluding shares of common stock subject to an option cancelled upon settlement of a related tandem SAR
or subject to a tandem SAR cancelled upon exercise of a related option), or (ii) the settlement of such award in cash, then such shares
of common stock will again be available under the 2018 Plan. Shares of common stock subject to an award under the 2018 Plan or the 2007
Plan will not again be available for issuance under the 2018 Plan if such shares are (a) shares that were subject to an option or stock-settled
SAR and were not issued or delivered upon the net settlement or net exercise of such option or SAR, (b) shares delivered to or withheld
by the Company to pay the purchase price or the withholding taxes relating to an outstanding award or (c) shares repurchased by the Company
on the open market with the proceeds of an option exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Change
in Control</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of the applicable award agreement, in the event of a change in control, the Board, as constituted prior to the Change in
Control (as defined in the 2018 Plan), may, in its discretion take one of the following actions: (i) require that (a) some or all outstanding
options and SARs will become exercisable in full or in part, either immediately or upon a subsequent termination of employment, (b) the
restriction period applicable to some or all outstanding stock awards will lapse in full or in part, either immediately or upon a subsequent
termination of employment, (C) the performance period applicable to some or all outstanding awards will lapse in full or in part, and
(D) the performance measures applicable to some or all outstanding awards will be deemed satisfied at the target, maximum or any other
level; (ii) require that shares of stock of the company resulting from or succeeding to the business of the Company pursuant to such
change in control, or the parent thereof, be substituted for some or all of the shares of Company common stock subject to outstanding
awards as determined by the Board; and/or (iii) require outstanding awards to be surrendered to the Company in exchange for a payment
of cash, shares of common stock in the company resulting from the change in control, or the parent thereof, or a combination of cash
and shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Effective
Date, Termination and Amendment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan became effective on May 15, 2018 and will terminate as of the first annual meeting to occur on or after the tenth anniversary
of the effective date, unless earlier terminated by the Board. If approved by the affirmative vote of a majority of the shares of common
stock present via the live webcast or represented by proxy at the Annual Meeting, the amendment to the 2018 Plan to increase the aggregate
number of shares reserved for issuance under the 2018 Plan will become effective as of July 11, 2025. The Board may amend the 2018 Plan
at any time, subject to stockholder approval if (i) required by applicable law, rule or regulation, including any rule of the Nasdaq
Capital Market or any other stock exchange on which the common stock is then traded, or (ii) such amendment modifies the option and SAR
repricing provisions in the 2018 Plan. No amendment may materially impair the rights of a holder of an outstanding award without the
consent of such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 54; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eligibility</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
in the 2018 Plan will consist of such officers, other employees, non-employee directors, consultants, independent contractors and agents
and persons expected to become officers, other employees, non-employee directors, consultants, independent contractors and agents of
the Company and its affiliates and subsidiaries, as selected by the Compensation Committee. As of June 4, 2025, approximately
38 individuals would have been eligible to participate in the 2018 Plan which includes approximately 4 officers, 21 employees, 4 non-employee
directors and 9 non-employee consultants would be eligible to participate in the 2018 Plan, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Options and SARs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan, as amended provides for the grant of non-qualified stock options, incentive stock options and SARs. The Compensation Committee
will determine the conditions to the exercisability of each option and SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
option will be exercisable for no more than ten years after its date of grant, unless the option is an incentive stock option and the
optionee owns greater than ten percent (10%) of the voting power of all shares of capital stock of the Company (a &#8220;ten percent
holder&#8221;), in which case the option will be exercisable for no more than five years after its date of grant. Except in the case
of substitute awards granted in connection with a corporate transaction, the exercise price of an option will not be less than 100% of
the fair market value of a share of common stock on the date of grant, unless the option is an incentive stock option and the optionee
is a ten percent holder, in which case the option exercise price will be the price required by the Code, currently 110% of fair market
value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
SAR will be exercisable for no more than ten years after its date of grant provided that no SAR granted in tandem with an option (a &#8220;tandem
SAR&#8221;) will be exercisable later than the expiration, termination, cancellation, forfeiture, or other termination of the related
option. The base price of an SAR will not be less than 100% of the fair market value of a share of common stock on the date of grant
(or, if earlier, the date of grant of the option for which the SAR is exchanged or substituted), provided that the base price of a tandem
SAR will be the exercise price of the related option. An SAR entitles the holder to receive upon exercise (subject to withholding taxes)
shares of common stock (which may be restricted stock), cash or a combination thereof with a value equal to the difference between the
fair market value of the common stock on the exercise date and the base price of the SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the terms relating to the exercise, cancellation or other disposition of options and SARs following the termination of employment
of a participant, whether by reason of disability, retirement, death, or any other reason, will be determined by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may not, without the approval of the stockholders of the Company, (i) reduce the purchase price or base price
of any previously granted option or SAR, (ii) cancel any previously granted option or SAR in exchange for another option or SAR with
a lower purchase price or base price or (iii) cancel any previously granted option or SAR in exchange for cash or another award if the
purchase price of such option or the base price of such SAR exceeds the fair market value of a share of common stock on the date of such
cancellation, in each case, other than in connection with a change in control or the adjustment provisions set forth in the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan provides for the grant of stock awards. The Compensation Committee may grant a stock award as a restricted stock award, a restricted
stock unit award or as another stock award. Except as otherwise determined by the Compensation Committee, stock awards will be non-transferable
and subject to forfeiture if the holder does not remain continuously in the employment of the Company during the restriction period or
if specified performance measures (if any) are not attained during the performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in a restricted stock award agreement, the holder of shares of restricted stock will have rights as a stockholder
of the Company, including the right to vote and receive dividends with respect to the shares of restricted stock. Distributions and dividends
with respect to shares of common stock, including regular cash dividends, will be deposited with the Company and will be subject to the
same restrictions as the restricted stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 55; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement awarding restricted stock units will specify (i) whether such award may be settled in shares of common stock, cash, or a combination
thereof, and (ii) whether the holder will be entitled to receive dividend equivalents, with respect to such award. Any dividend equivalents
with respect to restricted stock units will be subject to the same restrictions as such restricted stock units. Prior to settlement of
a restricted stock unit, the holder of a restricted stock unit will have no rights as a shareholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant other awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based
on, or related to, shares of common stock, including shares of common stock granted as a bonus and not subject to any vesting conditions,
dividend equivalents, deferred stock units, stock purchase rights and shares of common stock issued in lieu of obligations of the Company
to pay cash under any compensatory plan or arrangement, subject to such terms as shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the terms relating to the satisfaction of performance measures and the termination of a restriction period, or the forfeiture and
cancellation of a stock award upon a termination of employment, whether by reason of disability, retirement, death, or any other reason
or during a paid or unpaid leave of absence, will be determined by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Performance
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 Plan also provides for the grant of performance awards. The agreement relating to a performance award will specify whether such
award may be settled in shares of common stock (including shares of restricted stock), cash or a combination thereof. The agreement relating
to a performance award will provide, in the manner determined by the Compensation Committee, for the vesting of such performance award
if the specified performance measures established by the Compensation Committee are satisfied or met during the specified performance
period and such performance goals will be determined by the Compensation Committee at the time of grant. Any dividend or dividend equivalents
with respect to a performance award will be subject to the same restrictions as such performance award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the settlement of a performance award in shares of common stock, the holder of such award will have no rights as a stockholder of
the Company with respect to such shares. All of the terms relating to the satisfaction of performance measures and the termination of
a performance period, or the forfeiture and cancellation of a performance award upon a termination of employment with or service to,
whether by reason of disability, retirement, death or any other reason or during a paid or unpaid leave of absence, will be determined
by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Federal Income Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of certain United States federal income tax consequences generally arising with respect to awards under
the 2018 Plan. This discussion does not address all aspects of the United States federal income tax consequences of participating in
the 2018 Plan that may be relevant to participants in light of their personal investment or tax circumstances and does not discuss any
state, local or non-United States tax consequences of participating in the 2018 Plan. Each participant is advised to consult his or her
personal tax advisor concerning the application of the United States federal income tax laws to such participant&#8217;s particular situation,
as well as the applicability and effect of any state, local or non-United States tax laws before taking any actions with respect to any
awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time an option is granted, and the Company will not be entitled to a tax deduction
at that time. A participant will recognize compensation taxable as ordinary income (and if the participant is an employee, will be subject
to income tax withholding) upon exercise of a non-qualified stock option equal to the excess of the fair market value of the shares purchased
on such date over their exercise price, and the Company will be entitled to a corresponding deduction, except to the extent the deduction
limits of Section 162(m) of the Code apply. A participant will not recognize income (except for purposes of the alternative minimum tax)
upon exercise of an incentive stock option. If the shares acquired by exercise of an incentive stock option are held for at least two
years from the date the option was granted and one year from the date it was exercised, any gain or loss arising from a subsequent disposition
of those shares will be taxed as long-term capital gain or loss, and the Company will not be entitled to any deduction. If, however,
those shares are disposed of within the above-described period, then in the year of that disposition the participant will recognize compensation
taxable as ordinary income equal to the excess of the lesser of (i) the amount realized upon that disposition and (ii) the fair market
value of those shares on the date of exercise over the exercise price, and the Company will be entitled to a corresponding deduction,
except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>SARs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time SARs are granted, and the Company will not be entitled to a tax deduction at
that time. Upon exercise, the participant will recognize compensation taxable as ordinary income (and if the participant is an employee,
will be subject to income tax withholding) in an amount equal to the fair market value of any shares delivered and the amount of cash
paid by the Company. This amount is deductible by the Company as compensation expense, except to the extent the deduction limits of Section
162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time stock subject to a substantial risk of forfeiture (&#8220;restricted stock&#8221;)
is granted, and the Company will not be entitled to a tax deduction at that time, unless the participant makes an election to be taxed
at that time. If such election is made, the participant will recognize compensation taxable as ordinary income (and if the participant
is an employee, will be subject to income tax withholding) at the time of the grant in an amount equal to the excess of the fair market
value of the shares at such time over the amount, if any, paid for those shares. If such election is not made, the participant will recognize
compensation taxable as ordinary income (and if the participant is an employee, will be subject to income tax withholding) at the time
the restrictions constituting a substantial risk of forfeiture lapse in an amount equal to the excess of the fair market value of the
shares at such time over the amount, if any, paid for those shares. The amount of ordinary income recognized by making the above-described
election or upon the lapse of restrictions constituting a substantial risk of forfeiture is deductible by the Company as compensation
expense, except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time a restricted stock unit is granted, and the Company will not be entitled to
a tax deduction at that time. Upon settlement of restricted stock units, the participant will recognize compensation taxable as ordinary
income (and if the participant is an employee, will be subject to income tax withholding) in an amount equal to the fair market value
of any shares delivered and the amount of any cash paid by the Company. The amount of ordinary income recognized is deductible by the
Company as compensation expense, except to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax treatment, including the timing of taxation, of any other type of stock award will depend on the terms of such award at the time
of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Performance
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#160;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant will not recognize taxable income at the time performance awards are granted, and the Company will not be entitled to a tax
deduction at that time. Upon settlement of performance awards, the participant will recognize compensation taxable as ordinary income
(and if the participant is an employee, will be subject to income tax withholding) in an amount equal to the fair market value of any
shares delivered and the amount of cash paid by the Company. This amount is deductible by the Company as compensation expense, except
to the extent the deduction limits of Section 162(m) of the Code apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Plan Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has the discretion to grant awards under the 2018 Plan and, therefore, it is not possible as of the date of this proxy statement
to determine future awards that will be received by the Company&#8217;s named executive officers or others under the 2018 Plan. Accordingly,
in lieu of providing information regarding benefits that will be received under the 2018 Plan, the following table provides information
concerning the benefits that were received by the following persons and groups during 2024 under the 2018 Plan: each named executive
officer; all current executive officers, as a group; all current directors who are not executive officers, as a group; and all current
employees who are not executive officers, as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name and Position</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    Shares Subject to Stock Options and restricted stock awards (#)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael H. Tardugno<BR>
    <I>Executive Chairman and former President and Chief Executive Officer</I></FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="width: 22%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">207,926</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stacy Lindborg</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">President and Chief Executive
    Officer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">318,102</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne Le Goff<BR> <I>Former
    President and Chief Executive Officer</I></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khursheed Anwer<BR> <I>Executive
    Vice President and CSO</I></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">90,653</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey W. Church<BR> <I>Former
    Executive Vice President and CFO</I></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">All current executive officers, as a group</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">641,681</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">All current directors who are not executive
    officers, as a group</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53,407</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">All current employees who are not executive
    officers, as a group</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">301,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors believes that the adoption of the increase in the number of shares available for issuance under the 2018 Plan will
promote the interests of the Company and its stockholders and will help us continue to be able to attract, retain and reward persons
important to our success. All members of the Board and all of our executive officers are eligible for awards under the 2018 Plan and
thus have a personal interest in the approval of the proposal to increase the number of shares available for issuance under the 2018
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast affirmatively or negatively for this proposal will be required to approve the amendment
to the 2018 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE PROPOSAL TO<BR>
APPROVE THE AMENDMENT OF THE IMUNON, INC. 2018 STOCK INCENTIVE PLAN AS<BR>
DESCRIBED ABOVE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>


<!-- Field: Page; Sequence: 58; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_013"></FONT>PROPOSAL
NO. 8:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF
THE ANNUAL MEETING TO <FONT STYLE="text-transform: uppercase">APPROVE any of the proposals presented for a vote at the Annual Meeting.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
of and Rationale for the Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that if there are insufficient votes of the Company&#8217;s common stock to approve any of the proposals presented for
a vote at the Annual Meeting, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient
number of additional votes to approve any applicable proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Adjournment Proposal, we are asking stockholders to authorize the holder of any proxy solicited by the Board to vote in favor of
adjourning or postponing the Annual Meeting or any adjournment or postponement thereof. If our stockholders approve this proposal, we
could adjourn or postpone the Annual Meeting, and any adjourned session of the Annual Meeting, to use the additional time to solicit
additional proxies in favor of any of the proposals presented for a vote at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
approval of the Adjournment Proposal could mean that, we could adjourn or postpone the Annual Meeting without a vote on the applicable
proposal and use the additional time to solicit the holders of common stock to change their vote in favor of the applicable proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">If it is necessary or appropriate to adjourn the Annual Meeting, no notice of the adjourned meeting is required to
be given to our stockholders, other than an announcement at the Annual Meeting of the time and place to which the Annual Meeting is adjourned,
so long as the meeting is adjourned for 30 days or less and no new record date is fixed for the adjourned meeting. At the adjourned meeting,
we may transact any business which might have been transacted at the original meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required for Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast affirmatively or negatively for this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES
IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING T<FONT STYLE="text-transform: uppercase">O APPROVE any of the proposals
presented for a vote at the Annual Meeting.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>


<!-- Field: Page; Sequence: 59; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_014"></FONT>STOCKHOLDER
NOMINATIONS AND PROPOSALS FOR<BR>
THE 2026 ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder wants us to include a proposal in our proxy statement for presentation at our 2026 Annual Meeting of Stockholders in accordance
with Rule 14a-8 promulgated by the SEC under the Exchange Act, the proposal must be received by us no later than February 9, 2026.
Such proposals should be directed to IMUNON, INC., 997 Lenox Drive, Lawrenceville, NJ 08648, Attention: Corporate Secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder may also nominate directors or have other business brought before the 2026 Annual Meeting of Stockholders by submitting the
nomination or proposal to the Company, not later than the close of business on the 90<SUP>th</SUP> calendar day, nor earlier than the
close of business on the 120<SUP>th</SUP> calendar day, in advance of the anniversary of the 2025 Annual Meeting of Stockholders; provided,
however, in the event that the date of the 2026 Annual Meeting of Stockholders is more than thirty calendar days before or more than
30 calendar days after such anniversary date, notice by the stockholder to be timely must be so received no earlier than the close of
business on the 120<SUP>th</SUP> calendar day in advance of such date of annual meeting and not later than the close of business on the
later of the 90<SUP>th</SUP> calendar day in advance of such date of annual meeting or the 10<SUP>th</SUP> calendar day following the
date on which public announcement of the date of the meeting is first made. The nomination or proposal must be delivered to the Company&#8217;s
executive offices at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, Attention: Corporate Secretary no earlier than March 13,
2026, and no later than April 12, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if a stockholder intends to utilize Rule 14a-19 under the Exchange act in connection with a nomination must give the requisite
notice to the Company as indicated in the previous above sentence not later than the 60<SUP>th</SUP> calendar day in advance of the anniversary
of the 2025 Annual Meeting, or May 12, 2026. Any stockholder considering submitting a nominee or proposal for action at our 2026
Annual Meeting of Stockholders is directed to the Company&#8217;s Bylaws, which contain additional requirements as to submission of nominations
for directors or proposals for stockholder action. Copies of the Bylaws may be obtained upon request to the Company&#8217;s Corporate
Secretary. Stockholder proposals or nominations must include the specified information concerning the stockholder and the proposal or
nominee as described in our Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_015"></FONT>OTHER
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors knows of no other business which will be presented to the Annual Meeting. If any other business is properly brought
before the annual meeting, proxies will be voted in accordance with the judgment of the persons named therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT ID="Aa_016"></FONT>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
website is located at www.imunon.com. You can view additional information on our website, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charters
    of our Board Committees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
    of Conduct; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    governance materials and reports that we file with the SEC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of those documents may also be obtained free of charge by written or telephonic request directed to the Corporate Secretary, IMUNON,
INC., 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Susan Eylward </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Corporate Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT STYLE="text-decoration: underline">Exhibit
A</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF AMENDMENT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTATED
CERTIFICATE OF INCORPORATION OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under the General Corporation Law of the State of Delaware
(the &#8220;DGCL&#8221;), does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST</B>:
The name of the Corporation is Imunon, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND</B>:
This Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;) amends the provisions of the Corporation&#8217;s Restated
Certificate of Incorporation filed with the Secretary of State of the State of Delaware on March 22, 2023 (the &#8220;Certificate of
Incorporation&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD</B>:
The amendment to the Certificate of Incorporation below has been duly adopted by the board of directors of the Corporation and the stockholders
of the Corporation pursuant to Section 242 of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>FOURTH</B>: The Certificate
of Incorporation is hereby amended by amending and restating the first paragraph of Article FOURTH as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">FOURTH: The total number of shares of all classes
of stock which the Corporation shall have authority to issue shall be 350,100,000 shares, consisting of (i) 350,000,000 shares of common
stock, par value $0.01 per share (&#8220;Common Stock&#8221;), and (ii) One Hundred Thousand (100,000) shares of preferred stock, par
value $0.01 per share (&#8220;Preferred Stock&#8221;). The Preferred Stock may be issued from time to time in one or more series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>FIFTH</B>: This Certificate
of Amendment, and the amendment effected hereby, shall become effective at [&#160;&#160;&#160; ] [a.m./p.m.] (Eastern Time) on [&#160;&#160;&#160;
], 20[&#160;&#160;&#160; ].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, Imunon,
Inc. has caused this Certificate of Amendment to the Restated Certificate of Incorporation to be signed by its duly authorized officer
on this ____ day of ________, 20__.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON, INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT STYLE="text-decoration: underline">Exhibit
B</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF AMENDMENT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTATED
CERTIFICATE OF INCORPORATION OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under the General Corporation Law of the State of Delaware
(the &#8220;DGCL&#8221;), does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST</B>:
The name of the Corporation is Imunon, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND</B>:
This Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;) amends the provisions of the Corporation&#8217;s Restated
Certificate of Incorporation filed with the Secretary of State of the State of Delaware on March 22, 2023 (the &#8220;Certificate of
Incorporation&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIRD</B>:
The amendment to the Certificate of Incorporation below has been duly adopted by the board of directors of the Corporation and the stockholders
of the Corporation pursuant to Section 242 of the DGCL.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOURTH</B>:
The Certificate of Incorporation is hereby amended by adding the following paragraph immediately following the first paragraph of Article
FOURTH.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Effective
as of [__] at [__] [a.m./p.m.] ET and upon the filing of the Certificate of Amendment to Restated Certificate of Incorporation of the
Corporation with the Secretary of State of the State of Delaware (the &#8220;<FONT STYLE="text-decoration: underline">Effective Date</FONT>&#8221;), the shares of Common Stock,
par value $0.01 per share, of the Corporation issued and outstanding immediately prior to the Effective Date and the shares of Common
Stock issued and held in the treasury of the Corporation immediately prior to the Effective Time (the &#8220;<FONT STYLE="text-decoration: underline">Old Shares</FONT>&#8221;)
shall, automatically and without any action on the part of the respective holders thereof, be reclassified as and combined into a smaller
number of shares such that each [&#160;&#160;&#160; ] ([&#160;&#160;&#160; ]) shares of issued and outstanding Common Stock immediately
prior to the Effective Time are combined into one (1) validly issued, fully paid and non-assessable share of Common Stock (the &#8220;<FONT STYLE="text-decoration: underline">Reverse
Stock Split</FONT>&#8221;). No fractional shares will be issued in connection with the Reverse Stock Split. Any fractional shares that would
otherwise be issuable as a result of the Reverse Stock Split will be rounded up to the nearest whole share. Each stock certificate representing
the Old Shares immediately prior to the Effective Date shall thereafter, automatically and without the necessity of presenting the same
for exchange, represent that number of whole shares of Common Stock outstanding after the Effective Date into which the Old Shares represented
by such certificate shall have been combined; provided however, that each holder of record of a stock certificate or certificates representing
the Old Shares may receive, upon surrender of such certificate or certificates, a new certificate or certificates representing the number
of whole shares of Common Stock to which such holder is entitled pursuant to the Reverse Stock Split or, at the discretion of the Corporation
and unless otherwise instructed by such holder, book-entry shares in lieu of a new certificate or certificates representing the number
of whole shares of Common Stock to which such holder is entitled pursuant to the Reverse Stock Split. The shares of Common Stock issued
in connection with the Reverse Stock Split shall have the same rights, preferences and privileges as the Old Shares. The number of authorized
shares of Common Stock of the Corporation and the par value of the Common Stock shall remain as set forth in the Restated Certificate
of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIFTH</B>:
This Certificate of Amendment, and the amendment effected hereby, shall become effective at [&#160;&#160;&#160; ] [a.m./p.m.] (Eastern
Time) on [&#160;&#160;&#160; ], 20[&#160;&#160;&#160; ].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, Imunon, Inc. has caused this Certificate of Amendment to the Restated Certificate of Incorporation to be signed
by its duly authorized officer on this ____ day of ________, 20__.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><BR></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><FONT STYLE="text-decoration: underline">Exhibit
C</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
2018 STOCK INCENTIVE PLAN AS AMENDED AS OF JULY 11, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
INTRODUCTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1
</B><FONT STYLE="text-decoration: underline">Purposes</FONT>. The purposes of the IMUNON, INC. 2018 Stock Incentive Plan (this &#8220;<FONT STYLE="text-decoration: underline">Plan</FONT>&#8221;) are (i) to align the
interests of the Company&#8217;s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of
such recipients in the Company&#8217;s growth and success, (ii) to advance the interests of the Company by attracting and retaining Non-Employee
Directors, officers, other employees, consultants, independent contractors and agents and (iii) to motivate such persons to act in the
long-term best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2
</B><FONT STYLE="text-decoration: underline">Certain Definitions</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Affiliate</FONT>&#8221;
shall mean any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries own directly or indirectly not less than
fifty percent (50%) of such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Agreement</FONT>&#8221;
shall mean the written or electronic agreement evidencing an award hereunder between the Company and the recipient of such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Board</FONT>&#8221;
shall mean the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Change
in Control</FONT>&#8221; shall have the meaning set forth in <FONT STYLE="text-decoration: underline">Section 5.8(b)</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Code</FONT>&#8221;
shall mean the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Committee</FONT>&#8221;
shall mean the Compensation Committee of the Board, or a subcommittee thereof, or such other committee designated by the Board, in each
case, consisting of two or more members of the Board, each of whom is intended to be (i) a &#8220;Non-Employee Director&#8221; within
the meaning of Rule 16b-3 under the Exchange Act and (ii) &#8220;independent&#8221; within the meaning of the rules of the Nasdaq Capital
Market or, if the Common Stock is not listed on the Nasdaq Capital Market, within the meaning of the rules of the principal stock exchange
on which the Common Stock is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Common
Stock</FONT>&#8221; shall mean the common stock, par value $0.01 per share, of the Company, and all rights appurtenant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Company</FONT>&#8221;
shall mean IMUNON, Inc., a corporation organized under the laws of the State of Delaware, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Effective
Date</FONT>&#8221; shall have the meaning set forth in <FONT STYLE="text-decoration: underline">Section 5.1</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Exchange
Act</FONT>&#8221; shall mean the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Fair
Market Value</FONT>&#8221; shall mean the closing transaction price of a share of Common Stock as reported on the Nasdaq Capital Market
on the date as of which such value is being determined or, if the Common Stock is not listed on the Nasdaq Capital Market, the closing
transaction price of a share of Common Stock on the principal national stock exchange on which the Common Stock is traded on the date
as of which such value is being determined or, if there shall be no reported transactions for such date, on the next preceding date for
which transactions were reported; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that if the Common Stock is not listed on a national stock exchange
or if Fair Market Value for any date cannot be so determined, Fair Market Value shall be determined by the Committee by whatever means
or method as the Committee, in the good faith exercise of its discretion, shall at such time deem appropriate and in compliance with
Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Free-Standing
SAR</FONT>&#8221; shall mean an SAR which is not granted in tandem with, or by reference to, an option, which entitles the holder thereof
to receive, upon exercise, shares of Common Stock (which may be Restricted Stock) or, to the extent set forth in the applicable Agreement,
cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one share of Common Stock on the
date of exercise over the base price of such SAR, multiplied by the number of such SARs which are exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Incentive
Stock Option</FONT>&#8221; shall mean an option to purchase shares of Common Stock that meets the requirements of Section 422 of the Code,
or any successor provision, which is intended by the Committee to constitute an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Incumbent
Board</FONT>&#8221; shall have the meaning set forth in <FONT STYLE="text-decoration: underline">Section 5.8(b)</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Non-Employee
Director</FONT>&#8221; shall mean any director of the Company who is not an officer or employee of the Company or any Affiliate or Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Nonqualified
Stock Option</FONT>&#8221; shall mean an option to purchase shares of Common Stock which is not an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Other
Stock Award</FONT>&#8221; shall mean an award granted pursuant to <FONT STYLE="text-decoration: underline">Section 3.4</FONT> of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Performance
Award</FONT>&#8221; shall mean a right to receive an amount of cash, Common Stock, or a combination of both, contingent upon the attainment
of specified Performance Measures within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Performance
Measures</FONT>&#8221; shall mean the criteria and objectives, established by the Committee, which shall be satisfied or met (i) as a condition
to the grant or exercisability of all or a portion of an option or SAR or (ii) during the applicable Restriction Period or Performance
Period as a condition to the vesting of the holder&#8217;s interest, in the case of a Restricted Stock Award, of the shares of Common
Stock subject to such award, or, in the case of a Restricted Stock Unit Award, Other Stock Award or Performance Award, to the holder&#8217;s
receipt of the shares of Common Stock subject to such award or of payment with respect to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Performance
Period</FONT>&#8221; shall mean any period designated by the Committee during which (i) the Performance Measures applicable to an award
shall be measured and (ii) the conditions to vesting applicable to an award shall remain in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Prior
Plan</FONT>&#8221; shall mean the Celsion Corporation 2007 Stock Incentive Plan and each other equity plan maintained by the Company under
which awards are outstanding as of the effective date of this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Restricted
Stock</FONT>&#8221; shall mean shares of Common Stock which are subject to a Restriction Period and which may, in addition thereto, be subject
to the attainment of specified Performance Measures within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Restricted
Stock Award</FONT>&#8221; shall mean an award of Restricted Stock under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Restricted
Stock Unit</FONT>&#8221; shall mean a right to receive one share of Common Stock or, in lieu thereof and to the extent set forth in the
applicable Agreement, the Fair Market Value of such share of Common Stock in cash, which shall be contingent upon the expiration of a
specified Restriction Period and which may, in addition thereto, be contingent upon the attainment of specified Performance Measures
within a specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Restricted
Stock Unit Award</FONT>&#8221; shall mean an award of Restricted Stock Units under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Restriction
Period</FONT>&#8221; shall mean any period designated by the Committee during which (i) the Common Stock subject to a Restricted Stock Award
may not be sold, transferred, assigned, pledged, hypothecated or otherwise encumbered or disposed of, except as provided in this Plan
or the Agreement relating to such award, or (ii) the conditions to vesting applicable to a Restricted Stock Unit Award or Other Stock
Award shall remain in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">SAR</FONT>&#8221;
shall mean a stock appreciation right which may be a Free-Standing SAR or a Tandem SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Stock
Award</FONT>&#8221; shall mean a Restricted Stock Award, Restricted Stock Unit Award or Other Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Subsidiary</FONT>&#8221;
and &#8220;<FONT STYLE="text-decoration: underline">Subsidiaries</FONT>&#8221; shall mean only a company or companies, whether now or hereafter existing, within the meaning of
the definition of &#8220;subsidiary company&#8221; provided in Section 424(f) of the Code, or any successor thereto of similar import.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Substitute
Award</FONT>&#8221; shall mean an award granted under this Plan upon the assumption of, or in substitution for, outstanding equity awards
previously granted by a company or other entity in connection with a corporate transaction, including a merger, combination, consolidation
or acquisition of property or stock; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that in no event shall the term &#8220;Substitute Award&#8221;
be construed to refer to an award made in connection with the cancellation and repricing of an option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Tandem
SAR</FONT>&#8221; shall mean an SAR which is granted in tandem with, or by reference to, an option (including a Nonqualified Stock Option
granted prior to the date of grant of the SAR), which entitles the holder thereof to receive, upon exercise of such SAR and surrender
for cancellation of all or a portion of such option, shares of Common Stock (which may be Restricted Stock) or, to the extent set forth
in the applicable Agreement, cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one
share of Common Stock on the date of exercise over the base price of such SAR, multiplied by the number of shares of Common Stock subject
to such option, or portion thereof, which is surrendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Tax
Date</FONT>&#8221; shall have the meaning set forth in <FONT STYLE="text-decoration: underline">Section 5.5</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<FONT STYLE="text-decoration: underline">Ten
Percent Holder</FONT>&#8221; shall have the meaning set forth in <FONT STYLE="text-decoration: underline">Section 2.1(a)</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3
</B><FONT STYLE="text-decoration: underline">Administration</FONT>. This Plan shall be administered by the Committee except to the extent the Board elects to administer the Plan,
in which case references herein to the &#8220;Committee&#8221; shall be deemed to include references to the &#8220;Board.&#8221; Any
one or a combination of the following awards may be made under this Plan to eligible persons: (i) options to purchase shares of Common
Stock in the form of Incentive Stock Options or Nonqualified Stock Options; (ii) SARs in the form of Tandem SARs or Free-Standing SARs;
(iii) Stock Awards in the form of Restricted Stock, Restricted Stock Units or Other Stock Awards; and (iv) Performance Awards. The Committee
shall, subject to the terms of this Plan, select eligible persons for participation in this Plan and determine the form, amount and timing
of each award to such persons and, if applicable, the number of shares of Common Stock subject to an award, the number of SARs, the number
of Restricted Stock Units, the dollar value subject to a Performance Award, the purchase price or base price associated with the award,
the time and conditions of exercise or settlement of the award and all other terms and conditions of the award, including, without limitation,
the form of the Agreement evidencing the award. The Committee may, in its sole discretion and for any reason at any time, take action
such that (i) any or all outstanding options and SARs shall become exercisable in part or in full, (ii) all or a portion of the Restriction
Period applicable to any outstanding awards shall lapse, (iii) all or a portion of the Performance Period applicable to any outstanding
awards shall lapse and (iv) the Performance Measures (if any) applicable to any outstanding awards shall be deemed to be satisfied at
the target, maximum or any other level. The Committee shall, subject to the terms of this Plan, interpret this Plan and the application
thereof, establish rules and regulations it deems necessary or desirable for the administration of this Plan and may impose, incidental
to the grant of an award, conditions with respect to the award, such as limiting competitive employment or other activities. All such
interpretations, rules, regulations and conditions shall be conclusive and binding on all parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may delegate some or all of its power and authority hereunder to the Board (or any members thereof) or, subject to applicable
law, to a subcommittee of the Board, a member of the Board, the Chief Executive Officer or other executive officer of the Company as
the Committee deems appropriate; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that the Committee may not delegate its power and authority to a member
of the Board, the Chief Executive Officer or other executive officer of the Company with regard to the selection for participation in
this Plan of an officer, director or other person subject to Section 16 of the Exchange Act or decisions concerning the timing, pricing
or amount of an award to such an officer, director or other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the Board or Committee, and neither the Chief Executive Officer nor any other executive officer to whom the Committee delegates
any of its power and authority hereunder, shall be liable for any act, omission, interpretation, construction or determination made in
connection with this Plan in good faith, and the members of the Board and the Committee and the Chief Executive Officer or other executive
officer shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including
attorneys&#8217; fees) arising therefrom to the full extent permitted by law (except as otherwise may be provided in the Company&#8217;s
Certificate of Incorporation and/or By-laws) and under any directors&#8217; and officers&#8217; liability insurance that may be in effect
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.4
</B><FONT STYLE="text-decoration: underline">Eligibility</FONT>. Participants in this Plan shall consist of such officers, other employees, Non-Employee Directors, consultants,
independent contractors, agents, and persons expected to become officers, other employees, Non-Employee Directors, consultants, independent
contractors and agents of the Company and its Affiliates and Subsidiaries as the Committee in its sole discretion may select from time
to time. The Committee&#8217;s selection of a person to participate in this Plan at any time shall not require the Committee to select
such person to participate in this Plan at any other time. Except as otherwise provided for in an Agreement, for purposes of this Plan,
references to employment by the Company shall also mean employment by an Affiliate or Subsidiary, and references to employment shall
include service as a Non-Employee Director, consultant, independent contractor or agent. The Committee shall determine, in its sole discretion,
the extent to which a participant shall be considered employed during an approved leave of absence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.5
</B><FONT STYLE="text-decoration: underline">Shares Available</FONT>. Subject to adjustment as provided in <FONT STYLE="text-decoration: underline">Section 5.7</FONT> and to all other limits set forth in this Plan,
the number of shares of Common Stock available for all awards under this Plan, other than Substitute Awards, shall be 3,970,000. All of the shares available under the Plan may be issued under the Plan in connection with Incentive Stock Options. To the extent
the Company grants an award under the Plan, the number of shares of Common Stock that remain available for future grants under the Plan
shall be reduced by an amount equal to the number of shares subject to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that shares of Common Stock subject to an outstanding option, SAR, Stock Award or Performance Award granted under the Plan
or a similar type of award granted under the Prior Plan, other than Substitute Awards, are not issued or delivered by reason of (i) the
expiration, termination, cancellation or forfeiture of such award (excluding shares subject to an option cancelled upon settlement in
shares of a related Tandem SAR or shares subject to a Tandem SAR cancelled upon exercise of a related option) or (ii) the settlement
of such award in cash, then such shares of Common Stock shall again be available under this Plan; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that
shares of Common Stock subject to an award under this Plan or a Prior Plan shall not again be available for issuance under this Plan
if such shares are (x) shares that were subject to an option or stock-settled SAR and were not issued or delivered upon the net settlement
or net exercise of such option or SAR, (y) shares delivered to or withheld by the Company to pay the purchase price or the withholding
taxes related to an outstanding award or (z) shares repurchased by the Company on the open market with the proceeds of an option exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of Common Stock available for awards under this Plan shall not be reduced by (i) the number of shares of Common Stock
subject to Substitute Awards or (ii) available shares under a stockholder approved plan of a company or other entity which was a party
to a corporate transaction with the Company (as appropriately adjusted to reflect such corporate transaction) which become subject to
awards granted under this Plan (subject to applicable stock exchange requirements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock to be delivered under this Plan shall be made available from authorized and unissued shares of Common Stock, or authorized
and issued shares of Common Stock reacquired and held as treasury shares or otherwise or a combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.
STOCK OPTIONS AND STOCK APPRECIATION RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1
</B><FONT STYLE="text-decoration: underline">Stock Options</FONT>. The Committee may, in its discretion, grant options to purchase shares of Common Stock to such eligible persons
as may be selected by the Committee. Each option, or portion thereof, that is not an Incentive Stock Option, shall be a Nonqualified
Stock Option. To the extent that the aggregate Fair Market Value (determined as of the date of grant) of shares of Common Stock with
respect to which options designated as Incentive Stock Options are exercisable for the first time by a participant during any calendar
year (under this Plan or any other plan of the Company, or any parent or Subsidiary) exceeds the amount (currently $100,000) established
by the Code, such options shall constitute Nonqualified Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with
the terms of this Plan, as the Committee shall deem advisable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="text-decoration: underline">Number of Shares and Purchase Price</FONT>. The number of shares of Common Stock subject to an option and the purchase price per share
of Common Stock purchasable upon exercise of the option shall be determined by the Committee; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that the
purchase price per share of Common Stock purchasable upon exercise of an option shall not be less than 100% of the Fair Market Value
of a share of Common Stock on the date of grant of such option; <FONT STYLE="text-decoration: underline">provided further</FONT>, that if an Incentive Stock Option shall be granted
to any person who, at the time such option is granted, owns capital stock possessing more than 10 percent of the total combined voting
power of all classes of capital stock of the Company (or of any parent or Subsidiary) (a &#8220;<FONT STYLE="text-decoration: underline">Ten Percent Holder</FONT>&#8221;), the
purchase price per share of Common Stock shall not be less than the price (currently 110% of Fair Market Value) required by the Code
in order to constitute an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in the case of an option that is a Substitute Award, the purchase price per share of the shares subject to such option
may be less than 100% of the Fair Market Value per share on the date of grant, provided, that the excess of: (a) the aggregate Fair Market
Value (as of the date such Substitute Award is granted) of the shares subject to the Substitute Award, over (b) the aggregate purchase
price thereof does not exceed the excess of: (x) the aggregate fair market value (as of the time immediately preceding the transaction
giving rise to the Substitute Award, such fair market value to be determined by the Committee) of the shares of the predecessor company
or other entity that were subject to the grant assumed or substituted for by the Company, over (y) the aggregate purchase price of such
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="text-decoration: underline">Option Period and Exercisability</FONT>. The period during which an option may be exercised shall be determined by the Committee; <FONT STYLE="text-decoration: underline">provided</FONT>,
<FONT STYLE="text-decoration: underline">however</FONT>, that no option shall be exercised later than ten years after its date of grant; <FONT STYLE="text-decoration: underline">provided further</FONT>, that if an Incentive
Stock Option shall be granted to a Ten Percent Holder, such option shall not be exercised later than five years after its date of grant.
The Committee may, in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an
option or to the exercisability of all or a portion of an option. The Committee shall determine whether an option shall become exercisable
in cumulative or non-cumulative installments and in part or in full at any time. An exercisable option, or portion thereof, may be exercised
only with respect to whole shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="text-decoration: underline">Method of Exercise</FONT>. An option may be exercised (i) by giving written notice to the Company specifying the number of whole shares
of Common Stock to be purchased and accompanying such notice with payment therefor in full (or arrangement made for such payment to the
Company&#8217;s satisfaction) either (A) in cash, (B) by delivery (either actual delivery or by attestation procedures established by
the Company) of shares of Common Stock having a Fair Market Value, determined as of the date of exercise, equal to the aggregate purchase
price payable by reason of such exercise, (C) authorizing the Company to withhold whole shares of Common Stock which would otherwise
be delivered having an aggregate Fair Market Value, determined as of the date of exercise, equal to the amount necessary to satisfy such
obligation, (D) in cash by a broker-dealer acceptable to the Company to whom the participant has submitted an irrevocable notice of exercise
or (E) a combination of (A), (B) and (C), in each case to the extent set forth in the Agreement relating to the option, (ii) if applicable,
by surrendering to the Company any Tandem SARs which are cancelled by reason of the exercise of the option and (iii) by executing such
documents as the Company may reasonably request. Any fraction of a share of Common Stock which would be required to pay such purchase
price shall be disregarded and the remaining amount due shall be paid in cash by the participant. No shares of Common Stock shall be
issued and no certificate representing Common Stock shall be delivered until the full purchase price therefor and any withholding taxes
thereon, as described in <FONT STYLE="text-decoration: underline">Section 5.5</FONT>, have been paid (or arrangement made for such payment to the Company&#8217;s satisfaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2
</B><FONT STYLE="text-decoration: underline">Stock Appreciation Rights</FONT>. The Committee may, in its discretion, grant SARs to such eligible persons as may be selected by
the Committee. The Agreement relating to an SAR shall specify whether the SAR is a Tandem SAR or a Free-Standing SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with
the terms of this Plan, as the Committee shall deem advisable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="text-decoration: underline">Number of SARs and Base Price</FONT>. The number of SARs subject to an award shall be determined by the Committee. Any Tandem SAR related
to an Incentive Stock Option shall be granted at the same time that such Incentive Stock Option is granted. The base price of a Tandem
SAR shall be the purchase price per share of Common Stock of the related option. The base price of a Free-Standing SAR shall be determined
by the Committee; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that such base price shall not be less than 100% of the Fair Market Value of a share
of Common Stock on the date of grant of such SAR (or, if earlier, the date of grant of the option for which the SAR is exchanged or substituted).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in the case of an SAR that is a Substitute Award, the base price per share of the shares subject to such SAR may be less
than 100% of the Fair Market Value per share on the date of grant, provided, that the excess of: (a) the aggregate Fair Market Value
(as of the date such Substitute Award is granted) of the shares subject to the Substitute Award, over (b) the aggregate base price thereof
does not exceed the excess of: (x) the aggregate fair market value (as of the time immediately preceding the transaction giving rise
to the Substitute Award, such fair market value to be determined by the Committee) of the shares of the predecessor company or other
entity that were subject to the grant assumed or substituted for by the Company, over (y) the aggregate base price of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="text-decoration: underline">Exercise Period and Exercisability</FONT>. The period for the exercise of an SAR shall be determined by the Committee; <FONT STYLE="text-decoration: underline">provided</FONT>,
<FONT STYLE="text-decoration: underline">however</FONT>, that (i) no Tandem SAR shall be exercised later than the expiration, cancellation, forfeiture or other termination of
the related option and (ii) no Free-Standing SAR shall be exercised later than ten years after its date of grant. The Committee may,
in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an SAR or to the exercisability
of all or a portion of an SAR. The Committee shall determine whether an SAR may be exercised in cumulative or non-cumulative installments
and in part or in full at any time. An exercisable SAR, or portion thereof, may be exercised, in the case of a Tandem SAR, only with
respect to whole shares of Common Stock and, in the case of a Free-Standing SAR, only with respect to a whole number of SARs. If an SAR
is exercised for shares of Restricted Stock, a certificate or certificates representing such Restricted Stock shall be issued in accordance
with <FONT STYLE="text-decoration: underline">Section 3.2(c)</FONT>, or such shares shall be transferred to the holder in book entry form with restrictions on the shares duly
noted, and the holder of such Restricted Stock shall have such rights of a stockholder of the Company as determined pursuant to <FONT STYLE="text-decoration: underline">Section
3.2(d)</FONT>. Prior to the exercise of a stock-settled SAR, the holder of such SAR shall have no rights as a stockholder of the Company
with respect to the shares of Common Stock subject to such SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="text-decoration: underline">Method of Exercise</FONT>. A Tandem SAR may be exercised (i) by giving written notice to the Company specifying the number of whole SARs
which are being exercised, (ii) by surrendering to the Company any options which are cancelled by reason of the exercise of the Tandem
SAR and (iii) by executing such documents as the Company may reasonably request. A Free-Standing SAR may be exercised (A) by giving written
notice to the Company specifying the whole number of SARs which are being exercised and (B) by executing such documents as the Company
may reasonably request. No shares of Common Stock shall be issued and no certificate representing Common Stock shall be delivered until
any withholding taxes thereon, as described in <FONT STYLE="text-decoration: underline">Section 5.5</FONT>, have been paid (or arrangement made for such payment to the Company&#8217;s
satisfaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3
</B><FONT STYLE="text-decoration: underline">Termination of Employment or Service</FONT>. All of the terms relating to the exercise, cancellation or other disposition of an option
or SAR (i) upon a termination of employment with or service to the Company of the holder of such option or SAR, as the case may be, whether
by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined
by the Committee and set forth in the applicable award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4
</B><FONT STYLE="text-decoration: underline">No Repricing</FONT>. The Committee shall not, without the approval of the stockholders of the Company, (i) reduce the purchase price
or base price of any previously granted option or SAR, (ii) cancel any previously granted option or SAR in exchange for another option
or SAR with a lower purchase price or base price or (iii) cancel any previously granted option or SAR in exchange for cash or another
award if the purchase price of such option or the base price of such SAR exceeds the Fair Market Value of a share of Common Stock on
the date of such cancellation, in each case, other than in connection with a Change in Control or the adjustment provisions set forth
in <FONT STYLE="text-decoration: underline">Section 5.7</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.5
</B><FONT STYLE="text-decoration: underline">No Dividend Equivalents.</FONT> Notwithstanding anything in an Agreement to the contrary, the holder of an option or SAR shall not
be entitled to receive dividend equivalents with respect to the number of shares of Common Stock subject to such option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.
STOCK AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1
</B><FONT STYLE="text-decoration: underline">Stock Awards</FONT>. The Committee may, in its discretion, grant Stock Awards to such eligible persons as may be selected by the
Committee. The Agreement relating to a Stock Award shall specify whether the Stock Award is a Restricted Stock Award, a Restricted Stock
Unit Award or, in the case of an Other Stock Award, the type of award being granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2
</B><FONT STYLE="text-decoration: underline">Terms of Restricted Stock Awards</FONT>. Restricted Stock Awards shall be subject to the following terms and conditions and shall
contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="text-decoration: underline">Number of Shares and Other Terms</FONT>. The number of shares of Common Stock subject to a Restricted Stock Award and the Restriction
Period, Performance Period (if any) and Performance Measures (if any) applicable to a Restricted Stock Award shall be determined by the
Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="text-decoration: underline">Vesting and Forfeiture</FONT>. The Agreement relating to a Restricted Stock Award shall provide, in the manner determined by the Committee,
in its discretion, and subject to the provisions of this Plan, for the vesting of the shares of Common Stock subject to such award (i)
if the holder of such award remains continuously in the employment of the Company during the specified Restriction Period and (ii) if
specified Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares
of Common Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during
the specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance
Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="text-decoration: underline">Stock Issuance</FONT>. During the Restriction Period, the shares of Restricted Stock shall be held by a custodian in book entry form
with restrictions on such shares duly noted or, alternatively, a certificate or certificates representing a Restricted Stock Award shall
be registered in the holder&#8217;s name and may bear a legend, in addition to any legend which may be required pursuant to <FONT STYLE="text-decoration: underline">Section
5.6</FONT>, indicating that the ownership of the shares of Common Stock represented by such certificate is subject to the restrictions,
terms and conditions of this Plan and the Agreement relating to the Restricted Stock Award. All such certificates shall be deposited
with the Company, together with stock powers or other instruments of assignment (including a power of attorney), each endorsed in blank
with a guarantee of signature if deemed necessary or appropriate, which would permit transfer to the Company of all or a portion of the
shares of Common Stock subject to the Restricted Stock Award in the event such award is forfeited in whole or in part. Upon termination
of any applicable Restriction Period (and the satisfaction or attainment of applicable Performance Measures), subject to the Company&#8217;s
right to require payment of any taxes in accordance with <FONT STYLE="text-decoration: underline">Section 5.5</FONT>, the restrictions shall be removed from the requisite number
of any shares of Common Stock that are held in book entry form, and all certificates evidencing ownership of the requisite number of
shares of Common Stock shall be delivered to the holder of such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<FONT STYLE="text-decoration: underline">Rights with Respect to Restricted Stock Awards</FONT>. Unless otherwise set forth in the Agreement relating to a Restricted Stock Award,
and subject to the terms and conditions of a Restricted Stock Award, the holder of such award shall have all rights as a stockholder
of the Company, including, but not limited to, voting rights, the right to receive dividends and the right to participate in any capital
adjustment applicable to all holders of Common Stock; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that a distribution or dividend with respect to
shares of Common Stock, including a regular cash dividend, shall be deposited with the Company and shall be subject to the same restrictions
as the shares of Common Stock with respect to which such distribution or dividend was made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3
</B><FONT STYLE="text-decoration: underline">Terms of Restricted Stock Unit Awards</FONT>. Restricted Stock Unit Awards shall be subject to the following terms and conditions
and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="text-decoration: underline">Number of Shares and Other Terms</FONT>. The number of shares of Common Stock subject to a Restricted Stock Unit Award, including the
number of shares that are earned upon the attainment of any specified Performance Measures, and the Restriction Period, Performance Period
(if any) and Performance Measures (if any) applicable to a Restricted Stock Unit Award shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="text-decoration: underline">Vesting and Forfeiture</FONT>. The Agreement relating to a Restricted Stock Unit Award shall provide, in the manner determined by the
Committee, in its discretion, and subject to the provisions of this Plan, for the vesting of such Restricted Stock Unit Award (i) if
the holder of such award remains continuously in the employment of the Company during the specified Restriction Period and (ii) if specified
Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares of Common
Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during the
specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance
Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="text-decoration: underline">Settlement of Vested Restricted Stock Unit Awards</FONT>. The Agreement relating to a Restricted Stock Unit Award shall specify (i) whether
such award may be settled in shares of Common Stock or cash or a combination thereof and (ii) whether the holder thereof shall be entitled
to receive, on a deferred basis, dividend equivalents, and, if determined by the Committee, interest on, or the deemed reinvestment of,
any deferred dividend equivalents, with respect to the number of shares of Common Stock subject to such award. Any dividend equivalents
with respect to Restricted Stock Units that are subject to vesting conditions shall be subject to the same restrictions as such Restricted
Stock Units. Prior to the settlement of a Restricted Stock Unit Award, the holder of such award shall have no rights as a stockholder
of the Company with respect to the shares of Common Stock subject to such award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4
</B><FONT STYLE="text-decoration: underline">Other Stock Awards</FONT>. Subject to the limitations set forth in the Plan, the Committee is authorized to grant other awards that
may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, shares of Common
Stock, including without limitation shares of Common Stock granted as a bonus and not subject to any vesting conditions, dividend equivalents,
deferred stock units, stock purchase rights and shares of Common Stock issued in lieu of obligations of the Company to pay cash under
any compensatory plan or arrangement, subject to such terms as shall be determined by the Committee. The Committee shall determine the
terms and conditions of such awards, which may include the right to elective deferral thereof, subject to such terms and conditions as
the Committee may specify in its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5
</B><FONT STYLE="text-decoration: underline">Termination of Employment or Service.</FONT> All of the terms relating to the satisfaction of Performance Measures and the termination
of the Restriction Period or Performance Period relating to a Stock Award, or any forfeiture and cancellation of such award (i) upon
a termination of employment with or service to the Company of the holder of such award, whether by reason of disability, retirement,
death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the
applicable award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.
PERFORMANCE AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1
</B><FONT STYLE="text-decoration: underline">Performance Awards</FONT>. The Committee may, in its discretion, grant Performance Awards to such eligible persons as may be selected
by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2
</B><FONT STYLE="text-decoration: underline">Terms of Performance Awards</FONT>. Performance Awards shall be subject to the following terms and conditions and shall contain such
additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="text-decoration: underline">Value of Performance Awards and Performance Measures</FONT>. The method of determining the value of the Performance Award and the Performance
Measures and Performance Period applicable to a Performance Award shall be determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="text-decoration: underline">Vesting and Forfeiture</FONT>. The Agreement relating to a Performance Award shall provide, in the manner determined by the Committee,
in its discretion, and subject to the provisions of this Plan, for the vesting of such Performance Award if the specified Performance
Measures are satisfied or met during the specified Performance Period and for the forfeiture of such award if the specified Performance
Measures are not satisfied or met during the specified Performance Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="text-decoration: underline">Settlement of Vested Performance Awards</FONT>. The Agreement relating to a Performance Award shall specify whether such award may be
settled in shares of Common Stock (including shares of Restricted Stock) or cash or a combination thereof. If a Performance Award is
settled in shares of Restricted Stock, such shares of Restricted Stock shall be issued to the holder in book entry form or a certificate
or certificates representing such Restricted Stock shall be issued in accordance with <FONT STYLE="text-decoration: underline">Section 3.2(c)</FONT> and the holder of such Restricted
Stock shall have such rights as a stockholder of the Company as determined pursuant to <FONT STYLE="text-decoration: underline">Section 3.2(d)</FONT>. Any dividends or dividend
equivalents with respect to a Performance Award shall be subject to the same restrictions as such Performance Award. Prior to the settlement
of a Performance Award in shares of Common Stock, including Restricted Stock, the holder of such award shall have no rights as a stockholder
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3
</B><FONT STYLE="text-decoration: underline">Termination of Employment or Service</FONT>. All of the terms relating to the satisfaction of Performance Measures and the termination
of the Performance Period relating to a Performance Award, or any forfeiture and cancellation of such award (i) upon a termination of
employment with or service to the Company of the holder of such award, whether by reason of disability, retirement, death or any other
reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable award
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V.
GENERAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1
</B><FONT STYLE="text-decoration: underline">Effective Date and Term of Plan</FONT>. This Plan shall be submitted to the stockholders of the Company for approval at the Company&#8217;s
2018 annual meeting of stockholders and, if approved by the affirmative vote of a majority of the shares of Common Stock present in person
or represented by proxy at such annual meeting of stockholders, shall become effective as of the date on which the Plan was approved
by stockholders (the &#8220;<FONT STYLE="text-decoration: underline">Effective Date</FONT>&#8221;). This Plan shall terminate as of the first annual meeting of the Company&#8217;s
stockholders to occur on or after the tenth anniversary of its Effective Date, unless terminated earlier by the Board. Termination of
this Plan shall not affect the terms or conditions of any award granted prior to termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
hereunder may be made at any time prior to the termination of this Plan, provided that no Incentive Stock Option may be granted later
than ten years after the date on which the Plan was approved by the Board. In the event that this Plan is not approved by the stockholders
of the Company, this Plan and any awards hereunder shall be void and of no force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2
</B><FONT STYLE="text-decoration: underline">Amendments</FONT>. The Board may amend this Plan as it shall deem advisable; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that no amendment to
the Plan shall be effective without the approval of the Company&#8217;s stockholders if (i) stockholder approval is required by applicable
law, rule or regulation, including any rule of the Nasdaq Capital Market or any other stock exchange on which the Common Stock is then
traded, or (ii) such amendment seeks to modify <FONT STYLE="text-decoration: underline">Section 2.4</FONT> hereof; <FONT STYLE="text-decoration: underline">provided further</FONT>, that no amendment may materially impair
the rights of a holder of an outstanding award without the consent of such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3
</B><FONT STYLE="text-decoration: underline">Agreement</FONT>. Each award under this Plan shall be evidenced by an Agreement setting forth the terms and conditions applicable
to such award. No award shall be valid until an Agreement is executed by the Company and, to the extent required by the Company, executed
or electronically accepted by the recipient of such award. Upon such execution or acceptance and delivery of the Agreement to the Company
within the time period specified by the Company, such award shall be effective as of the effective date set forth in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.4
</B><FONT STYLE="text-decoration: underline">Non-Transferability</FONT>. No award shall be transferable other than by will, the laws of descent and distribution or pursuant to
beneficiary designation procedures approved by the Company or, to the extent expressly permitted in the Agreement relating to such award,
to the holder&#8217;s family members, a trust or entity established by the holder for estate planning purposes, a charitable organization
designated by the holder or pursuant to a domestic relations order, in each case, without consideration. Except to the extent permitted
by the foregoing sentence or the Agreement relating to an award, each award may be exercised or settled during the holder&#8217;s lifetime
only by the holder or the holder&#8217;s legal representative or similar person. Except as permitted by the second preceding sentence,
no award may be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law
or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate,
encumber or otherwise dispose of any award, such award and all rights thereunder shall immediately become null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.5
</B><FONT STYLE="text-decoration: underline">Tax Withholding</FONT>. The Company shall have the right to require, prior to the issuance or delivery of any shares of Common Stock
or the payment of any cash pursuant to an award made hereunder, payment by the holder of such award of any federal, state, local or other
taxes which may be required to be withheld or paid in connection with such award. An Agreement may provide that (i) the Company shall
withhold whole shares of Common Stock which would otherwise be delivered to a holder, having an aggregate Fair Market Value determined
as of the date the obligation to withhold or pay taxes arises in connection with an award (the &#8220;<FONT STYLE="text-decoration: underline">Tax Date</FONT>&#8221;), or withhold
an amount of cash which would otherwise be payable to a holder, in the amount necessary to satisfy any such obligation or (ii) the holder
may satisfy any such obligation by any of the following means (or by other means that the Committee deems appropriate): (A) a cash payment
or delivery of cash equivalents to the Company; (B) delivery (either actual delivery or by attestation procedures established by the
Company) to the Company of previously owned whole shares of Common Stock having an aggregate Fair Market Value, determined as of the
Tax Date, equal to the amount necessary to satisfy any such obligation; (C) authorizing the Company to withhold whole shares of Common
Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the Tax Date, or withhold an amount
of cash which would otherwise be payable to a holder, in either case equal to the amount necessary to satisfy any such obligation; (D)
in the case of the exercise of an option, a cash payment by a broker-dealer acceptable to the Company to whom the participant has submitted
an irrevocable notice of exercise or (E) any combination of (A), (B) and (C), in each case to the extent set forth in the Agreement relating
to the award. Shares of Common Stock to be delivered or withheld may not have an aggregate Fair Market Value in excess of the amount
determined by applying the minimum statutory withholding rate (or, if permitted by the Company, such other rate as will not cause adverse
accounting consequences under the accounting rules then in effect, and is permitted under applicable IRS withholding rules). Any fraction
of a share of Common Stock which would be required to satisfy such an obligation shall be disregarded and the remaining amount due shall
be paid in cash by the holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.6
</B><FONT STYLE="text-decoration: underline">Restrictions on Shares</FONT>. Each award made hereunder shall be subject to the requirement that if at any time the Company determines
that the listing, registration or qualification of the shares of Common Stock subject to such award upon any securities exchange or under
any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a condition
of, or in connection with, the delivery of shares thereunder, such shares shall not be delivered unless such listing, registration, qualification,
consent, approval or other action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company
may require that certificates evidencing shares of Common Stock delivered pursuant to any award made hereunder bear a legend indicating
that the sale, transfer or other disposition thereof by the holder is prohibited except in compliance with the Securities Act of 1933,
as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.7
</B><FONT STYLE="text-decoration: underline">Adjustment</FONT>. In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting
Standards Codification Topic 718, Compensation&#8212;Stock Compensation or any successor or replacement accounting standard) that causes
the per share value of shares of Common Stock to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization
through an extraordinary cash dividend, the number and class of securities available under this Plan, the terms of each outstanding option
and SAR (including the number and class of securities subject to each outstanding option or SAR and the purchase price or base price
per share), the terms of each outstanding Stock Award (including the number and class of securities subject thereto), the terms of each
outstanding Performance Award (including the number and class of securities subject thereto, if applicable) shall be appropriately adjusted
by the Committee, such adjustments to be made in the case of outstanding options and SARs in accordance with Section 409A of the Code.
In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete
liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate
and equitable by the Committee to prevent dilution or enlargement of rights of participants. In either case, the decision of the Committee
regarding any such adjustment shall be final, binding and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.8
</B><FONT STYLE="text-decoration: underline">Change in Control</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to the terms of the applicable award Agreements, in the event of a &#8220;Change in Control,&#8221; the Board, as constituted
prior to the Change in Control, may, in its discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that (i) some or all outstanding options and SARs shall become exercisable in full or in part, either immediately or upon a subsequent
    termination of employment, (ii) the Restriction Period applicable to some or all outstanding Stock Awards shall lapse in full or
    in part, either immediately or upon a subsequent termination of employment, (iii) the Performance Period applicable to some or all
    outstanding awards shall lapse in full or in part, and (iv) the Performance Measures applicable to some or all outstanding awards
    shall be deemed to be satisfied at the target, maximum or any other level;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change
    in Control, or a parent corporation thereof, be substituted for some or all of the shares of Common Stock subject to an outstanding
    award, with an appropriate and equitable adjustment to such award as determined by the Board in accordance with <FONT STYLE="text-decoration: underline">Section 5.7</FONT>;
    and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    outstanding awards, in whole or in part, to be surrendered to the Company by the holder, and to be immediately cancelled by the Company,
    and to provide for the holder to receive (i) a cash payment in an amount equal to (A) in the case of an option or an SAR, the aggregate
    number of shares of Common Stock then subject to the portion of such option or SAR surrendered, whether or not vested or exercisable,
    multiplied by the excess, if any, of the Fair Market Value of a share of Common Stock as of the date of the Change in Control, over
    the purchase price or base price per share of Common Stock subject to such option or SAR, (B) in the case of a Stock Award or a Performance
    Award denominated in shares of Common Stock, the number of shares of Common Stock then subject to the portion of such award surrendered
    to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to <FONT STYLE="text-decoration: underline">Section
    5.8(a)(i)</FONT>, whether or not vested, multiplied by the Fair Market Value of a share of Common Stock as of the date of the Change
    in Control, and (C) in the case of a Performance Award denominated in cash, the value of the Performance Award then subject to the
    portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed
    satisfied pursuant to <FONT STYLE="text-decoration: underline">Section 5.8(a)(i)</FONT>; (ii) shares of capital stock of the corporation resulting from or succeeding to the
    business of the Company pursuant to such Change in Control, or a parent corporation thereof, having a fair market value not less
    than the amount determined under clause (i) above; or (iii) a combination of the payment of cash pursuant to clause (i) above and
    the issuance of shares pursuant to clause (ii) above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
For purposes of this Plan, a &#8220;<FONT STYLE="text-decoration: underline">Change in Control</FONT>&#8221; shall mean:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of an amalgamation, merger or consolidation of the Company with or into another entity or any other corporate reorganization
    of the Company, if more than fifty percent (50%) of the combined voting power of the continuing or surviving entity&#8217;s securities
    outstanding immediately after such amalgamation, merger, consolidation or other reorganization (or, if applicable, more than fifty
    percent (50%) of the combined voting power of the ultimate parent company that directly or indirectly has beneficial ownership of
    the securities of such continuing or surviving entity) is not owned directly or indirectly by persons who were holders of the Company&#8217;s
    then-outstanding voting securities immediately prior to such amalgamation, merger, consolidation or other reorganization;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    sale, transfer or other disposition of all or substantially all of the Company&#8217;s assets to an entity that is not a parent,
    a Subsidiary or an Affiliate of the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    transaction as a result of which any person becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange
    Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented
    by the Company&#8217;s then-outstanding voting securities. For purposes of this subsection, the term &#8220;person&#8221; shall have
    the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude: (i) any parent, Subsidiary or Affiliate
    of the Company; (ii) any employee benefit plan (or related trust) sponsored or maintained by the Company, a parent, or any Subsidiary
    or Affiliate; and (iii) any underwriter temporarily holding securities pursuant to an offering of such securities;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#160;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    change in the composition of the Board over a period of twenty four (24) consecutive months or less as a result of which individuals
    who, at the beginning of such period, constitute the Board (the &#8220;<FONT STYLE="text-decoration: underline">Incumbent Board</FONT>&#8221;) cease for any reason to constitute
    at least a majority of the Board; <FONT STYLE="text-decoration: underline">provided</FONT>, <FONT STYLE="text-decoration: underline">however</FONT>, that any individual subsequently becoming a director whose election,
    or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of the directors then
    comprising the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named
    as a nominee for director, without written objection to such nomination) shall be considered as though such individual were a member
    of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result
    of either an actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stockholders of the Company approve a complete liquidation or dissolution of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="text-decoration: underline">provided</FONT>,
that with respect to any nonqualified deferred compensation that becomes payable on account of the Change in Control, the transaction
or event described in clause (1), (2), (3) or (4) also constitutes a &#8220;change in control event,&#8221; as defined in Treasury Regulation
&#167;1.409A-3(i)(5) if required in order for the payment not to violate Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.9
</B><FONT STYLE="text-decoration: underline">Deferrals</FONT>. The Committee may determine that the delivery of shares of Common Stock or the payment of cash, or a combination
thereof, upon the settlement of all or a portion of any award made hereunder shall be deferred, or the Committee may, in its sole discretion,
approve deferral elections made by holders of awards. Deferrals shall be for such periods and upon such terms as the Committee may determine
in its sole discretion, subject to the requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.10
</B><FONT STYLE="text-decoration: underline">No Right of Participation, Employment or Service</FONT>. Unless otherwise set forth in an employment agreement, no person shall have
any right to participate in this Plan. Neither this Plan nor any award made hereunder shall confer upon any person any right to continued
employment by or service with the Company, any Subsidiary or any Affiliate or affect in any manner the right of the Company, any Subsidiary
or any Affiliate to terminate the employment or service of any person at any time without liability hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.11
</B><FONT STYLE="text-decoration: underline">Non-Uniform Determinations</FONT>. The Committee&#8217;s determinations under the Plan (including without limitation determinations
of the persons to receive awards, the form, amount and time of such awards, the terms and provisions of such awards and the Agreements
evidencing awards) need not be uniform and may be made by it selectively among persons who receive, or are eligible to receive, awards
under the Plan, whether or not such persons are similarly situated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.12
</B><FONT STYLE="text-decoration: underline">Rights as Stockholder</FONT>. No person shall have any right as a stockholder of the Company with respect to any shares of Common
Stock or other equity security of the Company which is subject to an award hereunder unless and until such person becomes a stockholder
of record with respect to such shares of Common Stock or equity security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.13
</B><FONT STYLE="text-decoration: underline">Designation of Beneficiary</FONT>. To the extent permitted by the Company, a holder of an award may file with the Company a written
designation of one or more persons as such holder&#8217;s beneficiary or beneficiaries (both primary and contingent) in the event of
the holder&#8217;s death or incapacity. To the extent an outstanding option or SAR granted hereunder is exercisable, such beneficiary
or beneficiaries shall be entitled to exercise such option or SAR pursuant to procedures prescribed by the Company. Each beneficiary
designation shall become effective only when filed in writing with the Company during the holder&#8217;s lifetime on a form prescribed
by the Company. The spouse of a married holder domiciled in a community property jurisdiction shall join in any designation of a beneficiary
other than such spouse. The filing with the Company of a new beneficiary designation shall cancel all previously filed beneficiary designations.
If a holder fails to designate a beneficiary, or if all designated beneficiaries of a holder predecease the holder, then each outstanding
award held by such holder, to the extent vested or exercisable, shall be payable to or may be exercised by such holder&#8217;s executor,
administrator, legal representative or similar person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.14
</B><FONT STYLE="text-decoration: underline">Awards Subject to Clawback</FONT>. The awards granted under this Plan and any cash payment or shares of Common Stock delivered pursuant
to such an award are subject to forfeiture, recovery by the Company or other action pursuant to the applicable award Agreement or any
clawback or recoupment policy which the Company may adopt from time to time, including without limitation any such policy which the Company
may be required to adopt under the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder,
or as otherwise required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.15
</B><FONT STYLE="text-decoration: underline">Governing Law</FONT>. This Plan, each award hereunder and the related Agreement, and all determinations made and actions taken pursuant
thereto, to the extent not otherwise governed by the Code or the laws of the United States, shall be governed by the laws of the State
of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.16
</B><FONT STYLE="text-decoration: underline">Foreign Employees</FONT>. Without amending this Plan, the Committee may grant awards to eligible persons who are foreign nationals
and/or reside outside of the United States on such terms and conditions different from those specified in this Plan as may in the judgment
of the Committee be necessary or desirable to foster and promote achievement of the purposes of this Plan and, in furtherance of such
purposes the Committee may make such modifications, amendments, procedures, subplans and the like as may be necessary or advisable to
comply with provisions of laws in other countries or jurisdictions in which the Company or its Subsidiaries or Affiliates operates or
has employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.17
</B><FONT STYLE="text-decoration: underline">Severability and Reformation</FONT>. If any provision of the Plan or any award is, becomes or is deemed to be invalid, illegal or
unenforceable in any jurisdiction or as to any person or award, or would disqualify the Plan or any award under any law deemed applicable
by the Committee, such provision shall be construed or deemed amended to conform to the applicable law or, if it cannot be construed
or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the award, such provision
shall be stricken as to such jurisdiction, person or award and the remainder of the Plan and any such award shall remain in full force
and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.18
</B><FONT STYLE="text-decoration: underline">Unfunded Status of Awards; No Trust of Fund Created</FONT>. The Plan is intended to constitute an &#8220;unfunded&#8221; plan. Neither
the Plan nor any award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between
the Company or any Subsidiary or Affiliate and a participant or any other person. To the extent that any person acquires a right to receive
payments from the Company or any Subsidiary or Affiliate pursuant to an award, such right shall be no greater than the right of any general
unsecured creditors of the Company or such Subsidiary or Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.19
</B><FONT STYLE="text-decoration: underline">No Limit on Other Compensation Arrangements</FONT>. Nothing contained in the Plan shall prevent the Company or any parent, Subsidiary
or Affiliate from adopting or continuing in effect other compensation arrangements (whether such arrangements be generally applicable
or applicable only in specific cases).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.20
</B><FONT STYLE="text-decoration: underline">No Restriction of Corporate Action</FONT>. Nothing contained in the Plan shall be construed to limit or impair the power of the Company
or any parent, Subsidiary or Affiliate to make adjustments, reclassifications, reorganizations, or changes in its capital or business
structure, or to amalgamate, merge or consolidate, liquidate, sell or transfer all or any part of its business or assets or to take other
actions which it deems to be necessary or appropriate. No employee, beneficiary or other person shall have any claim against the Company
or any parent, Subsidiary or Affiliate as a result of such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#160;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<IMG SRC="proxy_001.jpg" ALT="" STYLE="height: 1100px; width: 850px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="proxy_002.jpg" ALT="" STYLE="height: 1100px; width: 850px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 77; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&#160;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</P>


<!-- eJwdzLEOgkAMgOHdxHdobjaU6Mams8MNbMShd1eVWCkpFw7fXmD//t9dU+pzrwMJ3CmwTO7k3jmPDWIppVqCSaX2wnNdX9BUGGVj7nhwHFPj57GlINzykm+i8bPmnn4wT+DZnmpfGiJDtyPYFOzssQ7+OCopiQ== -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*<!
M!@8&!@<&!P@(!PH+"@L*#PX,# X/%A 1$!$0%B(5&145&14B'B0>'!XD'C8J
M)B8J-CXT,C0^3$1$3%]:7WQ\I__  !$(")@&I ,!(0 "$0$#$0'_Q "J  $
M @,! 0$!            !08#! <" 0@)$  !! $# 0('!PX+!@0# PT!  (#
M! 4&$1(3(3$'%!46(D%1,E)35F&2E",S-#4V<7)S='61LM'20E15@9.5I+&S
MM-,7)%=EH<((-X+#)45B&$-&@X3!X7:BH^,F.$1C1P$! 0$
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M 1 1 1 1 1 1 1 1 1 1 1 1 7/]%?<_%^67O\S(JFK6B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M B B B N?Z*^Y^+\LO?YF15-6M$!$!$!$!$!$!$!$!$$)A>[)?G"93: B B
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MR7YPF4V@(@(@(@(@AL!]K&?C['^*Y3* B B B B B"&R'VSPOX^7_"<IE 1
M1 1 1 1!HY/[6WOR>3]4K[C?M=2_)X_U0@W400V)^O9?\O=_AL4R@*$PO=DO
MSA,@FT0$0$0$0$0$0$0$0$0$05^3[M]-_D61_P#:5U441 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q
M\W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QG
MSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[
MB>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKX
MSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W
M]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+
M7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOT
MEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;
MEKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYW
MZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q
M\W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QG
MSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[
MB>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKX
MSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W
M]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+7QGSOTEO[B>;EKXSYWZ2W]Q \W+
M7QGSOTEO[BT+5+(8J]@Y8]09:82Y2"&2.:</8YC]]P0&A!TM%%$0$0$0$0$0
M$0%S_17W/Q?EE[_,R*IJUH@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@K\GW;Z;_(LC_P"TMOPB
ML9)IV-CVAS793'!S2-P0;3$5Y\W\#_)%'^@8GF_@?Y(H_P! Q$/-_ _R11_H
M&)YOX'^2*/\ 0,0/-_ _R11_H&)YOX'^2*/] Q \W\#_ "11_H&)YOX'^2*/
M] Q \W\#_)%'^@8GF_@?Y(H_T#$#S?P/\D4?Z!B>;^!_DBC_ $#$#S?P/\D4
M?Z!B>;^!_DBC_0,0?="10P4\Y''&QD;,U9#6-   ]%6M11$!$!$!$!$!$!$!
M$!$!$!$!$%:\(_W":D_()%(*IHB B B B B B B B B B B B B B B B B
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M#W3FD9<D_$Y>:V;(B$H>^-_$,W]XNA17:<TCHXK,3WCO8UX)&WR!$?DG#_\
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M0OM!!^=<;_FF()-%4$0$0$0$0$0$01VB/K.>_/=K_M5F441 1 1 1 1 1 1
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M$0$0$0$0$0$0$0$0%7-0_7M._GNJ@O"**(@(@(@(@(@(@(@(@'N*_%_@!_\
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M90TLW'LW![47'Z)_\.A \Z3^1_\ N+]'*L[Z+GGAH_\ +K,?AUO\9B&>N$>
M3[LKOYJE_P 6-?KI#?7\^LYC+FF=2VJCQM+3M;QGU.:#R8X?(0OW-I#6&%U-
MC(+5*=G4X#K0$CG$[UAP476?4FIL/IS&RW,A:9&T-/!FXZDKO>L"_"$<60U3
MJ9S8H][61NN=L.X&5Q<3]X(8_H+4K,JU8*[-^$4;6-^\T;!>E61$!$!:NI/N
M>S'Y%-^H4'!__#T[;&Y[\HB7Z"1=]?)8HIHWQ2QM>Q[2',< 00?405Q/5_@0
MHVI77]-S^(6P>8AW(B+A[SUL0S8K.'\*FKM(7&8G66/GF8.P3[#K?LE"_0N
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M$!$!5S4/U[3OY[JH+PBBB("("("("("("("(![BOQ?X ?_,:?\BL(/V@B B
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M(@*K^$+[00?G7&_YIB"315&G<M^*L:[Q>>;<[;1-Y$*/\MG^2\C_ $/_ .M
M\MG^2\C_ $/_ .M/+9_DO(_T/_ZU4/+9_DO(_P!#_P#K3RV?Y+R/]#_^M!EA
MRQEE9'Y.O,Y';D^+9H^4G=2ZBB("(([1'UG/?GNU_P!JLRBB("("("("("("
M("("("("("(*UX1_N$U)^02*0531$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!5S4/U[3OY[JH+PBBB("(
M"("("("("("(![BOY=V/LB;\-W]Z+C"B#O/@A\%>-U=4NY3*SRBK#/T60Q'8
MO> "22MCPP>"7&:1H5<MB9Y36?.(98)3N6D@D%I0?GY$%ATC]U>GOSG5_P 0
M+^E*&B(@B B B B B B B B B B B B B B B B B B D\4<\,D,C0YDC"U[
M3W%KAL0@Q5:E:I!'!6@CAAC&S(XVAK6CV !94!$!$!$!$'Y*\!?_ )I:E_)+
M?^88N2>$W[O]3?E\B*UO!Y]W>EOSK6_7"[+_ .(7[NM.?D,7^.Y!^A-8Z^P.
MBVT7Y5M@BV9!%TF!_;'MNN1>#WP5WAJN]GLS0H6L7?@FEKLEVF.\[Q(PEC@@
MZ-#K+0=C4!T'Y,!>'NB\6-9GBN\3>JJKKGP=ZKESV-ET=)#C*#8F>,P5IC4:
M^4/.[BR)!<_"+J30N CQ?G/BVW!,9O%]ZS+'$LVY^[7XHPNEKVL]29*K@V0L
M[9K+&R'IM$7, ?K(/U+>\$ID\%L>'AQ&+&>$,+39#& [B8.)ZJ_*V5T-G<5J
MFKINR(/'IY(&,XOW9O.=F[E!U&IX&_"UB8)A3R;*L1W<]D%Y\8*A? UKW!Z,
MN9F;*"?:S#$R/I,#^UA0?M^A?@OT*=V#?I6((YH]QL>,C0X;KVB"("J_A"^T
M$'YUQO\ FF()-%4$0$0$0$0$0$01VB/K.>_/=K_M5F441 1 1 1 1 1 1 1
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M[7_:K,HHB B B B B B B B B B B B"M>$?[A-2?D$BD%4T1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M5<U#]>T[^>ZJ"\(HHB B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B#C%WP :&L69YWV,GSED<]P$S-MWG
M\!8'?^';0@[[64_IF?N(,@_\.F@_79RG],S]Q9(?_#SH2*5D@GRF[' C>9G[
MB"[ZZT!@=9MH,R<EIOBAD,?1>&?7-M]]P51/_LZ:#_C.4_IF?N(+]8T%A9M$
MLTK))9%$1L8"'CJ[,D$B:/T5A]&T+5'%R6'Q33]5YF<''EL&^H!!;%QJ_P"
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MV4L,HG'#V DA=10?+=NO3JS6;$K8X86%\DCNP-:.\E:KM1X"-F+<[)5VMR!
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M>I&66/FQO5 W&VZ#;PNH]/9GKG&92O:,.PD$;MRW=;>1R>-Q=-]J_<BK5VD
MRR.#1N?4$&IB]2Z?R-&Q<I92M/! TNF>QV_3#1N2Y8L3J?3F3M^*T,K7LV.B
M)C'&[<AA]:#/FM4:>P1B&4RE>J9=RQLCMBX!9V9W"'%>5&Y*MXB&<O&>H.GL
M/E0:N$U)IW--F.-RE:T8OK@8_M:#[0M2CK72%N^W'U<Y3ELN<6MC;("7'V!
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M3FEL3C<_X-<YI85/%\M4+Q:A>=WFTT[LE09?!E-:UAGY<[D83PQN*AQS&O\
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MGAX#A:CW!(03J*H(@(@(@(@(@(@CM$?6<]^>[7_:K,HHB B B B B B B B
MB B B B"M>$?[A-2?D$BD%4T1 1 5#RVD,)+F(LS=S%^&9DF\6]OIQLW["Q@
M]0*"Q,Q./K9:YFC([K35V1/<YPX-C9VC90)TAIBU@KU3K.DJV;C[DDXF&XF)
MW+P\(,%+3.E8Z>2I-RDEB7(QB*Q8EM"6Q(W;8-#BIFWI+#VK6"LR1OYXKLJ[
M'8;   ._0@A+^@],W<M:<^W:C=;(GM48K)9%/L?=OC4\[%8/'7Y,G+(R$R58
MZ8$CVLB;$S<AC04$9A*&GL+@KF/PMV%[6LEE[;+=P7#O<\;[!3.$BAQF%Q56
M7(-F=TF,$[Y-^L]PWW:2>W=!(OR./9:;5?<@;8=[F$R-#S]YN^ZJ%W1V&OZA
M;?DRU_QV$]1D3+>PB:=@0U@[6M<@G:^-Q,V8N96*833O@%24!X>QC&'?AL.X
MJ%;H/3-73<N'<V04Q,;'-TFSXWCMYA_JV09],X#3]">S;HWI+UJ1H9+:FL>,
MR\!W-W]04E1.(K9"_P!/*B6Q9G!?"^P'ECF^CP8WU()2U?HU.'C-N&'EOQZC
MVLWV]FZ,O4G]#A:A=UN72V>#U./?Q]NR#W+<J0OX2V8F/X%_%SP#Q;VEVQ]0
M6K'F</+(R./)5'O<=FM;,PDD^H %!)(@Q330P1NEFE9'&WW3WD-:/ODK##?H
M3UW68;<$D+02Z5CVN8-NT[D(/7CE/:!WC,6TQ B/,;2;^]]JPS9;%P3&&6_6
MCD&V['2M:X;_ "$H$^5Q=:4Q3WZT4@[V/E:TC?Y"5Y\KXGHF;RC5Z8=Q+^JW
MCR(WVWW09*V2Q]MY96NUYG ;D1R->0/YENH,4D\$3XF22L8Z1W%@<X N/L'M
M7FQ:K5F!]B>.)I.P<]P:-_9N4&1TD;8S(Y[0P#<N)[-O;NO$%B"Q&)()F2,/
M<YC@X?I"#,B B B B B B B B B B B B B B B B B JYJ'Z]IW\]U4%X11
M1$!$!$!$!$!$!4_17VVUO^?3_@1H*Q!D\KC:&JY\?$\EVK9F3RLA-AT,!C9R
MD$;2"Y9I-=7(,!//%E:-^63)0TZ\[()6OB$HW)L0 <@YNQV 03FEM27[>;L8
MV>P^[!XKUXKAI2U-G!P:Z)PD&Q[]PKJ@X-DX\JW'ZS<;D<KAJJD&,,?$&7G
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MG7R,U.Y6CEB9)&UD@='+MR:6R CU**KZ'I5>>^0MS.?EX<D]\A:7&:)H!W(
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MNIV72,'-DD<L9XOBDC/)KV'V@H(6MI$=>W:OY2S>MS4GU&S2-C8(H7]X8V,
M;GUE16KJ#,=H[%T8W%S*UW$PM<>\B.Q&U!84501 1 1 1 1 1!':(^LY[\]V
MO^U6911$!$!$!$!$!$!$!$!$!$!$!$%:\(_W":D_()%(*IHB B J)=T'4NWK
MDDV4O^)VYFRV* >.C(\?]0U!(9K2PR5NI:KY2Y0E@A="#6+0#&[U;.!"S>:V
M/BTW-@JCY:\$D+HW2-.\AY^[<2>]SD$U0I04*-6G -HH(61,'R,&P6V@YVS0
M$D%K(6*FILK6-RT^Q*V,Q@%[S\K5GO:%-O(U,@W4&2AM046U>JPLY/:#N2=V
M][B@WQI)KX\4VYE;MLT;_C;'S%I+G@;-!V [&I%HS#LS6<R9YO?DZW0L1';@
M&$ .V_"016,\'=&E8HOFREZW#1<74:T[@8X'>IVP W+5N#0F)=B<S1GFGGDR
M;R^U:DV,KG=[?5L SU!!;J5<U:E>N9GRF*)K.H_;D_B-MSMZRH+5&F8=15:E
M>6[8KB"TRPQT.V_-@('N@4&A6T+C8*V5:;EV:W?K.@FO3R"2?IN&VS3ML LS
M]&X\Q:;;%--$_#%OB\C=MW-#0US7_(_UH-7(Z)\?S]?,/SF09)7>3!$TL#(P
MX .:WLWV<I/5>E:.I\?#2N2RQLCL-F!C(#MV@MV08M0Z2J9K'4*(LSU(J<\<
ML/0V&QB&S!Z0/8%GPN!MXR>62;.Y"\'LXAEAS2UORCB @SX>GD(;67L6[$KF
MV+6]>)[^0BB8T-&VW8-SN5.H*CF](PY/)P92OD;="]' 8#-7(].(G?BX.!6I
M)H##28";$F:U]5L^-/M%^\[K'PI*#?PFE8,3)=LF_:MWK3 R2W.0YX:T; -V
M   6E@-%C#9>WDO+5^S+9 $XF+-I"T;-+M@.Y!-6\!6MY[&9>263JTHI60Q]
MG#>8;.<H?-:,&3S<>7CS-^G895%=O0+  S<N]8*"PXC'38ZIT)<C9N.YEW6G
M(+^WU>B I1!!U,%6K9W)9<2R/FMQ0QEIVXQMB'<U5Z_X/L==R-^P;]V.O>>Q
M]RFQX$4SF()#.:1K9.UC[<%VS0LU(W112UBT'IO&Q9LX%3&%PM'"8Z&C381$
MS<DN.[WN<=RYQ]9*"51 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5<U#]>T[
M^>ZJ"\(HHB B B B B B J;YW5<;'>DD;?MEV??0CC 8YPE+.08P CT$$?GM
M<7FZ<U,:^+MU,G0K!SXI#"3$V5I+)@0XM<%M8S4=FA6KXV+&Y?)9!M<6+,<D
ML#I86/)#>;^89N[;=K0@V[&OZ'0P[Z-"[=DR(L="")K0\/K$!['AY :0M:SX
M1*\ R3S@\B^''RAE^4"/C "T.];]W;;]H:@E<?K&"UD33L8R[3+ZC[59\P9M
M/#&0'$!A<0>T=A6&MK3J6<8+&#R%6MD)1%4LS=/9SR"YH<QKBYG(#LW""LTM
M5Y*S1N27X+U/AJ6.I$^,P$D&81B$\7'L'<\J?GUU5K"[/'BKT^/IS.BM7XPP
MQ,<P[/(:7![FL]9 09KNM61W[U&EAKU^2K%%-*8.F&"*5O,.!>YJLN)R%/)8
MRGD:KBZ&Q"V6,D;'9XW05_65Z]BX\3E89WMJUK\8OQCN?7F^IEQ_ )!3-9&W
M)J7!8NK8=$QK9+UYX^ B]%K#\CWE!JPZ^J2"K:=B[T>+LSMA@R+PSI.<\\6D
MM#N88X]SB%'XO6MJ)^K)\O4GBJT,CT82.FX]K6!L+0QQ+GN+D%CQ.I?&L@,;
M<Q=K'VGP&:&.<QNZL;2 XM=$YPW&_:%%:GS5_%ZCTQ!6@LV&68[H=5AVWE>Q
MK"TDO(  0;,&MZ#F5NK2LUWG)-H6(I.'*M.\;LY[$@M=ZB%-4<K!:RN2Q\<;
M^=)D75E[. ?,"X,'R@=I05;P@934M"G%)C1%#5;/4Z]DNWD=U;#8C%&W^]RD
M]8V<_5PMI^'CA:]M>9\EB5W9"V-G+=K/X3CZD&_0R5EN"P,SJ]BU)9BJME='
ML2WJL&\K]R/1'K7,LCJ)\V>U ;6HLSCZ=2\VLPU:PD@B#8V[OED,;P-W(+)+
M/D,MJ7*T!J&:C7Q]&O)"8>F'3&9I<9WEX=NP*PZ,STF=TQCLE*YCI9&O:]S!
MLUSHGF,N'R$M0<VQ=V.[5RMO(^$"W0GBR%UC8NO7#(V12D,]!["5TO1V4OY+
M2V)OY ;69X-W[-X<NT@/V]7(=J"E^#;464MORE?+W'3%QEM57O\ 5#'.^!S/
MO-+%M:!SN7RN2U++=LN?"\UIZ41[HH)^99^EH!0=#L.+:\S@=B(W$'^9<(T]
MG\+<PF/L9/PFWX+LD ,\(G@:&/\ YXB@N.NJ&4QM#RC4U-EXGNMTX.D'Q=,-
MDD;$2 8U?,5C9,7#+&_*WKQ>[</M.8YS?D'!K$$#=UK#5FR#:V'OW*V/>67;
M,(9PB<!NX .<'/+?7Q7B?64(O"ACL5<R,IHPW6]#IM8Z&;?8\I'-06+#YFKE
M\54R-8/$<["6M>.+FD'8AP]H(43J^_<I^;OBT[H^OG*L,NW\*-^^[2@2ZMQ\
M&#SF5->8Q8VQ8AF9V<WFL[BXM4-)JA^.S6I);AGDI5Y,8P,;L1"+(V+S\F_>
M@ML>5@=G78EL;W2QTQ9D>-N#&O<6-#OE=L55O"!?U'CM/7Y\0V&/IU)99;;W
M=L08.Z-GK<Y!L9J[?GO:9P]:[)5-^.::Q8C ,HBKL!+6%P(!<7A;6EKF0%[/
M8B[;?:=CK$0BL/ #WPSQB1H?Q !<$$[D69!V.M^3NB+?1=XOU=Q'U-NPNV!.
MRHPL93":DPU%^<LY'QBM8DR$4HC(B9$S<3,X-;P!=V ((F#+9^' 8;5DV6G>
M+=JN9Z)#.@VO:D$8:S8;AS Y2>J?.#&X_-YF?4$E:2&0^3:L 8Z%X'9'&\.;
MN]\A01>H=07GY]E23(Y:BR#$P3V(\?6\8<)IG'?GZ$FS6@+I.$L038>E+7R3
M[T3X@6VW[<I ?6>( W00&O<I/AL+3MQ6C /*E-LT@^"=* \*&SNO<-:EP-;#
MYECYYLU2CD8S?=T+W[/"":R6LQC?*$PP60FI47EMNVT1M:WCVN+6O<'/#5*U
MM1XYUG+POY1FA!'.][MMGPR,+Q(SY.PA!%#6PLBHRC@[]JS+29;DKL,3'012
M^XYE[@ YWJ"L^'RU/,8Z"]4+C%)N-G#9S7-):YKAZB"-B@@QK+'G!^4^A/OX
M[XGXML.KXQU>CP6A/KJK6%V>/%7I\?3F=%:OQAAB8YAV>0TN#W-9ZR @L-7/
MU+5[)U8F/)I1PO<_LXO;.PO:6JLGP@U98L/XIA[]J7(T3;@@C#.08" >1+@
M@LNH=0U<!BW7[,,SV-EA861@.?O*\,"AH]900-R++^*N4K%:A)>$,IC)F@C&
MY+"QQ&X]8088]>1.I5[#L+D&NMRM9CX"&"2WR:7\F#EZ( &Y+EE&M8(J64DF
MQ-Z*SC>#K=,\'2LBD[I6\7$/8@\3:ZQ,,.0L00SV:E,0=>Y%Q,0,Y'8"3V\
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M[.3N8""ZR"5PQK#>;%' SX3@6.WE*"SV9M8U+CY:V.KVZ\U:/A 9Q$ZO./=
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MQ)>HP3&&:U%')T'S<7. =TH^QS_O#?M*#WCLUB,HZ=E#(063 0)1$\/X%W:
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M?D$BD%4T1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 56U3_P#(OSS606E$!$!$!$!$!$!0N/\ NZ=^9/\
MWT%O7.*%O/XO.ZJLOTMD+3KM\="1CX&Q&&%@C9N7O"BM7(:9SSL=;R-RKXQ=
MO9>C8NU:[@2RK5>"V%A=L'$)EJ&J,M/JB\,7)7,N&CH8^-SF&3:=Y,KG;$@$
M(+)D<1:CS&FA4I%]/$TK4K>X S",0Q,'R[$J$BTUDH](:4Q+ZQ+W7ZMC);;;
M,V<;,G+_ -:"NY2]EL5IG4]*M1%D9+(V1!D631/AD\>EZ8'82XR-WX[+M%.M
M'4IUJL?UN")D;?O,&P05O'T+8UCJ+)V(7,8:]2K3<2/28P%[S\YRK\F%S1TM
MK)T=)[<CE;MK@S<<A$\B!A^8-T&E?T]?QV?R,\./RUB*>G4BIOHVN@&]!G#I
MS>FW8>L%= TYBO(^#J4W-:U[0Y\K6O=(.K*XR/V<_M/:4'-&:?U57HX>[4JE
MF4L9#).L%Q'^[B^3M(?P T)?T+??3U16IU7B,5L=5I!SPTV(:SNO+Z7J,CB4
M$OC\%<O7GVC4RE6."G,RM)D+;I91/,S@2Q@>\!H"A<)I>\:N#Q=G$Y2&.H83
M<=/>)J[P=H,#&//+=P!"#=CPN:MPV*=C%3QFSJT6[4A+.#JT;^;"""21M&T+
M??ALV=*ZS,=-S<CEKMK@S<<A$\B!A_F8-T&"2S8TOD]2W*F/;>KBG6:)HYX@
M*IJ0[&.<$@M'K5IT12?2T=B()1PFDK=:4-[")+&\KO\ JY!+8? C%/F<,IDK
M74 &UJ<S!NWO57,G3S.'U-8SN.H.OU[E6*&Y6C>ULS70$EDD?,@.[';$(*4=
M&V<S<O34L#)A:TF+NUG&Q*#+-+9 #26,+]@U6'AG<NS3%"; STACK<%BW/*Z
M,Q?[LW8-AX.)=S06'75*_;P]4TZK[$M;)4[)A80'O9!*'N#>1 W5>K^7L0_4
M4,>GK-L92RZW5>PQ -=/&UIBGY.''@0@M&"I-P6EL;C[D\>U2DR.>1QV9Z+?
M2[3ZE^:V8!\8S1&5QY.(+!@-[<)Y@6C8]^@MLM"G!X-L:ROE\<[/5KS,H&FU
M#N;+G[N!.ZK-/3<$-_3%<Y7'^)6XZT^;/C</9/ ]\NSO2]?+9!9]48S&Y+7L
M1CRV..$R#Z]C(D6HMA+58]H!!<O7@\E\@U<_DLC?H37H:K*="#QR%IEAJM]$
M [G8/0;NN,B<GBL#GL3=Q\&;K,>Q]8782YK++"Q[=]P#P6/(T</2Q/@ZQU#*
M8Z48S,59[CVVH1L >4DB"Q:*O8G'ZAUM:M9/'1,NY%KX'FU$><8!7+ZXG/@[
MLX(FDVW0R;+,1-V#:RWJ%Q$>SE19?+=[(ZRGST+Z% G3DU:IUKM=^TX<7,Y[
M.4#BK%BQG-'7[UEYDIV3X_-:R<$C=W#;>&-K]FL0;L4%/S5SU6TS'6S+JB:Y
M'!Y0BAFZ) VFA<'>Z3'3W':?UC3.:)HV*!CQ]6_?KRV>J?E:[8!!/S24N'@J
M#,A0_P#A@C\=VM0_4=H6@[^DJ)J67,9BEF:UNWXS;%\R0O;DZ[*70#QL(X@\
M;O0=6P>0Q47A'U3EILE095M4ZC()3:A[2Q@#A[I<JJXR*"M+IZQ/XS"[(EXG
M;F(8J1A+N0D+=R0\(.BT+&.BU;X0[C\E0Z%ZE!'4D-J$]4LAXGUJIXT/PU'0
M>7CFQ]J?%068;5#QV 2 3.=L]A+D"Y&<GA]?Y26SCZ]O-"LVMCQ=@+PV!P[7
MD.VW*FWY1N!U;2SE1U'(Q6,)#3EBCNP,D@E9M[]R"FQ8V=NGJDSKM)MNGJ2Q
M<=6@OPQO?#*&CE"_=2=F"I=TOK2:.2..YD159"RUE(9[$[89&G=_;L$%UU-9
MQ=M_@]%?(X][*&0KR6=K4.T3&- W.[E$2FF;WA7E%^AMDZ4;*)\:A^K.$+VD
M#TE!6W5QCYM*Y07Q*(<#'1M0TLE#!8AD8=^\N[6K/;QE9FF,!/6N58[-3+/N
MSTH\K$9^,NP)9*2 'H-@04KNG-;3,GBAMY*&)D++>4AFGG$)W!?V[-*F*&6A
MO:E\'F1GDJ58J%*W#:#[D!,9Z)C:3L[UH*V^JP^".]AQ;H^/OR1E;!XW!N6F
M4'??DK+/FFX77>9R6-GQ61BRE*",[Y""+Q>2)H9Z8>?<(,/@UU7#AM%X*LSQ
M.9TV3E99#[<<!@A<_MFV>M6EF;NF9]2XZC!BLD,CE'VZMN2[!T )2-Q,"X'L
M5$E8S3M.:RRF;K''96+)48(W-@NPL,$L+0W8!Y]P5 4<9#2H:+9+D\8^2+43
MK]QD=N$LKL>@F933-[PKRB_0VR=*-E$^-0_5G"%[2!Z2WM#VL?!DL7+DLA0A
M9C=.5JD7.U%VS2.YR[;.]0: @IN(JMBPFD*\UJB'U=4FU88;<'H0;^[/I* =
MIQ\>'UE!X_1D<T0U,2SQN#=]<6^N[;=R%=/F@P.3UO???R&/.,LZ8;3?(;4/
MUWF#L.U4K!8Z?'X_PAT[>6HSOLX^.M1F\;A^KB%I8S;TE UK@*UO3&!LXK*4
M/*'DJI2R546X09&Q-:03N[;=CFJ:UWG[F4RE#'MC@MX*M'$Z:&+(00^-2[;[
M.)=OP:@D<IFXO']'ZHJ04&24(K%>QB67H.<<3P6,X'<!1$.3S&"T7D1B[=#R
MOF,I/9F#+L!-2.7Y2X#D@EM*YBI4TOE<57Q.)JSB$2!V1OP667IR>WJ\2%FT
M]>9G-<X+*R5Z&*90HOKF)MJ!SK,TH+ R-L9]R%1W)% 1 1 1 57\(7V@@_.N
M-_S3$$FBJ"("("("("("(([1'UG/?GNU_P!JLRBB("("("("("("("("("("
M("(*UX1_N$U)^02*0531$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!5;5/_P B_/-9!:40$0$0$0$0$0%"
MX_[NG?F3_P!]!;U\@L06&%\,S)&AQ;NQP<-QWCL44CL5YNH(IHW]-Y8_BX'B
MX=[3MW%?4!$$9#I'3<-\7X\5 VP)72AWJ$CN]X;W!RDT!$!$#DWVCOV1 1 C
MGAE#C'*Q_%Y8[B0=G-[P=O6$) [R@AK&F-*Y2_-;FH5I[#7M$Y!W!>P=@D:#
ML2/E4R@(@(@(2!WE ?'0OUIZ[Q#8A<7131G9[3ZG,</[PH/S#T3\6<5]%C0/
M,/1/Q9Q7T6-/,/1/Q9Q7T6-!Y&A=$\=W:8Q0^_6C6)FC-!RPLEAT[B)&/&['
MMKQ%I09_,/1/Q9Q7T6-#H31 [3IK%?1HT&*/16@Y@_I:>P[^#RQ_&O$=G#U%
M9?,/1/Q9Q7T6- \P]$_%G%?18U@ET9H..2*)^GL.U\AV8#7B!<@S^8>B?BSB
MOHL:>8FB-R/-K%?1HT#S#T3\6<5]%C3S#T3\6<5]%C0/,/1/Q9Q7T6-/,/1/
MQ9Q7T6- &A-$'NTUBOHT:>8>B?BSBOHL:!YAZ)^+.*^BQIYAZ)^+.*^BQH,4
MFBM!QOB8_3V':^0D,!KQ N(67S#T3\6<5]%C0/,/1/Q9Q7T6-/,/1/Q9Q7T6
M-!C.AM$C<>;6)W_)HUD\P]$_%G%?18T#S#T3\6<5]%C6*;16@X&@RZ=P[ YP
M8TOKQ %SNP!!E\P]$_%G%?18UIV_!OH*P&F33E$<?@V=+]39!ZBT9H*2"-U?
M3V(E81Z+Q!&\+:\P]$_%G%?18T'D:%T43]S&*^C1H[0NB&C<Z9Q7T6-!A9HS
M0CYC#YN8?J!G/AXO%RX[[;[+*S0VBG#[E\5]&C0>_,/1/Q9Q7T6-/,/1/Q9Q
M7T6- \P]$_%G%?18T\P]$_%G%?18T#S#T3\6<5]%C7DZ%T2-R=-8H >LU8T&
M'S-T&7/C&G,.96 %T?B\1<T.61VA]%!H/FOBOHL:#+YAZ)^+.*^BQI%H_252
M>*>OI_&Q31O#XY&5V!S".X@@()J6:&!G.:5D;=P.3B&C<G8#<I+/! &NEE8P
M%P:"X@ N=V #?UE!]1 1 ) [RD4T,P?TY&/X/+'<2#LYO>#MZP@*K^$+[00?
MG7&_YIB"315!$!$!$!$!$!$$=HCZSGOSW:_[59E%$0$0$0$0$0$0$0$0$0$0
M$0$05KPC_<)J3\@D4@JFB("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("JVJ?_D7YYK(+2B B B B B B H7
M'_=T[\R?^^@MZYGJ"/+Z9S3SA!'T]0R] ,<=FU[Q'U\?(6 DA14F^*S@9=/Z
M6PDK(I;,=B:>Y,SJNVBV+W[;C>21SEI3ZKS]"2QCK,E>6U5S6-KFPR/BV6O>
M=ZV>IX07!F4LG6$N*!9XLW$1V0-NWFZ9S%O9^Y-C\!E[D&PEK49Y8]QN.4;"
MX(*!'E-;FYIV!V2H?_&:TDGV-]B&-@E]'TO33SHS,6(G%K)8^O8@S4M&:Z^,
M^FR,;AT4()Y2%!IU]99\X_4DD4[;?DB6K/U75'UGS57]LK3&_P!8 .Q5VQ>8
MFR&HKU>L]CJ%2G"7O W+YY_3 !]C6()3-6YJ.'OVH'UF/BA<YK[#^$((];W>
MH+GN)U3E;&?IXQF9CNQW:=DBQXA) V&:( @L+NR1J"I8.#,FAX,R,JS:2Y:,
M8,'N-H9/E[5,VM?Y:=N6NU+( K6IHZ^.%">7QAD#BT[S,&S7/060Y75.6R^:
MKXZ]7I05*M6:/JU^K(7SQE_ ]HV"U\9J?/:B\@UJ$U>C)/AFY"U*8NMVN=TP
MQC20@E/!V+8QV:%OAU_+M[JEGN"[GVD+%K^*_)+I05;C8-\Y"WMCY^D6/+7(
M*M!)J2K)X0;V-O5H8Z>2FG,<D!D,SXZ['%I.XXA;]_7%VSE&TX+@Q\<>.K69
M)!2ENN?)9!<& 1C9K0J+UI3,V<Q@J]RW7,$^[V2M+',!,;BWDT/[0'=X4=J3
M(YN/.X#%XRQ!!X\RV9I9(^J6" ,(+1N%!4':BUI!B,KDI;U$MQ.2=5DC%<[V
MVLD#2\GEZ!V<MC+:SR#\WFJE3("FS'N;%&#0FM]>4L#SS='V,:J,$^O[]N?%
M50]^+=+C&7+3C2EMR,>]Q8(@Q@[!NTDDK0MY7.9SS-F?.*TS,_+7+C6>ULI9
M"\MF:R0@@%OJ029S^9C,=?&MI02V]5W:3G&'T>#0\\R 1N_L6Q8U3G\2S.T)
MY:UNY!;H04Y^D8F$WSL#(T$^X02]*]J:GJ^EA\A?KVJ\V.GLB5D'1?SC>QNQ
M )&PW5LR8O'&7?)[FMM"!Y@+AR:9 -V[CV;J"FU-5V,M+@(Z+6M;/C9;M\.;
MN6- Z8C^0F10-+4MMFG=)\<CC\7'9QW5<(ZQFE+O4R&!G<Q!<-%9^[F,/-/<
M(=-#=GK%XB=#S$3M@\L?VL)'>%'Z_BOR2Z4%6XV#?.0M[8^?I%CRUR"J16M3
M8ZCKK*4;U6.&CEKDW0? 7F<QL:YX+MQQ4GD=:7)<O/1K7A0BK5*\A?XC-==+
M+89U #TQLUK0J+UI?+V,Q@*5VQ6->9[7"6,M<S9S'%A(#]CL=MPH+5?W4Z#_
M #C9_P L]05J+4VKS@'ZA=<I^+P9)T!J=#MDB%KH$E^_8Y)LMD<!E?"-EGSL
ML,KFKP@Z>V[Y8VB+<@D[-W5&YBM69;RK4J2W3?CLP3&208Z>H*TL;"\=L@V+
M'+0IZBUP_3>"RS[U R96U3ABAZ!#81-N"YQWW<@D+VK,WITZE@R$L-]]*A7M
M5I&Q&'<V'F$,> 7=S@F)U/FI<M3H'(^-BY!,#.,;/6%29C"YI^J;!S"H);P8
M,MC1>*-BR)0YCBST./$;J1U9E+&+KT>CD:E)LT_"6>9IE> &D[0Q-]VXH*)Y
M[9WR3FS%+%8L4LI1@KSRUGUNK';<SW<3U-7=39W3EG,1Y.S!?9!A7WX71P]
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MUGC'YS#XIC7E^0I>-12]G -(+F@_*X-*E<!E8LOC8[\4+F12/D$?(@ES&/+
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M68@=,]_!@[>+G^QKNXE!/9"_4QU.:Y;EZ<$0W>_8G8;[=S=RJ)I3PCX?.O\
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M(@(@(@(@(@(@(@(@(@(@(@(@(@(@*K^$+[00?G7&_P":8@DT501 1 1 1 1
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MCL&2$M!W^^TKZ@(@+Q9NU:AKB>5K.M,V&('^$]_<T(/:/>UC'/>X!K022>X
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M@(@(@*+Q69Q^7AGFHRF2.*=\+G\2T%[._;<#<?*$$HB B B B B B B B B
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MR43"9HYI#&RL_9LKHB1S'<5!$8[(ZJMX:GJ%HO-M2SM>9Y<C$REQ,NQ@,+W
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MV-D?>7(/=7$09K4U^EJ&.*\,9B*$;62#DPS3AYEE ]\2U:V%I8O):7H6]0W
M^CB9[T3H[!#H91#*8F/EY>Z+ U!'##9:WI'(UZ&)D\0R&:@DJ4'D1&.B'L+]
MP_W#7EN^RM.C8<=C,S?Q?FS5Q-_Q5DY-:3JQ3P\BW<.V:=VE!>ESW5=ZU1UW
MIB>MC9[KQC[XZ,3F-=L3'V[R%H0:<&4R%OPAXZ2Q@[-%\6#N<(YI(B9/JC.X
MQN<E'762&5P]>:_A;(N6VUYJM/F^2JYS2>V4.+'[$;%42S-89$8J*$5Z_E<Y
MDXTP]O3#P_<R;;[[=+TU7KWA'M1SY>2K:Q3(J%F6$4YA(;%HP=CBU[2 S<]C
M5!U>I;CN4ZUJ,$,FA9(T'O >-QNJ[8U(<7FLM4R B96AQ@O5Y1N"YD6XF:[?
MUM*"$I:BU7E98*%:#'U;4>-AN77S,?(QALDED+&-<#OL.TK9Q&K[UNYA*DM2
M&*6:W?JW@"7!LM(=\9]A0:V6UKF*IS3*U2L^2KFJ5"!K^0#A98P[N(/?N]7K
M&C)1THQDGUGVNWJ/KM<R/O[.(>24%?S67U -24<-BF4V]>A-8DGG8]_2Z;VL
M]RQS=]^2KD^M=0&&G4@J4O*9SDN+GWYF$%L1E$K$$E!F-87[=^C1\E,EQC86
M6I9(Y2R>Q(P2%D8#@6- />=UHS:_L4L/A\[/CQY-M1/CG8S=T\-II(:WV%CG
M M03<&;SM*[IRMEZ]1C<E',R3I!_U&R!U&1[DD$%H(4OIG,6<S1GO/C8V!]N
M9M38$%\$;N#7N^5Q!*#3S^5R%*UB,=C8X#=R$DH9)/N8HF0LYO>0T@N49?S6
MI\7C'F_Y)K2,MB+Q^63A5Z);OU.F7<N7JX;H(&+7^2;@]46 :-V;%>+.BF@9
M)'%.V?Y'$E31R^L_*-3"[XH7Y8);<D_3E=## UP8&<>0+GDE!E\'QN&#4AN1
ML98\O6NH&'=F_%G:U2FK++(&8(NK13=3-5(QU ?0+C[MNQ'I!!4;NK]61T,_
MEHH<:*6*OV87PN$AEGC@?L2'!VS2NE-(<T$=Q&Z#G$AS_G_J88A])CO)V/+W
MV6/D'89-F@,+5FDUK?FP&!OMFQ>-%V)YFGN/+F,D8=N$48<PO)0:M;7.:LX>
ME)6AHRVI,_Y++]I&0/!87B4 ^D%M3:RS.'9GZN2@J6+E)E,UG0!\4<QNO,;
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MEIINPU9!%/)#[&.0:.A[6.-W)5:]S+L>&L><;D0>I /?,+]R6E=(0%SC&_\
MF?J#\U54'1UR37^,DHST<O6RN29+/EJD3X19<(.!.Q 8$'5IR1#*0>W@5P'
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M 5NZ:@U+BZ>6E-&_/ 98!0H7+4;[#&]TA=)N0!ZP"4%X1 1 1 1 1 1 1 1
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M \PUY04_3U#P>6,7BQ=TSJ66U)#$)IHF2=%SSWN:0_W*_4V3 ;A[[6^Y;4E
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M-%::&F],U,.V?K.C#W22]P+Y"7'9!'>#G3.1TIIEF+NR0/G%B20NA<7,V?\
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M;N-RG('?8CL[T!TT+0PND8.1V;N0-S\BJ_A"^T$'YUQO^:8@DT501 1 1 1
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MKWWVF!SJSYO1#.W8M!7:<!=Q=W$U9<8TMJ!O3A:8S'Q;&>.P:X A$?G^AI*
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M#AV]?]KE</"@:@T]2\<>65O*]#KN!VVCZPY(*3G17JVM2-TB(F0#3A-H4=N
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M>7SDW<#<;^Q!]6B,IC3?- 78#;#.9K\QU WV\4&\B B B B B B B B B B
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MZ"JP:X\'TTCX&9S&;3N.["X-#W/[]]U)3X%\^=J9":\'5:;":5-L36MB>]G
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M^?\ 4:JCJ-^8TMF,C3Q$!='J+[$V[!7NN(8]WWB#N@ZMI_"UL'AJ6-K^X@C
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MQDJD5O)L90AK,8_%UXIF23RQ"5TCS+ONSM[ M^AD]1YZUB,=8N38IXQ!N6S
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M[T^2GMPNE-RHRM.TGL,<;BYNWL(+D$?7T70J6_'V6+5FXRK+7B?;F=,WA)_
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MU +>RV$I9G%V<?=:XP3M >&GB[L(<"#ZB"$&KF-,X?)X2+$6H2:D8B#&!VQ
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MS3NFD@NXJ-\KB27N;9C!.Y065%4$0$0$0$0$0$01VB/K.>_/=K_M5F441 1
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M\L^IL9E73MZ5.I8C9#Z^K.6[O^:-D$G*R^R_6='+ *@C?UF.:3(Y_9Q+3OL
M%[0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0%5_"%]H(/SKC?\ -,02:*H(@(@(@(@(@(@CM$?6<]^>[7_:
MK,HHB B B B B B B B B B B B"M>$?[A-2?D$BD%4T1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4([3N)>) 89=
MGEQ<T3RAIY=I[ Y ;IW%,:&MCG  V %B8 #YR\,TUAV.>YD,K2\[N(GE!)^7
MTD!VFL.]S'.AF+F>Y)GE)'WO27MVG<4]KFNCG((V(-B8@CYRH-T[BF-#6QS@
M ; "Q, !\Y>&::P['/<R&5I>=W$3R@D_+Z2 [36'>YCG0S%S/<DSRDC[WI*%
MSN-J4I,))!U0YV6K-/*:1XV))[GDH+PB@(@(@(@(@(@*%Q_W=._,G_OH+>BB
MB("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("J_A"^T$'YUQO^:8@DT501 1 1 1 1 1!':(^LY[
M\]VO^U6911$!$!$!$!$!$!$!$!$!$!$!$%:\(_W":D_()%(*IHB B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M<=QWM0>G8_7KVN:Z/ EI&Q!?/^ZC<?KUC0UL>!  V #Y_P!U!Y9C==Q\N$.
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MZR4/-K6GQLI?U8?]9/-K6GQLI?U8?]9*'FUK3XV4OZL/^LGFUK3XV4OZL/\
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M@(@(@CM$?6<]^>[7_:K,HHB B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B JOX0OM!!^=<;_FF()-%4$0
M$0$0$0$0$01VB/K.>_/=K_M5F441 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 57\(7V@@_.N-_S3$$
MFBJ"("("("("("(([1'UG/?GNU_VJS**(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@*K^$+[00?G7&
M_P":8@DT501 1 1 1 1 1!':(^LY[\]VO^U6911$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!5?PA?
M:"#\ZXW_ #3$$FBJ"("("("("("(([1'UG/?GNU_VJS**(@(@(@(@(@(@(@(
M@(@I>LQ9??TM2BOVZT=J[.V8UY3$YP97>\#=ORA:WFQ_S_/?3Y54/-C_ )_G
MOI\J>;'_ #_/?3Y4#S8_Y_GOI\J>;'_/\]]/E0/-C_G^>^GRIYL?\_SWT^5
M\V/^?Y[Z?*GFQ_S_ #WT^5 \V/\ G^>^GRIYL?\ /\]]/E0/-C_G^>^GRIYL
M?\_SWT^5 \V/^?Y[Z?*GFQ_S_/?3Y4#S8_Y_GOI\J>;'_/\ /?3Y4#S8_P"?
MY[Z?*GFQ_P _SWT^5 \V/^?Y[Z?*GFQ_S_/?3Y4#S8_Y_GOI\J>;'_/\]]/E
M0/-C_G^>^GRIYL?\_P ]]/E0/-C_ )_GOI\J>;'_ #_/?3Y4#S8_Y_GOI\J>
M;'_/\]]/E0/-C_G^>^GRIYL?\_SWT^5 \V/^?Y[Z?*GFQ_S_ #WT^5 \V/\
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M0$0$0$0$0$0$0$0$0$05?P5?:/+?GN[^LKZHHB B B B B B B B B"H:O\
MM_HK\OM?Y2132J"("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("(*CGONAT=
M^76?\I(K<@(@(@(@(@(@(@(@(@(@(@(@(@(@(@A<K+<\9QU>M8Z)GDD#G\ _
ML:PN[BO/B&9_EH_1V('B&9_EH_1V)XAF?Y:/T=B(>(9G^6C]'8GB&9_EH_1V
M(IXAF?Y:/T=B>(9G^6C]'8@>(9G^6C]'8GB&9_EH_1V('B&9_EH_1V)XAF?Y
M:/T=BH>(9G^6C]'8GB&9_EH_1V('B&9_EH_1V)XAF?Y:/T=B!XAF?Y:/T=B>
M(9G^6C]'8H'B&9_EH_1V)XAF?Y:/T=B!XAF?Y:/T=B>(9G^6C]'8B'B&9_EH
M_1V)XAF?Y:/T=B*>(9G^6C]'8GB&9_EH_1V*C!:K9J"K/,,QN8XW/VZ#.WB-
MU-TY'RU*\CSNY\3''[Y"@V$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$05?
MP5?:/+?GN[^LKZHHB B B B B B B B B"H:O^W^BOR^U_E)%-*H(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@J.>^Z'1WY=9_RDBMR B#5CO4I9.G':
MA>_WK7@E;2#6FN5("!-9BC)[@]X;_>L['L>T.8X.:>X@[@H/'6A$@CZK.?O-
MQO\ H7V26.)O*1[6#VN.P0>7V:\?'G-&W<;C=P&X6/QZE_&H?GA49#9KMC;(
M9HPP]SBX;%>!<J..PLQ$_(\*#96":S6K@&:>.,'N+W!O]Z#W%+%*P/BD:]I[
MG-((1\T+'M8^5C7.[FD@$H,B(/#Y8V%H>]K2X[-!.VY^1&RQN<YC7M+F^Z /
M:$'M$!$!:E^*>:G8C@E,<I8>F\>IWJ05#3&IS8=Y/R+N%MCBUKG=G/;U'_ZE
M>D$+D/MKA?QLW^$5*6+$%:"6>>5D<4;"Y\CR&M:T=I))05O!ZWTIG[4U7&9:
M&>>/OCV<PD>UH>!R"]Y_6>F-..B9ELI%7?(-VQ[.>\CV\6 D!*)ZI=IW:L=J
MK8BF@D;R9+&X.8X>T$*LT-?:.R.4.,J9NM+:WV#!N \^QCR UQ026>U-@=/5
MV3Y;(1UF/.S =W.?^"UH)*V\1F<7F:4=W&W(K,#^Y[#W'V$=X/R%! S:_P!&
MP9?R3+G*S;?+@6'?B'>]<_;@"IW+YK%86D^[DKD5:!O>]Y[SW[-'>3\@0C6P
M6I<%J&LZQB<A%98T[/VW:YGX37 $*/R^NM(X:_'0R.9@ALO(' [NX;^_+00Q
M*)^QDL?6HF]/<ACJA@>9W/ CXN[CR[MBH; :RTSJ,RMQ.4BL/C[7LV<QX'MX
MO .R!G]9:8TX8FY;*15WR=K(]G/>1[>+ 3LIF#(X^S1%Z"Y#)5+"\3M>#'Q;
MWGEW;!! 8C76D<U?DH8[,P366$CIC=O+;WA< 'K?SNI<%IZLRQELA%68\[,W
MW<Y_X+6@DH-K$9G%9JDR[C;D5F!W<]A[CW[.'>#\A4%8U_HVMEQBILY69;Y%
MI82>+7>]<_;@"A$[E\SB\+2DNY*Y%6@9WO>>\^P#O)^0+5P.IL#J&N^QB<A'
M98P[/VW:YGX37 $(-#,:ZTEA;\5#(YB""R\@=,[N+=_?EH(9]]RGY\CCZ]$W
MIKD#*H8'F=SP(^+NYW+NV*"&P&L],:C=*W$Y2*P^,;OCV<QX'MXO .R9_6.F
M=.&(9;*15W2>X9LY[R/;Q8"=D&]-=IW\'9M4[$<\$E:4LEC<'-<-B.PA;F/^
MP*?XB/\ 50;B("("("("("("("("("("("("("("("("("(*OX*OM'EOSW=_
M65]441 1 1 1 1 1 1 1 1!4-7_;_17Y?:_RDBFE4$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$05'/?=#H[\NL_Y216Y 7/=6V;-O)T,+#*8V3;&4CU[
ME4>[NA*8J@T)9&66;%KWO["IJ]=O8G3CYK+V26HXPWD-R"XGB#VH*S@=)U<C
M1;?R,LLDMC=P])>:#9M.ZGCQS9G/J60"T.]7+< _?W""'U6^S%JB6:ON)(F1
MR CU<&[J:U+E(LII2K:9L";+ ]OO7AIW""QOT_CLK2QS[37DLJL#>+MNPA4;
M 8#'7LOE:T[7F.![@S9VQ['[()G6=*"C@*%: $1QV=F[G<]H<5J2X;1PQQD\
MH,$W0WV;,''GM[U!*:2OV(-,V[$^[F5S(8M_6UK=]E%X#!-SXGR>3FD>7R%K
M6@[(%JL_2F:I259GFI9.SV./J! *W-4?=5@/QD/^*@Z.OA.P)VW4'*<AF;]W
M-XUSL-8#ZF\GB_:7G?U]RE-&6Y[60RMAU1X;9>9.M_!'$]D?_54=#104NQKK
M$5[$T#X+1='(YAV:W;=IV]\L/^T#"_ 6_F,_>5#_ &@87X"W\QG[R?[0,+\!
M;^8S]Y!1M29+#Y&PVW2CL13D_5 YK0UWR]A/:K-IC6$\DL%"Z'2.>X,CF'?]
MYZ"YY#[:X7\;-_A%<O\ #A=E9@,30&_2O9.)D_RL9V[*&>M?PN&O@1HS+TZ[
M63T,DR*(-]$='CN8D\&TK,MK?PBY"S$'3LMQUF$^J(%[./Z&!1?CG3,U/B='
M>$_#4VED%3+="#M)+(K,KHG,_0Q7C6^-I5? YAIX(1'+1BH3UGM["R5^V[D5
MCTCECJ7PL27;<#0ZMIR"2NW?<1F9L3S_ (I6FW+R:=UMX4ZM",,C&*-]GR3B
M-AW_ $RH-O!XC'2^ 6WSK-/.C;M./K,T3W%KU6L!FYM2ZI\%M2_$'QP8Z:7\
M*6'JL#S_ $ *"[Y&R,1X;Z(K1 #)X5WC/RN9S(=^B(+#X(*U3.:4U1;O0"23
M)Y*RVV?6]KF _P#>B.38K.S9;3>@=/6XP^J=2&"7M.[XV.C(:?Z==A\(LK,3
MK_P<WZT0$TUF6I(?;$XL9_[A0/!S*S*Z]\(U^S$#/%:CJQGV1-+V;?HC"X]E
M<Y-B=-:\T]4C#*C-2""+M.[(WND):/Z!!UGPP5ZF"TOI:Y0@$<F,R==M0^\8
MUA.WZ6+-C;(RWAPR(LQ C&X4>+?(7\"?\4H?$(S+2:=UYX4*]",,C&(-\#V3
MLB8[?],JV=/8G'3> :Z7UP3+2NVG_+-"]Y8_^;@@K&GLW+J74G@KHWX@^*"A
M/-^')"96-<?Z *]9.P,5X<,6*T0'E+#$6?E+>?\ I!%8? ]!5SVF]4WKT ?+
ME,I89:^5CHP>/Z7KDF*SDV4TQH;3MJ/E4?J0PR]I!?$PQG@?Z=!V+PD2LQ6N
M?!UD*T0;/);DJO(]<3BQG']#RG@\E9EO"#X1;]F(&>"Q%4B/LB:7L_\ ;1/C
M3\&TX@D\)>%A8&5:.1L&!OO0\R,V_1&NX8_[ I_B(_U5<36XB B B B B B
MB B B B B B B B B B B B"K^"K[1Y;\]W?UE?5%$0$0$0$0$0$0$0$0$05
M#5_V_P!%?E]K_*2*:501 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1!4<]
M]T.CORZS_E)%;D!<YU6R:AG,;F!&70LXMDV]1!/]X*HW\GK7&1T7/HS"6PX#
M@PL(V_"6SDH,AEM*OZT 9:?&).FWVM.^VQ]9""/TQJ;&1XJ&M;G$,L +2'>L
M*-9.,_K"M/6!->JUN[]O4PD[_P Y*#;E:U_A #7 %I@((/K!B50U#0L8>S8I
M-)\4F>)8_P";<?I&Z#L^-^UU+\GC_5"HNDONBS_XQ_\ B%!M>$+[55?RH?JE
M1F8TG6CQ4%ZA%M)'&V22,DO#QMN3LY!8L;:@SNFYX86,BD,#HG1M&S6/V[-A
M["H+26=IX^K+CK[^A)%*XCF/TA!KYNY%J+-XVG1WDCB<2^0#L[2.1^\ %L:M
MECAU-@Y9'!K&&)SG'U 2(+=YS8#^485.'?8[=^W8@XYSS_C6;R'C5?J5F="=
M^W81W;1]GR*W:.I9>M4A,TL'B<D)?&QONPYY!!/8@NR*#P8V>\;^A.G'[QOZ
M$#IQ^\;^A.G&.TL;^A!R/*6KNI\KXE09M6C=V'N;\LCET'":>H8B(=-O.8CT
MYG#TC][V!49,A]M<+^-F_P (JL>$K2=O4VGV0T71B[5L-LU^8]VY@(X;^K=0
MQ6+]#4FMLMIV')8!^.H8Z<6KW7?&\3S,[HXP-]V+U#C-0Z-U3J._1PC\G0RY
M$P;6+&213C<\7!RBL6-\&M^SHK45/)FO%ELU:=;F> 'MB?SYL9N%&W<;K746
MF\1I&S@9*0B,#,A>=)&83!7^"V))<4$[D-/973>M8]1X;$BY2FH"G:J5PR.6
M,,V#7,!V!]R%ZT[H_(Y&SJ[,YRI'5LYR$UXH"&R.@K\. YH*W!C==T-&3Z)C
MP)DE>9:\61$C/%?%I7DN>Y3&5T+?P5G1^6P-.*U)A(#!8K@-CDGB>"'O:?6[
MM*"2P>$R^:UQ-JK+8LTH(*/BE"M,6.F^5[]M]E!8?':PT16SV'Q^!=?BMV9)
ML;:A<QD;'R@-VF#B-@U!AG\%V2H:.TY'C&U7YG%7A>.X $TI()9S4R<;G=8:
MNP&4R&#DQV.Q ?(UE@L=++8?MW ;^B" @\1XS/Z.U9J+)4<(_)8_+\)2RL6,
MDBG9N=B'>H[J)9X+<E?T5GXK[:L>;RE\WR=@X12 [B/D@V<K0U;K=F Q.3P#
MZ,%2W'/D[$KXRR1T0+=H "=PY3&:PF9PFNF:KQ>,\>KV*7BMVM#Q9,.[9[=R
M [N"#QIS2.0R-_5N<SE-E6?-0^+PUSQD=#7X</35:K8S7>-T;:T3%@3-*_K0
M09$2,%;Q:=Q+GO\ 6"@E\IH3(8)^CLK@:D5J?"0F&Q  V-]B)X(>6GV]I4EA
M<+E\WKI^JLKBS1@K4?%:%>8L=,=R=WO WV[R@A</C]7Z'9G\5C\";\%RU)/C
M;$)8QD;Y0&[3!Q&P:M:7P6Y.CHK 18X579K&7A?[0-I92=S&'H)E^-SNL=5Z
M=R.0P<N-QV(YR\+#F.DEL/V.P W]$$!!C,_I#5^?RE#"OR6/S 9(Z.L6,EBG
M9OWAWJ.Y0;^C=,9##8/4E[*QQ,R65FL6K+&;$1AP)#-PND8_[ I_B(_U54;B
M("("("("("("("("("("("("("("("("("(*OX*OM'EOSW=_65]441 1 1 1
M 1 1 1 1 1!4-7_;_17Y?:_RDBFE4$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$05'/?=#H[\NL_Y216Y 7B2..1CF2,:YKAL6N&X(01L.#P\$HEBH0->
M#N"&#L4J@A[>G\-<E,L]&-SSWN&[2?O[+>J4JE.+I5H&1,]C1L@\''4O'1<Z
M#/& -NIZ]MMDNXZC>:QMJNR4-.[>7J0;;&,C8UC!LUH  ]@"U*^-HU9IIH*[
M&22DF1P[W;G=!]N4*=Z-L=J!LK6NY .]JVFL:UC6- #0-@/D0:5/%X^B^1U6
MLR(O]UQ]:Q7<)BK[^=FG&]_ONYWZ0@S4L;0H,+:M:.('O+1VG[Y7B[B<;>>U
M]JJR5S1L"[U!4:?FS@/Y.A4Z@CO)&-Z,\/BK.G,_G*WWSM]]RMZ-C(V,8QH#
M6M :!Z@%![1 1 6K>K.M4YZ[93&9&%G,#<@%!J8?#U<34$$ W)[7O/>\J500
MN0^VN%_&S?X14T@(@(@(@(@(@(@(@(@(@(@(@(@T<G]K;WY/)^J5ZQ_V!3_$
M1_JH-Q$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$%7\%7VCRWY[N_K*^J*(
M@(@(@(@(@(@(@(@(@J&K_M_HK\OM?Y2132J"("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("(*CGONAT=^76?\I(K<@(@(@(@(@(@(@(@(@(@(@(@(@(@(@T
M+V.KW>B93*UT;B6.C>6.!(V/:U:?D*O_ !N_]*D_:@>0J_\ &[_TJ3]J>0J_
M\;O_ $J3]J!Y"K_QN_\ 2I/VIY"K_P ;O_2I/VH'D*O_ !N_]*D_:GD*O_&[
M_P!*D_:@>0J_\;O_ $J3]J>0J_\ &[_TJ3]J!Y"K_P ;O_2I/VIY"K_QN_\
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M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@J.>^Z'1WY=9_RDBMR B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M&</?;C;]*^LD9(T.8]KFGN(.X0?&S0O>YC9&%S>]H()"]/>R-I<]P:T=Y)V
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M2TGDHIG?[S7KN9)OWD>IR";T7]SM3\*3]<JU("* B B B B B B B B B B
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M%-%BW1<&N#GM9ZB[]NR\:EH2W\+;@B&\FP<P>TL.^R"MZ=U3BZ^*BK7)C#-
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MGZ<897/,R;^F2.Y@'L4O:J5[<+H;$0DC)&[3W'9!DAAB@B9%$P-8QH:UH[@
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MS/+O! V[0K<@(H"("("("("("("(*OX*OM'EOSW=_65]441 1 1 1 1 1 1
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M0<=#,6=-OWLL\>-GJ!G;RX^YV_\ TKK^!R'E#$U+!.[RS9_X;>PH)A% 1 1
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ML!09UA\9K=?H=>/J[;]/D.7Z$":Q!79SFF9&W?;D]P:-_P"=88LCCYGB.*Y
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M7C,DTK(V#O<]P:/TE>*URI::75[$4H'>6.#MOT(-A$&M!<J6'RLAGCD=$=I
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MS[A&_D,*JN&\R?)L'E'[*]+J?7O?';W'8@Z#IZ/ BO-)B!]2=)Q>?3]TT?\
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M(@(@(@(@(@(@(@(@(@J.>^Z'1WY=9_RDBMR B B B B B B B B B B B B
MB B B B B B H'/.S1AAAQ;6\Y7$/D/\!OM05#14+Z^;S,+Y"]T>['/]\6OV
M)5KU#@YLQ%7B%OI1L>7/;QWYJBF6Z=.EJ[%P8II8YI9UFM).PW[=_P#TJZ9S
M"09-U:2S8>V"N2]\0[G(*CIB.*74MN?&-+*#6;$$]^X_:NGH(O,Y6'%4);,G
M:1V,;[YY[@N;Z>;=&KF.N[]>2)TC_DYLW 03.OK$?3QE5[]F/F+WGV!O9_\
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MF&L(,C61&,;N]>Q ]BV<Q1-_%VZK3LZ2,AOX0[0@HNG=35<52..R+)(9('N
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MR67]4H*KH7[03_E$GZH4+I3&1933V2JR=A=/NQWO7AHV*"(T\+3-4T(+._.
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M>/E7:YK)3MN!Q=R6LZ>MD=:TIL<0YC(P97M&P.V^Y07JWF:52]5IRE_5GVX
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M7M=[E67(Y3%T]01LO8^-F\>[+CNU!"XET-W6L]J@W_=FL/-P&S3NW;_J5TU
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M" _'T)(60/J0.B9[B,L:6M^\%ZGIU+$;8YZT4K&G=K7L#@/O H-AK6M:&M
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ML32O!WVY@#_U!,OIF63(T+N,;6@?"=WM(+ =CN/<@H,NH-.3W[5>]2LB&U$
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MJS"*W7=O&\]Q6AC=/Y.3+LR>6L1/EC;M&R-!LYF7(,SF'97M@122 20 ^DX
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MX$O/W@4&OC<+JRM9J];)PNKQN;RC:YW:P>H#B%NY[ 7+=VMD:%AL5J$ ;/\
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MJ068PX,E8'-#N_8J-S>&=E60-%R2#IDG=GKW09<+BG8NJ^ VGS\I2_F_O&X
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M#WM &RQ>(TOXK#\P(,D=>"(DQPL83W\6@+*0' @@$$;$%!XCBBC;QCC:UOL
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M?Y"Y[5(S63FK]^X>UM?%'YQ9L1^EQ06'#_<)<_$V%%Z;Q>>LXQLE/+="+J.
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MB@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@J.>^Z'1WY=9_RDBMR B B B B B
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MT\8Z5@D[MWW"E=0XG)MR]3+XZ(2OC #XD$)3?DI=;U);D+8I71N)C!WX,Z9
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M$>H!!8U6;>!FGU#3R8F8&0L#2S8[G;?]J#%J73+<ST)(Y&Q3,["XC<%B^Y#
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M(@(@(@(@(@J.>^Z'1WY=9_RDBMR B B B B B B B B B B B B B B B B
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MH!AM6&1!Y(:7>O9!'^<V _E&%3;'LD8U[#NUP!!]H*#TB B B B B B B B
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M*YUX1/L?'?C)$'J.WH&1[&-@CW<0!]2>NAL8R-C6,&S6@ #V (/2* B B B
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MW2EG+TW=YW<2JEK''6S+1RE2,O?5<"]H&YV!Y JC6MZ[KS47,IUYQ;D;Q:"
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M7]U@.(+/;ML@AL!3I6=3"QC82VE5C(#R#Z3B-O6KQ=SE2ED:E&2.4R6" PM
M+1N=NW<H*GJ]CZF8P^4+"88GM;(1ZN+N2P1SQYW6-6S5#G5ZT0Y/((]SN?[R
M@Z8N=Z&^S,_^.C_O>@]ZWSTM5C,?7<6OE9O*\=X8>S8+QI7,X&%T&.IP6>K*
M?2E>UHY. W[=G%!:Y\Y4@RU?&/9*9I6AS7 #AL=^\[_(IE!SO0WV9G_QT?\
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M09'-:]I:X @]X*P14J<+^<56%CO?-8 4&RL4D,,NPDB8_;NY %!E1 1 1 1
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MU:TLT,TD+'OBWZ;B-RWEMOL@H>AOLS/_ (Z/^]ZN.6RM;%TWV9S\C&CO>[U
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MFQ_[B0$%SCH004/$H&B.,1EC?7MOZU7*^DF18*UBW6^75FZ@EZ>W$]GJW^1
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M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@J.>^Z'1WY=9_RDBMR B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B"K^"K[1Y;\]W?UE?5%$0$0$0$0$0$0$0$
M0$05#5_V_P!%?E]K_*2*:501 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M!4<]]T.CORZS_E)%;D!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$%7\%7VCRWY
M[N_K*^J*(@(@(@(@(@(@(@(@(@A=1Z<GRTF+FJY'Q.>C.^5C^D)@><9C(()'
MJ<HOS8U7\;(_H#/WT#S8U7\;(_H#/WT\V-5_&R/Z S]]6H>;&J_C9'] 9^^G
MFQJOXV1_0&?OI0\V-5_&R/Z S]]/-C5?QLC^@,_?2AYL:K^-D?T!G[Z>;&J_
MC9'] 9^^E#S8U7\;(_H#/WT\V-5_&R/Z S]]*'FQJOXV1_0&?OIYL:K^-D?T
M!G[Z4/-C5?QLC^@,_?3S8U7\;(_H#/WTH>;&J_C9'] 9^^GFQJOXV1_0&?OI
M0\V-5_&R/Z S]]/-C5?QLC^@,_?2AYL:K^-D?T!G[Z>;&J_C9'] 9^^E#S8U
M7\;(_H#/WT\V-5_&R/Z S]]*'FQJOXV1_0&?OIYL:K^-D?T!G[Z4/-C5?QLC
M^@,_?3S8U7\;(_H#/WTH>;&J_C9'] 9^^GFQJOXV1_0&?OI0\V-5_&R/Z S]
M]/-C5?QLC^@,_?2AYL:K^-D?T!G[Z>;&J_C9'] 9^^E#S8U7\;(_H#/WT\V-
M5_&R/Z S]]*'FQJOXV1_0&?OIYL:K^-D?T!G[Z4/-C5?QLC^@,_?3S8U7\;(
M_H#/WTH>;&J_C9'] 9^^GFQJOXV1_0&?OI0\V-5_&R/Z S]]/-C5?QLC^@,_
M?2AYL:K^-D?T!G[Z>;&J_C9'] 9^^E#S8U7\;(_H#/WT\V-5_&R/Z S]]*'F
MQJOXV1_0&?OIYL:K^-D?T!G[Z4/-C5?QLC^@,_?3S8U7\;(_H#/WTH>;&J_C
M9'] 9^^GFQJOXV1_0&?OI0\V-5_&R/Z S]]/-C5?QLC^@,_?2AYL:K^-D?T!
MG[Z>;&J_C9'] 9^^E#S8U7\;(_H#/WT\V-5_&R/Z S]]*'FQJOXV1_0&?OIY
ML:K^-D?T!G[Z4/-C5?QLC^@,_?3S8U7\;(_H#/WTH>;&J_C9'] 9^^GFQJOX
MV1_0&?OI0\V-5_&R/Z S]]/-C5?QLC^@,_?2AYL:K^-D?T!G[Z>;&J_C9']
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M0$0$0$0$0$00G@UI^+Z=FDY[^,9.]+][:=T?_:K@HHB B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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MQX2N+W1NWV["51KY.V[SM;6GR,T%4P D"8Q-!V5TQXK"L/%[1GCW.TAEZO\
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M@B B B#R&-!)#1N>\KZ6M=W@% (!&Q0-:T;  !!B?7KR.Y/AC<?:6@E9@
M!L$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$&AX/_ +EZ_P"67_\ -2*R**(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@*-RWVZTY^43_ . ]!S;PE6J5K(TJ=>'G
M<8-GN;W[/[HUXT/?H,P^<HF,,MNKROY^N1H9W?S*_$=>Q'VIQWY+%^J$441
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M:&D^[4&"D=2:2N9^I6T[9R5>Y?EN4IH7Q@-=/VF.7F06@%5VYX/,VW&Z/I,
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M4X<>>PY<=]]M_8B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B J#X5;,-3"X:Q-(&119ZB^1
M_L:U^Y0:^F)&ZPOC5%IX-6O+)%BJ?P18=G32CX4KF.ESX,3CI?+M%\M[QZUU
M'B"T_LZIV[8@0@L>K(M(0Z\Q<.<@+\<S38$$;8YI-G";9G9%N5XU-#HD:$?+
MA*_1HOS5-EKFR6+?9PWW$VQVV*#+!YI0:LTRS1$^\SK1%]E:1\D'BNQW,N^X
M7;Y8HYHI(I&[L>TM</:'#8A!Q?):"TC%K_3V.9B(Q5GH6Y)8N3]G.9ML5OY^
M;#:3UEHX,@EBI04+[&10QOF(YD>H;E!ETW?QFI-<:N+(Y7U)\35A>R:-\)(/
M)KAL[8KSX.=-8.KG]66(*+&2TLO)!6=N[T(C&-VH*Y8IZ8BR.<9K:E;BNS7I
MC5RCV2F 0D_4>E(SL9Q7<L''T,+CV'(^/!E=@%OX8;=C^PE!R?7D>FG:ZT\S
M43X!1\F6=S,\L9SYC95*QEV8N#5YTE9F\D/K5((9>;W11W)Y1&XP%_L84%PU
M%IC%:.;I_+X9CX+,62K5[3P]Q-J*<\']55*G)X-_*.KH\_'SR+M07Q"V-DQG
M+-^P1F)!;L?I&#):!@MZFH/FR5;'V!$^=SNLR-I<Z,/4IX-]*:<KZ;P669CV
M"[/CF]2;=V[NHWM00^EM*:=I^$358@QS&C'MQSZ8Y.^I.EB<7K8Q>"Q6LLKJ
MV]FH39%?*24*;"]P; RNT N8!ZR4'/[=G/VL;I&&O9DFR&+RV5BAD<=W3>(L
M,C6N_"#>*ZIA,O6S.O*&1K.WALZ3$C?DWLH+[G_M%EOR*?\ 4*_/FE(_!%+@
ML*S(4B^\^O&)R8+9WE/RM&R"[8_3^)U1J74T>4KF>GBG04*-8O=TX@V/=[OP
ME0,C8J18W'8O-3NFH8K64M1SY2YY-5L9< Y!<-,C"RZUQL^C8YQB15G&3>!*
MVJX[?4@WJ=[P5UK(XRIE<;;HVHP^"Q$Z-X]@/K'RA!QD9344]1O@]<^49,3&
M":[_ ,M WZ_WRWT%+XS3>&SVI\]0O5>KC<)!4I4:A<1&TOCYO>0"-WH*PR2>
MLS'X9T\DL6,U]4@K.>27"![2]K"2K[J;_P P=,_FO)_JM0<:PQT+-H>O!4AF
MDU0:KNB*C9_&.OOZ!W:OT[C3<&*QHO'>V*L0L'U=7B.?_5!QC4DVB(_"/F#J
MGI=#R;5Z'4;(=G[GWBA<G%-%X/M6D17(\*[*U#C660\/$/59SV#_ $@Q47;3
M@\%7E>&3#X][+D37R1O,%IFP:TD]LH 6MI32>'U3IQN<S,;Y<EDC-,+ >X/K
M O(8V'V!J#:\CLS>L8\#F;$E^GB,-"\M>2T3SRNVZDH;WD *C:FCCP^+UOIX
M2/..IW<5/68YQ=THK+P7QH)JL-+3ZCTZ_0<4W5COCRC) V9M<5=O3;+SV&ZS
MZ6T/AL]0U#;>)X+_ )<OLBN0S/CDCXO]%!%MR-S.XC263U#C[F0Q<4-J&^RN
MTO'C,3^#)I6,V+@NCZ!@TS&<G-IW+=6A*]A\0[0*L@!WV#_2;R07A% 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 56U[A;V9Q^)@JUA/T\Q
M4FF82T#HQNW>3S0:7D++X/6'E'$5NMC<G]LZX>UG1F'=88''YP"@=*OUOIW%
MOQQT7-9VMV9!*V]68")9"\=A<@W<DS5<&K\?J&MIB2RUV!\5F@%J!AAE?,)"
MTESDU#7U3J7!-K2:9?3DBR5*41OM02\XV2;O.[2@Z/%!! "(HF1@^IK0U$%8
MR&(R,^O,!E(X-ZE>A:CEDY-]%TNW$;)D\1D9]=:=R<<&]2M3N1S2<FCBZ7;B
M-D&M%CLM2UCJ;,LI&6"7&5VU@)& S2Q!Q,?R*%T5'JBEF,_X_IR2I#D;S[0F
M-F"3I>@ &$,))0;3;^O<<V[CKFG?+;'2R>+VVS0Q-?&\[ADS';;;*QZ,P]G
M:7QF-LO8Z>%CS)P.[&F1Y?Q;\C=]D&CD\%;N:[PV1=39)2@QMF*5[BT@2/<"
MT;%;^LM/.SFE[^+J\(I7-8ZN>YK9(G![$%3LPZJU3-A:61P!QU:I=BM79GSQ
MR"5T':&1!GJ)2MHA][#ZLHY2$P/MY^Y<HS!P+V<]C%,TM063%LU+;T?/6S%,
M,R8JS0'9['"9W$M;("T]G-;>CZ%[%Z1PM*U!QM5Z3&21<@=GM'=N-P@INFV:
MOBUIF\E;TI+7K905&%YMUW] 5F%I)#'$E9H8=3Z6RV?%# OR=/)73<@?'/'&
M8II&@/;('H-3%:.RV+L:)DE8V5]>YD+62D8X;,DMQ%9],Z.R>$U_E[;(]\1+
M2>*KN3?0?-*)'Q;(.D9B"6QB,E#$WE))5E8P=V[G,("B='T;6+TI@Z5V/IV(
M*44<K-P[9S1VC=J"K25M0Z:U)G+F/P;\G2RABFVBFCC?#.QO @B3;=KE$0:-
MS\<>GK$L#'VWZG?E<D&/;QA$C2-@3MN&H+##@\G@-8NN8JL'XG)@F_ 'M8*\
M[>Z=@<1N'>L!79!5F8J_'X1+66=!M2?@XZS9>3>V43%Y;LHNS5S^G=4YC)X[
M"OR5/*QP.DCBE9')#/ WAW2;;M<$$'-HO43L!+=$,'EI^?CS/BW4' .C.S8
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M)XJEF2"+JRLB>Z./?;FX#<-_G7)?/;PI_P##S^TA \]O"G_P\_M(3SV\*?\
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MJGF<34R-,/$%AG./F-G +4SN<H8+%V,E>+Q!"6 A@Y/)>X- :$&*]JC#X_3
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MK8;6&ELW*8,9F*UB4#?IL=L_;Y 5*H"$@ DD #O*"HP>$/0TM]M-NH*AF+^
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MM3U;.=KQS02NCDC/+=KV'8@JT/OXV'&>49;<;*G1$IG>>+ QPW!W*"!Q6O\
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M28.9Z'K8$'>ZT(KUH80XN$<;6<CWGB-E]08\S7DFPV2@A9R?)4F8UOK<YS"
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M%LJA\5[EVOE]'=FR"81 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6.
M7(T(7%LD[>SU#<_W(/'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&
M_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"G
MYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3
MRYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC
M?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3
M\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH
M'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES
M&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"
MGYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI
M3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RY
MC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A
M3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\T
MH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'E
MS&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_
M"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GY
MI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3R
MYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?
MA3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\
MTH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'
MES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&
M_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"G
MYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3
MRYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC
M?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3
M\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH
M'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES
M&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"
MGYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI
M3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RY
MC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A
M3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\TH'ES&_"GYI3RYC?A3\T
MH'ES&_"GYI3RYC?A3\TH'ES&GLZQ'R\2L\-JO."8I6NV0$0$0$0$0$0$0$01
MN>OOA:V"-VSGC=Q'> HRC@Y;,0EDDX-=[D;;DJHW_-IG\9/S4\VF?QD_-2AY
MM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9
M/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GF
MTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD
M_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/
M-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C
M)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\
MVF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,
MGYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2A
MYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\
M9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:G
MFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?Q
MD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4
M/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_
MC)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2D/-IG\9/S4\VF?QD_-2AYM,_C)^:
MGFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?
MQD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ
M4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,
M_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S
M4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS
M^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-
M2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-I
MG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^
M:GFTS^,GYJ4/-IG\9/S4\VF?QD_-2AYM,_C)^:GFTS^,GYJ4/-IG\9/S4\VF
M?QD_-2AYM,_C)^:GFTS^,GYJ40&<&(P3:IO6YQXQ(61-BKOF<YP:7$!L>Y[@
MH+SATS\+E?ZLL_N(0\X=,_"Y7^K+/[B><.F?A<K_ %99_<0/.'3/PN5_JRS^
MXGG#IGX7*_U99_<0/.'3/PN5_JRS^XGG#IGX7*_U99_<0/.'3/PN5_JRS^XG
MG#IGX7*_U99_<0/.'3/PN5_JRS^XGG#IGX7*_P!66?W$#SATS\+E?ZLL_N)Y
MPZ9^%RO]66?W$#SATS\+E?ZLL_N)YPZ9^%RO]66?W$#SATS\+E?ZLL_N)YPZ
M9^%RO]66?W$#SATS\+E?ZLL_N)YPZ9^%RO\ 5EG]Q \X=,_"Y7^K+/[B><.F
M?A<K_5EG]Q \X=,_"Y7^K+/[B><.F?A<K_5EG]Q \X=,_"Y7^K+/[B><.F?A
M<K_5EG]Q \X=,_"Y7^K+/[B><.F?A<K_ %99_<0/.'3/PN5_JRS^XGG#IGX7
M*_U99_<0/.'3/PN5_JRS^XGG#IGX7*_U99_<0/.'3/PN5_JRS^XGG#IGX7*_
MU99_<0/.'3/PN5_JRS^XGG#IGX7*_P!66?W$#SATS\+E?ZLL_N)YPZ9^%RO]
M66?W$#SATS\+E?ZLL_N)YPZ9^%RO]66?W$#SATS\+E?ZLL_N)YPZ9^%RO]66
M?W$#SATS\+E?ZLL_N++C\S4L6)#2FF#XN)(D@D@=L[?8\90TD'9!TRG:9/5C
ME[B1L1\H7U11$!$!$!$!$!$%7S_VP/X#5:(=A%'^"$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!5366K
M7:8J8Z=N-?=?<NLJQ0MD$9+W@D();3^:R>1J3SY3"28IT<FS8Y96R%S=M^>X
M4JRQ7EAZL<T;H_?M<"WL^4(#)H7N<UDC'$ $@$$@.[B?OH@)E[TF/Q5^ZRN9
MW5Z\DHB#N)?P:7; H.=YGPHU,;H_#:A&-DF%\@-K"38L["7$G;U;*=LZU@CG
MTC##5ZSL[Z4>S]NG&&"0O^78%!A?K*3$X&?)ZBK,KN;<=%'%7>V8O:2 P]A6
M2[JN6#6>)PS!7-.U0GL/G).X,7L.^VR!K/4\V P=6_0;!/UKT$.[MW,+93L2
M"TJT1SP2EXCE8\L.SPUP/$^PH#+%=TKX6S1F1HW<P.!</OA5O3^IK63U'JS&
MSQ0LBQ<T#(GMWW<)6%Q+T&._JR2'6&FL/5\6FK9&.VZ24$N<TP,+@&D%6E 7
M.,=X1<QE,I<JT=(69Z];(OIS6FV6!K"QVQ=L0@Z.ZS79*R)TT;9'^Y87 ./W
M@DEBO%RZDT;.+>1Y. V'=N=T!4C2OA&H:DS^6Q,-1\)J\W0RE^XG8QYC+VA!
M%9/7V4HVM?0QU:Q&#@JR5]P[=YF;N>:Z9BK3[F,H6I  ^>M%(X#N!>T$[("(
M"(*EJ#5.H</;@C;IN*>"Q=CJUY?'0PO?+W;MX'96:ID;+<<;67KPT'-)YM,X
MD8T>H\R&A!FKSU[,39H)F2QN]R]C@YI^\0OJ ^:)CXV/D:USR0QI(!<0-]@O
M#+51P86V8B'2&-I#P=WCO:/E[.Y!J4\M'9RTE2N*\T#*PD-F.PQY$A<6F,QC
MM&P[>2P7]5X>AF*.,FM1"6PV9Q<9&!L0B .S]SV%W+L09,IJ&OCLAA*[PPQ7
MW3#KF0-9&(HC+R^4'98,OJ.GC=.WLU6,5R*O$7@12C9_;M[H;H):M?QUB26.
MO<KRR1':1C)&N<S[X'<@OX^.T*;KM<62-Q"9&\_F[[H(34^?R& A99CQ<5BF
M'P,DD-CIO:Z:41#9G!V_>IR:>&O$^6:5D<;1NY[R&M ^4E!$8S4-6_E\I1@:
MQ[:D-61MAD@>V46>?=M[."F$ D ;E>:61QMMSV5+U>=S/=B*1KRW[X:@"W5Z
M'7\8BZ.^W4YCCOOQVW^_V*+R.I\1BLEC*%B>,36Y'L[9&M$09&9-Y-SV;[;!
M RV?K8OR(\-9+'?NMKB42 ,8UT;I.IOZQLQ2U2]2NQ&6K:AGC!(+XGA[=QZM
MVH%?)8^U)+'7NUY7Q_7&LD:XM^^ >Q8Y<GBJWV1?JQ?5.GL^5K?3[^/:>]!I
MYK+1XVE)(PUWS\"Z&O)897,Q'J#GK;OY.GBL9+>MO;&QD1>07#=Q#2[BTG8$
MH/&+S>.RF.BNPV8>!@9+*WJ-=T@]O+9^W<M@V*S8F2NFC$;^/%Y<.)Y=VQ^5
M 1!!5]5823-V<4;4(DA@BD+S*P,<9'%H8WM[7#BIJS<I4F"2W:A@83L'2O#
M3]]R#VQ[7M:YK@YKAN"#N""B Z:%DL<3I&"1X)8PD!S@WOV'KV1LT+I'Q-D8
M7L +V C=H=W;CU;H/%2]C[3Y&UKM>9T9V>(Y&O+?O[%0M?56$DS=G%&U")(8
M(I"\RL#'&1Q:&-[>UPXH)JU>HTHVOM6X8&$[!\KPP$^P%R]M<U[6N:X%I&X(
M[004!1F<S=#"8VU>MR-#(87R!G(!TG ;\6;]Y08]-9N_EZ\L]JM2A9LTL%>W
MXSWC<B0AK0TA2=.]C[A?XK<@GX'9XCD:_C]_9!DER^*A+&R9"JQSWEC0Z5H)
M>.PM&Y[PB EK)XRD^..U>K0.?[ALDC6%WW@2@\36JE8!UBQ%$"TN!>\-&S>\
M]J],R%"2L+3+D#H"0!,)&EA).WND'UTT+'QL?(QKI"0QI(!<0-SL/6B"H:O^
MW^BOR^U_E)%-*IHB B B B B B B B B B B B B B B B B B B B J-D?N
MLD_-<7^*]!T' =M _C"MU11$!$!$!$!$!$%6S_VP=^ U6F+ZU'^"$01%$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0%RGPR133U-)113F&1^H:S62@;EA((#D$/K7&Y.A1TUBLUJ&Q>HW\ZP
M7)WL$'U+8;1'BH7*5*6$SNN\1A &8U^DYY[,#'%T<4X"#I/@OP=#%Z7H7X0]
MUO(TZ\MJ1SR>6S?0'R!H*OZ OCV-D8YCP"UP((/K!0?F/2U(Y3+XK1\Q);AI
MLT)6GV/'!A_2]3/@NLRYG4.!9(/M#@YH'_).^8Q?J!45F_C:%CP8W;D\#'35
M]1SMCD/>QDLK0]7_ #>EL#8\(6D<.RNT8UF*LGH,<>#@'EW$H*';K]+1.H\5
M$][*]76WB]?8]L;.2MEV@S26M\Y7T]$80_1TUD1@EV\\;B ]05TX["8S1^B\
M_BICY=GR%?G,)2Z2=\I/58];&J[-NO%X7C7>YO.[C&2.;ZHWH)ZM@]-8;PIZ
M(AP98(I*%F1[&/+P=X' 2??>N[H"X3X/<)FKN6U-;J:BGIUH=3V.M49$US9M
MG G=Q05L8[!Y72NNL[EY2<Y6OV0R4R%KX'1;=%C%*5L4W5FM].0YP2N$VCZU
MBU&'%AE>'GW6R#K^N,WY"TCF,B#M(R L@_&R>@U<"QMK(::NZ"N3Z=OT(J6]
M*Y8F: R86CN?T$DH)W4?VQ\,_P"18_\ 47?]._<_AOR"O^H$&PB B"JZY_\
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MS)E:"[L#R-D$MX/6\,);,<;XZ3LE;?08\$;52_=FP/<WV*V(*QKF&6&C3S<
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M6W=L@CLQFZ&%BHQ.KS2&>405JU:,.>\M:7;-'8   I&C8-FK%,:\L!>-S%*
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MX,/;[=W+80%YMVJU.K-9LRMB@A8Y\DCCL&M:-R2@]-<'M:YIW! (1 1 1 1
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MM 6#,8G$9:!L&1HP66-=R8V1@=Q=[0@]C&8V'Q$15(F>)QEE;9H'2:1Q(9[
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M?(RY:;QZ:&:W-4FBE8!RKRU!LQ[4$U@,,</CA5==GMRF6266Q,?3DDD/(GY
MJWJG0SL_D8[C,Y=H$4W59!6V!DB<[D02@T[G@XQK[-8PW[=>F(:L5FDPCA9;
M3^M<UG?H!KLT;XS5L0#*-R+:>S>F)P-GGV]J">HZ=J4<9E:+Y'317K-N:0$
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MS/.[S5M@!\<I]? OW0:&E]0Y^_D\7C[-R7G9O')^P^(R5^;8OO![EV% 1 1
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ML_\ ;!WX#5:8OK4?X(1!$41 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 RU#RCC+M+QB2#QB!\?5C.SV<QMR;\H7(_]C;_CKG?Z5 _V-O\ CKG?Z5/]
MC;_CKG?Z5%/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]
MC;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\
M8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]
MC;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\
M8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]
MC;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\
M8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]
MC;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\ 8V_XZYW^E0/]C;_CKG?Z5/\
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M4X^SEWKVRE0@LS6HJD#+$H DE:QH>\#WSAVE BBCAC9''&UC&- :UHV  ]0
M1U2H:SJQK1& @AT18.!![P6H$%>O6@9!!#'%$P;,C8T-:T>P +Z@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@J&K_ +?Z*_+[7^4D4TJFB("(
M"("("("("("("("("("("("("("("("("("("HV1^ZU_YJB_Q7H)V;#TLCA8
MY)[AJ/K3N?%9#@W@57Q$;#C7D\(371N["!V%P/RER#I^)QM7&X^O4K;F*-OH
MDG<G?M)7I11$!$!$!$!$%6S_ -L'?@-5IB^M1_@A$$11$!$!5_,9*]7R5^**
M<M9'@I[#!L.R5KM@Y!4;65U*9[-V/+%D%&'&2&OTV$3FSL) \J=QF.OMUWF[
M#LS8=$VM5>ZN61!C@_JAK"0W?9B"3P8OQ9[/U;.0EM,8VM+$7LC:6"7GZ +
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MLW9"Y_,.VY[J"NPW]0#-FT_*$TQGG8\4^FS@8G,WYEW?R#ET% 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1!6=7XW,6;> N8RI%9?1M2R/
MB?-T=Q)"Z+L=L??*-Z^N/BM5_K$?Z:H=?7'Q6J_UB/\ 33KZX^*U7^L1_IHA
MU]<?%:K_ %B/]-.OKCXK5?ZQ'^F@=?7'Q6J_UB/]-.OKCXK5?ZQ'^F@=?7'Q
M6J_UB/\ 33KZX^*U7^L1_IH'7UQ\5JO]8C_33KZX^*U7^L1_IH'7UQ\5JO\
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MI.]?%!XHZYP=RK?LCQF**M6;8+IH7,ZD+M]I(O?-)"^::SSLKD<^[:S''#+
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M"("("("("("("("("("("("("("("("("("T-1_8,?XX?W%![T_]@'\8Y;B
MB B B B B B"K9_[8._ :K3%]:C_  0B"(HB B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B M#4?V#'^.']
MQ0>]/_8!_&.6X@(@(@(@(@(@(@JV?^V#OP&JTQ?6H_P0B"(HB B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M ;N<P$H(G)Y>Q6SHK"=K(3B+,X:X-[98WL#3N5*X"U/<P.(M3OY2S48))';
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M0NCW$GX)5&]IYC&.T;Q&W;E#\YY)70U 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6AJ/[!C_ !P_N*#W
MI_[ /XQRW$!$!$!$!$!$!$%6S_VP=^ U6F+ZU'^"$01%$0?  -]@!N5\R>/\
M?QMJDV7IB=AC>\#<\'=C@/E(0>@   !L B FPWWV&Z @  V  0  !L  B B
MB   -@ $(!!!"#YL"-MALH;4. R.5.U7,R4XI8'U[48C$HDB?ZV;D<'_ "H)
MF*-D4;(V#9K&AK1[ $V&^^W:@^H@(@(@(@(@(@(@(@(@+X  -@  @Q7L;X]%
M7C<_BQEJ*5XVWYB%W,-^< LR B B B 0"02!V=R(&PWWV[40$0$0-AOOL-]M
MMTV&^^W:@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@+0U']@Q_CA_<4'O3_ -@'\8Y;B B B B B B
MB"K9_P"V#OP&JTQ?6H_P0B"(HB B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B M#4?V#'^.']Q0>]/_ & ?
MQCEN("("("("("("(*MG_M@[\!JM,7UJ/\$(@B*(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+0U']@Q
M_CA_<4'O3_V ?QCEN("("("("("("(*MG_M@[\!JM,7UJ/\ !"((BB("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("T-1_8,?XX?W%![T_]@'\8Y;B B B B B B B"K9_[8._ :K3%]:C
M_!"((BB("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("T-1_8,?XX?W%![T_P#8!_&.6X@(@(@(@(@(@(@J
MV?\ M@[\!JM,7UJ/\$(@B*(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+0U']@Q_CA_<4'O3_P!@'\8Y
M;B B B B B B B"K9_[8._ :K3%]:C_!"((BB("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("T-1_8,?XX
M?W%![T_]@'\8Y;B B B B B B B"K9_[8._ :K3%]:C_  0B"(HB B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M OA('>4 $'N(*^H"("(";C<C= 1!YLVZ=2,26;$4,9<&ATCPP%Q[AN5Z0$0$
M0$Y-VWW&R!1OT<C69:I6HK$#R>,L3P]CMCL=B$0$0>:]RG8ZWB]F*7I2&.0,
M>'<'CO:[;N(7I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M%/11QPQLBC8UC&-#6M:-@T#L  " B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB HS.::P.<K0PY;'QVFQN)8'[CB3ZP0@WL9C,9B*3*>.J15J[-]F1C8;E94!
M$!$!$!$!$!$!$!:&H_L&/\</[B@]Z?\ L _C'+<0$0$0$0$0$0$05;/_ &P=
M^ U6F+ZU'^"$01%$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%H:C^P8_P </[B@]Z?^P#^,<MQ 1 1
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MRU3IVK#:T3C%)DF@=O:*<;GM_3Q5;M9/,ZAHW:U["QV64[<3YZ<#SO8A9+-
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M$SC^EB#K*Y3IM@C\,NMFL&P-"J3\QB#JR("("(.5^'3[A]O;?@75&M:UK6M
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MZW@(K<F;,LQZ>1IQUW- V+ P/&X/_K3#8NYC_'+%^\VU;LN9SD9%TF<8QQ:
MW=WWR@B\[I6UE,C)9AR3((YJT$4P=!U'[02&5O!VXXAQ=L]5J7!Y*7$:EM36
M"^)@S?BE00D/#YGR#??U@CW*"S5=/6@ULUW(B>T;=>=T@AX#A7&S&;<C]\E;
M&8TU/D+YFBOB&"Q'#%>A,?,RL@>7M#';C@>T@H/LFE*DUW4$\DSBW)U6P/C
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MWD7_ .X1#%F:Q#%8#R9 ^L2USI 1L&.(("E8M1X"6B;T>5J.JA[F&<2MX!S
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M6.'I .(0="TI%TM/8YOU7;I$MZK!&_BXDC=@]RJCAOMY2J]!XM5+N4EMO,9
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M3#%B"'R,X1PR,]PU\P<&D%5 ,M5[N9:_KV[$'EB8TC5V863%Q8'2C8N$@(V
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M1_8,?XX?W%![T_\ 8!_&.6X@(@(@(@(@(@(@JV?^V#OP&JTQ?6H_P0B"(HB
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M.3_86LV(5R441 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MN@JR0!L;HF,]"2"4#TNSW8*VYLGFJ52[3M9J3K-NP,9/#5:^<B:'J=*&-K7
MD$=A([&H,F,R.I<P<.R/*"MSQHL3GH,<7R1R\-B#W!_K6*CG]1V\IDC79:DC
M+K\,,3ZO&O&^LXLC<V;UEY;LY!8M&Y*S>H619NSSS13\'ML0"O/$2T$LD:T
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M&QW0>&X:F:^0KR,+X;CY73,<>_JCBX*%\R<6ZNZ*:S<F>Y[G/FDD#I';Q&$
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M/[!C_'#^XH/>G_L _C'+<0$0$0$0$0$0$05;/_;!WX#5:8OK4?X(1!$41 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M[.>MI 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M%F2_$Z6:R2R8UWANT<&Y#&QD;!RM^E?M2_\ .&0_S4B"MZI?/#J#'62^PZM
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MHA$ZO'7+ -ATH22QO\Q*#*VO7CL36&Q@2RM8U[O6X,WX_HW7U 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 6AJ/[!C_ !P_N*#WI_[ /XQRW$!$!$!$!$!$!$%6S_VP=^ U6F+Z
MU'^"$01%$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0%H:C^P8_QP_N*#WI_[ /XQRW$!$!$!$!$!$!$%
M6S_VP=^ U6F+ZU'^"$01%$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%H:C^P8_QP_N*#WI_[ /XQRW$
M!$!$!$!$!$!$%6S_ -L'?@-5IB^M1_@A$$11?+,S:]::9S7.;'&YY:T;N(:-
M]@/64$'I?4LF8@N"QC)*-BM(QLE=[P\[2L$C';M]H*G4'RT^Q'5F?7A$LK6$
MQQE_ /=Z@7;';=5_3VH+URI;M9/&P8Z"&66/JFV) 70RNA?OZ+-@"U!86/:]
MC7L<'-< 00=P05X%RB)Y(#;AZT;.<D?,<FL]\1Z@@-R6,%=\_CU;I->6ODZC
M> <WM()]H7U]ZA!'&Y]N!HDX\"Z1H#N?=M[=T#QRDR2:)UJ$211]25A> YC/
M?.'J"]2VJD#)72V(HVQL#Y"YP:&M/8"[?N!V0&/8]C7L<'-< 6N!W!!]82_:
M\3HV[7#GT8'R<=]M^#=]D"EDZ5RO#/'9A(D/'9L@=M)MR+/P@OC'L>"6.#AN
M1N#OVM.Q'\Q0!<J.LOJML1&=K>3H0\<PT^LM[]DFLUZ\9DGFCBC&^[GN#1V#
M?O*#XZ[2:*W*U"!.0(=WCZKN-_0]J16Z<D[H&68G3-!+H@\%X .VY"#5R>2A
MQC*<DP:(I;(B<]SPP,!:7<R3ZALO4N0BCGH1QNAD-EXV'68T]/B7=1H/NQ\@
M09X[=269]=EF(S-:28P\%X .VY"C'ZFJ'RJ87UWMJ1,<Q_78UDTCP[9G,]C>
MUNR"6-^I&8&36(8I)>(8QTC=W.=W!OM7EMNF;!KBS$9F[;Q<QS&XW'8@33P5
MX7S3RLBB8-W/>X-:/ODK0R69I8S'&Z98I"Z,N@9U WJ_@'UH)$V:P )GCV+G
M-!Y#W3-^0^^-CNL-7+5Y:4UR:2O# R61HEZ['QEC7<0\N'8-T&9]VFPUP^U"
MTSD"'=X'4/?LSVKP;M".1T;[<#7M:Y[F&1H(:SO)'L"#V'L+W,#VEP );OV@
M'?8_>.R^/G@9U.<K&]-G-^[@.+3OZ1]@[$'SQRDV66)UF$211\Y&%XY,9[YP
M]06GCL]C+^*&0CM0LK@'J.,C?0_"/J*#=8]CV->QP<UP!:X'<$'UA'O9&QSW
MN#6M!+G$[  >LH(2#5>,DQ]"[$^,PSV>E(XRM'1]%SMWG[S5-&[28*Y=:A'7
M($.[P.IOV@,]J!8F;7KS3/WXQQN>[8;G9HW.P59CU;=\7E9)AC'>YUVP5#.-
MI!9!+"7[=FP:>2!8UD]E2K9BQ4LD7B_7NDR!OB[ _@X#W[@05*G+PMU%6P_3
M+I'TI++G^I@8]K #\KMR@DIYX*\3Y9I61QL&[GO(:T#Y24-NF&@FS$&\!)OS
M&W ]SOO( M5G6'UVSQF9C0YT0<.8:?61W@+Q7N4IVA\5N"1O4,>['APYC^#V
M>OY$&O/GL55O4*3K,/.T'\#U&CW'[3V!;+<I"Z];@YP=*O U\DO682QQ)W:]
MO>W8#?<H/<MJI R5TMB*-L; ^0N<&AK3V NW[@=D:YDC&O8X.:X M<#N"#ZP
M@(@(@(@(@(@(@(@(@(@(@X'@L)D/"-/F\QE-09&K7AR,E6K5J2<&L;&I^QX&
MX(87OJ:MSL=@ F)SYP0'H+/X*M0W\_HZK:ONYV8I9())/?\ #UJ[("("("Y/
MK^?+Y'5.FM)4LC+1AOLEFM3PG:0LC!/$% /@7QOQHS_TEO[JU=+^5-*^$(:7
M.6LW\=<QQLP&R>4D3FDH.Q(@(@(@A]:9J?!Z6S&2K@&:"L3'N-P'GL!*Y1@?
M!A)G<-C\ME-5YMUN[798?TIPU@ZH#P$&EJK1E[0V'EU%A=3Y5\]*2(R0V91)
M'(Q[PS9=ZH7/&\=3M\>/7@CDX^SFW=!Z1 1 5=Q>I7W<];H-Q4XK1/FB9?W!
MC?+7($C"!VMV)V!*"Q(@K^/SV=M9ZSCK&"B@A@ >^P+8>0QX=P/#@._BIZK9
MJV8NM7GBE9N1S8X/&X["-P@2W*D,L,4MF*-\IVB:YX:7GV-![RD-ZC+*88[<
M+I 7#@UX+MV[;]@]FZ S)XMM;QCQ^MT>1:9>JWANWM(WWV[-EJ93-4\92;+U
M(GOD+.E'U TR!S@"6>W8'=!NR21Q1ODD>UC&@ESG'8 #O))4+%JW&S4,/>8^
M+H79NF]YE:!!]1?-Z?S$$P;E-CJ[7V86F?ZRTO ,G9OZ/M7F]:@Q]"W=L;]*
MO"^5^WO6#<H(W%9NP^O:=F*#<:8"PDOF#XBR3M!YD-&_J(4D;V/B>QLMR!KG
M %K72-!(<0 0/E)0>HK=.266&.S$Z2,;O8UX+F]NW:%];E<3XL;#<A5Z <6F
M42MX;M&Y&^^VX0!:K!KG=>+9K ]QY#8-=W$_(4AR!DR=^F8>(KQ0R=0GL=U>
M7Z-N*!6M5;40EK3Q31DD!\;@]NX[QN%&7\S%C\OA:$D)>;[Y0'[[",1MWW(]
M>Y(""1@N49)C%';A?*"X<&O!<"W;?L'LW2/)8MM4V/*%8P\BTR]5O#=O:1OO
MMV;(-7*9JGC*39>I$]\A9TH^H&F0.< 2SV[ [K;CLU7320-L1&:-H<^,.!>P
M'N)'>$&GC<O6NSWXZ[HY&0.C E9('MDYMY=FWL6Y+<J0RPQ2V8HWRG:)KGAI
M>?8T'O*#TR]3DFDACLPOE8-WQM>"YH!VW("T\?F:MZ>_%6+'QUW1ALK) ]LG
M-O+U>Q!$YK5%S&9.:"/%">K6JP3V[ F#'1,GD>P$,(]+;IDE6%MNJZ>6!MB(
MS1M#GQAP+F@]Q([P"@T+FH,10QS;QN020OGCA#V2L+2Y[PSL/R;[E;GCM!AK
M<[< -C;H O;]4_ ]\@PX[-8^Y=R%*&>-TU20,D >TD^BUQ( ]0Y;%9FY'&^*
M.M"]6,#7<3+U&\ [?;8NWV0>,;D1DL;6M=+IB5O+CORVV.RB<;G;=K*OA&+<
M*)EGAAN!_+>2N2UX<P#T6[@@%!.LR6.?!UV7:[HMW#J"1I;NWM(W^391[L[B
M8\ACZ)M0E]N%\L1$C=B&EH'W^1=V(-FOD(77+\?*#I58F.?,)FG9Q+N37M[V
M<0T'<J"H:L=;Q61R/2IB.-[VTV^.,'6+=^(>7 "-SD%@?9JPRPQRSQ1OE.T3
M'. <\^QH/>4%_'B2>-UR /A9SE89&AS&^^>/4$&K1SV-R.(@R;;44=9S Z1S
MI&[1[@'9YWV!6\UP<T.:X$$;@CM!"#&+E$2SL=:AYP,YRM+QO&T]N[AZ@HW3
MF=?F:]FP(J[*[)G-A,<XE<]@.V[P .!/L02R("("("("("("("("("("("XY
MJCRIJOPA.TN,O9H8ZGCQ9F\6/%\KR0@VSX%\9\:,_P#26_NKWX/;66Q>J=2Z
M3O9"6]%09%-6L3'>0,D /$E!U5$!$!$%"\*.>R.G]'VK=%_"S++'!&_ULZGK
M4!#X&(7Q,=<U9G7V" 97,L  N05[.86_X.;6$RV,U#D;4$V0BJVZMJ3J->V1
M=]0$0$0$0<#P6$R'A&GS>8RFH,C5KPY&2K5JU).#6-C4_8\#<$,+WU-6YV.P
M 3$Y\X(#T%G\%6H;^?T=5M7W<[,4LD$DGO\ AZU=D!$!:&H_L&/\</[B@]Z?
M^P#^,<MQ 1 1 1 1 1 1!5L_]L'?@-5IB^M1_@A$$11>;4[J]2Q.V%\IBB>\
M1L]T\M&_$?*4'.=&YO$Q0ZMR\,\IQ779;?/(PEX>8@Z9O=N0Q=(:X.:".XC<
M("YXZ2K'A:$U\,%&+5&1?;,GN SQFP&E_P @D+4%HTGQ&GZO%G&(RSN@;[(#
M,XQ#YA"YGDK=>7/WVQFG$]IRD;X&,)L;BN_TYI">YX;NQJJ/;)].<*EF,P#$
MQV<4V5VP$0GBCEY\_E:./-3V$Q6-OW,*+-..6OY/R3Z\<C-VB%]IO2(!]C"@
MQ5H,?;SC:!8PY$Y+)F_\)XG,QX87?_006;*(>;EC3S+]J>"#;*UJ]F:S$986
M,I1F$F1N[=V]=%7_ $O;IU<%A:[[0>;4LT=9[871-?VR3 ,;N_BP,:>.Y4[G
M_M#E_P AG_4*@Y56EQD.+OY7%!IIXZ/&3GIMV DK<A8'X0B.Q73<!!)3P6.@
ME^O=!KYOQDGIO/SB@Y[1MUY=>P-C-.)[;]V-\#&$V-Q$?3FD)[GAN[&JZ:GJ
M5K/D.&:-KXSEH>3' $'BQ[ANB.9S^(Q4)H9XV=:3&/@P[2.WQAEJ4<8OE'H*
MTXRI6BS]6RR%@FFS63;))L.1;P/8?FJC/G^O7QF*?J:>B^-F:B>]\4;F0MC#
M26EX>7=Q[RL6/@KC'Z1E;$W;RO/XNXMV(KO$[HP/DX;((>Y1V==FI0@79[F:
M8)&CTW$PO#1^EH7NJ-.W,5K1V,B@?5&+A(#&#@)&0/'Z0@W-2TZTLUR>2%CI
M(,! Z)Q )8[K%VX^7<+QCWXT:MHP&,#*,RF3?.>&SNC('&/<^PLVV0636EB"
MKB:AE\4:UUV)O7M[FO"=B1)( 1N 1L N6NDQC<&SQ\QDR8[IX_E'P)EBN2%X
MC:?<D>B2$'0J<!&LKU-[-X*W5NL!'83=:U@_ZMD4==BIQ:7MAUB*G'%GK!CE
M?$'UXR+#N/5:2!TU! VIZ,F,C-BI!%-8P,46'C;N6^,ME?\ 6.7;[QP5[QF#
MQ5N]JB6:I$Z5^0?'U2T%[6OK,:0T^H;.*#SH,V+%*W<L@]8R,JD_D;!$_P#_
M (@>L&KH)#EL5&QIX9+:C-]YDC9_\-LB*BJ'B#]0PUNG&<BS*Y)]X$;O\4D:
M\1\_:QP+ %%R34#I+'PU;-*N:>48W)&6'J10N;S Z[ 6=SME1>M+6J=7 X6%
M]H/-J::.JYL)B:_W<P#&[OXL#&GCN587L:]KF/:'-<"""-P05!S+',PMS#8&
M@V.N]T&98RY"&C=LK!(=I JS>BXQTHW7*M6(TIH*8EJF=[I&VWCA6V>SC(-F
MJH[A;M0TZEBS*[:.&)\DCO8U@W*Y=CL]B;]6MGCDJ\CV9:&>^6NW94B?$^&*
M-Q]C.7:5%>)=08FO3PF)R%^*I!=DGOS&4\2^"2PZ2*)OXQ3%6OJ&OKV%]FI3
MZ-@7WB=L[C(808FM]#AL" &H)77C'-Q5!PGKP0LR,+IYK$75A8P!VSI&[MW:
M'[*CO\697TH\/ZT-<OGN2,9T(S2?9'3] E^T8?LYH]XTJ@^&T[.YF**]7\?Z
MN3>RM'6(M<7PN$9DEY_6SZ.W8I.+(Z5AJTKV.$<-2M<H^-V!Z,+2(GL /L<S
M<!Z(]4K&)BATID+S8F0OFO,;+*SN>^0NC:=QV%6TT*LVILS 8FAMG$0"78 <
M^3Y6G=!SQYN6-/,OVIX(-LK6KV9K,1EA8RE&829&[MW;UUTO2'"/3=#:<2L/
M5+'MB,+2PR.+>#"7;,V]RHJ81 1 1 1 1 1 1 1 1 1!RCP)N T]G?S]9_58
MNKH.5^ O[B'?G&==40$0$0%RO4/_ )SZ*_-UO]21!U1<JR?_ )XX+\PR?WR(
M.JH@(@(@I_A3_P#+[47Y,/UPIO1?W'Z;_-53_"""L^&'_P N,_\ >K_X[%<]
M._<_AOR"O^H$&PB B N/:2BCJ:YM58)+'C?CN5?D(R7E@@DD$D#MCZ(W+D'7
M\?D*=ZHVS6DYQ.<]H=L1N8W%CAL?80O2"FYEEB277#*X<978> ,#/=$ELO8%
MLZ3GQ,US-6,3TO)[S7$9A&T;I6Q[/X_*!L"@K&O[D#<OT2:D4K:].0/E8Z2>
M8=<GC!V@,X;;O<JGXBX6<JZC$!;EAOACFCTR]PMJHG</5H79L<T6J-VJ_,P[
MBM5Z%;G%2E.VQ?)NX;#DM&4XN''UH[S8^H^CCF8T$;G>&V_F(OE:-BY!VQ[&
M2,<Q[ YK@0YI&X(/J*YGB686]AM'4FLKR"ODVQW(> ]&>*I*2)![00HJL21D
M.Q+'W:M=CL;4BI,DJF>5[X[+]VUB'LXO'HKK^IZ<L^F\S#$SG,^G+P8.]Q#2
M>(5%6R6IL%ECC+CGL?B*V0;XQ9D'U#DZ!^P=OZF.(!^5<YMTH"R"5]?8LI,,
M <W8LB$=ET0[>[8;(BQBSBV2Y5U>N)[=>7/2WHF;MD="7. :XM[0'$-V7C#1
M4K^1AB?)0M0.SE=_^ZP\*IXT92. )/( MVW0;U:M(&:5K11_4LC RM+L.P,H
MS==K?O%G(+J>8BB?B\D)!)P?4E:_I#>0C@?<_+[$%3\'UB*:CD&Q/IS,99:!
M;J,,<4_U)O:6=H#P-@[90^KO*4F7NWJSZXKXBM4FGYM<7^A+XP\1D$ >BP;H
M*5XBX6,HZC$!;EAOACFCTB]PMJ>P]6A=FQS1:HW:K\S#N*U7H5N<5*4[;%\F
M[AL.2#0E.+AQ]:.\V/J/HXYF-!&YWAMOYB+Y6C8N1\%J2[J&)EV!UX-S)-6&
ML1:$<A/#J2\_<N''AV(.@:,FPL][4,N'Z1J.FK\3$ &$B$ [;*N:_N0-R_1)
MJ12MKTY ^5CI)YAUR>,': SAMN]R*U+F/:*]V6I /&[+M1M<]@'4?M(0&CYJ
MMVC)L+/>U#+A^D:CIJ_$Q !A(A .VR"N:NK ZDMW7S3>*4J>+?<K->6QS0&>
M?D7[?!^Z4=2B;)F<Q'8O0NFWRYFKUJI\;$$I/$OD+^UI;Q,?8@S4I:,^D\H]
MXH6:]7)4Y#<KQ;0RLC,1>\L[0U[6#9^R:QR>+FMU_%'T&,-.C+!*6&22>/KG
M9M;8@,$>V[W(B:O^*13Z\HU!%'E+%226LQK )7L=5:.3?_6%7,<_$QL@N6;^
M/LXIF3A\8?!5\7J,(JO8WD'/>"02T.0='T686:4P_2:0T5_0!&Q#=SL"JGY5
M+<%G=/51([*,BRQ<Q@.\0<Y[XY#^'R'%016,JT+E5H;:I7:S\S0!\5J]"ONU
MO:W8O?N=M@]6[(Q8+%9S3<LT%6O#T;4$3BP!HF>^-T;1\O8=E1+TZU<:HSC.
MC'M+C*)E :-GETE@'=5HT:0\&63VJP_:VX_W ]VUK]G**RZ@DPT6II1EH!*9
MJ5)N/9_#?,R=Y>(?_K!+"5"XN>I;ULQ@;2 ,^3BEK,C+IAZ?:;#W$_7-MVL0
M:;YZ+M'Z<95MT*[*5Z)F2?/#U(896P/;]78"S^'LNF:19PTWC&B7J,Z/H.Z9
MB!822W9A+MF[=R"EX84)L_7K")CLA';RIR0V]/HRO/#J?_2_=O!6O2$5>#3U
M/I0QL+N9=Q:!N0\]I03B("("("("("("("("("("("Y5C/\ SQSWYAC_ %HT
M'55RK ?^<VM?S?4_4C0=51 1 1!R?PX,X:''YQKKK"#E/AM^T&"_/M;]5ZZL
M@(@(@(@Y1X$W :>SOY^L_JL75T'*_ 7]Q#OSC.NJ("("T-1_8,?XX?W%![T_
M]@'\8Y;B B B B B B B"K9_[8._ :K3%]:C_!"((BB(  '<$0$(!!!" OER
MHRU4MUW'B)XGQN<._9PXH,,N(@FAQT1>0*DS)!L!Z18TMV/Z5G0-AONCRP,<
M7D!H!+B>[9 DAAE=7>X;F)_./8^LM+?[G(@PYC&QWZ+JS[+H(72-=/Q#?JD8
M.[F.+@=@[UK-#-#/&V6&1DC'=SVD.:?O$(&PW)V1 W87<=QR WV]8]6Z(/DK
MXHXWOE>UK -W.<0 !\I*^M<US6N:06D;@CM!!0$  0%&18+HY<Y"7)6)8VF5
MU>L_B61.F]V0=MS\@)V""3!CD:2"UPW(]HW:=B$V!V0$(!!!"!L$E8YT4C62
M%CBTAKP 2TGU@%!KT*<6-QT-5LSGLB:3)-)L"]Q)<][B-AVDDE;&X*!L-]T(
M!!!"#Q=--G0EGD9$(9.3'O?P:'.:6?W.7TSP-F9"Z:,2/!+(RX!S@.\@(/37
M,=N6N!V)!V]H["$(!VW" A (((0$0" 000B!L-]]NU.+=B-AL@(@$ @@A$!$
M!$!$!$!$!$!$!$!$!$'Y^TSJNKX.9L]A=0U+D74R<MFM8CCYLE9(K*_PY:-Z
M+Q4AOV+.QZ40A]VY!/\ @CP>0PNBZL-^(Q3S323F(][ ]7U 1 1 7(O""+N"
MU=I757B<UFE2CF@M"$;O8) 1R09&>'+03>]][^@6AIJ]-K+PELU+2I6(<72Q
MIK-FF9PZKW$H.T(@(@(@A-<XBUF=(YK'U0#/-6(C'M<TAP"Y9IWPP:<PN"QF
M*R]6_5NTJT=>6(P^N(!B"*UAX0L5K/ SZ>T]1NVKMV2)NYBXL8&O#]RN^8VL
MZICJ59[@>A7CBW]1+&AJ#.B B FPW)V0$0?&6:SI7PLGC=(P;N8' N'WPOH
M"!L-P=D0  .X)L$!'.8QKGN<&M )))V  0" =D0-AL1L-D0?,=0BH0S,:XGJ
M6)YB3W[S2.E(_F+D)9&PDD-:T;DGL  01\[:+\C3RK\DPPLA,4#"]@AYR'MD
M#O6X@;!2*   .P(@( !W! V";#??9   [@FPW!V0$  [@@)L-]]NU W8WB"6
MCD2 .[<]_8FPW!V0$FEK01[S21QL)VW<0T$G[Z 7L:6@N +CLT$]YVWV";!
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M/#M]AL7;;)K2*]YOS>)V(H7]6'D]\9D!:9 -@ YB"!S-K/8W,^,Q6*KW5\5
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MX(!.()(HN-EOO'G?>,J1OYW.X[*X2C;MT(S*UG4>Z%[8K3S)Q<R-^^T;PWM
M.^Y0><+JRQ>U)/2ZL+JYFM0,A;"\21&JXMYOD/HN#]BI75.3M8S%LLP2LA!L
M,9+8?"Z=D##WR.8P@D((L/S5S/:5L1Y&D(I<9,^5C(C,Q_;$9.F\/;V.W]$K
M#)JG)TA;R$S('T'MR K0M:1*UU'EL7.W(/4X%!J9_*YO"U,7=S8KSNKY,OB?
M786!_*G-Z):2[;9WK70Z9L"I ;3XWSF-O4=&-F%WKX@D]B"AG5.3AMZGC,]0
M.HT[<L51\3V3-Z(WCDW)VE8],K->MZ9U33S$=66Q4I&=CF1[-'5B);L'%VSF
M$$;H++EA9CSFFSR@=7=;DCX.B)D9)XM*_J,?RV'8-MMEI:>ARS=0:F-B]!+7
M%M@9&V L>"88RWTB]W<U!)ZGR4^.QS98;M6H73-8Z>PTR-8"#[E@(+W';8 *
MIT+N<RV5TE>;=K11S8ZP^:(UGG<L?&)-B7C;EZMQZ*"_79GP4[,L89SCA>YH
M>[@S=HW'(^H+G%+56>O1-JU+]">=^3979=%:1D/3?7?,7!A=V\2Q!T# 7ILA
MAJ%J9K!+)"#(&>YYCL.RIE#5M^_F[U.">MQ+[D$$1AD#H9*Q+1)(_N>UY"!1
MU+F\GBJ4M9M>M-?OFK7YL,@A$,3G3.> X<CRC< M6U>U'2S+K;A4C=%C,;X_
M'L7A^]B5A$1W&W>2J/=_6.2J9/,0MM49A#3O2,KQQO)@=59R9U9-]B7^MBVX
M\SJ<N\ENFI-R$EUD;)Q"XQ1QO@-@[LY[DC8M4$0_7>38[&-D?6CD%6*>S"(9
M)#-U971F.)S?<<0PG<KI5Z26O0MS1<>I'!(YFXW&[6DC=!3Y<QJ.O@([]W(8
MNJ;3X71R&)[A R5G+@6<MY7^H;+4H7<YELKI*\V[6BCFQUA\T1K/.Y8^,2;$
MO&W+U;CT4$K/D+6*R&J[4XKSF#&5[$)9&8WEF\_&)Y+G;[%JE<%<RSI[]')R
MUY;%8Q.ZL##&QS)F[@<7%VQ!!""41 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M+5A\SJLEBV)[DTM.1MH1U"&AL1N_7B' ;G?<[($.F.F8'W<E+<F99ZKGR,:
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M/_8!_&.6X@(@(@(@(@(@(@JV?^V#OP&JTQ?6H_P0B"(HB B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M4]EM;)=25D+#(\,Z$C.8 ]A*YX[ Y&.6IUJV5VMT8(Q!6+ QCA8DE++#BU_
M-$B#K61@$F-NQ^+]<OKR-Z/+AU-VD<-_5OW;KE8H9:3&5Y7>6_%J>6;)&XQ
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MNM?:KN>V6(M<TCINX.VY <@#V$A!OUKE>U"98'\VB62/?8CTHGF-P[?80O2
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MZP0-B$&>E8OOS]*T_)SEEC)9"N^H7#I!E4/8S8?^G<J[* B B B B B B B
MB B#E/@2^T&=_/MG]5BZL@Y7X"_N(=^<9UU1 1 1 7*]0_\ G/HK\W6_U)$'
M5%RG)?\ GC@OS%)_?(@ZLB B B"G^%/_ ,OM1?DP_7"FM%?<=IO\U5?\((*U
MX8?_ "XS_P!ZO_CL5ST[]S^&_(*_Z@0;"("("("(.683+9>YJ XR>]8X"P^
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MC<AR"4>QDC',>T.:X$.:1N""HZMIO!T:%NC%6<8;'UT/ED>YPVV Y.)( '8
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MR1$/8QQ+OWD'8D0$0$05'PE59IM!:A9'&7/\4+MA[&$.*QZ%U+@)-'X #+5
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M")3* .ST^P\5<\52FK6,P^1H L7C+'^!TF,_O:@A)L-??I_+U8VQFQ+=L3P
MNV:[><RL!(WVW6_8J9"XS!S/JMAEANB:>+J!_ =)[-@[8;]KD%9JZ6N0:@MV
M(\=3V,]N=EY\CGEQL-.S.GZB"X[GV*1T=B;N*KW6RU&4HI'L,51DQE9&0W9[
MF;^X:\]S4%I1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1!!
MW<-:LC5,>[&LOU1%$XGUF$QJ(IXG/6I7V[M2&!\F1IS=)LHDXQP,XNW*"?RU
M?)#+XB]3JLG$0FAF8Z3IEK)RP\P=COMP5<MZ6NW*,E5Y8ULIS(<_?N%U[C&4
M'G%Z<NPPM><56H__ !&K*88YC*>$(])Q<[Y3V!7E!R?,X#+QNSV1LU6'A3RW
M*T9S(^2*9CC$UC#[AK!L"%)VX\]#:QF2EH0>.392%L=43#B60U)@3SV["=R0
M@LN!PEZC9IRSAF[<>]DI:=P)I)>JX#Y%H4\+DF9*&O9@A\1J3W9HY>>[IO&W
M$AI9ZN(>04$9'I;,U].4JCHQ;D%\ON0B<P]>%C##&"\?(UA<%-XC!7ZF/TI!
M)'$UU">5TX8?1#3#+&.'SP@L>;H/R6'R-%CPQUBM)&UQ[@YPV!*JD>+S5J<Y
M"[5B@E??IO,+91(&Q5@=SOL-R2XH+>N:3Z2S-O)9&6>O'O-%DH3<?.7N>RT"
M(0UA]PQ@V!""6;BM1VJ&:FL4H(;4\].:"N)N0)JEKN)>!V<BQ;=[%9;(/R,[
MZ[(I+-"@SI]0.X/AG?(]O+[SD&HS 9HS.JOAB%6LZ_+7F$F[IG7"XM:6^KAS
M(*L-[&6IM'VL8P-\8?B7UVC?LYF+@@T,Q%GG:BQ]B#%QVJ=:$EF]@1%L\A+7
M/((._%G8%%8S3V7CU6,C9JL(9-<Y6S.7ODCF.\36,/N&L;L"$&]7Q69?HO(X
M6>I$R=E":I6<)>8F!C+&O/8..Z9_#9:S?MBI%$^OD:]>"Q(Z3B8! ]Q+@-O2
MY->@V:&%O07:,KVM#8KN4E?L?X-J4O8I#/5K[W8VW1A9//2LF3H.>(^HU\;H
MB [U$<MT$?C,)?J^;_5X%U9MEU@M/8'V/2V;[1N5.YN@_)8?(T6/#'6*TD;7
M'N#G#8$H*:_&ZEEG\L.QT N,NP/;3$XV,<<+X3Z>WME)4CI[#9#'OQ\EL1[Q
M8PP2%AW'4,O/L06*Y'*^G9BAZ9D?"\-Z@W9R(V'(>L*C8_3F6KZ>R=>*E'6)
MMP3U*!L&2-G0+'E@>?<M>YIV"#;RF*S]V:8LI0L9DZE:&WO-N:QA>YSB.ST]
MVO6*QA]1FCG,3'% *<L62=%,9 72NNESV,VV]'B7G<H-FI@+>/LT*T+&#'T\
MGXS7'+M9'+7D8Z/;Y'N44-,YV*MXI'!"YEVI#7M2&78P=&5[RX#;TN37H++D
ML%9O3:B:U[&1W<7#6B=[)&]7<GY!S"J]W3V;RO7NW\17<\7X)VT18]VQD!@<
M.H-MCN[D$%DP&$MT;%!\D$,38\:8GLB)+6R.DZA:WEVD!:N,PF2@U9;OFI%!
M"\3=66*4[6N1'2+HO4]@!!<@M--]IU<&U&R.3D\%K3N.(<0W](7I 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6AJ/[!C_'#^XH/>G_
M + /XQRW$!$!$!$!$!$!$%6S_P!L'?@-5IB^M1_@A$$11$!$'R[:91HVK3VE
MS8(7RN#>\A@+B HW!:B9EA98^A:ISPMC>^"<,Y%DN_!X+"X$'8H)-+EIE2I9
MLO!+88GR. [R&#= AE$L,<@[ YH<-_E1 6EE\I#B<5<R,T;WQUXR\L8-W/\
M4&M^4E!NPRQS11RQG=CVAS3[01N$0$0%YMVX*-5]F8G@TM!V&YW<0T(/2(/$
M%Z%]V[4:TAU9D3GN.VQZF^VWZ%ZEMP16:M4DB2</+-AZHQN4'U8A8I7KMFG)
M6:]U0PR@O:' .?N6EN_<1L@RH@+3R^1&.?4?%CGV[=F001LBX->0&F0[N>0
MT (-F_;92H6[;VN,=>!\K@WO(8TN("T<+J2AF9[4=7EM!!6E<X[;$66=1J"1
M7R::*O#+-*X-CC87O/L:T;DH*W!K& TII/)5YMD2PLCIN$8EEZXWC+?2X@$
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M7N\32FR3&6P\[,<SIO+6N^0O#55:6)Q5\:1DGJQSM;<O1UWO'(FO$93#_P!
M"HJ_:G^YK.?FZS_AE<MGQ-'%NOXX0LLMM/H\8YY.E"3(^>4-F.SO08!L @\4
MR\XO 0L>UT>5A?CB6$EO&*UN W?U"(O78+$L,->:6<@1,C<Z0GN#0-SN@H^,
MR>/M4+F0FR+8),I-'"PPO8YU.,M(@#N\-?Z_PBIO2-JO%IW#1OF;O(Z2"!WP
M_3+R'CVE[6%Z"=L2PPUYI9R!$R-SI">X- W.ZYQ5N5K9QV;?:@^K9>!SXVR-
M<*T!BDB@9)MW.)?N?E*#''?HRXW&8E]FO V_+9LSS2/:S_<C9<]K6EW>9-P
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MK/%8ZT^K6@JB?T?2=LZ E[ 3W<RQ;&LGD:EH$0R2&**HYL[20*/*SL97_)*
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M5:M-]45*L]I_-SOK\[H'"(CL(''<%2^&DS[\SJELLE0QLL!L ]/=KC#&6?\
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MIXI$_A)/U&\&O!V+25YGS6%K>+&QDZL77Z?1+Y6CGU=^''V\MNQ!ND@ DD
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MZ9;N)R]L>SO7S.VRBK9HM[7C)V([4MACW0MZCZPJM)8S;9K?66C8%7! 1 1
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M1ON0$&6KE,;;FMPUKD,LE5_"=C' F-WL</440$0$AGAL1-EAD:]CAN'M.X*
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M:DQEO,OEDAI06.NV*($LL![70D;;<=V(.CU(98:T4<MAT[VMV=*YK6EWRD,
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M"[J]3?MW]7';N05G/_;!WX#5:8OK4?X(1!$41 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6AJ/[!C_'#
M^XH/>G_L _C'+<0$0$0$0$0%HYX9$8'*G&C>X*<IK?++Q/%!0L97\$<M5KI1
MAY)^(ZYOEAM<_7U>OZ0<I/2!Q(SF2;IYV^&%6/?@2:PL\CN("?D]UL@W\_\
M;!WX#5:8OK4?X(1!$41 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MJV?^V#OP&JTQ?6H_P0B"(HB B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M+SSR51OBUD2>.&5CH^-FMR>TN;+L2'Q2=[-U%U[NFF:;TDRP^LV&GDXX[X(
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MG;?8(@(]T;1R>6@ ]Y]6_8@%S0YK2X;G?8>L[(US' EK@1N1N/:#L4!SF!S
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MECI[ ,9)8/)[B1VN[=R 5N9C#/R$=(PW7UIZMCK12A@?L2QT9W:[Y'E!JXG
M0X@U2RS)*8*CJXY@;D&3GN5YJX)U+*R6FY&=U?G/+'3V 8R2P>3W$CM=V[D
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M'#5)<?'-:+'W&M="#&_N?L&E_9Z&Y.WI;+-3S6)LY*QCX;!=:A#B]O!X;Z)
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MD\$<\$L+RX-D8YCBUQ:=G#8[$=H*!5K5Z56"M7C#(H8VLC;[&M&P1 1 1 1
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M5BU;Q=I;433_ "7:W_GB*@Y8REDL Z?%P&W8ELWZT4KZCV1SOB;#*]H:^4M
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M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M0)Q*0/D$;I$%_;8@=8DKMD:98XV/>S?T@UY(:2/82TKZHHB B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M!6,XC#15)*S<94$#VAKH1"P,< 2X MVV(!*#+'&R*-D<;&M8UH#6M&P '<
MH^GCY8LAD[L\[9'V2QC.+./"&+<L9\I!<3N@W3B\0RI+3&/J^+R.+GP=)O3<
MX]N[F[;$KW'6K1%IC@C86@AI:T#8..Y ^^4![&/8YCVAS7 AS2-P0?45CLT,
M=8CDBFI5Y6/#0YKXVN#N'N=P1ZO4@^/HXXAS?$JY!!!^IM[>7+?]<_I*RMI4
MVVWVVUH18>P,=,& 2%H]1=W[(->##UFP7ZUB.*>M8LOE$,C YHZFSG @[@[O
MW*RR8UCK6->SBR&H)"R)K=@'N;P:1[ UI(0>B 001N"HR]IG%S0TX8J=2&"*
MPV1\0A;PD8T.' @;#;TT'J;"4SEHKKHH'"&M'%#&8P>D8W$AS#ZCL5(FE1%B
M2UXI!XP]G!\O!O-S?>EW>0@08O%U8PR&C6B8"TAK(FM +"7-V 'J)W"9&D+3
M:CP_@^O:CF8[\'T7#^=I(0>12I,M/M,K0BP]@:^8, D<T=P+N\A8J%4TJ,-<
MR<W#DZ5^VW.21Q>]W\[B2@SOK5Y.74AC?R9P<7-!W;OOL?D7EU*D+,EEM6$6
M'L#'S<!S+/>EW>0@]24JDM8U9:T3X"T,Z+F LXCN'$]FR/Q^.(J\Z<!\6.]?
M>-IZ1'O/>H KUVN:X0QAP>YX/$;ASN\_?*1QQQ-+8V-8"YSB&C8;N/(G[Y)W
M*!)6KREQD@C<7,XN+F@[MWWV._J05Z[7-<(8PX/<\'B-PYW>?OE!YBQV.JL#
M(*5>)O4,NS(VM',_P^P>Z^5>XXXXF\8V-:W<G9HV':=R@Q^)TH[3[3*L(L/8
M&OF# )'-'<"[O(6MF<3/;H.@I2UX'F;J$2PB6&3<[N$C-V[@H,F+PE6CC8*C
MVQSEL7"21T8'4W)>=Q["23LM@P0/+W.B82]G!Q+02YOO3[1VH-+-8B6Y3='2
M?6@F+F;F6$2Q2-9W,D9NW=JS8G'MQN,K4^KU.DT\G[<>;B>3CMZMR4'OQ#'M
MLOL,IP-F<X.?,(VA[B 6[EVVY.QV7VK3ITXW1U:L,$9>7%D3 P%Q[R0U!ZM4
M,?9>R2S3KS2,:YK'21M>6M>-G $]P*>*5389:=7B,[6%C9> YAI]0=W[(,3L
M;C71VF.H5C'8.\S#$TB4^UX]:S-@@86%D3&\&<&$- XM]Z/8.Q %>NUS7"&,
M.#W/!XC<.=WG[Y4=DM/P6,;-CZ3(*<-B7_>@R$;21N^N-V&W:X>M!(6*L,\M
M21_?6E,C/PBQT?\ <XKT@\0X[&UVAL%&O$T2F79D;6CJ$;%_8._Y4FQ^-=T
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M$UC6L<7=Y('8=T T:$<0A93@:SIB/@(VAO =H;M[%]-*DVS):%6'QA[.#YN
MYN:/47=Y"#ZQC(V-8QH:QH :T#8 #N "^NCC<YCG,:7,)+21N6DC;L0.G&)#
M(&-YEH:7;=I [0-UB&&PS*TL!QM,0R_7(A"S@_MW[6[;%!E=C<<_Q?G2KNZ#
MR^'>-IZ;CZV>PKYTHBYSS&WFY@:YVPW+1ZC\G:@08O%U8PR&C6B8"TAK(FM
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ML[W3HO>*[F8V6^(F.&SHQ+&-G,70M)C&V)+N49G'92X\-AED<T1=)K.T1B(
M<$#/'?(._ :K3$]G2C](>Y"(<V>^"<V>^"*<V>^"U<_+&<%E@'M^PI_U"@Y<
M+\'BXN46]"M_\,@Z\M9[_%Y(62%T@C[-RW=K%*:6IP338-UN OX8W),/7C#2
M"^TWL<W8 $A5$G?N0QW=74W\^K:H=2#9CBU[6P%AV<!MN"%7<G6=6+702&K!
M _%/DD9#U0QK(I&<N'KXG;=!+:?H5)+F$?/&96#&7]G3Q"/LFL,<-V=S=QW!
M1MV0MS.>KP%\K)*]][X)8/2@>Z(;20RCO9+[U!*]!D.-U3%%%Q:<' UC0-MW
M"![=@M#4T]7QV>L8W.M6L RO5+6%^TKY3L"0.P[[%!TB._5==GJ!Y$D4,4KO
M>\92]HV/K.["H#6%NC!#AI[)Y0QY:![]@7[;-=L[8>Q1490!%#2Q#'-:<S8F
M:TC8LAE;.YFX]6S7!5S::+,Y-KGS6)HK.2L"F*VS',DB=P)F];7@AH 5&G6F
M$M;)V)<C.-GXU\5V&GPCA+.0W$3@>43/<E>+WC,T&/=/(^J+.'9!'%7I\Q)(
M)22U@?\ 6BX%K@B.T7G024K3' O#H7@L80'.!;W#Y2N9X:>272NIXA*;+!1+
M(;#H.A-)]0VZ<@[ Y\?=N% U;/7KMN&S7DD%K#UH:Q;&7ALL4KG/!(!#?= J
M3Q\#(LQ4F$8!?FLDY[_D<P@$_(=@@M.H PZ=S36.#GNH6  #N23&53\_7;*^
M_+TN3V8&%L9VW(=U2[8?+V(KH'-GO@J'UXJ6!Q%J?D(Z^:EEFV:7%K'2R-Y;
M#<[>D@]XPE^,TF\QO8?*\[W-<"',#F3^Z"LD3@-4Y"3<<3BZ@#O5N)9D&OJF
M:"&'%69/2KULE%+8#07[,XN:'$-W.S7$%4;)35'5[@AQ\L(R.($&-CZ;CM-U
MY'?^@GFUZ(L;JE1E/6\YAC$KYYW->0-_L1C=VJMUK=$RTLI##(S&U9,<V<&)
MP(=#!,PGCMN>!D9N4$OI^C7EO8F2Q5;P-#)F-DC.QD<]IKV,(/<>"U:=N6;6
ME8%_!D>0N@UV5RUK 8CM+)*=^3I=MPJ,$UL2:8Q<4=B6N_&Y-@N.-=SS%L7@
M.XN&SP"0=PKQI5\<. IM$CW<C*]ID8(G$/D<X'@/<@@]@05&!S'96.F(G^-0
M93)V;#RP@&"=D@C]/N._-BMVEJU2IIS#,9#'&X8^LUP[B2UG<Y153UA8J'+7
MJ_!S[-K"""H6L+]I7RG;M'=V[%:3+,L^JFL)XLCN7P:[:Y#6;Q.VDDE._)TN
MVX5$T:=:KX/J@AK /CQU,O:QN\A$7%Y&P[20M7/OJY*3(WJ[3(UV#CZ+RP@[
M]<N[ X @]@*#1I1/&I;,4MN9TC+U^?H"L P1RL(:\S>MI!  4A-5HT]$8+@]
M].2*&@?&(8A(^%[&]CY&'W303VHB(=&^SBY9Y:<;)AI^,,$<18 >NYWH-/:W
M?8.V5MS1'CVHW[^B=/!H/J)WF08='V*=B:Y8J-=%5\1H0 .88SU86NY]C@.X
M. 6MJJNR:[EYA&'O;A8VQN W[>L7;!!3\_-/:MY:(;@-9EV"K'7(#>59X;(^
M0[\G2[;@!'TWU9;DL1=4BCR+)9)6P]4, NW0'\/6!NTH.H:5='#@*8$CSN97
MM,C!$XA\CG \![D$'L"I])M*WG'4>@\2-RV1FM.+"UKH)HG1;\B-B'$A!-Z$
M=*<?:LVW?5C,*Q)]8I,$!_2]KBH/7]N3QF6")_ .QX(,=<S26")-S$'=H8UF
MW)R*VJ-N/SEK4N,G4ARM^:0EC@P,F87,/+N/+=>*,U:UBL!3+'F6EEVML1OC
M<W@Y@D(]T-B$1 S 04;M=\$AENXU]6@!&7;3-M2G;L'H^Z8Y=$P=6G'D=0V'
M11B1^4YAY W^QXV[M*"!MY0XS3F2.Y9)/F+<4<G OZ75G=]5V )V:.T*NYME
M)SJ@H6YXZ,V(95J-CJF5\KV2D%GI@%C^X[E!-4):S=34JSHG^-0Y/)RRR%A#
M1%."Z,\_E;L%9-32P5VX:W(>5>MDF2V.(+]F=-[ [9NYV:]P*@A\.TMCTLXQ
MEC#>ORM81L8XI1*Z,$>KT2%8Z3VMU'FG$[-=6I[.]1VYH*K.]E>A#9G:3!7U
M+9FG&Q=M&9) '[#<D!Q!5=S(BF? ^ 6*-6WC3%6@96ZSGN,[G<1R^MN=N'!4
M=#P=6G'D=0V'11B1^4YAY W^QXV[M*G*F0K6H72QD@-EECV>.)WB>8R=CZB6
M]BBOO-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9
M[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^
M"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"
M<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<
MV>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-G
MO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO
M@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X(
M'-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S
M9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9
M[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^
M"!S9[X)S9[X('-GO@G-GO@@<V>^"<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"
M<V>^"!S9[X)S9[X('-GO@G-GO@@<V>^"C=0.C\1B:UP.TP_N*#-I_P"P#^,<
MMQ 1 1 1 1 6CGL?+D<'E:$,QBDLTY862>\+VEH)00-74MBG6AJVM*9:!\+
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M!#5LAJO)97)5J>1BC$$K]A(QON0X@ ;,*L6.IZOCNPOO9*M)7!/-C&@$]GX
M01>2R^;NYV3%8R:.#ICTGNVW=L-SW@K-C;^HZ68CH9,=>.1OHS,;V-_G ""]
MHH"CLG]8;^&/[B@FM/\ V ?QCEN**(@(@(@(@+'D:%6_C[5*RSE#8A?%(-]M
MVO&Q0<P?JN[BY'4F:QP5L0[,YSP2NF;MZI# [B2K7I6.*V^;-RYZMDYYHA")
M*P#(8F,)=P8W=Q^_N4&+-_;.?_T_JA2S/<M^\%4>D0$00&0IU+F9Q\=JM%,P
M4[3@V1@> 0^(;[%;'F_@?Y(H_P! Q \W\#_)%'^@8GF_@?Y(H_T#$#S?P/\
M)%'^@8GF_@?Y(H_T#$#S?P/\D4?Z!B>;^!_DBC_0,0/-_ _R11_H&)YOX'^2
M*/\ 0,0/-_ _R11_H&)YOX'^2*/] Q \W\#_ "11_H&)YOX'^2*/] Q \W\#
M_)%'^@8GF_@?Y(H_T#$#S?P/\D4?Z!B>;^!_DBC_ $#$#S?P/\D4?Z!B>;^!
M_DBC_0,0/-_ _P D4?Z!B>;^!_DBC_0,0/-_ _R11_H&)YOX'^2*/] Q \W\
M#_)%'^@8GF_@?Y(H_P! Q \W\#_)%'^@8GF_@?Y(H_T#$#S?P/\ )%'^@8GF
M_@?Y(H_T#$#S?P/\D4?Z!B>;^!_DBC_0,0/-_ _R11_H&)YOX'^2*/\ 0,0/
M-_ _R11_H&)YOX'^2*/] Q \W\#_ "11_H&)YOX'^2*/] Q \W\#_)%'^@8G
MF_@?Y(H_T#$#S?P/\D4?Z!B>;^!_DBC_ $#$#S?P/\D4?Z!B>;^!_DBC_0,0
M/-_ _P D4?Z!B>;^!_DBC_0,0/-_ _R11_H&)YOX'^2*/] Q \W\#_)%'^@8
MGF_@?Y(H_P! Q \W\#_)%'^@8HV7 X,9BFSR52XFI9)'09L2'Q()+S?P/\D4
M?Z!B>;^!_DBC_0,0/-_ _P D4?Z!B>;^!_DBC_0,0/-_ _R11_H&)YOX'^2*
M/] Q \W\#_)%'^@8GF_@?Y(H_P! Q \W\#_)%'^@8GF_@?Y(H_T#$#S?P/\
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M@>;^!_DBC_0,3S?P/\D4?Z!B!YOX'^2*/] Q/-_ _P D4?Z!B!YOX'^2*/\
M0,3S?P/\D4?Z!B!YOX'^2*/] Q/-_ _R11_H&('F_@?Y(H_T#$\W\#_)%'^@
M8@>;^!_DBC_0,3S?P/\ )%'^@8@>;^!_DBC_ $#$\W\#_)%'^@8@>;^!_DBC
M_0,3S?P/\D4?Z!B!YOX'^2*/] Q/-_ _R11_H&('F_@?Y(H_T#$\W\#_ "11
M_H&('F_@?Y(H_P! Q/-_ _R11_H&('F_@?Y(H_T#$\W\#_)%'^@8@C8L#@SF
M+C/)5+B*E8@=!FP)?*I+S?P/\D4?Z!B!YOX'^2*/] Q/-_ _R11_H&('F_@?
MY(H_T#$\W\#_ "11_H&('F_@?Y(H_P! Q/-_ _R11_H&('F_@?Y(H_T#$\W\
M#_)%'^@8@>;^!_DBC_0,3S?P/\D4?Z!B".RN$PT-&26+&5&/:Z,M>V%@(/,=
MH("M" B B B B B B B J)F,9A<WE'01770Y")GI;,.Q#51$26]0::NTX[5P
M6:TKMMB2X[ @'O[01NLFLHGS:AP\3)3&]X8UL@[V$R;!P08\_I_)T\39GFSU
MFPQG#>)_+9V[P/6\J39D/$-"PR [/?"8V??>2$%'%VAYN.H&M/XP9NMU.(X[
M]WZJOU3(>/:)LO)W?'4DB?\ ?8U!4\52U&<$^U0O.;$QSR8&DAW9WD*S:'@H
M2LL7A/)+<=Z,Q?WMW[4%=Q>,MY#.YEE?)2U"R:0ET>^[@7GL.Q:KSBL#D:-L
M33YRQ:8&D=)_+;M^^XH(C)XG#YS*3^)WG0WX?KNS#MNP\?7LM"&]G\#EJ5.[
M:%F"=P W/([$[;[GM0=.10%'9/ZPW\,?W%!-:?\ L _C'+<441 1 1 1 6#4
M-*W?P65IU)NE8GIS1Q/[N+WM(""IT-68?%4Z].;"93'NBC:SQ9E"61@(]3'0
MM<URV=/,DN:AR.8AQ<]&I-4BAVF9T9+$K7%W4,?>-@=@2@\9O[9S_P#I_5"E
MF>Y;]X*H](@(@B9OM[0_(K7Z\2ED!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!1<WV[H_D=K]>)!*(@(@(@(@(@+4R'V!;_$2?JH/M+[#
MJ_B6?W+:0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%$P_;V_\ D57]>5!+(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@BX?MW>_(ZOZ\JE
M$!$!$!$!$!$$5F_M9/\ ?9^N%*H"("("("("("("("J>9TK'?N-NU[;ZMD ;
MO:-]]NP'L((*#3IZ.?X[%:R.2EMNC(+6NW]7M))4IE-/^/Y7'WO&N'BSF'AP
MWY<7<N_<*B1S.-\IXV>GU>GU./I[<MN+@[NW"K]O2+[..QU$Y#C'6WWVC]V2
M?PNQ!<!%&(Q&&C@&\>/JV[ME4\?I4TJ>4J-O%T5MA: 8_K9((W[^U!+X+$^2
M: J]?J[/<[EQX]_R;E1M33/B6:DOU;?3CD)YU^&X(/>-]T$8_1EL7+5FOFY8
M#-(YQ$;"/='?8D/"W:.G,K6MPS2ZALS,8[=T3N6SOD.[R@972;;=XWJEV2I.
M?=%H[S[>P@A8\=I Q7X[M^_);E806<M]@1W;DDH+HB@*.R?UAOX8_N*":T_]
M@'\8Y;BBB("("("("("(*EF_MG/_ .G]4*69[EOW@JCTB B")F^WM#\BM?KQ
M*60$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%%S?;NC^1
MVOUXD$HB B B B B M3(?8%O\1)^J@^TOL.K^)9_<MI 1 1 1 1 1 1 1 1
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M"(*EF_MG/_Z?U0I9GN6_>"J/2("((F;[>T/R*U^O$I9 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 47-]NZ/Y':_7B02B("("("("("U,
MA]@6_P 1)^J@^TOL.K^)9_<MI 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 43#]
MO;_Y%5_7E02R("("("("("("("("("("("("("("("("("("("("("("("("
M((N'[=WOR.K^O*I1 1 1 1 1 1!%9O[63_?9^N%*H"("("("(*O?U?A:-AT#
MY'R/:=G]-NX:5*XO,4,I$Z2I+RXG9S2-G-015O6&&J69J\KY><;BUVS-QN$J
M:PPUNS#7B?+SD<&MW9L-RJ)?)96AC(1+;F# >QH[W.^\ H*MK;!3RB,R21;G
M8.D;LU!8+^1K4*;[<SCTF\=RT;^Z.P66G;AN58K,))CD;NW<;%!I8[-4<E+9
MBKEY= 0'[MV4,_6^"8]S2^;<$@^@@W<=JG$Y&TVM7=(9' D;LV'8L\.H,9+D
MWXX2.$[7.&Q&P);Z@4&;)YFEC#7%DO!F<6LV&_:%N6[=:G ^>Q*V.-O>XH*P
MS7.!=*&%\S1O[LL]%6"[DZ=.B;LC]X=FGDSTMPX[ A!7O/G ^_F^8I[%9>GE
M8'S52XL:_@>0V[=MT$A(]L;'O<=FM:23\@4)YR8WQ&O=WDZ4TO2C]'M+D$\B
M@*.R?UAOX8_N*":T_P#8!_&.6XHHB B B B B B"I9O[9S_^G]4*69[EOW@J
MCTB B")F^WM#\BM?KQ*60$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0%%S?;NC^1VOUXD$HB B B B B M3(?8%O\ $2?JH/M+[#J_B6?W
M+:0$0$0$0$0$0:.3LR5,=<L1AI?%"][0[NW:-U&Z=RTV2Q0MV1&QW-X/'<-
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MD0N'F+X3_CP?GR)YB^$_X\'Y\B'#S%\)_P >#\^1/,7PG_'@_/D0X>8OA/\
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MV.S=_P!JK& RLV%L9(R8ZQ+UGMVXM(VX%W[4%TQFJ?'[T-;R;9BY\O3>.P;
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MY&M(W:#L2@U86S3ZLT\^?46/M6(V3NC93JD$PEFQ#WB1^S%U9 1 1 1 1 1
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M."#GMRZ4;6;[>WBL8Q.*%OQL8^J+&^_6Z3>I\[;=!ML@@9++*R)C7R;=1X:
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/!$!$!$!$!$!$!$!$'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*<!
M!@8&!@<&!P@(!PH+"@L*#PX,# X/%A 1$!$0%B(5&145&14B'B0>'!XD'C8J
M)B8J-CXT,C0^3$1$3%]:7WQ\I__  !$(")@&I ,!(0 "$0$#$0'_Q "Z  $
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M:],-D];9_(-<@OX[=Y,<_-Y*[7?AG3]%N5).3TF1G-.2(!T4
M
M                                    $G]6_P#PJ!SGAS\A-9^SH2Z
M
M     "L4OQDI_P!NN_W" 7D
M
M           $G]6__"H'.>'/R$UG[.A+H
M                                       *Q2_&2G_;KO\ <(!>0
M
M                                             2?U;_\ "H'.>'/R
M$UG[.A+H
M              *Q2_&2G_;KO]P@%Y
M
M                  !)_5O_ ,*@<YX<_(36?LZ$N@
M                                                K%+\9*?]NN_W
M" 7D
M                                                    $G]6_P#P
MJ!SGAS\A-9^SH2Z
M                     "L4OQDI_P!NN_W" 7D
M
M                           $G]6__"H'.>'/R$UG[.A+H
M                                                       *Q2_&
M2G_;KO\ <(!>0
M
M 2?U;_\ "H'.>'/R$UG[.A+H
M                              *Q2_&2G_;KO]P@%Y
M
M                                  !)_5O_ ,*@<YX<_(36?LZ$N@
M
M    K%+\9*?]NN_W" 7D
M
M        $G]6_P#PJ!SGAS\A-9^SH2Z
M                                     "L4OQDI_P!NN_W" 7D
M
M                              _)YX*\+YII61QL3FY[U1K6I]*JH&E\
M*M7^O\;ZU$/A5J_U_C?6H@'PJU?Z_P ;ZU$/A5J_U_C?6H@'PJU?Z_QOK40^
M%6K_ %_C?6H@'PJU?Z_QOK40^%6K_7^-]:B ?"K5_K_&^M1#X5:O]?XWUJ(!
M\*M7^O\ &^M1#X5:O]?XWUJ(!\*M7^O\;ZU$/A5J_P!?XWUJ(#<J97&WF/?2
MNU[+6KR<L4C9$1?T])]2?U;_ /"H'.>'/R$UG[.A+H
M                                                *Q2_&2G_ &Z[
M_<(!>0
M                                        "I<4OQ>;3]G2@?'P6UCZ
MAQOJT8^"VL?4.-]6C ?!;6/J'&^K1CX+:Q]0XWU:,!\%M8^H<;ZM&/@MK'U#
MC?5HP'P6UCZAQOJT8^"VL?4.-]6C ?!;6/J'&^K1CX+:Q]0XWU:,!\%M8^H<
M;ZM&/@MK'U#C?5HP'P6UCZAQOJT8^"VL?4.-]6C T=%J5:>R;Q!5KQ0Q-MTN
M4<;48U.=5I?I/ZM_^%0.<\.?D)K/V="70
M                                       5BE^,E/\ MUW^X0"\@
M
M                               %2XI?B\VG[.E FP          !6]/
M^56]_K='_:M+M)_5O_PJ!SGAS\A-9^SH2Z
M                                        "L4OQDI_VZ[_ '" 7D
M
M                                 J7%+\7FT_9TH$V           *W
MI_RJWO\ 6Z/^U:7:3^K?_A4#G/#GY":S]G0ET
M                                           %8I?C)3_MUW^X0"\@
M
M                                  %2XI?B\VG[.E FP          !
M6]/^56]_K='_ &K2[2?U;_\ "H'.>'/R$UG[.A+H
M                                              *Q2_&2G_;KO]P@
M%Y
M                                     *EQ2_%YM/V=*!-@
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M;GL@'C$U;\[?_P!-N>R'C$U;\[?_ --N>R >,35OSM__ $VY[(>,35OSM_\
MTVY[(!XQ-6_.W_\ 3;GLAXQ-6_.W_P#3;GL@'C$U;\[?_P!-N>R'C$U;\[?_
M --N>R >,35OSM__ $VY[(>,35OSM_\ TVY[(!XQ-6_.W_\ 3;GLAXQ-6_.W
M_P#3;GL@'C$U;\[?_P!-N>R'C$U;\[?_ --N>R >,35OSM__ $VY[(>,35OS
MM_\ TVY[(!XQ-6_.W_\ 3;GLAXQ-6_.W_P#3;GL@'C$U;\[?_P!-N>R'C$U;
M\[?_ --N>R >,35OSM__ $VY[(>,35OSM_\ TVY[(!XQ-6_.W_\ 3;GLAXQ-
M6_.W_P#3;GL@'C$U;\[?_P!-N>R'C$U;\[?_ --N>R >,35OSM__ $VY[(>,
M35OSM_\ TVY[(!XQ-6_.W_\ 3;GLAXQ-6_.W_P#3;GL@'C$U;\[?_P!-N>R'
MC$U;\[?_ --N>R >,35OSM__ $VY[(>,35OSM_\ TVY[(!XQ-6_.W_\ 3;GL
MAXQ-6_.W_P#3;GL@'C$U;\[?_P!-N>R'C$U;\[?_ --N>R >,35OSM__ $VY
M[(>,35OSM_\ TVY[(!XQ-6_.W_\ 3;GLC'KF8IYC?9;E)+*P1X)T3I)*TT"=
M:SHO).V:T#IH
M                                              !4N*7XO-I^SI0)
ML           5O3_ )5;W^MT?]JTNP
M
M
M              *EQ2_%YM/V=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                                         !4N*7XO-I^SI0)L
M       5O3_E5O?ZW1_VK2[
M
M
M        J7%+\7FT_9TH$V           *WI_P JM[_6Z/\ M6EV
M
M
M                                    !4N*7XO-I^SI0)L
M  5O3_E5O?ZW1_VK2[
M
M
M   J7%+\7FT_9TH$V           *WI_RJWO];H_[5I=@
M
M
M                             5+BE^+S:?LZ4";           %;T_Y5
M;W^MT?\ :M+L
M
M                                                        "I<4
MOQ>;3]G2@38           K>G_*K>_UNC_M6EV
M
M
M                      !4N*7XO-I^SI0)L           5O3_ )5;W^MT
M?]JTNP
M
M                                                  *EQ2_%YM/V
M=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                 !4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                                            J7%+\7FT_9TH$V
M         *WI_P JM[_6Z/\ M6EV
M
M
M            !4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                                       J7%+\7FT_9TH$V
M    *WI_RJWO];H_[5I=@
M
M
M     5+BE^+S:?LZ4";           %;T_Y5;W^MT?\ :M+L
M
M
M                                "I<4OQ>;3]G2@38           K>
MG_*K>_UNC_M6EV
M
M                                                          !4
MN*7XO-I^SI0)L           5O3_ )5;W^MT?]JTNP
M
M
M                          *EQ2_%YM/V=*!-@          "MZ?\JM[_
M %NC_M6EV
M
M                                                     !4N*7XO
M-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                    J7%+\7FT_9TH$V           *WI_P JM[_6Z/\
MM6EV
M
M                                                !4N*7XO-I^SI
M0)L           5O3_E5O?ZW1_VK2[
M
M
M               J7%+\7FT_9TH$V           *WI_RJWO];H_[5I=@
M
M
M                                         5+BE^+S:?LZ4";
M      %;T_Y5;W^MT?\ :M+L
M
M
M        "I<4OQ>;3]G2@38           K>G_*K>_UNC_M6EV
M
M
M                                  !4N*7XO-I^SI0)L
M5O3_ )5;W^MT?]JTNP
M
M
M  *EQ2_%YM/V=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                             !4N*7XO-I^SI0)L           5O3_E
M5O?ZW1_VK2[
M
M                                                        J7%+
M\7FT_9TH$V           *WI_P JM[_6Z/\ M6EV
M
M
M                        !4N*7XO-I^SI0)L           5O3_E5O?ZW
M1_VK2[
M
M                                                   J7%+\7FT_
M9TH$V           *WI_RJWO];H_[5I=@
M
M
M                 5+BE^+S:?LZ4";           %;T_Y5;W^MT?\ :M+L
M
M
M                                            "I<4OQ>;3]G2@38
M          K>G_*K>_UNC_M6EV
M
M
M          !4N*7XO-I^SI0)L           5O3_ )5;W^MT?]JTNP
M
M
M                                      *EQ2_%YM/V=*!-@
M   "MZ?\JM[_ %NC_M6EV
M
M
M     !4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                                J7%+\7FT_9TH$V           *WI
M_P JM[_6Z/\ M6EV
M
M
M!4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                           J7%+\7FT_9TH$V           *WI_RJWO
M];H_[5I=@
M
M                                                     5+BE^+S
M:?LZ4";           %;T_Y5;W^MT?\ :M+L
M
M
M                    "I<4OQ>;3]G2@38           K>G_*K>_UNC_M6
MEV
M
M                                              !4N*7XO-I^SI0)
ML           5O3_ )5;W^MT?]JTNP
M
M
M              *EQ2_%YM/V=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                                         !4N*7XO-I^SI0)L
M       5O3_E5O?ZW1_VK2[
M
M
M        J7%+\7FT_9TH$V           *WI_P JM[_6Z/\ M6EV
M
M
M                                    !4N*7XO-I^SI0)L
M  5O3_E5O?ZW1_VK2[
M
M
M   J7%+\7FT_9TH$V           *WI_RJWO];H_[5I=@
M
M
M                             5+BE^+S:?LZ4";           %;T_Y5
M;W^MT?\ :M+L
M
M                                                        "I<4
MOQ>;3]G2@38           K>G_*K>_UNC_M6EV
M
M
M                      !4N*7XO-I^SI0)L           5O3_ )5;W^MT
M?]JTNP
M
M                                                  *EQ2_%YM/V
M=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                 !4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                                            J7%+\7FT_9TH$V
M         *WI_P JM[_6Z/\ M6EV
M
M
M            !4N*7XO-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                                       J7%+\7FT_9TH$V
M    *WI_RJWO];H_[5I=@
M
M
M     5+BE^+S:?LZ4";           %;T_Y5;W^MT?\ :M+L
M
M
M                                "I<4OQ>;3]G2@38           K>
MG_*K>_UNC_M6EV
M
M                                                          !4
MN*7XO-I^SI0)L           5O3_ )5;W^MT?]JTNP
M
M
M                          *EQ2_%YM/V=*!-@          "MZ?\JM[_
M %NC_M6EV
M
M                                                     !4N*7XO
M-I^SI0)L           5O3_E5O?ZW1_VK2[
M
M
M                    J7%+\7FT_9TH$V           *WI_P JM[_6Z/\
MM6EV
M
M                                                !4N*7XO-I^SI
M0)L           5O3_E5O?ZW1_VK2[
M
M
M               J7%+\7FT_9TH$V           *WI_RJWO];H_[5I=@
M
M
M                                         5+BE^+S:?LZ4";
M      %;T_Y5;W^MT?\ :M+L
M
M
M        "I<4OQ>;3]G2@38           K>G_*K>_UNC_M6EV
M
M
M                                  !4N*7XO-I^SI0)L
M5O3_ )5;W^MT?]JTNP
M
M
M  *EQ2_%YM/V=*!-@          "MZ?\JM[_ %NC_M6EV
M
M
M                             !4N*7XO-I^SI0)L           5O3_E
M5O?ZW1_VK2[
M
M                                                        J7%+
M\7FT_9TH$V           *WI_P JM[_6Z/\ M6EV
M
M
M                        !4N*7XO-I^SI0)L           5O3_E5O?ZW
M1_VK2[
M
M                                                   J7%+\7FT_
M9TH$V           *WI_RJWO];H_[5I=@
M
M
M                 5+BE^+S:?LZ4";           %;T_Y5;W^MT?\ :M+L
M
M
M                                            "I<4OQ>;3]G2@38
M          K>G_*K>_UNC_M6EV
M
M
M          !4N*7XO-I^SI0)L           5O3_ )5;W^MT?]JTNP
M
M
M                                      *EQ2_%YM/V=*!-@
M   "MZ?\JM[_ %NC_M6EV
M
M
M     !CR.+HY+'6J5^%):T\:QRQ\U1'-7YN;>2@5+Q6Z1]76/7K7M!XK=(^K
MK'KUKV@#Q6Z1]76/7K7M!XK=(^KK'KUKV@#Q6Z1]76/7K7M!XK=(^KK'KUKV
M@#Q6Z1]76/7K7M!XK=(^KK'KUKV@#Q6Z1]76/7K7M!XK=(^KK'KUKV@#Q6Z1
M]76/7K7M!XK=(^KK'KUKV@#Q6Z1]76/7K7M!XK=(^KK'KUKV@$[@M9P>OQV4
MQE18$G>CY>J625SW-3DBJLCG$H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(B""[3L]7@]F*7I^-T/1W+G]/(    ^7VJL<K(9)XV2/^(QSD1SO[D/H
M
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MS>L1T)HYL=&][YW.16/Z'-8!<P
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M1&KYP)H
M                  :V:P.&V"HVIE*45JNDB2)')YNMO-$4T,CJ>L7XL7'<
MQ4$R8YJ)31WFA1.7Q?\ [4 S9C6\!F;-*UD<=#8EIN5U9[^?-CN:+S:?>4UC
M Y>]1NW\=#//3<CJTC^?5&Y'([F@'%K6DY#(\;KN1O859\+/1[)\LC4=$Y>P
M1IUG Z=JVMNF=A\/7JOE[GO;S5ZI]'4X#/L.H:OL$43<OB*]M6=S'O3D]O\
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M.US58\CG=?U:%^29 ]60Q.<Q9?I8SSHTY3J.L;1LW$R3=-BP2XR"!B=A7?\
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MJV>PWX\B*J*O,"0
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M3=?;6U6Z%D9%7?(B=;4>@&7!\5M4SF5JXVDM[MYU<C.NJ]C>YJN[W*7H
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ML,+57OD>[S-:A:E+9+16M=Y\AN@J
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M@,*P
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M,U]/?32)K:=X[16%.XEY65L.AY2M3FD<[*0S,K<N4KN;.?1_C,.SYN'>X:&
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MO0*QSD5$<B-.FGG<6M6VMWB=XZ.'Z8ZKX_P^L@/.7
M                                                           &
MALL&R3XQS,!<JUKO:-Y26&*^/H^<C=*U=FK81:LEI;-N>>2S=LJG)9K$O>YP
M%A                             !KYV@_*X/+8^-[6+:I3P->[S(LK%9
MS-+5,/)K^LXG$RS-EDJ5F1.>WN15:!*@
M           B\Y@WYS%RTTR5Z@KW-5+%.3LIDZ5Y\D<4'Q26?3_;O7RT3$?
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MO\$@(
M
M
M
M
M
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MXKSZL3K<;.]C)E:BO:G>[N1QS#9\SQKKYV[%@-:Q-G&M5O@\TST1[N;/TSL
M@OA#[HOT-P?[5/\ DCX0^Z+]#<'^U3_D@3^IY?C)/FZL6Q:UBJF,5'K//"]%
MD3DQ>GE_3/.D[%/FX,+>EPE:&QD6Q\ZT,O<Q[_H=WM XO\(?=%^AN#_:I_R1
M\(?=%^AN#_:I_P D!\(?=%^AN#_:I_R3JFHW=KLX9)-HQ]6ID>V?_0UUYL1G
MS+\=X%=W?*<5:>3KLU/ XV[36LBRR67\GI-U+W=\L93?A#[HOT-P?[5/^2 ^
M$/NB_0W!_M4_Y)OX?.<>7Y3'19'5,-#1=:B;:E9(G6R%7^6YO].!V-W5TNZ4
M[^7<<-^$/NB_0W!_M4_Y(#X0^Z+]#<'^U3_DCX0^Z+]#<'^U3_D@="T7(<0[
MC,BNWXBC15BQ>"I6=SZ_/U]7*20^]WN;]1J4EU'$TKTSI')9;9=R1K?F5O.2
M,#G7PA]T7Z&X/]JG_)'PA]T7Z&X/]JG_ "0'PA]T7Z&X/]JG_).WU)+3J=9;
M+&,L+"Q9FM^*U_+RD3S]R*!R',YSCO#E[\6,U7#346V9$JROD1'OAY^0YW.=
MI'?"'W1?H;@_VJ?\D!\(?=%^AN#_ &J?\DM^E9?BK:RL[-MP.-I44JN=')6>
MCGK-U-Y-[I9 +EM5G8ZV!N2Z]3@M9-O9^#P3+RC=S>B/Y^4SS-./?"'W1?H;
M@_VJ?\D!\(?=%^AN#_:I_P D?"'W1?H;@_VJ?\D#KFMV]@LX*E)GZD%;).Z_
M"(8%YQM5'JC>7E/^8H^VY/C!3S4D6LZ[B[E#LV*R:=Z(_K_;, K?PA]T7Z&X
M/]JG_)'PA]T7Z&X/]JG_ "0)? 9KCE/FJ$>8U;#P4'2HEF:-Z*]C/V[CK&2\
M/AQEZ3'Q,ENMK2K6CD[F.F1J]#7=Z=RJ!Q#X0^Z+]#<'^U3_ )(^$/NB_0W!
M_M4_Y(#X0^Z+]#<'^U3_ ))T_1[6YVL3/)M>,JTKR6G)'%7=S8L/0WDY>3Y
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MI_R0.IZ3;W*WB))-JQM2E>2RY&15EYL6%&IR7X\A/@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MP^ES_4D]J _!?A]+G^I)[4?@OP^ES_4D]J _!?A]+G^I)[4?@OP^ES_4D]J
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MOM6H[7POV*C.RYR=S62E>@[D?T >X-#VV/:]2QN71K62RL5D\:>9DT?<\LH
M         'A?C^_GQ'N-_(J5D/6FM[EI5?7<+ [9L/&L5"NQ8UN0M5BM8!-?
M#K2/2K#>NP_S#X=:1Z58;UV'^8!\.M(]*L-Z[#_,/AUI'I5AO78?Y@'PZTCT
MJPWKL/\ ,/AUI'I5AO78?Y@'PZTCTJPWKL/\P^'6D>E6&]=A_F ?#K2/2K#>
MNP_S#X=:1Z58;UV'^8!\.M(]*L-Z[#_,/AUI'I5AO78?Y@'PZTCTJPWKL/\
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MG3FT#Z
M
M              #@WNEHV+I.*D5B=;<S&B._OAE S^YQ?RT&Y]L3?=QG<@
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MY\4L-JV-V^^_$7\5+%7FL5XXWQ3LCG._5K,-JK!9A=U1S1MD8OTM>G-
M
M           !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P           \(<>_
MQF97_P!BM]TA[%U__P @P_ZC!_ @$P
M   $#P\_Z38?^X;_ /&!<
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ME:S?LRL;$QD')5<>BJ-..C1J5(U565X&1-5?H8WI R
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M3IQ7*-J*Q7D3FR6-R/:X
M                                    #A7NE?D+C/MN'[B4#+[F[Y!7
M/MB;[J,[@          !X0X]_C,RO_L5OND/8NO_ /D&'_48/X$ F
M                           @>'G_ $FP_P#<-_\ C N
M                           !R/B7\O>%7VG9_P#V, X'B,S+I^7S6R,Y
MHVW>SN/=^B6-K)H?_J\DM5P[\1@N*E%47K9K="21/H?+7[5X%\W21GX.N(Y/
M3OH8QI"[OA\W=XF+:PTCF9+$ZQ7OUV?G'0RHUT8$96VF3.5^,&=Q:/C=9Q.-
M_OC\CHF.EIK6D+P32;P&GV7O#V_A/0WK\)[+XW7^7U@<JR.(S&TU>$E);3XK
M\N(O/KS?/UUF]</\!<= VF?9N*U*U;A6*]7U=]2_%]%F&QR>!Z0/'&6B;-IW
M$&)WF?OG2O\ F\"0FOY/&9O2])RZN?:P^UTEJ3_-/2>[R''2- QV,RV_<2I\
MM4@LW8<DD,39V(_HJ]Z,Z4<!T/1:VE4J&1@UF5CJ[;\OA#&/>]K)_,YJ(XM@
M
M                X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >
M$./?XS,K_P"Q6^Z0]BZ__P"08?\ 48/X$ F
M         @>'G_2;#_W#?_C N
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M]#P-F3AUJK=5^#<5:2#']HDBI%(K9'/1>?4KRU@
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MK_$?<GW-1R&7BH>]6Q6I8*\,+7)-6=SZ8^;CNP
M                                               .%>Z5^0N,^VX?
MN)0,ON;OD%<^V)ONHSN           'A#CW^,S*_^Q6^Z0]BZ_\ ^08?]1@_
M@0"8                                 "!X>?\ 2;#_ -PW_P","X
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M8M77N:L,O0_JC2(])
M                           X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
M          >$./?XS,K_ .Q6^Z0]BZ__ .08?]1@_@0"8
M                  "!X>?])L/_ '#?_C N
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MU9Y$16QRRM:X"6:YKFHYJHJ*G-%3S*@
M                                        !PKW2OR%QGVW#]Q*!E]S
M=\@KGVQ-]U&=P           \(<>_P 9F5_]BM]TA[%U_P#\@P_ZC!_ @$P
M                                $#P\_P"DV'_N&_\ Q@7
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M>A /1NBV*,VEZ[)2=,M9,= V)9?C\F,1OE$X
M                                             #A7NE?D+C/MN'[B
M4#+[F[Y!7/MB;[J,[@          !X0X]_C,RO\ [%;[I#V+K_\ Y!A_U&#^
M! )@                                 ('AY_TFP_\ <-_^,"X
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M.2(?8
M              .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A#
MCW^,S*_^Q6^Z0]BZ_P#^08?]1@_@0"8
M    "!X>?])L/_<-_P#C N
M
M                               <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=
M1G<           /"''O\9F5_]BM]TA[%U_\ \@P_ZC!_ @$P
M                     $#P\_Z38?\ N&__ !@7
M
M                                                 .%>Z5^0N,^V
MX?N)0,ON;OD%<^V)ONHSN           'A#CW^,S*_\ L5OND/8NO_\ D&'_
M %&#^! )@                                 ('AY_TFP_]PW_XP+@
M
M
M       '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W           #PAQ[_ !F9
M7_V*WW2'L77_ /R##_J,'\" 3                                  0
M/#S_ *38?^X;_P#&!<
M
M                           X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
M          >$./?XS,K_ .Q6^Z0]BZ__ .08?]1@_@0"8
M                  "!X>?])L/_ '#?_C N
M
M                                             <*]TK\A<9]MP_<2
M@9?<W?(*Y]L3?=1G<           /"''O\9F5_\ 8K?=(>Q=?_\ (,/^HP?P
M(!,                                 ! \//^DV'_N&_P#Q@7
M
M
M   .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A#CW^,S*_^Q6^
MZ0]BZ_\ ^08?]1@_@0"8                                 "!X>?\
M2;#_ -PW_P","X
M
M                      !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P
M      \(<>_QF97_ -BM]TA[%U__ ,@P_P"HP?P(!,
M               ! \//^DV'_N&__&!<
M
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M$=D]23^8E.'S+4>+RLUFC8JNLYBW.R*=G1(D<CN;5<@%R
M
M                                                     #A7NE?D
M+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_P#XR;OZI6_@/;VM?)S"
M?9]?[M -L
M
M                                                    .%>Z5^0N
M,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_ /C)N_JE;^ ]O:U\G,)]
MGU_NT VP
M
M                                                   X5[I7Y"XS
M[;A^XE R^YN^05S[8F^ZC.X           >%N/\ ^,F[^J5OX#V]K7R<PGV?
M7^[0#;
M
M                                                 #A7NE?D+C/M
MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_P#XR;OZI6_@/;VM?)S"?9]?
M[M -L                                           *+O>U[3J\4US
M'ZS%>QT%3MK-EUML*L5%[V] %<CXD[9!I]_9;^HPUZ;*4%FHJ76R=NDSVI\R
M<V]SBR[9OLNOZAB<\W'-F=<?5:L*R=*,\(;U :MSB3#CL_M^.LT.5?!XV.VL
MK'\WR];$=T(TA,5Q,VV9V$N7],<S$Y21C(;-6PEE\22][72-8!T+;,X[7=9R
MF92NDZU(>T2)7="/.:0<5MCHLP-S.Z;X'BLK+"R&[%<9-R6=.IBN8!O.XB[E
M=V+8<5@M.AOMQ5E(I977F0?'\W<\W<=Q<Q4NEY78K]&:H_'VG5;%/J21W;IY
MF,<!$3<4=NQ$%7*;%H[Z6'F>Q'6([+998$D\RR,+)DN)$&%VN#&9>O%7QEND
MZQ1R:2\V2="=3F. @F\4-AETRWMD&K(ZA';5(XUG5)GU&KR6?XI-W.)%>SF-
M8Q>!JLR$F5A2U(]7]#:U7\X\"3W[;I-/P,>391;95UN*#LU?T=TA 9CB'L#]
MHRF UK7(LA/CHHWVWS6FP=\B=2-C:H%UU#8W['@H,C+C;-"5SG,EK3M5',>W
M^]$YH43*\1-BGV/,X;6]9CR"XIK%MOEM-@57/3GRC:!MW.*=6EIN-S4N%NLN
M79TK5\6Y%;,^QYNDT(.)&QXG)XNKMNI^]=;(3-AKVXK+9V,E=YF2 6O [D[*
M;;M&!6BD28CP?E.DG/M>W;S,>=V]^'VO5,*E)LJ9=TZ+,K^2Q=BB*!4).)>R
M7[65?JNHKDZ&.F?%-;?82'M7Q_&;"TDY.)C4@TB6'$2M;GKR5GLG58I( (3*
M<2=^Q.:QN(FT6NEC(/E;23WQ9_2I$;^7XB;AC\CKN'9J$#\KD:LTSJJWFM2+
MLE=W=8$C8W7=,7KV>RV<U&&DE&NV2%C;K)NV57<E3R" 9Q7V+&T\7E,_I:T\
M-=['E>AMLGZ$F[VN>P#L5JW5ITI[EB5&5X872R/^9&,3J5QQN'BEN-O&2YW&
MZ')-@X^MR3/M,98?$SSR)&!M[%QJQ.(JZ=D8:BSX[-=JLDROZ7UVQ*QKBWNV
M]&[QB]>BK,DBN8IUYMI)/H<J(B(!AXA;K=U2##+3Q;+T^0OLJ1Q.E['RWD3A
M]_SS-HQNO;'J_O9-?AE?4ECM,LL>L*=3D=T 0^-XD;UF[&63"Z1!;@HWYJCI
M5OLBYOB_0]"QVMVRN,RVD8N_A606<VZ=MAB3H_P98?XP).?;GUN(&/U5*35;
M9Q;KBV>OO16N<WHZ2M9_BU5P^^TM;6CUUWO@BM7>ON@FL][& 638MN=@MCU+
M$)12;WYFGC[59.GL>Q1O\QEWG9WZIJN1SC:B65K+%RA5_0CNTD;&!%:]LO$+
M)7:*7]+@IT)DZGVFWXY58U6\T7H0F]UW"CI^%2]/7DL2RS,@K5H_CSS/\S0*
M0G$O9\/=QJ;;J/O91O3-ABMQ66SI%(_S-E$_$+;I]IS^"P.HPW_>M\22RNNM
M@[I6\T[GH!T_#6LQ:Q$%C)XUE.\YKUDJME25&*CE1OEM[EYH<@L\3.(=;/T<
M%+H5=+]N%\L$7ODSO8P"W8C=\I:W*'6K^'94G7"I>F5LZ2]#U?T+$1UKB3-4
MO;]53%L=\'JD4[7=K_7];.L#5PV[<2LO5QUZ#0J_@=ID<K)??*/^KD+UMF<=
MKNLY3,I72=:D/:)$KNA'@<T=Q6VO'4,5E\UI:5\1==!RM0W63/:V?O8O06;9
M]_R%+8HM;U[!KE<IV';SM65(8H(_I>X#-J&_6<OF+V S6'?BLQ5A298%D25D
ML7Y<;R)L<6:D'$>/5? >=;M65GW^ON;9>SK;&!O;EOF;PNS8? XC 1Y&S?KR
MRL1]E*_+LC4P_$K*2Y3,X;-ZXN.R=+&/O,C2RV>.6-GZ6 5NGQ>VYV AV2QH
MBKA7=[[,%UCWL8UZL5W0=OQEVGD<?4OU9$?!8A9+$_Z6/3F@')&<3MIS<M^?
M5-.7(XVG,Z-;4EIL"SN9^::9,CQAKMT>GL>-Q:SRR9%E&6G-)V3H9@+7KN;W
MZ[DDAS6H0XZIT.5;#+T<Z]7S)TM(O=]WRVN9;7<9C,&S(6LJL[8F/G2#DL/2
M UWB'>M9VQK^>U]^(RC:JV((^V;/'/&W\E[2K^./(R:AKN:K:_'+9RN4=1CJ
MK9Z41WF;Y:M G*'$788-FQ.#V74_>U^221*DT=MEEKG1_,Y&$9C>)&]9NQED
MPND06X*-^:HZ5;[(N;XOT/0"?SV_Y/"TL#6DP#IMARG4D.+BG:K6*SSJZ4PX
MG>=NGNY+$9+3WULK%16S48R='UK'T,67S, KT'$SB'/G[6!CT*NM^O6;/+%[
MY,[HW%@S/$/->_[]>UW7/?+)5Z[);RNG;#!6ZTYHSJ ^,;Q1EGQFU-OX1]',
MX.E)9GH/DZFO:QG6BL>5Q>+6YU]>@V2YHC$P[VQO=/'?8YZ,D=TH[H LV>XD
M7F9K%877,,R_=N8YM_G/.E9C(7EETO:KV?IW??+"6,9<IV%AGAD\IBJG]J-_
M<CF@0VV;_=QN>JZ[@<([*Y>6!9WQ=JD,4$7Y3W&GA>)-V6[EL/G<"[&YBG1?
M<C@[5)8K$3$\['H!%:[Q"XB;#CJ62HZ'7?2LJO3,N28G<U_0[N<=%V_.NUG6
M<IF6UDG=4B1Z1*[H1W-R(!S+)\8UQF?U7&RX9O896A1M33]M_4);=T$E>XI+
M3XDU=0BQC96ODBCEM]KRZ'R,Z^72!:--W)^QV-EB?2;![U96:DU4?U]HD:_'
M.>6>-DU?0:&TOP;5\(RRTUK)/\5&M<[K1W2!>+N_U(KFD,Q\#+-78)'HR?KZ
M5C:QJ.(*QQ%V*_F,KCM2U9,FS&RK%;MRV6P1K*GGCC QOXNPIHN;SK,0]E[$
MV(Z]S&S2<G1ROE2/XQMV>*=/X&Z_L-"FDZ7[\%.2%TG2L$DG-'@=-*7DMTDQ
M^[4]=2BUR38F6]VZOY*BQJ[R.G]/2!6]4XP5=BT_8LPV@V*[B:\TTM+M>?4Q
MC%>U4<;E_BB^#!ZK+3PS[F8SL#9*N/9)R1.;>IRN>H$EJVYY^[G9\'G]9EQM
MQM?MXI8W]O7D9_C:7H
M  '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W           #PMQ_\ QDW?U2M_
M >WM:^3F$^SZ_P!V@&V
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M=H9[#5<I225M>?KZ.U;T/\AZL7FB_I0#;
M                #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !
MX6X__C)N_JE;^ ]O:U\G,)]GU_NT VP
M
M                         :T.,I07[UV-B]O;[-)I%<YW-(DY-:WGYFIS
M7N0V0                                               '"O=*_(7
M&?;</W$H&7W-WR"N?;$WW49W           #PMQ__&3=_5*W\![>UKY.83[/
MK_=H!M@
M
M                                                 !PKW2OR%QGV
MW#]Q*!E]S=\@KGVQ-]U&=P           \+<?_QDW?U2M_ >WM:^3F$^SZ_W
M: ;8
M
M                                               <*]TK\A<9]MP_
M<2@9?<W?(*Y]L3?=1G<           /"W'_\9-W]4K?P'M[6ODYA/L^O]V@&
MV
M
M                                            '"O=*_(7&?;</W$H
M&7W-WR"N?;$WW49W           #PMQ__&3=_5*W\![>UKY.83[/K_=H!M@
M
M
M                                         !PKW2OR%QGVW#]Q*!E]
MS=\@KGVQ-]U&=P           \+<?_QDW?U2M_ >WM:^3F$^SZ_W: ;8
M
M
M                                       <*]TK\A<9]MP_<2@9?<W?
M(*Y]L3?=1G<           /"W'_\9-W]4K?P'M[6ODYA/L^O]V@&V
M $7L.3V"@V-^+P<-]O2]TROMI6[/I_O8_F!2J'$+/V=7L[)/JL4./9C);D3D
MOH][^AO-&<NS.A8W.8O(JD=>[6?.D;7RP,E:]\7/YG(G>@'U#E<4^ZZDS(U7
M6VIS6NDK5E1/I5OG,LTT4$3Y9I&1QL:KGO<J-:U$^=54#Y6Q7:^%CIHT=+S[
M)JN3F_DG->E/G/F+.86:S%6BRE-\\C>MD39F*]S?I1J+S5 (/8MGQN"QN2L/
MGKR6:U*6RVFLS62RI&U7=R$N[-8JI5J3W;U:HEF-BL;-*UG-7)SY(KN7,#+8
MR&-H1MDN7J\#5:KD=+(UB=*<N:HKO[SY3,85EF&HN4II9E:U8X>V9UO1WF5K
M>?-0,5/)JLV7;99!!#3E:U)NW8[J:K$>KGHG]7RY^93/!G,+8A=-#E*<D;8U
MD<]DS'-1C>Y7*J+YD 4\GB[5B:M7R%:6>+^LBCE:][/\347FA^0Y7%/NNI,R
M-5UMJ<UKI*U943Z5;YP(38MGQN"QN2L/GKR6:U*6RVFLS62RI&U7=R%@JS=O
M6@FZ>GM(VOY>?EU)S ^(LUB+%F:K!DJDEB+GVD3)FN>SEY^IJ+S0B-?V["YJ
MA?N068F05+,T,CGR,[DB>K.M>2]S7<N;0):E>H7:_A%2Y!/#^=BD:]G=^EI"
MY/:<74P&8RU*S6OICZTLTD4,[7<UC:KNE7-ZND#;R>QU:&$M9!>S=-%C);K:
MJR(CWMB9UJB&?#[!C,K%!V-RLME]>.62LR9KY(NMJ+R<B ;B9?$K>6BF1J^%
MHG-:_:M[7Z?B<^9$8G9J]]VQ=M&RM%B\@^H^1\B=+T9&R3K7GR1OQP,&,V>E
MD<_<Q=58I8H<?!:;<CE1['I*][.E.7T=!.T\QB;RS)3R-6PL7];V4K).C_%T
MKW ?-+(XNW(^.K?K3R,8USVQ2M>K6O3FU51J^93YN9+&8UK'7K]:LCUY-=-*
MV-%7Z$ZE0"L[;NC<)8PU*G#4LW,C(Y(F36FUHVL:Q7];G\G$_L6:]Y->RF66
M#MO ZLDRQ(_IZ^A.?+J ^_?_ !45."Q<O5:O:01RJV69K.E)/-WNY&6+*8E;
M4=5N0JNL/C21D22M61S%3FCD;YU0#Z2]12O)86U D+'*U\G6WI:K5Z515\R*
MBF&?,86BY6V\G4@?UHQ6RS,8J.<G-&^4OG RW,AC<?"V:[=KUHE7DCYI&QM5
M?[W'U)D<=##%+)<KLCD:KHWND:C7-1.I5:OSHB=X"G?HW:Z3T[4,\*JJ))$]
MKVJJ?I:?H$!K>UTLMAF9&=(Z37V;4*-DE;W^#/<Q>]4;\S.HG*>0QUVLMBI=
MKSP)SYRQ2->SN\_-S0/NCE,;D6/?1O5[+6.Z7NAD;(C5^A>D 5+*;[1QE?8K
MLL/.GBI(ZZR(]$=-9=WNB8COR$<AFK;KA_?K)TI[-6""K6J2QW'V&)'+X5U\
MFMY_1T 62Q=H5*OA5FW!#!W+VLCVL9R7S>4O<?4%FO9A9/7FCEB>G-DC'(YK
MD_0J 4K)[Q+CMD7$)AGRHEK&PK827EW7U>G7RZ?['0&[=F[]J^S7==9?KTYW
MP2VI[:5622Q_'9"G0_JY 63"[+2R>$;E)F/HM:Y[+$=KE&L,D;NAS7*IO5LG
MBYJB7(K]9]=51$F;*UT?-5Y?&1>0&)-BU]8)Y_?BCV4+T9+)V[.ECU\S7+S[
ME,TV5Q%2)LLV0JQ1NC[1)'RL:US.Y.I%5?-W@?*7L>E+PYUR#P;IZDG[1O9]
M/T]7F/JMF,/9J/M5\C4EK,7DZ9DS'1HOT*Y% QU\OA9$M+%DZ<BUN:V%;,QW
M9<OR^2^299K<$$+95DC\ONA3K1.T<J<T:WZ54#G>(XE7,IC,C>9K[V)4QE.^
MYG;=2OBL=2N:SR4[VM8=$JV8+56"S!(CX9HVR1O3S.:].:*@$%AMSQ>0ENPV
M)JU2>'*6:44,D[>N9:[^CK:B\O.3]W+8K'NB;=R%6LLJ\HTFE;&KU^AO4J<P
M,5C)XRBG5<OUJ_D]2=K*UGD\^GGY1]RYC$Q6XZ<F2JLLR(BQP.F:V1R+]#>?
M,"!AV[&19S-8N[+7J)26JC9IIVL29UEBOY-1W+S<B?2Q7=,L#9HUE1B/6-')
MU(U>Y'<OH4#]BG@G1_92L>C'N8_I<B]+F]RM7E\Z&I/F,-2LQU[63IP3R?$C
MEF8Q[N?T-<J*H'U9RN(HJJ7,E4K\NGGVLS(_C^;XRIY^1L6,EC*<3)+%ZO#&
MYBO:^21K$5J>=R*J^;O -R%!]3PR.W ZOT*[MFO:L?2GS]2=W(T;>?J^\MS(
MXR:I?[%CE:C;4;(W.3YEE[VM V)\QAJ3>5O)U*[N;4=VDS&*CG)S1.]2*L[/
MB:FPXO"RRM\(O022QKUM1J(Q6HB+^E_5Y($I3R>)LVY*L.1JRV(_CP,E8Z1O
M+Z6HO-#6V',U=>P=_*V6O=%6CZG-9\9RJO2C6@5ZMM>S07\=%FM62K6NSI#'
M/7M):6*1Z<VI,U&-Y$SA-NP^97,>#V(FMQ]Q\$JND9YHT15D[E^(!*X_*XB^
MV1]'(U;2,7DY8)6R(U?H7I53!#F<'+X2K,K3>M?OG1L[%[)/I?W]P&T^Q7C6
M%'S1M65W3&BN1.MW+GR;]*D7LF?;@*^-E\%[;PK)U:7+KZ.GPE_1U@2>9O38
M_%W+<,$<TD,2N;'),V!KE^A9']S3%/F,-2;RMY.I7=S:CNTF8Q4<Y.:)WJ!D
MM9'&T(63W+U>O$Y41KY9&QM55_2XIC.(<"R5NNFUD4F?M8M95G3I:E9CW]OY
MO,O0!<:MVA<K)9JW()H._P#I8Y&O9W>?O:?=7,XFY%-+4R-6>.+GVCXIF/:S
ME^4K5[@,#<SA5BL2IE*2LK]/;N[9G3'U>;K7GW&Q4R-"ZU75+D$Z=+7<XI&O
M[G>9?)^GD!\7<CCL;$DER[7K,5>7:32-C;S^CFX,R&.2M#:6[7[&7^KE[1O0
M[N5?)7S+W( HY#&7('6*EZM8B:JHLD4C7L14\_>T@H=KQLVPXS%TI(+;;=:U
M*MF&9KVQNK*Q%9R;]/6!M;-L#-=QT,Z57VI[%J*K6@:Y&=I-,O)K5<[N:A&X
MS9L][\5\9G-?\"?9BD?7G@L>%0N6+O<QZ]#%8X"S,NT5@BG2W L,KFMCDZV]
M+W.7DB-7S+S4^G9C$-NMHNR51+3O-765B2K_ ',Y\P/B[F\/0FC@MY.G7ED^
M(R69D;G?W(Y3YLY7%4.:W,A5K\FM<JRRLCY-<O)%\I?G5 ,L<L<L3)(GM>Q[
M4<US5YM5%\RHJ%*L[?L<NQ9O$XG68KC<:ZNV69]](.:SQ)+W-6-P%IP^0O20
M1-RM*"A<E>](ZS;+9U>UB(O4U>3#4S>R5\._&Q-8R>6SDZM.1C9$1T7A//D]
MP$LR_C^Q@F\,@[.9Z,B?VC>E[E\S6K\ZGY)=H0).Z:Y!&D"-6;J>UO9H[S*_
MGYN8"#,XBU4?:KY*I+7:[DZ9DS',:OT*Y%Y&!,W@8JK[;\O22!LJQ.F6=B1H
M]/.Q7<^74!I:]L4689EEC@1C:>2FJ(Y']:2I&UKNT_SZB7 PT\QAK-F2K6RE
M.:PSGUPQS,>]O+Z6HI])G,*ZQ#63*4UGEY]G$DS.M_)>2]+>?-0-/,Y[&8BM
M866W72=E:6:.LZ9K))>S:KN3$4W<+D$R>'QM](NR2U5BG2/GSZ>U8C^7,#\3
M*8EEU*"Y"KX8J<^P[5O:_P"3.?,7<WAZ$T<%O)TZ\LGQ&2S,C<[^Y'* M9'&
MXZ-DMZ]7K->O)KII&QHJ_0BN(&UM="AGZN.LNAC@EQDMWPQ\R,C:D<C(^G_/
MK L5>Q!9ACF@E9+$].;'L<CFN3Z45##;R.)QZQ)?OU:[I%Y1MFE;&KU_1U*G
M,"M;+NGO5F\+AJ4%2Q<O];E2:TE=L3&<OT.57.ZO)0E-FV*AKF'ER5O^J9)'
M&C4<C5>Z1R,1$Z@(^GNF&7+Y:G9LU:\51M18K,EAB,G\*8KTZ2RVLACL?62>
MY>KUXE5.4LLC8V+S_2X#\\/QT<$-A]VNV*5.<<BR-1KD1JN\E?G[DYF!F?P"
M003>_%#LYWJR*3MV=,CD^9J\^]0-H_+%BO6A?-8FCBB8G-SWN1K6I^E5 5<O
MBKE5]JKD*L\#.?7-'*U[&\OI<T^,?DL7>C?+2O5K+&NZ5=#(V1$7Z.;0%J_0
MHMZK=R"!%:YW.61K$Z6^=?*^CF(\CC$JQ6_#JRP2=S)NU;T._N=SY*!@=G,!
M%5@M2Y:BRO-_52NG8C)/\+N?)3:2W426.+PB+M)&*]C.M.IS4^=J?.@$>_*M
M2YCXJZ5YV36989GI88U85C8KNYOG>[FG)6IWH;T>4Q*75H)D:JW/.M?M6]K_
M /9SY@8ERF)BO1TI<C59:?RZ('2L25W/Z&*O,V ';P=LL':L[5&=?9]2=73S
MY=7+Z#XCNT'0PSMMP.CE>C(WH]JM>]5Y(UJ_.H%:@WBBEO7:5YD->YE8YGMC
M99CF9'V7_K3S]?F:;&L[GB\[CZ,SIZU:U967HING:Z7E'(Z/FB=RK\4"9R-^
MKC<?:O6GM9!!$Y[E543FC?F[R$T[:'[#C*UZS%3K/LM[2O!%;2P]8NE'<W=S
M>3DZN3D W,SLU?&RXAD3&6?#,NS'OZ)$3L7N8YZJOG[TZ?,9=9SZ9ZC8M)6[
M'LKUJMT]?7S\'E6/J\R>?D!M39?#4I.SM9.G#)UHSHDF8Q>I4YHWDJ^<R7,A
MCL="DMR[7K1J[EVDTC8VJOT(K@/IERI(^)C+,3G21]I&U'HJO9^4WZ4/QE^A
MV*S)<@[)).SZ^MO3U]73T\_IY]W(#Y3*8EEU*"Y"KX8J<^P[5O:_Y,Y\Q[YX
MJ.TRJZ_62RYZL;"LK>M7(B.5J-Y\^?)0/NQ8KUH7S6)HXHF)S<][D:UJ?I52
M"V#<\/A]9NYV.Q!;@A8O9I%,SE,_YF->!*X3(VKV)K6[<-:*65%565Y_"(^7
M/DG*3DWF9:V5Q$MR2G#D:DEIG/K@9*QTC>7TM1>: &W:*5UL^%P=CU=*R]:=
M"+U='+J\W/GW$'7V_%-S>;QEN6O3\!GKQ,DFG:WMW3Q)+W([D!-W,GB<>V-U
M[(5:S7KR9VTK8^I?T=2H1MS;,34V#%X5\S.WO02S1NZV]*(SDB)_>_J\D".@
MWBBEO7:5YD->YE8YGMC99CF9'V7_ *T\_7YFED;=HI76SX7!V/5TK+UIT(O5
MT<NKS<^?<!6'[K1\)V*E29#/<Q78H^.2S'"V19.2NY.=YD9SY*6N[E\50DBC
MN9"K ^7NC9+*V-7_ .%'*G,#%;R>+I([PN_6KM:U'*LLK6>2J\N?E*G<9(9H
M9XHYH9621O;S8]BHYKD7YT5 -:+*M9?R->PV""&NM=(YEL,59'3?,YGG9W]R
M<_C&7'Y/%WDD=3OUK'9NZ7]C(V3H7Z%Z57DH&6Q8KUH7S6)HXHF)S>][D:UJ
M?2JJ*V0Q]FIX56N02U^2KVT<C71]WG\I.X#XQ^7P]])/ ,C5LI'\?L96R=/]
M_2JF"3/XKL[_ (->K6)ZL3WR01S-<]O0G/DY$YJT#1UK:,5F\?C)H[%:.U;I
M0V74DG:^6-)6(\F%5$1550,,&=P<U>Q-!E*<L5=/Z9[)F.2/_$J+W%?T;:I]
MJQ3LDM.O7KO=_0-CLI/)T_\ \U$1.AP%F        #A7NE?D+C/MN'[B4#+[
MF[Y!7/MB;[J,[@          !X6X_P#XR;OZI6_@/;VM?)S"?9]?[M -L
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MYGVH6UG+RD<J2\W0]"&I9NX/'8S>J<N.IRS_  J:LL$W.*.&"5T:QSS]GWK
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MM?)S"?9]?[M -L
M
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M6:A.V&=%;R1'O8DB<OI[G ;8   :L66HR9BSB4<[PF"M%8>U4\GLY7.:WO\
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M,JO1BN3I7^C>K%__ %H;8$6FVX-Z8U8K"R-O7I:<#VM7DLT77U)_ET*2@
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MBRC;"L;*V1.]R1G5N'^0AMZXB-EON=5M3UI6WG(^>-\3^^-SV\^OI\R. M
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MI(ZIB((UD@D@>[O5SXI>74Q7+WJWN)I<)BG18V):<:LH.8ZHWYHE8Q8T5O\
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MT VP
M
M                                               X5[I7Y"XS[;A^
MXE R^YN^05S[8F^ZC.X           >%N/\ ^,F[^J5OX#V]K7R<PGV?7^[0
M#;          "JB(JJO)$ QMR..[:M"EN%9+$+I8&(]%62-O+F]OTIWH&Y''
M+-4@\+A5]EKW5V(]%65(_C*WZ>GGW@9#XMVZE&K-:MV(X8(FJZ25ZHUK&_2J
MJ!]B*6*:-LD4C7L=YG-5%10  'X^6)CHVOD:U7NZ6(JHBN7ESY)]*\D _0
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M1C7L>U>;7-<G-%13\=D\;$M5BW(4\(F6&'RT_I)&\^;&_2Y.E0/H
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M?)?75J<_(7\H#:X54K5:EL,D^2EG1V?R#>3V1L\MD[D<_FQJ=[RLYVI<3/\
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M
M
M                                           '"O=*_(7&?;</W$H&
M7W-WR"N?;$WW49W           #PMQ__ !DW?U2M_ >WM:^3F$^SZ_W: ;8
M
M
M !S3FB<P                                       #A7NE?D+C/MN'
M[B4#+[F[Y!7/MB;[J,[@          !X6X__ (R;OZI6_@/;VM?)S"?9]?[M
M -L        *SLF=R-&]A<5C*L$E[)23)$L[E2&*.NWK?(_I[U JV0X@9_%5
M,W6MXVI)E<=:H,Z8GN2"Q%?D1C'MY][%+)AL]L2;/-@LU!0ZW8[PV":HK^GH
M23LW,<D@%/XH18^?:=&COX:QDZZMR?54@9UO=R8P>&XO5-<OY? :;/0G?<J5
MG5[;.Q6=))49\SG_ )8&SD=DN8'-,N;!0H/N5M<OVGS4W2_$CFCY1,Z_RC4N
M6MMEVSAY)F:M"..6W9E9X*Y_.)RU'_T4G6 R_$G*X>PKK+\"QK;[878M+/:W
M^R=*D:2<V*K4=\_26.YO,^-K;DRU4C\+Q$D:58F^:RRTU/!_\W/\E0+U66PM
M:%;",2;LV]KT?%Z^7?T\_F/C(L1N,O?3X-+_  J!S#AOGK#:.EX3LV+%-J_A
MCI/[:/B>R-/XS6OYZSF<QK+I(V1K4W.[39T_.V""5J.4"<@WN_-A<?\ ^#A3
M,3YM<7+6[^ADL3U[5_T]*1MZR\Y"#(3T)XZ%IE:PYO*.9\?:HSO[UZ>:<P*%
MPV@LU,5M-=;LEB>+8+[$L3^4][VHU.IYKZ13OX_=-WBOY.2]86MBWOF<U&)S
M<DW<QB?%8!TLX_O6 PM2#)RROGO['E9GIA^EZI8@?YHTAY+Y$<7G<X#<KX2M
MLVU9^IL3?"TQ=#'P0LYN:QLL\:R2S-1/,]35PE+'YS3<#EMIR2R4<=!;CGBG
M=RBF=#,L+9IORE1& 0Z8K.V](6K3Q-R:A>V6*6I1<]62,QB/23D]7][&.5A=
M=#;B*&5R^)9KBX?(LB@FEB2PMEDT"JY&/8\"_9!;C,?<=2C8^RR![H(W_%=(
MB<VH[E\RJ4B'>'9.+5&4:T;GY6I-:M-?S_H(8&<I/\^T5& 5C!;5GY*.FXK7
ML5C85N8);G*=\O90-C<UO3\[E,>(V79L12VJY;=5L<ML94:WG)Y*RR11.Y<U
M[F-1WD@=$O['=K[-/B8*3)T9@I;[$ZD8]\K)$8D?-W)J(I3<-Q"OOV3"XFU;
MP-GP_M6OCQ\[I9:DC(UEY2+S5' 5;5'6^7#=:W2L_@>Q+$C_ (BO21.7,Z'C
MMYGR=33DK58_"\M)(EJ)WFKLJHOA'^;7^2@$]F<U/B,QKT+X6+3OV9*LDWSQ
M3*SKB_R?R5"EV=E]\9<9/)CJ\E1-P92HR*KT=_0QO:^?_)Z*C0-'8>(^5P,E
MN6>3 QM@M]"8Q;/7?DAZ^GM/(56M4MO%7\7>T?J+@("_LLF%RFXW:V,A7P#W
MI?=DYOZY*TB+UN_OC:;FP<04PMC/2,K135,70K/D?U]/5:N/Y11=7F1O+O<H
M&OK'$1UW8:6&LW\'==<KROAEQDRO[)\/>L<J.+;EMC=B-@Q=.S'&VC;IVW]O
M_:9-61).G^Y6<U IN!XD7\MB\*]^/AAOW,QX++77GRB@2/PE9?V1 Q<9VOAA
MRBVL'X#):1G@"6%]\6PN?T)*O\2L V\;D-NHW^(=K%4Z$M:KF99I&V'O2296
MUXU=''T]S2RQ;EFL_<9!K->ET,Q=6[//=Z^2>&(KHHFMC QY;;MAH08[PF/#
M859*?:SOR=MKD[;GR6&)L;D5Q"OXI7'Z]K>02.A3]\)K<,]RPLCZ<#ZK^CSL
M_.^=H#8,YM5[&:59KRXV.2?861/=!.Z:O/R1ZQN1T?GB=RYJTZ=GKU^EAK=J
MI6BFFB8BL9)*V"/O7DKGO?YFM\Z@<SJ[]E;]W+X>+(8.W.F&GMP6Z$CW1QOB
M5&JQY;^'<F4GT37Y;DL3YWXZ!S'^4O-JQHK5D5WG<!5O&C9;!J*OH1)+>L/B
MRB?-4[.=M1R_M7DK3WRY+GH8IZ\$>*L9#(4X+/?U*^DQ%YK^ARM>!$X/B3?R
MN(IOCQ\$60M9J&G% _J[H)HTLI-^Q'C1LM@U%7T(DEO6'Q91/FJ=G.VHY?VK
MP+]K.9FS"9>988VUH,E-5JN3SRMK\F.>O_S\RK2;W?9AKB+3@]^8LVF*96[^
MA\KW^0_Z>E8EZP(:?:K>)7/.Q>(JNM2[=%C^3GO1LKYX&<I7F&3*[M0W/(RW
MY<:_P757V7P0K-V7DO?WL1WF>JM N4FUVFU-&G\&BZLU+"R;S\HTEKNG7H*?
ME^).5P]A767X%C6WVPNQ:6>UO]DZ5(TDYL56H[Y^D#%+LEC7;6_WH86/5=AJ
M0NDEZUB@9)6BYRR='?T--;9MBRF6T>Y.KL7<6'+XSP:>A/SAGYV&+TJB]2QN
M O./V+98<_<PV6IT99TQ3K]9:;W-1Z,?T+$[MOXBN8WB-DES^#Q]RS@)_?"5
M8I:U"=9IZ;^A7HDCN]K@-:/B-L%;7LAL-RACF4&3RU*S$D>V62=L_8-<]SO)
M9&8?&"M^',86Q?PMU\^#NS03XR97M8Z*/RHY&N W=7V+:,=CM#AR%.AX!DZ\
M%6'LGO6>)W@_6QS^?<[J1AE7?]D7 OVMF-HK@F2N=V/6_P ,6LV3LUG_ "/T
M] &E!L4^&R>YOIP,L6[NRTZ=-DCNF/M)JL?>]?H0P6-ARN W#8<IL%>NY:.K
M1O;X(KNB=$L.Y=S^]J@2> XF26L[B,=<O8&U[X];6)CK"ROK2M9U],II5.(6
MZ2ZO0V!^*Q?97K5:O5K))(DBOFE[)5>H$LFR\079;+X9M+"+;I58[:V.J9(7
M1R\^4?1Y^OFTC[G%1KX-:9!+BZ$V1Q3;\LN1F5L$3%\E&-Y<E>Y5 Q>-Z%V$
MJR-?C&7I<K+06=]C_P  Q86)(Z=)/G8K2%S^_P"1R^H[=3JW\:^W096>ZY0F
M>Z&6"=_+R/G8\"Q93:+F!M[G=?C:<F0HXO%R2OC61&SK*][>GDY?,TEUVW/8
M3*K6V*I0; _%6[\;Z;GN=&E/DKXW]?G[G :K-OW6!-7N7L9C$IYF[7A1D;Y%
MFK-G17MZ^?<]2T[5FY\+CZSZM9L]NW=AIU(WNZ&+-.O<KU^9J 05_:-NP565
MF2Q%*>>:>I7QLM:160S3VG]'1(C^;V=!AM[AL>"DR=/,5*#YV86WD*,U;K2*
M1:C>;XGM>!J1[=O:V]>KKC,2BYRK)+4Y22_^%6-B2+V_Y?DJ+NQ9/,Z?EJ%J
M**'(RY=<&]:ZKT.=(]&.D9U?1&Y7 4_:F-@H<:(H^YD<.-:SU9A/U;]RGHM_
M663.]\:^17!0.^?HG7^BE_R@=U 4"EBLE;P'"ZKB;BU[D,N:DJ2+YNN![G-:
M_P#0XZ15V.'8=IX>W&1K#,UF7AMUE^-!/%&Q'QN K?"O)7==JXB"_.Y^+SDL
MZTY7>:O<;*Y%@_NE1O-I+:I@\3DN'VJW,W<Y8RC!:DL5Y'=,$JK(O)\WZ& 1
M$#+3L+2IQ):K83-[;%#3@>Y['I06-9'-^EC)71EJBP+*6T9_5\/:EQU*_@8K
M34A[_!INU="]T7T=;0,6&QN'J[[5AU:!8JE"M/'FI8W.6&1[D3LHG?ES-4J>
M(H1X=*.:V?2YF/GRSI)LDZWSDAEGLJL3GPHO<P#T&4^[L&RW<_EL3@*U!/>R
M*%;,UQ7\GRSMZVQL2/\ 1YW 5V/B#L67?K=?"XRDRSDJUUTR6WOZ*\M*1(WH
MJQG1,_D<EC<)-:K5Z\UEB,[I9D@@9S5$<][W^9C?.!RQ-]RN19LV*AR&&M3P
M8.6Y!=Q[WK$SH7H<QW>OEG1-$???IV DOOB?,['UUZV<^]BQHK5<KO.X"@W^
M)66QUZMX7)@423(QUWXN.SVM^*.27LD>Y6*K#>O;EN#OA=9H4,6M3!6)6O[9
M\G:3MBB296LZ>YK@)V#>6,R-YE^)D%1,'%EJLOSNAY?TS7_I8637K^1OZ_C[
M]ZJV*U8K-F? S^QUIU(SR@.8Q\2,I!EL+6NRX!5NWXZTN.JV5FMU5E7DBO<Q
M58I$;KL6RYG1MMN4J5),.SPFJWJ>_P *>V%_9OG L5S:H<)E=MEAQ4<EMJXB
M"'D]S5LS6FJR-'\^:-1I(6=MV7"6YJ>;JT'R38NW;I355D2-7TV]3XI&O DI
M-KM-J:-/X-%U9J6%DWGY1I+7=.O04_Q@;A\&LIL2XS&^!P6'5X(D?)VTLB6T
MK\_H1H%DAV?9J6:LXS,U<?UNQ$]^L^JZ3DG8.1KHG]97J>\;Q)5U6PN*Q/1G
MFHRM&DLJ.A>Z/M4?)]+ /NWQ*OX?&Y&')P8YF2KYJ/&M?VKHZBK-$DR3/5_>
MUK6FLWBO-'0V5.VQ%^UCL8EZ&:C*KZ\C.KH5C_G:YH%FAV+;X<UC\;D:>,8N
M4I69:2PND=V,L#4=T3\_C)Y7G:.%-K*V-%Q,^2G9*]Z/<QZ*Y7N;U>>17>=P
M$=-NVT38W+Y_'8V@_$8^:PU8I'O2S8BJ.5LLK%3R6^9>E"2H[7L.8VJU0Q=6
MA[VU8Z,\UB=7I*^*VSKY1HWNZP)/;,]F<7=UZAB:=::?)6I8.<[G-9&C(EDZ
M_)*Y8W_+XY,IC;V.K2YBO=HUJS(7N9!86_W1/YNYJSS+U ;-C<-DPMN[1R^,
MJV;/O38O45H]?*9:_P >%6OYJCB,Q.ZYW-X[)+6NX*Q_\,EF;+4F>V2M*G]B
M6)Z]8&EKVR;=!@N'N-KPT;%K*XU\BSS.DY11P11N1[_G<[O)=^_Y>!D^+EQU
M9V>9F(L<R-KW)6>L\7;MG^E&= 'QE=ZV# P[#6RM*B^]2Q7OC5D@5Z0S1=?9
MN1S7=[7-4D&;9L6-S%&OGZE!E:]1M68757/<^!:K4>YDG7W.[E J>.XONGDQ
M%J>U@UK7[,4/@,%E7WJZ3KR8^1/XT)"]O^VP4L]EXL5CGX_%9B6E)$KWI/.U
MDR1=3/F:!*.W3,8*YF8-AJ4N5;"NR<:TW/7FQC^A8G=IYW$5@>)[[&6PE2W=
MP,[,F_LVQ4+"R3U)%9UM27\M %3?MM?A<?L,^-QK<9+D&59(FOD\(Z7V/!NU
M:3>EV,]-MN],NSPOKQ7XF,:BOYL_H&.:C>KS- @MHLYY=SV.!)X? 6Z?+)V7
M-_-&N5Z<_HZ^HR:OL6T8[':'#D*=#P#)UX*L/9/>L\3O!^MCG\^YW4C (=_&
MAB0RY5+6#\ 9:5G@"V%]\5A:_H65/XD86J3=L\W+;0_P2BW#X%W.U*Y7K/*S
MP=)N42 0N#XJ23W\%%:MX*:+*3LA2M2LK):J/E3FSM?F?]#C>=O.S+A+NS5<
M91=A*TTW]$Y[TMRP5WK&^9J_$3S=S0,.!IV,GQ3S^2M14)V4ZM):DBM>LL,4
M[)%9V7T*[^V=7                                       !PKW2OR%
MQGVW#]Q*!E]S=\@KGVQ-]U&=P           \+<?_P 9-W]4K?P'M[6ODYA/
ML^O]V@&V        $)LNMSY6?%7Z-_P/(XZ61]:9T?;1JV5O0^.1G-O-K@*Y
M+P\LW*^2EOYE)<C?NT9Y[#(.B)K*,B/9#''U%M7 \]KCSOA/Q<6^EV'1^5*D
MO7U 8LK@?#-AU_,>%="XUEMO8]'/M?"6-9Y^?=T\C)M& ]_\8REX3V'3<JS]
M?1U_]/*V7IY<T\_2!$Y_3*>9R3[5J=>PDPUG'/@1O>J6'M?UH_Z6])$P:?L'
MOMKUS*;+':9AWR+!"RIV2RI)"Z'G,[K7RP(9_"[*)@I\''L->*AV_;M>VBGA
M,CDF[9$GD63RS-E\;5S_ !,Q,D++/1BX5=DW+$YD,CXG(^LQ'.[GJUSE<!T&
MK[[LSV4[9_/'>#U_!6]#45)?*[3O1>:IYB"V+5<Y>R4]W$; E%;-'P2S%)!X
M0Q6HJJCXTZF]+^\#4?HEJB[7I<!E65)\7C74.=B#PADT#NGSHCF<G<VGQC>'
MDE/WL67,NL25L]8RDCW0(BRNL,<Q6=SOI<!%:WBZV4XAYG8:L=EM"&)&1)-$
M^)K[SVI'-*Q'HB]S&-:=0 CM>P/O*F7_ /$]MX;E+%WXG1T=OR\CSKSY"A@?
M ]BSF7\)ZO?&&HSL>CEV?@J/3XW/OZNL#)KGOS[V<\L_JLK8G[^AK%6+M')'
MS:Q51%Z.116Z-M-7/Y;,U]MJ)8NR=SIL9VSXH4^) QRS)R8T"8O:IGDR<N3Q
M.>AJ6[=.&O?62KVK)5AY],S&];>AZ<R$R7#.W)6UNICL['!4Q#.;*]FIX4R:
M?\_)Y; )^?6]GMXZ%EG:$]\*]QMBM9AJ=C'R1.7931=H[M&*:;=<S]*+8<RN
M2;;SUFBD%=\-=&11-BYN9''&]Z^=SN]7. NT';)7A2=R+*D;>T5/-U<N_D5+
M!:-4P>6S^0;<=(E_FVO"K.258WO=*]C/I1SWJX#YUW1DP=G 3KDNV][<(_'<
MNRZ.TZWL?VGQEY?$(ZYP^M3U]FK)FD97R&09D*_*#G)6M,<Q_/GU<GMYL 3\
M/LIE+.5M9G84FFNX67&JE:MV#(F/>CT<SF]XJ:-F([VN6[>;I].'E<L%:K1[
M"*1KXEB57^6[RP-O$:,F&^#,RY)94PT.11>4')9DNN1_TKRZ"%T#%5Y=CV?8
MX(YVTK,ZLQS9XW1*C9.4EA[6O1%1LD@%]V;7FY[!V,?X2M>5SF2066MZEAFB
M<CV2(GZ%0AETNO#B-4QL%M6,PUR"SU*SJ6=8F.:[GW]RO5_,"K3\+LG)A<G@
MX=@@AH6IY9NM*/.VYTDG;<II5?Y;44Z'M.!78=;R>'6UV"W(%B6;HZ^C]/3S
M0#6KZK S)[):GF2:'+UZ\,D"LY(UL,;HU[^??U=17,?PUIU-,O8"UDIK$EF5
M)7WNA&2]<73V+OG^(C&@2^*P>PP9.*YE\_'92&!T<<%:MX+$Y7^>29.M_4XR
M[SI[-MP[*"W75'LG21D[6=;D16K&]OG3X['*@&C!I%.KND^PLL^0^DD+*?1Y
M$<G2V-947Z58Q&D;3T;,XV"OBJNR)%AX+"211,K<K:1(_K[#M^OX@"UH^>9/
ML:4MF9!4S5E\MF):G6^)'QI&J0OZ^YZHANOTF]CKS+6M96*@JT(*4T4]?PF-
M\=9.43TY/8J/:!I1</\ )T<G6OX_/,?82A'4GFR%9;DB]#U?VL3NMG0JJX^Z
M&AYG$XBC2QVR<WU[%Q[O":W:P6&6GK)TSQM>WFYOS.0#"SAO/!@Z]:IEHH;T
M><]]DF2JG8)/WMZ&PH[N86S;-:^$>!EQCK:0O[2&1LG1ULZX7H]$>Q5\IB\N
M] ("GI.3?FH\MD<S!(Y,98H+6K5.PA;',K7<V<WO5'%AU/#7=?P%+%V[\=OP
M2-L,,C(>Q_HF(C6HY.IW>!5)^&-6:QN,OOB]/?F+E G9]U-_/M'/;W^5SD\L
MV,IPZBO:+1UJ+)O@EK=FYEY(^;NU[^TDZ?I?U. V8-$I5-QBS\-IS8XL>RO'
M3Z.YLC$[-)NKZ>S\@CI^&-6:QN,OOB]/?F+E G9]U-_/M'/;W^5SD\L"T8O7
M;F(PF"QE#)HQ*<D:VI'0H];3>]9$\_D*]R]7,CYM*JNW:'9G6W(C8$YT^CFU
MUAK5C;/S^E&.5H&M)H779GF]\OZS9H,QR['\RQK.Q^-\_3\8W<OJ,V0V)<FS
M()%!/BGXZY66+J62)RN<BL?S3H7FX"#H:%G62ZRE_9(YZ^#F:M6)E3LUD8R)
M8D[5W6OED4_A=E$P4^#CV&O%0[?MVO;13PF1R3=LB3R+)Y8%HGT^]')G;-+/
M/JV;V2ANL<V+FUJQ1-B6*1O5_2,=R(9.&<LS,I-:R=9MR_;H32K5J=C B494
ME1$CZU[W?.Y5 LF;T]F7REVX^])$RQ@K&+<QC>3D2=Z.61'%<JZ%F(GZVMK.
M4^RPUEDD$%:AV#)4:Q8^<GEN\L"5;H-?X'2:_+D'\_#);45MC$8Z*5UA;+'(
MU57XBAFKYZPV\N7V*.;M<?-4BBJU>PA:LJ<EF>U7O5[P-Z34.NEIU;P[_P C
MF@DZNS_K^Q@=!]/D\^HK;^'603&28!,^B:Z^97K4\&_\2D2O[18$FZ_B 25[
MA\VT[-2LR;H;%K+5\E4E;%_TLU:-L;>Y5\M.XU).'UO)6<U:V#-,MKD,4E!\
M<%?L&1-:_K1T?-[P)3&:]LL%^C-D]D99AJ,<C(H*O@RS*Y.E'V%ZW]2H88-"
M[+4]?P/OES][+M6QV_8_UG@TW:]/3U 3L>N]&Q9C+^%<_#J$%7LNCXG8J]>K
MGS[^?652KP\O8RO@),5F8H[^-QO@#Y9JW:PV8.?5R?&CT5H&U/HM^:C0>_/R
M/R].])<ANOA1T:.E;T.B['GW0JT6=)RF4P>?I93/]K8R3&,:Z*#LX*W9][>S
MB5S@->]P_NY.#8/#<TQ;&5HT:\LC*W2UCJCW/ZT;U^9W,G\_K,63R=;)2N62
M.OC;]5]-&]\[;:-YHC^:<OB <?QT.4RES2<=!E<E:AQN0AF?5GQSZCJL,#'?
M]5*O<^1OQ6\CK>:UF[E\?/#:S*I/'DVW<;.R!&K56+DL;%;S_I.0$5;T7+9:
M*S+E]C>^[UUGTWUHEB@J257];'MB<]_4Y5^,)=&RF3=D[.;S<4]N?$6,=66"
MLL,-=EE.3W]"O<KG@3B:K_X[5+/AO_DU::'I[/\ KNUB;%S\_D^8CZ.DNJYA
MEU]])(DS%S)]BL?3REL1)"Q/.OQ$Y@:^8T#WSBW=GOGV?O\ MK)_4]78=A&D
M?T^6;TVF5UW9FRK;<C6UT1U3H\EUAC71MGY_2C'JT#3PV@^]BZHOOGVGO,^^
M[^IZ>V\-Y_I7IZ.9E?H---]K;77MNA>V&1L]5&<V3/>SH27]#@%;0Z+-&36+
MEET\;6R<K#6=F]KW2+*Q[.]>3F*I6IN%^4]X]8Q46S0I!B>M[V34>UBLRJ[J
M:][.U3X@%DN:KG,EB$KY/88I;D%R&U1MPTTA["6'S<V=;^LUGZ5G;%?/69]C
M:S,9&K%59=@K=#*L$:\^F*-7@9M4U//X&*G3=GJ4F,A8YJU8<=X.YW-//VG:
MO--NB9J:"IBK^R+:PU:RR9(GP+X5,D3^T9'-,KUZFM4"YXKWY]\,WX:_G6\)
M8E%.AK52/LTZO,J\TZOG4@,CJN99G+^6P69BI27XHF7(YZWA+'.A3I9*SD]G
M)Z(!KXC1JV%NZ_/7NO>F-I6X'->SF^9]Q[97RN<2VV:RNQ8AM)+*0OCM06&/
M?&DL:O@?UHV2/NZV 05?1LC+EK61R6:AE=/AIL:^"O5["&*.5R.18^;WEFUO
M%WL-@*6,N7V6GUH6PLFCB['G&Q.EO-.IW>!SZ+A=E8\)!A&[!6CHUK44\*LH
M\IY5BE25$L/Z_++@S3^FAN-7P[_SR:Q)U=E_4=O V#Z?*Y=(%&VW 5LK>TW6
MH%LOL4^AMV=L+FQ+02/E*U[_ #?TBL1.1UVW798J3UG.<QLL3HU<Q>3D1R<N
M:*!S*GPVR\5+ 4'YZHVIB+M6Q79!0[)TRUOSZ]HO-3[RO#C+6<;FL+1V-E3$
M9&::985J=K-$Z9W6YC'];?(5P&E6P,.TY3>>E]F""2;&)4N=DYBMLT6\^MB2
M>?I<66+3,C?O.N[%F([LC*$].NRO7\&CC993E(_O>]5>X#0H:%G62ZRE_9(Y
MZ^#F:M6)E3LUD8R)8D[5W6OEF]\ ^>E3:Y[Y?'NNL>$=C]-OPOIZ.H"8R6K)
M>SD>32YT=.)M4>RZ.?\ U+FNZ^?/YNDT:VE]C2TFO[X<_>#H\KLOZ_IKK!]/
MD 1^2X?):FR]MF46&U/EH,E4E2%%\'F@A2'DY%7RVN%S2,UEL3GJN5V%CY<A
M32LQ(*RQUZ[?RFQ*]RN>H%GNZ_X5G<!E/">GWMCM,[+HY]IX0UK?/S[N72:.
MH8"WK>%9BI<BRW#!(]*KDA[)S8E7FC7][NI0*[8T#*^#97$4M@;7PN0GFDGK
M^#=<\;;"\Y8XI>KDC7ELPVLQ8G,9B]%/SCNQ4XV0='+LFU(UC3OY]_,"L;[0
MRMS.Z1[W3N@ECR%E_A'9=JR+E6?\=/H<)>';[=3)SY#+J[+6[56RV[#"D;('
MTN^%(XW*[R6@;$6FY>Y=M9#+Y]7W5Q\M.K+3A\%;6;*O-TC.;GJLBF"IHM]^
M7CRN9RM6Q-#2GK,=5I^#/D2=$:Y\SNM_6H%7EU7:,9D^'N.JY=CY<?6R,<5S
MP->R2)L<361S,ZRRKP[DDJS329E5S3\G'D??!L*(QL\3.R8Q(OS2,[N0'S>X
M?7\O5S\F8SD<E_(XY*#)HJW9PUH>KKY,C5ZJJJI:,MK$.2RN&NS6$2*E7N0O
MAZ/ZUMMB,7OY]W+D!7L5I6>H,Q=!=FZL50D8L,;*R1V9(XOB0RS(_DK$-FQH
M?;:]G\1[Y<O?+*RWNU['^K[2=)NCEU ;N8TJGE\I<M6IU6"SA)<9) C>_E(_
MK61'FEB]:V.K;QJY#96V*U%%[.*"MX.^?R>EJV7];NKD ;H7+3*FN>^7]3<C
ML>$=CY^BUX3RZ.HEL5KMO&[+G<DS(,?4R2QROJK#Y;)F,;'U))S^+R:!'YS4
M+63SLV2K95L#+&'EQUF)T':];'=3FN8[J;R5%<;$FH==+3JWAW_D<T$G5V?]
M?V,#H/I\GGU 0,&B9FA N,H[(D&'\)65D3:W_BXV.?VBPLGZ^YA8X=0J\]M9
M:G6:#.2<Y8T;T+&Q8&P*WF!%XC4MCJ38J*YLJ34<?_51PUNPFG1K>EB6).MW
M4B$9-P\R7O==P<&PI%@+,TCWUO!N=AD<S^M\,<W7R1C@+3!K,U3);'?I7VPR
MY&G6A@_H>M*SJS'L:_S^7\8G*S)HZ\+)IDEE;&U))$;T(]R)WNZ?FY@?H
M                                   <*]TK\A<9]MP_<2@9?<W?(*Y]
ML3?=1G<           /"W'_\9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M                                '"O=*_(7&?;</W$H&7W-WR"N?;$W
MW49W           #PMQ__&3=_5*W\![>UKY.83[/K_=H!M@
M
M
M                             !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&
M=P           \+<?_QDW?U2M_ >WM:^3F$^SZ_W: ;8
M
M
M                           <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=1G<
M          /"W'_\9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M                        '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W
M       #PMQ__&3=_5*W\![>UKY.83[/K_=H!M@
M
M
M                     !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P
M     \+<?_QDW?U2M_ >WM:^3F$^SZ_W: ;8
M
M
M                   <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=1G<
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M%<^V)ONHSN           'A;C_\ C)N_JE;^ ]O:U\G,)]GU_NT VP
M  ^<Q56[BLA3:]&NL598FN7S(KVJT"CXK1K='AE)J3K<3IWXZU6[=$7HYSJ_
M^8CY>'5Y^.X>5?#X.>O68)9EZ5Y2I$B=S0*U/P?R<.1RC<;=PS:-Z^MI9+5!
MEFY7Z^]T<3G\VJT[?%$R&*.-B(C6-1K41$1$1.[S)R0#B5_A7M"P[ACJ.?IQ
M8K-6Y+;V/@<Z=LCUY]!;*6C7*>TZWF'7859C=?9C7QHB\WO;_;0"LOX17GX;
M)01Y>**]\)GYFA81G-D;_F8\W:_#3/7]AR>6V+,5;/A^"EQLT5>)T21I)^;
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M[%T9_'1UHF<EYQ*R#L>;BH2\)\S S498,ABYY<3CWU'PWJ[IZZ]3E7M6,_+
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M-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M       '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W           #PMQ__ !DW
M?U2M_ >WM:^3F$^SZ_W: ;8
M
M
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M'CK;JC,5F+D\5:.Q<CJUDD6FR1O5_3F[/Q,U:I6U^XY\ZT,N_H@OHQ$@C?\
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M6XE;/G9ZR,I7:%2.%W6U5ZXVHCD-?=]0R.>W#3K3*[7T*D>0CO.5[4Y-LQ=
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MYN^05S[8F^ZC.X           >%N/_XR;OZI6_@/;VM?)S"?9]?[M -L
M             !&Y74=6S%EMG)8.A:G:B(DLT#'NY(24<4<,;(XV-8QC4:UC
M4Y(U$[D1$0      8DQ^.COS7XZ<#;<L:1R6$8B2/8WS-5WG5 ,H
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MHU5^CFH&4             .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN
M     'A;C_\ C)N_JE;^ ]O:U\G,)]GU_NT VP
M
M
M                     X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
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M-Z +I/MNLP86/,R9FHW'O^)9[1.AWZ&F?#YO#9FBEW%WX+<"JK>N-W-$7Z%
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M<W?(*Y]L3?=1G<           /"W'_\ &3=_5*W\![>UKY.83[/K_=H!M@
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M)20V=TBM/@LUD8YD#VJURK''SZ(SJF%Q4M3C1L%B*B^*K+@H421L?3$Z1'L
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MD1[!QCQUV>OJ^19CYKU/&YF*Q>JQ,ZW.B^GH H=9DF4W'?<I1P%ZI3N:?89
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M'V[%ZRU6/GM3+,YD?/GT,Y^9I9V4:4%VW<B@:EFRC$FE\[G-C3DUO]R 9
M  1VQZQB]DK4Z^0;(K*UR.U'T.Z5[2+GTDB #FHYKFKYE3D!&:SKF,UC"P8K
M')(E6%SW,21W4[F]RN4DP!@S6&AS&,L4);-J!LJ-YRUI5AE;TN1WDN0#3US7
M<1K&(AQ>*A6.O&KG<W.ZG.<[SN<I)@      !\9.A2R-5U2Y V6!RM5\;OBN
MZ5YHB_2A]@
M          #YH8ZCC:_8U(&Q1];W\D[^;GKU.<JKWJJJO>H'T   U<UAZ67Q
M%W'74>L%J)8Y$:O2[I4RX^E7Q>.I4*_/LJM>.")'+S5&1M1J<U R@ 5;):-@
M[VS5<_;?;GL5G-?! ^95KQ/:G)'LC^9P%I
M                               X5[I7Y"XS[;A^XE R^YN^05S[8F^Z
MC.X           >%N/\ ^,F[^J5OX#V]K7R<PGV?7^[0#;
M
M
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MTHLK$ZG=*<W)WK] "6>&)$665C.:\DZE1.:@
M
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MQI:\WC*.#R'&#%8R%*]%N$J2-KM^(CU1H"+3< FS<*:W@J]&6P\C\E_2/_\
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MG-YJ^M+W(KW'9] V_"IJ.H1S1/H/R#)(:-61\DSGK"[YGN Z*
M
M
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M3-C^(DD;7HW^[FG<'U:KW0N?!$YT/]4JM159_A^@#]
M
M
M#A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X__C)N_JE;^ ]O
M:U\G,)]GU_NT VP
M
M                                                          X5
M[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/_XR;OZI6_@/;VM?
M)S"?9]?[M -L
M
M                                                       .%>Z5
M^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_^,F[^J5OX#V]K7R<P
MGV?7^[0#;
M
M                                                    #A7NE?D+
MC/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X__C)N_JE;^ ]O:U\G,)]G
MU_NT VP
M
M                                                  X5[I7Y"XS[
M;A^XE R^YN^05S[8F^ZC.X           >%N/_XR;OZI6_@/;VM?)S"?9]?[
MM -L
M
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M.5CW*WZ41J^8^FW:+K;J:6X?"&LZU@1[>T1OTJWS\@/L
M                                                           X
M5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/\ ^,F[^J5OX#V]
MK7R<PGV?7^[0#;        #D/&'_ ,QX<?\ =-0#F<-/PGB%Q"__  "S8^5^
M+O=-'%V'[0]-X:M5K8*A5BQC*4?@S>JFG)S85>G-T?T+R50/-65US/XS99^&
M^,M)'AL[82[&_GY=:LG-9XFEHS."Q.2XJZUJ=R!/>7'8-9ZM'S1R2HJM S6<
M1C=0XPZI#@(4JPY:K89>J1=T:I$U7-?TF#ABJ-X/;3^A^4^[ Z#P<_%IK/ZN
M_P"]<<?3/KPZ\9^ 1W1W>'8A/USE%Y/^!7(!\6-7BIW.%&DY+FVA-%/;OQ<^
ME)K/)9.AQ9=NP.'T_>>'][7JC*,U[))3M00=S)H'JU%YL TMHTC4:_%;1,?#
M@Z;*EN&ZZS"C/(D5D:D5NV$@@XK8G'8W3ZV7AAUM$CQJRLKQM1)I._F\#M'#
MW&24JE]9M)K:Z]\K/Z&&Q'8[9&IW/58SD&[U'V>,LD;-3BS_ "P#%\"DF9 C
M>4GQ^<@&WPTPF-OW.(>NY3&+C76W0N?A?CLKQ*WNDC>1&KX'/Y[8X-*SEB.;
M%:G,LS_IMH[_ *9KP/3F5PV*S-)U+)4HK-=7(Y8I$YMYM\QP+A;I^L3[/O;I
M</5<N.V%6TE5G? C'*K>@"BZGBK=VYMCX>&M3843/VT6U-<AKK'_ .CE(=#R
MU9*N_P#""%,6S'*VM=YTF/1[8'+%WL1S0+7QT_%=GO[ZOW["J:;@;29#"2S<
M(:%&-O9/]\TOP2/CY)S27H:!S.I5H6\CQ&@?H=S-VI,Y>9!9A9W0*KW>=Y.Y
MBALNMXS@W5L4EN96K=LJVIVS6<^;FN9%U@3R9C9+_&+6I\OK2XJ>+$7$B@\*
M9:61$8_OYL,O"?3M8V[5;F;SU*/(Y'(79_"9IN][/T, YO;6Q>X73X5UI\E:
MGNK:%.=WE<H2?9L.0LYO0-<S7=F,'L25YU_/1<D[.4#XQV,M7=SX@+#P]J[%
MTYN7G)-;BK]A^T/3.JUDHZ]1@]Y(L2]&N5U".1LK(5<Y55.IG<H'%>'&MX+<
M;^Z9C8J4=Z\F:FJHR?O2"&/XK6H4#*<Z&D<7=?K2O?C<9E:24D5W6D:2V?+C
M 2T*F7SFJ8+'Z=#KF42:O;\/EF1BRQ1IW]DC?CJIZ'XO_BVV;]53^-H' MJH
M9RUG= FPDG+(T=.K7*[?RU@[U86[2<KA=\XA9VW)69+5NZY62>L_O1'M>WJ8
MX!J>DZE8XI[Y0FPE-]6FRDM:%6>3$KXRKX[&6KNY\0%AX>U=BZ<W+SDFMQ5^
MP_: 3?$B@E;$<-*SM4BK\\PO7A(Y62-YO=WQ(_S>68=(IULMQ1KV,5KT6NIA
MH)67Z:R_TTZR)R3R *II>7R&IV,IE;#^>#R^1NT+/T5[+.^.0^)HGS<-^$$;
M,<R^Y^8LHE-[T8V?G8=_1*YP';M.UIC[MV/)<+:&$@DIOC=.VW#9[5'JB+"K
M8RI8O1]1EXQY_%OP5-U*'"PRQU^CR&O56 >AF,9&QK&-1&M1$1$^9$..<6*%
MO7;=+B#B$8EO'],-Z)>YMFM*O0!5,GC,KJG!_/YQ\ZNSF;6&>]:;YV-LR?$:
M26T\-])QW"^:_1IQ0VZF.CM07V+RF=+W.1W6!@U6_<R7%#3;USOGLZ+#)([Z
M7.>XL^K_ ([.(?ZE0^Y8!H<1<90RO%3AW2OUHYZTL-Y)(G][7<F$+9JP:/Q0
MN5=<@["O;U>Q;FJ,[XTFA1ZL<!L\,] T_8] AR67I,NWLBMB2U<E7G*U_6YO
M<XM? S(W;VA0-M3.F2K<GKP2N\[HF <>H93)ZKQ!VW:6*Y^);L,M'*QIYV1R
MNYLF(Y+\J\,X:<5I8J>4W:2O:F8OG@>!T'BQINM:EJM3.8&E'CLCCKD'@TT/
M<Y_Z'CC!K&OMBU3()AZ\=N_L51MQ_1Y<B2HJN:\#N^)P^'P=1U/$T8:L"R*]
M61)TM5Z]RJ>5=<R^1U+=MHV57*[#3;1<QV3;^:YR=4<P$99\O@?C.F-)N>U]
MS/F?WO.U:9@K,&PU9I^$]+")&UZI?CO03N8JM^A@''.'V(N6\+9EBX6T\\WP
M^=/#9;L,#O\ !TR'0\U@,1?XKZ9C,AAX$JMUA>=%W)\<2LZ^3 )'4:%76^,>
M<P6(8L6-L8=EQ]5%YLBF1S6EFXNZW@KNH9[*VL;!+>K8UZ06'-YOC YYE*%'
M6N!T>8PM&*K?NX>A'9M1)RD5)^CK-[:>&^DX[A?-?HTXH;=3'1VH+[%Y3.E[
MG([K ZM@,C;R?#S'7KG?8L81DDKOI<Z+O<>/]5S5C6-0S=-BNZMBP;7U$^F;
MPI]-S6@=/T#)QZ+H7$>;KYOQV:LUX/TRHC8F$%PER^+UW<,/3@S,=MF>QC/#
M>3^:PW^:O1J@;6Q>?CS_ 'XP].:I\EL!]F5?ND Y+Q_:K]=UMJ5DL<]BK<H/
M,DOD/\@I5&K[V<3--GMZ<FJ1/=/"SL)FV&W)9&\FQ/6("%XL9C&;!M^>CDS,
M=1<!0Y8Y%=R66]UH]Y<MWVIVU:-H/*98JN;RU6ODE8O^4C .B+P[T'$[#@+]
M168FY"Y[*\4$K8O"_I8]'=[SSIFLWM%/)<4:>(J3^"/R[I<G=B^/#71ZL5K
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M=(77X&U$RJ68+U6'NC>QB=SNDYGNJ4\3O.3U2AF?!,#E[M23+(UODU9'KWL
M[#Q+UEF"QV(VO7XHX+6NL8WL_,V:EYG1*27"S!V&8ZSM63<V3+9_IM2/^:*N
M_OBB:!U
M                       X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
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ME*QD)J&YYZBRW;DLRQ5Y6L9UR&_E^%C,HW /EVC,,N8IDS8KK7M[=_;+YW.
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M?N,B=S6O8G1T4GZ' 5VAP<=C(I(<=N^P5(72ND6*&9K&=3R3RW"QF2NXB_\
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M*,-2.U"_HG:D34:CD5/,X"9IUUJ4JU99Y)5BA9&LLB\WOZ4Y=3E^=RGZ
M
M          #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_\
MXR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M         .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_P#C
M)N_JE;^ ]O:U\G,)]GU_NT VP
M
M
M        X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/_ .,F
M[^J5OX#V]K7R<PGV?7^[0#;
M
M
M      #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_\ XR;O
MZI6_@/;VM?)S"?9]?[M -L
M
M
M     .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_P#C)N_J
ME;^ ]O:U\G,)]GU_NT VP
M
M
M    X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/_ .,F[^J5
MOX#V]K7R<PGV?7^[0#;
M
M
M  #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_\ XR;OZI6_
M@/;VM?)S"?9]?[M -L
M
M
M .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_P#C)N_JE;^
M]O:U\G,)]GU_NT VP
M
M
MX5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/_ .,F[^J5OX#V
M]K7R<PGV?7^[0#;
M
M                                                          #A
M7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_\ XR;OZI6_@/;V
MM?)S"?9]?[M -L
M
M                                                         .%>
MZ5^0N,^VX?N)0,ON;OD%<^V)ONHSN          '-.?+GW@>%N/_ .,F[^J5
MOX#V]K7R<PGV?7^[0#;
M
M
M  #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@        C=I=DH-6SK\9U>&MQ
M\[JZM^-VB,7IY 4^IH52I0JY#6,A;HWUB9)VDTLLT=KFG/E:CD4QZWF;&4WZ
MVVY0DIW:V#9%9@=WM1_;JO5&_P SV. \N<?_ ,9-W]4K?P'M[6ODYA/L^O\
M=H!M@
M
M                                               !PKW2OR%QGVW#
M]Q*!E]S=\@KGVQ-]U&=P         ,4^5Q-1_93Y&K"_Z))6L=_]%45_#GY!
M\J2U'X]U=O9*Q'+-VO->:J[GT]'(#PWQ_P#QDW?U2M_ >WM:^3F$^SZ_W: ;
M8
M
M                                            <*]TK\A<9]MP_<2@
M9?<W?(*Y]L3?=1G<        &CL<>4^#F99BG*E]U&;P54\_:]"]/(#FF)N\
M%J])D<K<-!.C4[=F18QMOK^?MNW\M7DGI*8=VP9>;6XECP+JD7-8VJRJ^WUK
MS6NG^'XZM \N<?\ \9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M                         '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W
M       _+CL;U,2T^JC_ )NT5O/_ "ZCXZ\E[X/[ZO@'@[.S5O5VW:\UY\_[
M/1R\P'AKC_\ C)N_JE;^ ]O:U\G,)]GU_NT VP
M
M
M                     X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
M -39ERJ:[F5Q2*M]*,W@O+S]KT+T@<PQ,'!26FQTRX.2?I3MW9-8UN=?S]MX
M3Y:.)72%PR;%EF:R]78)*D75V:JZJEOK7FE?_+X_2!Y;X_\ XR;OZI6_@/;V
MM?)S"?9]?[M -L
M
M                                                         .%>
MZ5^0N,^VX?N)0,ON;OD%<^V)ONHSN         !CN8[&V9$?8HUI7_EOB:Y?
M_P!9^PI?9D9(T@K-Q[:[>S<URI+VO->;5;RY(Q$ \,\?_P 9-W]4K?P'M[6O
MDYA/L^O]V@&V
M
M                                                       '"O=*
M_(7&?;</W$H&7W-WR"N?;$WW49W         O^')1M+12%;?8O[#MN?9]IR\
MGKZ>_IY@<_Q%SBCD<?#:?)@:KW<VR03T[+7L>Q>ER?UI;,'%MD<LWOS/BI(^
MA.S\$AEC=U?^I9'O \5<?_QDW?U2M_ >WM:^3F$^SZ_W: ;8
M
M
M                               <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=
M1G<        &'+9&#$XC(Y*9%6&G5EG>B>=S8FJY0*%)N&V8OP#WWP%>9V23
MHHPT)5<])U3J2&594:WS=ZO+3A5VV2::QFEHP1N8B0TZW5(L?Z7S.Y=3O[D
M\8<?_P 9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M               '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W        !BR^*
MJY/$7\=:5Z0VZTD$JL7D[ID;TKT@4BSP[@EDJ/EVK8GOK2=I JV8_P"C?T*S
MFGD?0XM.$UZ3$RS2.SF5O=;4;T6YFR-;^EO2UH'BGC_^,F[^J5OX#V]K7R<P
MGV?7^[0#;
M
M                                                    #A7NE?D+
MC/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X__C)N_JE;^ ]O:U\G,)]G
MU_NT VP
M
M                                                  X5[I7Y"XS[
M;A^XE R^YN^05S[8F^ZC.X           >%N/_XR;OZI6_@/;VM?)S"?9]?[
MM -L
M
M                                               .%>Z5^0N,^VX?
MN)0,ON;OD%<^V)ONHSN           'A;C_^,F[^J5OX#V]K7R<PGV?7^[0#
M;
M
M                                            #A7NE?D+C/MN'[B4
M#+[F[Y!7/MB;[J,[@        TMGR<^'UK-9&O$DDM2C/-&SYE=&Q7 4Z'&[
MWBJT.1K9_P!_%5B/GI3Q10I)^K2,1.A?H1QGU_:(<YM;DIV9?!FX=KI:ST5C
MX;"3JUS9&?,] /)O'_\ &3=_5*W\![>UKY.83[/K_=H!M@
M
M
M                            !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=
MP        )(XY6/CD8US'M5KFN3FBHOG14 _(HHH8HXHHVLC8U&L8U$:UK6]
MR(B)YD0KN?K5,3(W,4:L,5^U?QM2>=&)U20RVF1JUW^3@/'/'_\ &3=_5*W\
M![>UKY.83[/K_=H!M@
M
M
M!PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P        )9HH8I)97M9&QJN>]R\
MD:UO>JJH%$GXIX.):SH\7FYX+,B,KV647I#*Y?-T*_I)E;F*V[&,2E<<Q:V1
MJ2S,DB<R6-]69D_921OZ7-5W2!XXX_\ XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                                         .%>Z5^0N,^VX?N)0,ON
M;OD%<^V)ONHSN        #1S^'3,X'+8OM5B6Y3F@Z_R.T8K>8%&NINF=HU,
M+;UF.DU)ZSK-_P *B?"C:\C9%6!C?+YNZ>XN$>*M1[E9R;&,;6FQ44$CD7O?
M+'*YS>:?H:H'BWC_ /C)N_JE;^ ]O:U\G,)]GU_NT VP
M
M
M                           X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X
M       (C;;5S'ZGG[M/_J:^.L2P_H>QBJB@4&SI\]9VO0XG)Y9U+(OZ,M*E
MJ:19(TC69)NM7+V2O5O0JM+%@*:8+;;V%J6+#Z$F-CN,AFF?,L$G:+&J,=(J
MKTO \D\?_P 9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M                   '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W        !
M\W[=?'4+=RQS[&"%\LO)JO7H8G->34[U I<'$K6I(F2Q5LP]CVHYCV8NVK5:
MOT<HR=P>PX;-7++JE.Y'.V)J/EL49:RN8B]S>J5K>8'B_C_^,F[^J5OX#V]K
M7R<PGV?7^[0#;
M
M                                                        #A7N
ME?D+C/MN'[B4#+[F[Y!7/MB;[J,[@        _)'LC8][W-:QK55SE7DB(GG
M50*'B]PUNE3;7PF%S5FBU[W1R5:,TD'EN5Z]FYWG:6[!;-B<ZR?P.5Z2P.1)
MZ\T3X9HE=YNMDB(J >)>/_XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                               .%>Z5^0N,^VX?N)0,ON;OD%<^V)ON
MHSN        #2S^&7,8#+8SMNR6Y3F@23S]/:-5O,"L0;+M-""*O=T>Z^6-B
M,ZZ,U>2N[E\[>M\;FH;> I9JYL%S/Y/'LQ_72CJ05.T;+*K6O617S.9Y/S]R
M(!X_X_\ XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                 .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN        "+V
MFS?HZQF[5!G5;AH3R5TY<_Z1K%5H''+UC&TI,'1QVYWK%'*)'[ZRNM.L+'$Y
M4Y3I)S_H%E<O9E]UNK1Q.XY;$8J:1U!,;!/- Z9\S(+#WN;W*]5Y=;0/*''_
M /&3=_5*W\![>UKY.83[/K_=H!M@
M
M
M          !PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P        :&Q9-^#U[
M+Y5D"3/ITIIVQ\^2.6-JN JN;;#36GAL+@<.MG,1S2S]K&C*W8PHWK?*D:<Y
M.:O1$/O2F>\URYKT^&QM&=D+;C'X]JM@L1O=T*[D[O1[0/)G'_\ &3=_5*W\
M![>UKY.83[/K_=H!M@
M
M
M!PKW2OR%QGVW#]Q*!E]S=\@KGVQ-]U&=P        )XH9H)8IF-?$]CFR-=W
MM5JIR5% \_W)L7%;H+A=^R'98Y[VU7,Q4N22&-_<Z))HV\GQG3-+3%6Y+V8C
MV%V8O2-9!-,YB0]BQG>D20HB+&!Y*X__ (R;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                                          .%>Z5^0N,^VX?N)0,O
MN;OD%<^V)ONHSN        #3V;'2Y77<QCH9^QEMTIH&2?DND8K0*K3VZUCZ
MD%.WIF:@DAC;'T5:[;$'D_FWQN^*9]?@R60V:_GY\3+C8)*,56.&?H[>=6/5
M_:RM8KD;RY\F@>1>/_XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                           .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN
M       "/V2W>QVNYB[2A[6S7HS2P1\N?5(QBJT"HXK3-=S-""]-F\IE'RL:
M];:9*=C7*OSL9 ]C&F;6)74=HRN%K9>QD*,%*&;^GE[=]69[U;V2R^=>IJ<^
M3@/)W'_\9-W]4K?P'M[6ODYA/L^O]V@&V
M
M
M                '"O=*_(7&?;</W$H&7W-WR"N?;$WW49W        !\9&
M]4QF.MWK;^BO6A?-*[Z&1IU*!QZQJ=K-2NR$?#G 5TF\OE;M/BG?S^>1E>)S
M4<7C3;5:I)8P+M<@PUFO$V?L(%:^"6-Z]/:1O:C0/(7'_P#&3=_5*W\![>UK
MY.83[/K_ ': ;8
M
M                                                         <*]
MTK\A<9]MP_<2@9?<W?(*Y]L3?=1G<        #)XZKE,;=Q]IBN@M0/AE:B\
ME5DB=*@<:FW.]AY74&;WKEQ(/(Z[%:5\S?T2K7?TJI=-/A@NR6=@FV*KE[,\
M3:Z256HRO#&Q>OLF-1SE\Z]_4!Y'X_\ XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                                         .%>Z5^0N,^VX?N)0,ON
M;OD%<^V)ONHSN        #2V3'6[^N9FC1F[*S9I310R<^72][%1 *AC-TPN
M(H5J$^O9;&/AC:SP5F.FE8BI\S'P->QQ]ZVDEW:,KG(,38Q].>E#!RL1]A+:
ME8Y7=JL?G1&HO)%<!Y/X_P#XR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M                                .%>Z5^0N,^VX?N)0,ON;OD%<^V)O
MNHSN           'A;C_ /C)N_JE;^ ]O:U\G,)]GU_NT VP
M
M
M                               X5[I7Y"XS[;A^XE R^YN^05S[8F^Z
MC.X           >%N/\ ^,F[^J5OX#V]K7R<PGV?7^[0#;
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M:5W3V3;,:O5WT(!,@
M        <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=1G<           /"W'_ /&3
M=_5*W\![>UKY.83[/K_=H!M@
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M(VNS-E',CF_B:JN Z7Q7LSVN".ASSO5\KY**O>OZJ\;+PQUBIP=3.]A(_+^
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M:]W9/5K7+S+R
M   .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_^,F[^J5OX
M#V]K7R<PGV?7^[0#;
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MK(37IX8D26S*O-TK_.KE-\
M             <*]TK\A<9]MP_<2@9?<W?(*Y]L3?=1G<           /"W'
M_P#&3=_5*W\![>UKY.83[/K_ ': ;8
M                                                    #BN3]S[J
M4]Z>W1R.1QR2JO5% ]O07K2.'6N:/7G3&ME?//R2:Q,Y'2.1H%P
M
M         #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !X6X_P#X
MR;OZI6_@/;VM?)S"?9]?[M -L
M
M
M        .%>Z5^0N,^VX?N)0,ON;OD%<^V)ONHSN           'A;C_ /C)
MN_JE;^ ]O:U\G,)]GU_NT VP
M
M
M       X5[I7Y"XS[;A^XE R^YN^05S[8F^ZC.X           >%N/\ ^,F[
M^J5OX#V]K7R<PGV?7^[0#;
M
M
M     #A7NE?D+C/MN'[B4#+[F[Y!7/MB;[J,[@          !XN]T;B)ZNZ5
M+_0O87:+.E__ *X5Z7-/3'"[<,1LNIXQ*UIBVZM2*&W7\TD;XVHP"\@
M
M
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MC9''&Q&,8U.EK6M3DB(B>9$/T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
2                    #__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
